GUIDE GUIDE 2012 Annual to

To The To the Meeting 2012 MEETING ANNUAL

INTEGRATED CARE

! Program Book ! New Research ! Exhibits Guide

AMERICAN PSYCHIATRIC ASSOCIATION 165th ANNUAL MEETING • PHILADELPHIA, PA • MAY 5-9, 2012 Guide to This Book

This is for themain TOC. Keep on pasteboard with 2 points overlap into live area.

GUIDE TO THIS BOOK PROGRAM BOOK, NEW RESEARCH BOOK, EXHIBITS GUIDE

his book contains the Program Book, New Research Program Book, and Exhibits Guide. Located within Tthe Program Book you will find a topic index in addition to program tracks (color-coded) that will as- sist you in finding scientific sessions of interest. The individual program for each day of the meeting is also color-coded so that you can easily find the day(s) of the meeting that interest you. The program is listed by start time with the formats listed alphabetically under those times. To make it even easier to plan your day a separate Days-at-a-Glance has been included with your registra- tion materials. The New Research Program Book lists the titles of the Posters that will be presented at this meet- ing, organized numerically by session/day. There is a topic index for the Posters only at the end of the New Research Program Book. The Exhibits Guide contains a list of the exhibitors and a floor plan of the exhibit hall, along with information about the Product Theaters. If you have any questions about this book or the ­scientific program, please feel free to stop by the Scien- tific Programs Office, Room 307B, Level 3, Pennsylva- nia Convention Center and an APA staff person will be happy to assist you. All central office APA staff will be for GPTMC© J. Fusco wearing green badges. The Liberty Bell at the Liberty Bell Center.

Contents

Guide to This Book ...... 1 Daily Attendance Log ...... 82 Scientific Program Committee Photo ...... 10 Saturday’s Program ...... 85 Welcome Letter from APA President, John M. Sunday’s Program ...... 99 Oldham, M.D...... 10 Monday’s Program ...... 117 Welcome Letter from Scientific Program Chair, Tuesday’s Program ...... 137 Kenneth R. Silk, M.D...... 11 Wednesday’s Program ...... 157 General Information and Key Locations ...... 16 Topic Index ...... 167 Shuttle Bus Schedule ...... 24 New Research Program Book ...... 191 Hotel Locations and City Map ...... 25 Saturday’s Poster Sessions ...... 192 Floor Plans ...... 28 Sunday’s Poster Sessions ...... 197 Presidents of U.S. Allied Organizations ...... 39 Monday’s Poster Sessions ...... 203 Presidents of International Allied Organizations . . 40 Tuesday’s Poster Sessions ...... 211 Special Acknowledgements ...... 45 New Research Topic Index ...... 219 Disclosure Index ...... 54 Presenter Index ...... 271 Program Book ...... 79 Format Descriptions ...... 80

165th Annual Meeting 1 For the treatment of schizophrenia

Schizophrenia can LATUDA can help put your Visit booth tear patients apart patients back together 1033 to learn more

October 4-7

Pursuing Wellness Through Recovery and Integration Save the date now to attend the American This four-day event will feature more than 100 expertly- Psychiatric Association’s 64th Institute on led educational sessions on a variety of topics, popular Psychiatric Services, APA’s leading networking events, and exhibits that complement the educational program. Further informa tion can be found educational conference on clinical on the Web at www.psych.org/IPS. issues and community mental health to meet the service needs of people Who Should Attend? with severe mental illness. • All APA members, including early career and psychiatric residents (advance registration begins th June 4) 64 • International psychiatrists • Symptom improvement was established in 2 studies for each dose1 • Primary Care Physicians • The safety and tolerability of LATUDA were evaluated in multiple studies up to 52 weeks1 • The recommended starting dose, 40 mg/day, is an effective dose with no initial dose titration required. The maximum recommended dose • Mental health professionals from all disciplines is 80 mg/day1 — LATUDA should be taken with food (at least 350 calories) Why Should You Attend? — For patients with moderate and severe renal or hepatic impairment, the dose of LATUDA should not exceed 40 mg/day • To earn CME credit (CEs have also been applied for) — LATUDA should not be administered with strong CYP3A4 inhibitors such as ketoconazole or strong CYP3A4 inducers such as rifampin. • To improve patient care When coadministered with a moderate CYP3A4 inhibitor such as diltiazem, the dose of LATUDA should not exceed 40 mg/day APA’s Leading Educational INDICATIONS AND USAGE Conference on Public, Community, • To learn about clinically-focused topics that offer and Clinical LATUDA is an atypical antipsychotic agent indicated for the treatment of patients with schizophrenia. Efficacy was established in four 6-week speci– c skill sets controlled studies of adult patients with schizophrenia. The effectiveness of LATUDA for longer-term use, that is, for more than 6 weeks, has not For more information, please contact: • To network with colleagues and obtain solutions for been established in controlled studies. Therefore, the physician who elects to use LATUDA for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient. American Psychiatric Association the challenges you face IMPORTANT SAFETY INFORMATION FOR LATUDA 1000 Wilson Blvd., Suite 1825 • Because your return on investment will reap both Arlington, VA 22209-3901 personal and professional rewards WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED Phone: 1-888-35-PSYCH or (703) 907-7300 Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Analyses of 17 placebo-controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of Fax: (703) 907-1090 The IPS Has Gone “GREEN” death in drug-treated patients of between 1.6 to 1.7 times the risk of death in placebo-treated patients. Over the course of a typical E-mail: [email protected] The Preliminary Program, which will include 10-week controlled trial, the rate of death in drug-treated patients was about 4.5%, compared to a rate of about 2.6% in the placebo group. Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g., heart failure, sudden Web: www.psych.org/IPS registration, housing, travel, and detailed program death) or infectious (e.g., pneumonia) in nature. LATUDA is not approved for the treatment of patients with dementia-related psychosis. information, will be available later this Spring, online only, at www.psych.org/IPS. Please see additional Important Safety Information, including Boxed Warning, and Brief Summary of Prescribing Information on adjacent pages. The American Psychiatric Association is accredited by the Accreditation Council for Continuing Medical Education Drexel University College of Medicine/ (ACCME) to provide continuing medical education for Behavioral Healthcare Education physicians. LATUDA and are registered trademarks of Dainippon Sumitomo Pharma Co., Ltd. Sunovion Pharmaceuticals Inc. is a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd. American Psychiatric Associa tion ©2012 Sunovion Pharmaceuticals Inc. All rights reserved. 3/12 LAT184-12

2 www.psychiatry.org

127-31307

CLIENT NAME: Abelson Taylor OPERATOR: BT FILE NAME: VW645_a01.indd QC Check Bleed: 8.375" x 11.125" JOB#: VW645 ROUND: 1 Trim: 8.125" x 10.875" DESC: Latuda DATE: 03/30/2012 ______Live: 7" x 10" ______

______Scientific Program Committee Photo Welcome Letter from APA President, John M. Oldham, M.D. This is for the main TOC. Keep on pasteboard with 2 points overlap into live area.

2012 SCIENTIFIC PROGRAM COMMITTEE

First Row – Seated Left to Right: Patricia I. Ordorica, M.D., Catherine C. Crone, M.D., Michael F. Myers, M.D. (Co- Chairperson), Kenneth R. Silk, M.D. (Chairperson), John M. Oldham, M.D. (APA President), Annette M. Matthews, M.D., Michele T. Pato, M.D. Second Row – Standing Left to Right: Stephen M. Goldfinger, M.D., Radu V. Saveanu, M.D., Kelli J. K. Harding, M.D., Lucy A. Hutner, M.D., Edmond H. T. Pi, M.D., James H. Scully Jr., M.D. (APA Medical Director and CEO), David M. McDowell, M.D., Francis R. Levin, M.D., Charles S. Price, M.D., Jair C. Soares, M.D., Nyapati R. Rao, M.D., Josepha A. Cheong, M.D. Not Pictured: Barton J. Blinder, M.D., Donald M. Hilty, M.D., Julio Licinio, M.D., Robert M. McCarron, D.O., Adelaide S. Robb, M.D., Joel J. Silverman, M.D., Madhukar H. Trivedi, M.D., Jesse H. Wright III, M.D.

Dear Colleagues and Guests:

elcome to the 165th Annual Meeting of the American in primary and psychiatric care. The NIAAA Plenary Lecture Psychiatric Association in historic Philadelphia, the will be presented by Bankole Johnson, DSc., M.D., Ph.D., W“City of Brotherly Love.” M.Phil., Chair, Department of Psychiatry and Neurobehavioral The meeting offers hundreds of sessions to learn the lat- Sciences at the University of Virginia. John Krystal, M.D., est science, clinical advances, and promising practices from Chair, Department of Psychiatry at Yale-New Haven among the best in the field, as well as numerous networking Hospital and Director, NIAAA Center for the Translational and social opportunities. The meeting also includes more than Neuroscience of Alcoholism, will deliver a Frontiers of Science 50 courses and 5 master courses on such topics as practical Lecture as part of the NIAAA track. cognitive behavior therapy, essential , Other special tracks include the DSM-5, Ethics, and the and child psychopharmacology. military. Look for symbols throughout the Program Book to The Opening Session on Sunday, May 6 will feature a unique help you find sessions in a variety of topical tracks that may event with two masters of , Aaron T. Beck, M.D. relate to your interests. and Glen O. Gabbard, M.D., who will discuss in conversational Special guest lecturers include Kay Redfield Jamison, format the commonalities and differences between cognitive Ph.D., psychiatry professor at Johns Hopkins Medicine and therapy and psychodynamic therapy. Another highlight is the author of An Unquiet Mind; and Sherwin B. Nuland, M.D., Convocation of Fellows, which will be on Monday evening. We ­author of several books including The Art of Aging: A Doctor’s are honored to have as the speaker Edward Kennedy, Jr., presi- Prescription for Well-Being. dent of Marwood Group & Co., a healthcare-focused financial FocusLive, Advances in Medicine, and Advances in Research all services firm. Mr. Kennedy is also an active advocate for the return by popular demand. The always popular MindGames, needs of persons with disabilities. APA’s national Jeopardy-like competition for residents, will The theme of this year’s meeting is Integrated Care — take place on Tuesday at 6:30 in the evening to allow more ­psychiatrists working collaboratively with primary care physi- people an opportunity to attend. cians and other health care professionals to coordinate quality Many thanks go out to the Scientific Program Committee patient care. Numerous sessions will be addressing integrated for its outstanding work under the leadership of chair Kenneth care issues, including a Presidential Symposium on New Ap- R. Silk, M.D., and vice chair Michael F. Myers, M.D. and to the proaches to Integration of Mental Health and Medical Health APA staff members who have worked so persistently to develop Services chaired by Wayne J. Katon, M.D., and Jurgen Unut- an outstanding program at the 2012 Annual Meeting. zer, M.D., M.P.H.; a symposium on Integrated Psychiatry Pri- Exceptional educational and networking opportunities mary Care Services chaired by Britta Ostermeyer, M.D.; and await you at our 165th Annual APA meeting. Have a wonderful, a workshop on Integrating Psychiatric and General Medical enlightening week! Care: Military and Civilian Models, chaired by Sheila Hafter- Gray, M.D. Sincerely, We are delighted to partner once again with the National Institute on Alcohol Abuse and Alcoholism (NIAAA) to highlight advances in treating co-occurring disorders, the use of technology and medication, and integrating treatment John M. Oldham, M.D. 10 www.psychiatry.org Welcome Letter from Scientific Program Chair, Kenneth R. Silk, M.D.

This is for the main TOC. Keep on pasteboard with 2 points overlap into live area.

Dear APA Members and Guests:

elcome to Philadelphia and to the 165th Annual Meeting of the American Psychiatric Association. WIt’s hard to believe that a full decade has gone by since our last meeting in Philadelphia. This historic city, known as the birthplace of this nation, the first capital of the was also the birthplace of the APA (then known as The Association of Medical Su- perintendents of American Institutions for the Insane). This is a true homecoming for the APA,, and Philly’s vibrant and culturally diverse environment provides a wonderful setting for the scientific presentations we have planned. As always, APA members will not want to miss two activities on Sunday: the Business Meeting (12:30 p.m.–1:30 p.m.) and the Opening Session (4:30 p.m.– © by B. Krist for GPTMC 6:45 p.m.). We are instituting a new structure to the Philadelphia skyline at night Opening Session. Not only will it contain the formali- ties of Opening Sessions of the past, but this year it will also contain “Cognitive Therapy and Psychodynamic CME Scientific Program and are open to all registrants Therapy: More Alike than Different? -- A Conversation at no additional fee. Between Aaron Beck and Glen Gabbard,” moderated For the second year, we are pleased to recognize the by our President, John Oldham. Please also make sure work of psychiatry residents in the Resident Poster Com- to attend the Convocation of Distinguished Fellows on petition sponsored by the APA Division of Education. Monday beginning at 5:30 p.m., which recognizes newly The editors of the journal Academic Psychiatry will select inducted fellows and distinguished fellows and hon- the winning posters in each of four categories: Commu- ors this year’s award recipients. Ted Kennedy, Jr., will nity Service; Curriculum Development and Educational; ­deliver the convocation address. Patient-Oriented & Epidemiology; and Psychosocial and/ This year the Scientific Program Committee (SPC) or Biomedical Research. These posters will be presented collaborated with APA President, Dr. John Oldham, to in two sessions on Saturday. Note also that the New Re- plan an exciting and eventful program reflecting his search poster sessions on Sunday will be devoted to the theme, Integrated Care. Once again, several work of Young Investigators as well. societies, other allied psychiatric organizations, APA We encourage all attendees to either fill out an components, and the National Institute on Alcohol evaluation here or to do so online following the meet- Abuse and Alcoholism, will present on the latest devel- ing as you reflect on your experiences. Your feedback opments and best practices in their areas. We also are on the relevance and quality of this year’s program to fortunate to partner with the Philadelphia-based Scat- your practice needs as well as your insights into gaps in tergood Foundation. The Foundation has a number of knowledge and clinical practice are taken seriously. They initiatives related to psychiatric, mental, and behavioral are carefully reviewed by the Scientific Program Com- healthcare ethics that have been organized throughout mittee and are essential in helping us meet your needs the meeting into a track. Hopefully, this is the begin- as we plan future meetings. ning of a strong and ongoing relationship between The Once again, welcome to Philadelphia. We are de- Scattergood Foundation and the APA. lighted to have the privilege of sharing with you the The Scientific Program Committee selected sessions best that our field has to offer. I have appreciated the covering a broad spectrum of approaches to teaching wonderful opportunity to work with the fine and hard- and learning: symposia, workshops and other small in- working members of the Scientific Program Committee teractive sessions (such as Meet the Authors), lectures, and the APA Staff who never said “no” and repeatedly case conferences, medical updates and forums. This year tried to make everything that the committee deemed we are continuing and expanding the recently piloted important come to realization in this meeting. seminar format which offers an extended (4- or 6-hour) Enjoy! learning experience to cover topics in a more interac- tive style than the traditional symposium and in greater Sincerely, depth than a workshop. Also back are the “Night at the Movies” evening media workshops (7 p.m.–10 p.m.) which offer thoughtfully selected films accompanied by stimulating analyses and discussions. All are part of the Kenneth R. Silk

165th Annual Meeting 11 General Information and Key Locations This is for the main TOC. Keep on pasteboard with 2 points overlap into live area.

2012 ANNUAL MEETING GENERAL INFORMATION

Key Locations in the Pennsylvania Drive and mobile streaming. Additional CME available. Convention Center Sales booths are located in the Arch Street Concourse, Annual Meeting on Demand Sales . . . . . Level 1 and Exhibit Halls C–E, Level 2, Pennsylvania Arch Street Concourse, Level 1 and Exhibit Convention Center from Saturday–Tuesday, 7:30 a.m.– Halls C–E, Level 2 5:00 p.m. and Wednesday, 7:30 a.m.–1:00 p.m. APA Alliance . . . . . Arch Street Concourse, Level 1 APA Art Association Exhibit APA Art Association . . Arch Street Concourse, Level 1 Located in the Arch Street Concourse, Level 1, Pennsyl- APA Job Bank and vania Convention Center. The days and hours of opera- Placement Center . . . . .Exhibit Halls C–E, Level 2 tion are as follows: Sunday, 10:00 a.m.–4:00 p.m., Mon- day–Tuesday, 10:00 a.m.–5:00 p.m., and Wednesday, APA Member Center ...... Exhibit Halls C–E, Level 2 10:00 a.m.–2:00 p.m. This exhibit includes paintings, APA News Room ...... Rooms 105A/B, Level 1 photography, ceramics, and crafts created by APA mem- APA Periodicals ...... Exhibit Halls C–E, Level 2 bers and/or their significant others. Stop by for infor- mation on joining the APA Art Association. Audiovisual Preview Room . . . . Room 310, Level 3 APA Job Central CME Certificate of Attendance and Evaluation . Exhibit Halls C–E, Level 2 Visit APA Job Central, located in Exhibit Halls C–E, Level Course Enrollment . . . . .Exhibit Halls C–E, Level 2 2, Pennsylvania Convention Center, to search the most comprehensive online listing of psychiatric positions! Daily Bulletin ...... Room 300, Level 3 The days and hours of operation are as follows: Saturday, Exhibitor Registration . . .Exhibit Halls C–E, Level 2 9:00 a.m.–4:00 p.m.; Sunday–Tuesday, 10:00 a.m.–4:00 Exhibits/ p.m. Candidates: Register to post your resumé, receive Publishers’ Book Fair . . . Exhibit Halls C–E, Level 2 instant job alerts, use the career tools and more. Em- ployers: Post your job opening during the meeting to get First Aid ...... New Hall D, Level 1 results as soon as possible. For more information on the Housing Desk . . . . .Arch Street Concourse, Level 1 Job Central, visit www.jobs.psychiatry.org. A representa- Lost and Found ...... Room 304, Level 3 tive will be available on-site to provide assistance. Meetings and Conventions Office . Room 304, Level 3 APA Member Center Message Centers ...... Located in Exhibit Halls C–E, Level 2, Pennsylvania Arch Street Concourse, Convention Center. The days and hours of operation Level 1 and Exhibit Halls C–E, Level 2 are as follows: Saturday, 9:00 a.m.–4:00 p.m.; Sunday– Registration ...... Exhibit Halls C–E, Level 2 Tuesday, 10:00 a.m.–4:00 p.m. The Member Center closes at 4:00 p.m. on Tuesday. A few of the many Scientific Programs Office . . . . Room 307B, Level 3 APA activities exhibited include: Membership; APA’s In- Shuttle Bus Desk ...... Arch Street Concourse, Level 1 ternet-Based Programs; Continuing Medical Education; Quality Improvement; Psychiatric Services; Clinical Re- APA Alliance Booth sources; Advocacy Tools; Career Development; Practice Management; and APA Periodicals. Located in the Arch Street Concourse, Level 1, Pennsyl- APA News Room and Communications vania Convention Center. The days and hours of opera- Office tion are as follows: Saturday, 9:00 a.m.–5:00 p.m., Sun- day, 9:00 a.m.–4:00 p.m., Monday, 9:00 a.m.–12 noon, Located in Rooms 105A/B, Level 1, Pennsylvania Conven- and Tuesday, 9:00 a.m.–5:00 p.m. Stop by the booth to tion Center. The days and hours of operation are as fol- obtain information on the Alliance’s program schedule lows: Saturday–Wednesday, 8:00 a.m.–5:00 p.m. These and information on membership. rooms are for the use of registered press and cre- dentialed public relations representatives only. APA Annual Meeting on Demand Sales APA Periodicals APA Annual Meeting on Demand includes over 300 hours of educational content from the Annual Meet- Staff from the American Journal of Psychiatry, Psychiatric ing. Content is available online within 24 hours, on USB Services, Academic Psychiatry, Journal of

16 www.psychiatry.org and Clinical Neurosciences, and APA’s CME journal, Focus, psychotherapeutic and pharmacological options; and will be on hand to demonstrate online access for sub- 5. Recognize mental health service delivery issues, scribers, and answer questions regarding submissions. ­including barriers to care. Visitors can also purchase or renew subscriptions to The APA is accredited by the Accreditation Council all APA/APP journals at the APP booth, located in the for Continuing Medical Education (ACCME) to provide Exhibit Hall. Complimentary copies of Psychiatric News continuing medical education for physicians. will be available at stands located throughout the Penn- The APA designates this live activity for a maximum sylvania Convention Center. Persons who wish to con- of 50 AMA PRA Category 1 Credits™. Physicians should tact editors or reporters of Psychiatric News are asked to only claim credit commensurate with the extent of their leave a message on the message board in the Meetings participation in the activity. and Conventions Office, located in Room 304, Level 3, Please note: Formats on the scientific program, as Pennsylvania Convention Center. Written announce- outlined below, have been approved for CME credit. ments, suggestions for articles, letters to the editor, or The scientific sessions on the official Annual -Meet other material for the newspaper’s consideration may ing program, with some exceptions, meet the criteria be left with staff at the Periodicals Exhibit in the APA for AMA PRA Category 1 Credit™. Sessions in the fol- Member Center, located in Exhibit Halls C–E, Level 2, lowing program formats are designated as category Pennsylvania Convention Center. 1: ­Advances in… Series; Case Conferences; CME Courses; Focus­ Live; Forums; Lectures; Master Audiovisual Preview Room Courses; Presidential Symposia; Scientific and Located in Room 310, Level 3, Pennsylvania Convention Clinical Reports; Seminars; Small Interactive Center. The days and hours of operation are as follows: Sessions­ ; Symposia; and Workshops. Saturday–Wednesday, 7:00 a.m.–5:00 p.m. The Scien- New Research Poster Sessions are NOT desig- tific Program Committee expects all presenters to pre- nated for AMA PRA Category 1 Credit™. Located in view their audiovisual materials prior to their sessions Exhibit Hall C, Level 2, Pennsylvania Convention to familiarize themselves with the equipment. For your Center. convenience, an audiovisual technician will be available Scientific sessions are open to all Annual Meeting to assist you and answer your questions. registrants with the exception of Case Conferences, which are open to APA members only. CME Courses and CME Certificate of Attendance and Master Courses require an additional fee. Evaluation To document CME credit earned at the Annual The Scientific Program Committee needs your feedback Meeting, participants should maintain a list of sessions to assess the effectiveness of the program and to help they attended. Credit is earned on an hour-for-hour plan next year’s Annual Meeting. ­basis. A daily attendance log is provided in this book for The general evaluation and certificate can be listing your sessions and credits. ­obtained by visiting the CME Certificate of Attendance Course Enrollment booth located in the Exhibit Halls C–E, Level 2, or via the web at www.psych.org/annualmeetingcme both dur- Ticket Purchase Is Required For All Courses. ing and after the meeting until August 10, 2012. You Located in Exhibit Halls C–E, Level 2, Pennsylvania will need your badge number to access the evaluation Convention Center. The days and hours of operation are and obtain your certificate. the same as registration. Course tickets not sold in ad- Certificate of attendance booth hours and location: vance will be available on-site at the Course Enrollment Exhibit Halls C–E, Level 2 Area beginning at 12 noon on Friday. You must be regis- Saturday, 12:00 p.m–5:00 p.m. tered for the meeting before you can enroll in courses. Sunday–Wednesday, 7:30 a.m–5:00 p.m. Daily Bulletin Continuing Medical Education Located in Room 300, Level 3, Pennsylvania Convention Educational Objectives Center, the Daily Bulletin accepts written requests from At the conclusion of this meeting the participant will be APA members for publicity of component, committee, able to: and allied group events as space allows. Four issues are 1. Review new research findings in the fields of psychia- published. The issue for Saturday/Sunday is printed in try and neuroscience and address gaps in knowledge; advance. Copy for the Monday, Tuesday and Wednesday 2. Acquire new knowledge and skills in clinical psychia- issues can be dropped off in Room 300 by 12 noon the day try, which can be utilized to improve patient care; before the publication date. 3. Identify and remove barriers to the transfer of new Exhibitor Registration knowledge for your practice, including provision of culturally competent care for diverse populations; Located in Hall C-E, Level 2, Pennsylvania Convention 4. Assess a variety of treatment choices, including Center. The days and hours of operation are as follows:

165th Annual Meeting 17 GENERAL INFORMATION

Friday, 8:00 a.m.–6:00 p.m.; and Saturday–Tuesday, Registration 7:30 a.m.–5:00 p.m. Registered exhibitors will receive Admission To All Sessions Is By Registration Badge red badges that will permit access only to his/her exhibit Only. booth in the Exhibit Hall and to ride the APA shuttle bus. Located in Exhibit Halls C–E, Level 2, Pennsylvania If an exhibitor wants to attend sessions, he/she must Convention Center. The days and hours of operation are register for the meeting and pay the appropriate fee. as follows: Friday, 11:00 a.m.–6:00 p.m. (11:00 a.m.–12 Exhibits/Publishers’ Book Fair/Career noon is for members only); Saturday–Tuesday, 7:30 Fair/International Pavilion a.m.–5:00 p.m.; and Wednesday, 7:30 a.m.–1:00 p.m. The registration fee covers admission to all sessions Commercial and educational exhibits will be located in ­(except courses), shuttle buses, and includes a badge Exhibit Halls C–E, Level 2, Pennsylvania Convention and copy of Annual Meeting Guide and for most catego- Center, along with the Publishers’ Book Fair, Career Fair, ries, the Syllabus. Registration badges are required for and International Pavilion. For your convenience, the all sessions and the Exhibit Hall. Only an APA member Publishers’ Book Fair, Career Fair, and International Pa- badge will admit you to the Business Meeting. vilion will be open on Saturday, from 9:00 a.m.–4:00 p.m. Badge Color Codes: Educational and commercial exhibit hours are as follows: Blue = Members Sunday–Tuesday, 10:00 a.m.–4:00 p.m. All exhibits in Yellow = Nonmembers the exhibit hall close at 4:00 p.m. on Tuesday. Silver = Press First Aid Red = Exhibitors Green = APA Staff Located in New Hall D, (outside of Exhibit Hall B), Level Clear = Temporary Personnel 2, Pennsylvania Convention Center, the hours of opera- tion are as follows: Monday, May 17–Wednesday, May Scientific Programs Office 26. First aid opens 30 minutes prior to the show opening Located in Room 307B, Level 3, Pennsylvania Con- and closes 30 minutes after the last event of the evening. vention Center. The days and hours of operation are Lost and Found as follows: Friday, 12 noon–3:00 p.m.; and Saturday– Wednesday, 7:30 a.m.–5:00 p.m. Come to this office if Located in Room 304, Level 3, Pennsylvania Convention you have questions about: Center. The days and hours of operation are listed under 1. Scientific sessions listed in the Program Book or Meetings and Conventions Office. Syllabus Meetings and Conventions Office 2. Adding audiovisual equipment to scientific sessions 3. Scientific program changes Located in Room 304, Level 3, Pennsylvania Convention 4. Submitting a scientific session for the 2013 Annual Center. The days and hours of operation are as follows: Meeting Friday, 8:30 a.m.–5:00 p.m.; Saturday, 6:30 a.m.–5:30 5. The 2012 Institute on Psychiatric Services p.m.; Sunday–Wednesday, 7:00 a.m.–5:30 p.m. The staff located in the Meetings and Conventions Office is in Scientific Session Capacity Guidelines charge of the logistics for the meeting. Lost and found If overcrowding occurs in a scientific session we ask your is also located in this office. assistance so that all in attendance can benefit. Please abide Message Centers by the following guidelines if you are in a crowded room. 1. Take a seat as close to the front of the room as Located in the Arch Street Concourse, Level 1 and Exhib- possible it Halls C–E, Level 2, Pennsylvania Convention Center. 2. Move to the center of the row and fill all seats, so The days and hours of operation are as follows: Friday- that chairs are available on the aisles for additional Wednesday, 7:30 a.m.–5:00 p.m. Messages can be left attendees and retrieved at any of the Message Centers. Registrants 3. Don’t stand or sit in the aisles or lean against walls. whose names appear on these monitors should pick up Overcrowding of meeting rooms may subject the ses- their message at one of the two Message Centers. sion to shut down by the Fire Marshall; therefore, Promotional Programs please either find a seat or attend another session Located in the rear of Exhibit Halls C–E, Level 2, there Shuttle Bus Service will be nine, 30- or 60-minute promotional product You must be a registered attendee or a registered exhibi- presentation sessions available–10:00 a.m., 12:00 a.m., tor to ride on the courtesy shuttle bus. Shuttle bus ser- and 2:00 p.m. on Sunday, Monday, and Tuesday, with vice will begin on Saturday, at approximately 7:00 a.m., a ­capacity of 250 with boxed snack or lunch (seating is and will operate daily throughout the meeting com- first-come, first-served.) mensurate with the scientific program schedule and will

18 www.psychiatry.org conclude on Wednesday, at 5:30 p.m. The Pennsylvania Future APA Meetings Convention Center will serve as the “hub” for all shuttle APA Annual Meetings bus routes. The Shuttle Bus Desk is located in the Arch Street Concourse, Level 1, Pennsylvania Convention May 18-22, 2013 San Francisco, CA Center. A detailed shuttle bus schedule will be available May 3-7, 2014 New York, NY on site and will be posted in the lobbies of participating May 16-20, 2015 Toronto, Canada hotels. Institutes on Psychiatric Services Smoking Policy October 4-7, 2012 New York, NY There is no smoking allowed anywhere in the Pennsylva- October 10-13, 2013 Philadelphia, PA nia Convention Center. Oct. 30-Nov. 2, 2014 San Francisco, CA Tape Recording and Visual Reproduction October 8-11, 2015 New York, NY Policies The Preliminary Program for the 2012 Institute on Audio recording is only permitted for personal use. At- Psychiatric Services, which includes registration, hous- tendees are welcome to use their own small, portable ing, air travel, and program information is available on devices to record any session except Case Conferences, the web at www.psych.org/IPS. unless prohibited by the presenters. Larger, professional recorders are not permitted except for use by registered members of the working press in accordance with APA Press Policies. APA has authorized a professional firm to record sessions. Badges of personnel representing this firm will clearly identify them. Attendees are not per- mitted to photograph (including with cell phone cam- eras) or video any session because the intrusive nature of the recording may disrupt the session.

165th Annual Meeting 19

Shuttle Bus Schedule This is for the main TOC. Keep on pasteboard with 2 points overlap into live area.

2012 ANNUAL MEETINGAmerican Psychiatric Association SHUTTLE SERVICE TOSHUTTLE THE PENNSYLVANIA BUS ROUTES CONVENTION CENTER Shuttle Schedule The Pennsylvania Convention Center will operate as the “hub” of the APA shuttle bus system. All routes will begin and end there. The shuttle will operate during the following days and times.

Hours of Operation Saturday, May 5, 2012 7:00 a.m. – 5:45 p.m. Sunday, May 6, 2012 7:00 a.m. – 7:30 p.m. Monday, May 7, 2012 7:00 a.m. – 7:00 p.m. Tuesday, May 8, 2012 7:00 a.m. – 5:30 p.m. Wednesday, May 9, 2012 7:00 a.m. – 5:30 p.m.

Walking distance hotels, not on shuttle route: Courtyard by Marriott Philadelphia Downtown Le Meridien Philadelphia Four Points by Sheraton Philadelphia City Center Loews Philadelphia Hotel Hampton Inn Pennsylvania Convention Center Philadelphia Marriott Downtown Hilton Garden Inn Philadelphia Center City Residence Inn by Marriott Philadelphia Center City

Route 1 – Blue Holiday Inn Express Philadelphia Midtown Corner of 13th and Walnut Streets Radisson Plaza-Warwick Hotel Philadelphia Curbside on 17th Street Doubletree by Hilton Hotel Philadelphia Center City Front Entrance Hyatt at The Bellevue At Doubletree Hotel Philadelphia

Route 2 – Red Ritz-Carlton Philadelphia Curbside on Penn Square Crowne Plaza Philadelphia Downtown Front Entrance Westin Philadelphia Across the Street on 17th Street Sofitel Philadelphia At Westin Philadelphia

Route 3 – Green Embassy Suites Philadelphia Center City Front Entrance Four Seasons Hotel Philadelphia At Embassy Suites Center City Windsor Suites Philadelphia At Embassy Suites Center City Sheraton Philadelphia Downtown Hotel At 17th and Race Streets

Route 4 – Orange Hyatt Regency Philadelphia at Penn’s Landing Front Entrance Sheraton Society Hill Curbside on Dock

Route 5 – Purple Holiday Inn Philadelphia Historic District Curbside on 4th Street Omni Hotel at Independence Park Curbside on 4th Street

Route 6 – Tan Sheraton Philadelphia University City Hotel Curbside on 36th Street

Route 7 – Pink Aloft Philadelphia Airport Front Entrance Four Points by Sheraton Philadelphia Airport Front Entrance Sheraton Suites Philadelphia Airport At Four Points by Sheraton

Shuttle information signs will be posted in the lobby of each shuttle hotel. Check the sign in your hotel lobby for additional information and changes. For questions regarding the shuttle or to make an advance reservation for a wheelchair accessible shuttle, please see the shuttle supervisor at the Arch Street entrance to the Pennsylvania Convention Center during shuttle hours.

24 www.psychiatry.orgAPA 165TH ANNUAL MEETING • INTEGRATED CARE • PHILADELPHIA, PA • MAY 5-9, 2012 39 Hotel Locations and City Map This is for the main TOC. Keep on pasteboard with 2 points overlap into live area.

HOTEL LOCATIONS AND CITY MAP

12 BLVD COLUMBUS CHRISTOPHER FRONT ST. FRONT DOCK ST.

HOTEL MAP 21

ELFRETH'S ALLEY ELFRETH'S 2ND ST. 2ND

DOWNTOWN ST. 3RD

1. Courtyard by Marriott Phila- delphia Downtown ST. 4TH 2. Crowne Plaza Philadelphia ia Downtown 10 Downtown 15 CHERRY S T. CHERRY LOCUST ST. LOCUST

3. Doubletree by Hilton Hotel ST. 5TH

Philadelphia Center City 4. Embassy Suites Philadelphia ST. 6TH Center City SQUARE

5. Four Points by Sheraton Phila- FRANKLIN SQUARE

delphia City Center ST. 7TH WASHINGTON

6. Four Seasons Hotel Philadel- Sheraton Philadelph 20. Sheraton Hotel Hill Society 21. Hotel City SheratonUniversity Philadelphia 22. Sofitel Philadelphia 23. Philadelphia Westin 24. Windsor Suites Philadelphia 25. AIRPORT Airport Philadelphia Aloft 26. Airport Sheraton by Philadelphia Points Four 27. Airport Sheraton Philadelphia Suites 28. 8TH ST. 8TH phia RT. 676 RT. PINE ST. VINE ST. RACE ST. VINE ST.

7. Hampton Inn Pennsylvania ARCH ST. FILBERT S T. FILBERT SPRUCE ST. WALNUT S T. WALNUT SANSOM ST. LOCUST S T. LOCUST MARKET ST. MARKET CHESTNUT S T. CHESTNUT

Convention Center ST. 9TH

8. Hilton Garden Inn Philadelphia Center City ST. 10TH 9. Holiday Inn Express Philadel-

phia Midtown 8

10. Holiday Inn Philadelphia His- ST. 11TH toric District

11. Hyatt at The Bellevue ST. 12TH 5

12. Hyatt Regency Philadelphia at 14

Penn’s Landing 16

CENTER 13TH ST. 13TH CONVENTION

13. Le Meridien Philadelphia PENNSYLVANIA 1 18 7 14. Loews Philadelphia Hotel 9

15. Omni Hotel at Independence 3 BROAD ST BROAD Park . 11 19

16. Philadelphia Marriott Down- 13

town ST. 15TH 17. Radisson Plaza-Warwick Hotel 0. Holiday Inn Philadelphia Historic District 0.

1 Bellevue The Hyatt at 11. Landing at Philadelphia Penn's Hyatt Regency 12. Le Meridien Philadelphia 13. Hotel Philadelphia Loews 14. at Hotel Park Omni Independence 15. Philadelphia Marriott Downtown 16. Hotel RadissonPhiladelphia Plaza-Warwick 17. Residence Inn by Marriott Philadelphia Center City 18. Ritz-Carlton Philadelphia 19. Philadelphia ST. 16TH 18. Residence Inn by Marriott

20 25 ST. 17TH

Philadelphia Center City 24 17

19. Ritz-Carlton Philadelphia 23 4 20. Sheraton Philadelphia Down- ST. 18TH 6 town 2 SQUARE

21. Sheraton Society Hill Hotel ST. CHERRY RITTENHOUSE ST. 19TH LOGAN 22. Sheraton Philadelphia Univer- SQUARE dtown

sity City Hotel VINE ST. 23. Sofitel Philadelphia ST. 20TH 24. Westin Philadelphia ALNUT ST. ALNUT ARCH ST. JFK BLVD. LOCUST ST. LOCUST W

PINE ST. SPRUCE ST. SANSOM ST. WINTER ST. MARKET ST. MARKET

25. Windsor Suites Philadelphia LUDLOW ST. CHESTNUT ST. CHESTNUT 21ST ST. 21ST

AIRPORT THE BENJAMIN FRANKLIN PARKWAY

26. Aloft Philadelphia Airport 676 RT. 27. Four Points by Sheraton Phila- ST. 22ND

delphia Airport ST. 33RD 23RD ST. 23RD

28. Sheraton Suites Philadelphia AIRPORT MARKET ST. MARKET CHESTNUT ST. CHESTNUT ST. WALNUT

Airport ST. 34TH

24TH ST. 24TH 25TH ST. 25TH

3. Doubletree by Hilton Hotel Philadelphia Center City Center Philadelphia Hotel Hilton by Doubletree 3. Embassy Suites Philadelphia Center City 4. Center SheratonCity by Philadelphia Points Four 5. Philadelphia Hotel Seasons Four 6. Center Convention Pennsylvania Inn Hampton 7. City Center Philadelphia Inn Garden Hilton 8. Holiday Inn Express Philadelphia Mi 9. 2. Crowne Plaza Philadelphia Downtown2. DOWNTOWN Downtown Courtyard Philadelphia Marriott by 1.

26 22 35TH ST. 35TH 28

UNIVERSITY CITY

27 36TH ST. 36TH

APA 165TH ANNUAL MEETING • INTEGRATED CARE • PHILADELPHIA, PA • MAY 5-9, 2012 38

165th Annual Meeting 25 Floor Plans This is for the main TOC. Keep on pasteboard with 2 points overlap into live area.

FLOOR PLANS / PENNSYLVANIA CONVENTION CENTER [ KEY Back of House Entrances C Concession Stand World Premiere 2011 Exhibit Halls D Dressing Rooms Meeting Rooms E Elevator The Pennsylvania Ballrooms FE Freight Elevator Shops F Fire Hose Conne Public Areas R Restrooms ConvenTion CenTer Stair, Elevator, Escalator T Ticket Offices original & exPansion FloorPlans Loading Dock Columns House Storage Telephone [ Offices Water Fountain

Terrace Ballroom

OVERLOOK TO EXHIBIT HALLS

Ballroom

OVERLOOK TO GRAND HALL

Exhibit Hall A Exhibit Hall B Exhibit Hall C Reading Terminal Exhibit Hall D Headhouse Exhibit Hall E Grand Hall

11th Street

Race Street Exhibit Hall F 12th Street

Reading 13th Street Reading Terminal Headhouse Exhibit Terminal Market Philadelphia Marriott Hall G SEPTA Market Street East Arch Street Public Transit Station

Broad Street Atrium Filbert Street The Gallery Shopping Center

Broad Street

Market Street

28 www.psychiatry.org FLOOR PLANS / PENNSYLVANIA CONVENTION CENTER

11th Street S R RR R RR F F

DRIVE-IN RAMP SE C SE F F R Exhibit Hall F RR 10 Loading Docks R E FE Reading Terminal Market T Reading Terminal Headhouse • Philadelphia Marriott • SEPTA Market East Public Transit Station • The Gallery Shopping Center S F F T Filbert Street Market Street FE

TAXI LANE Ticket 12th Street Offices FE 101

105A 107A R R R RF E B B 107 105 E 104 SE 108 Kitchen AB 5 Loading Docks Race Street Arch Street SE

111B B 114 109 RR R R Hall

Lecture 111A 109A Auditorium S N 13th Street Concession Stand Dressing Rooms Elevator Freight Elevator Fire Hose Conne Restrooms Offices Ticket SE Back of House Telephone Fountain Water Columns C D E FE F R T S R R R R DRIVE-IN RAMP RR EE FE 4 Loading Docks 119 BA SE Entrances Exhibit Halls Meeting Rooms Ballrooms Shops Public Areas Escalator Elevator, Stair, Loading Dock House Storage Offices SE KEY 100 level [ RR RR 123 124 125 RR Exhibit Hall G 126 SE BA R Broad Street Atrium R S S lans E E E SE

Broad Street ansion Floor P riginal & exP World Premiere 2011 The Pennsylvania ConvenTion CenTer o [

165th Annual Meeting 29 FLOOR PLANS / PENNSYLVANIA CONVENTION CENTER F F F S RR C F F DRIVE-IN RAMP SE FE SE SE RR FE S SE SE R R R R SE Exhibit Hall A F F E C S E Concierge 14 Loading Docks E Grand Hall FE Vine Street Ramp R R R R

RR BRIDGE OVER ARCH ST. S FE SE F F SE FE SE SE SE S R C

DRIVE-IN RAMP RR R S FE F F SE Business Center Exhibit Hall B RR FE

F F E SE RR BRIDGE TO PHILADELPHIA MARRIOTT, 1,408 ROOMS 6 Loading Docks 8 Loading Docks

DRIVE-IN RAMP SE F F C R Exhibit Hall C R FE S F F F N F F F Concession Stand Dressing Rooms Elevator Freight Elevator Fire Hose Conne Restrooms Offices Ticket F F Back of House Telephone Fountain Water Columns S C D E FE F R T R R R R E 13 Loading Docks E F F FE SE Exhibit Hall D

DRIVE-IN R R SE R DRIVE-IN RAMP R R F F F SE Entrances Exhibit Halls Meeting Rooms Ballrooms Shops Public Areas Escalator Elevator, Stair, Loading Dock House Storage Offices KEY 200 level R F F F [ R Exhibit Hall E SE

Hall E Prefunction S S lans SE E E E ansion Floor P riginal & exP World Premiere 2011 The Pennsylvania ConvenTion CenTer o [

30 www.psychiatry.org FLOOR PLANS / PENNSYLVANIA CONVENTION CENTER 300 301302 RR A FE 30 3 RR RR B DD A Room A Food Court Dressing

PREFUNCTION OVERLOOKING Bar

Stage GRAND HALL EE Kitchen Overlook Overlook Cafe Grand Hall Ballroom Free Wireless Access E Food Court B FE R Room B Dressing DD R RR RR FE VIP 304 305306 E FE A 307 B RR 308309 N Concession Stand Dressing Rooms Elevator Freight Elevator Fire Hose Conne Restrooms Offices Ticket Back of House Telephone Fountain Water Columns C D E FE F R T Entrances Exhibit Halls Meeting Rooms Ballrooms Shops Public Areas Escalator Elevator, Stair, Loading Dock House Storage Offices KEY 300 level [ lans ansion Floor P riginal & exP World Premiere 2011 The Pennsylvania ConvenTion CenTer o [

165th Annual Meeting 31 FLOOR PLANS / PENNSYLVANIA CONVENTION CENTER FE N Concession Stand Dressing Rooms Elevator Freight Elevator Fire Hose Conne Restrooms Offices Ticket Back of House Telephone Fountain Water Columns C D E FE F R T SE FE SE DD D Entrances Exhibit Halls Meeting Rooms Ballrooms Shops Public Areas Escalator Elevator, Stair, Loading Dock House Storage Offices SE KEY 400 level R R R R I [ II IV III SE R lans SE SE E E E ansion Floor P riginal & exP World Premiere 2011 The Pennsylvania ConvenTion CenTer o [

32 www.psychiatry.org FLOOR PLANS / PHILADELPHIA MARRIOTT euqnaB 03 03 03 04 04 04 04 04 03 05 BRIDGE TO 310 309 K ING ING MEET- ROOM MEET- ROOM CONF. SUITE III DBL/DBL DBL/DBL CONVENTION CENTER oitpece

II ELEV. 04 04 54 06 06 06 06 06 04 54 CONF. SUITE

STORAGE SVC. ELEV.

Rt DBL/DBL

pahS CORRIDOR DBL/DBL 02 02 42 03 03 03 03 03 02 52 Un MEETING ROOM 308 cnerefno 2 BAY HOSP. SUITE 22 02 82 03 03 03 03 03 22 52 Ce MEETING MEETING ROOM 306 ROOM 307 moorloohc 42 42 83 63 63 63 63 63 MEETING 42 42 ROOM 305 PARKING Se MEETING ROOM 304 retaehT PRE-FUNCTION 05 05 06 06 06 06 06 06 05 05 MEETING ROOM 303 LEVEL 3 MEETING ROOMS MEN teeF .qSHxWxL teeF 302

ROOM WOMEN 024 004 095 005 095 095 095 095 554 024 MEETING 301 2 BAY HOSP. SUITE ROOM MEETING 9x02x12 9x02x61 9x02x92 9x23x61 9x32x72 9x32x72 9x32x72 9x32x72 9x32x12 9x02x12

DBL/DBL

mooR gniteeM mooR ELEV. 803 mooR 803 903 mooR 903 013 mooR 013 703 mooR 703 503 mooR 503 603 mooR 603 403 mooR 403 303 mooR 303 203 mooR 203 103 mooR 103 CONF. SUITE I 1201 Market Street | Philadelphia, PA 19107 | Phone: 215-625-2900 | Fax: 215-625-6000 | Sales: 215-625-6880 www.PhiladelphiaMarriott.com 1201 Market Street | Philadelphia, PA 19107 Phone: 215-625-2900 Fax: In the heart of business district and in America's historic quest for liberty, to the finest restaurants, shopping, this grand hotel commands a towering presence. Walk and entertainment Philadelphia has to offer or take in the sites sounds of some our nation's best cultural and historic venues. With over 92,000 sq ft of event space, direct access to the Pennsylvania Convention Center via skybridge, and hallmark Marriott service awaiting you, your event is in outstanding hands. K

165th Annual Meeting 33 FLOOR PLANS / PHILADELPHIA MARRIOTT

34 www.psychiatry.org FLOOR PLANS / PHILADELPHIA MARRIOTT 502 ROOM KITCHEN MEETING

euqnaB ELEV.

FREIGHT ELEV. 0082 MEN

024 024 024 024 021 021 021 021 09 02 02 04 09 09 09 04

SERVICE

SERVICE ELEV.

STORAGE

ELEC. PRE-FUNCTION CORRIDOR PRE-FUNCTION noitpece 0054 007 007 051 007 007 512 512 512 512 051 051 051 07 07 WOMEN TELEPHONE Rt SALON I SALON L SALON J SALON K pahSU TION II 43 64 64 64 02 81 81 64 43 43 43 02 REGISTRA- cnerefno 33 64 02 64 64 62 02 64 33 33 33 62 SALON G SALON H Ce oorloohc ESCALATORS 0042 053 053 053 053 001 001 001 001 07 22 82 22 07 07 07 82 Se retaeh BALLROOM OPEN TO BELOW 0073 PRE-FUNCTION 056 056 011 056 056 061 061 061 061 011 011 011 06 54 54 06 SERVICE CORRIDOR 9,000 SQUARE FEET Tm LEVEL 5 BALLROOM ESCALATORS teeF .qSHxWxL teeF 000,3322x041x542moorllaB dnarG 000,3322x041x542moorllaB 029,422x96x27 050,181x53 029,422x96x27 029,422x96x27 029,422x96x27 055,181x43x64 055,181x43x64 055,181x43x64 055,181x43x64 050,181x53x23 050,181x53x23 050,181x53x23 SALON F SALON E 89401x02x72205 mooR gniteeM mooR 89401x02x72205 49301x12x72 49301x12x72 89401x02x72105 mooR gniteeM mooR 89401x02x72105 TION I REGISTRA- x23 SALON D TELEPHONE SALON C SALON A SALON B WOMEN mooR gniteeM mooR

II noitartsigeR II

I noitartsigeR I STORAGE PRE-FUNCTION CORRIDOR PRE-FUNCTION

G nolaS G H nolaS H F nolaS F E nolaS E D nolaS D C nolaS C B nolaS B A nolaS A I nolaS I J nolaS nolaS J nolaS K L ELEV. MEN STORAGE STORAGE 501 AV ROOM ROOM BANQUET STORAGE MEETING 1201 Market Street | Philadelphia, PA 19107 | Phone: 215-625-2900 | Fax: 215-625-6000 | Sales: 215-625-6880 www.PhiladelphiaMarriott.com 1201 Market Street | Philadelphia, PA 19107 Phone: 215-625-2900 Fax: In the heart of business district and in America's historic quest for liberty, to the finest restaurants, shopping, this grand hotel commands a towering presence. Walk and entertainment Philadelphia has to offer or take in the sites sounds of some our nation's best cultural and historic venues. With over 92,000 sq ft of event space, direct access to the Pennsylvania Convention Center via skybridge, and hallmark Marriott service awaiting you, your event is in outstanding hands.

165th Annual Meeting 35 FLOOR PLANS / CROWNE PLAZA

36 www.psychiatry.org Presidents of U.S. Allied Organizations This is for the main TOC. Keep on pasteboard with 2 points overlap into live area.

PRESIDENTS OF U.S. ALLIED ORGANIZATIONS

Academy of Cognitive American Association of American Psychological Depression and Bipolar Therapy Psychiatric Administrators Association Support Alliance Donna M. Sudak, M.D. Barry Herman, M.D. Suzanne Bennett Johnson, Allen Doederlein Academy of Organizational American Association M.D. Indo-American Psychiatric and Occupational Psychiatry on Intellectual and American Psychosomatic Association David E. Morrison, M.D. Development Disabilities Society Rudra Prakash, M.D. Ms. Sharon Gomez American Academy of Michael R. Irwin, M.D. Group for the Advancement American Board of American Society for of Psychiatry Frances R. Levin, M.D. Psychiatry and Neurology Inc Adolescent Psychiatry Jack Drescher, M.D. Larry R. Faulkner, M.D. American Academy of Child Gregory Bunt, M.D. National Alliance on Mental and Adolescent Psychiatry American College of American Society of Illness Martin J. Drell, M.D. Emergency Physicians Addiction Medicine Kevin Sullivan, J.D. David C. Seaberg, M.D. American Academy of Stuart Gitlow, M.D. National Association of Family Physicians American College American Society of Clinical County Behavioral Health Glen Stream M.D. of Obstetricians and Psychopharmacology Inc and Developmental Gynecologists Disability Directors American Academy of John M. Kane, M.D. James N. Martin, Jr. M.D. Mr. Patrick Fleming Neurology Arab American Psychiatric Bruce Sigsbee, M.D. American College of Association National Association of Physicians Psychiatric Health Systems American Academy of Abdel F. Amin, M.D. David L. Branson, M.D. Mr. Blair Stam Psychiatry and the Law Association for Academic Charles L. Scott M.D. The American College of Psychiatry National Association of Psychiatrists Social Workers, Inc American Academy of Karen Broquet, M.D. Naleen N. Andrade, M.D. Jeane W. Anastas, Ph.D, and Association for Behavioral LMSW Dynamic Psychiatry American College of and Cognitive Therapies Michael Blumenfield, M.D. Psychoanalysts Robert Klepac, Ph.D. National Council for Mirian Tasini, M.D. Community Behavioral American Association for Association of American Healthcare American College of Medical College Linda Rosenberg, M.D. Seth Powsner, M.D. Surgeons Darren G. Kirch, M.D. Patricia J. Numann, M.D. National Institute on American Association for Association of Chinese Alcohol Abuse and American Group American Psychiatrists Alcoholism(NIAAA) Psychotherapy Association Paul D.S. Kirwin, M.D. Edmond H. Pi, M.D. Kenneth R. Warren, Ph.D. Kathleen Ulman, M.D. American Association for Association of Directors of (Acting Director) Social Psychiatry American Medical Women’s Medical Student Education National Institute of Mental Association in Psychiatry Rama Rao Gogineni, M.D. Health (NIMH) Gayatri Devi, M.D. Janis Cutler, M.D. American Association for the Thomas R. Insel, M.D. Advancement of Science American Neurological ACMHA: The College for National Institute on Drug Association Behavioral Health Leadership William Press, M.D. Abuse, (NIDA) Eva Feldman M.D. Ron Manderscheid, Ph.D. American Association of Nora Volkow, M.D. Chairs of Departments of American Neuropsychiatric Association of Gay and Mental Health America Psychiatry Association Lesbian Psychiatrists David L. Shern, Ph.D. Stuart Munro, M.D. Daniel R. Wilson, M.D. Kenneth Ashley, M.D. Philippine Psychiatrists in American Association of American Nurses Association Association of Women America Community Psychiatrists Karen A. Daley, M.D. Psychiatrists Jesus Salvador A. Ligot, Jr., Hunter McQuistion, M.D. Patricia Ordorica, M.D. American Orthopsychiatric M.D. American Association of Association The Brain and Behavior Turkish American Directors of Psychiatric Donald Wertlieb, M.D. Research Foundation Residency Training Neuropsychiatric American Psychiatric Benita Shobe Association Karen Sanders, M.D. Association Alliance Council of Medical Erol Ucer Ucer, M.D. American Association of Kay Brada, M.D. Specialty Societies/ Practicing Psychiatrists Gastrointestinal and American Psychoanalytic Janis G. Chester, M.D. Endocrine Surgery Association Ajit Sachideva, M.D. Warren Procci, M.D.

165th Annual Meeting 39 Presidents of International Allied Organizations This is for the main TOC. Keep on pasteboard with 2 points overlap into live area.

PRESIDENTS OF INTERNATIONAL ALLIED ORGANIZATIONS

Albanian Psychiatric Bolivian Society of Czech Psychiatric German Association Association Psychiatry Association for Psychiatry and Dr. Afrim Dangëllia Dr. Fernando Dr. Jiri Raboch Psychotherapy Dr. Peter Falkai Algerian Psychiatric Garitano-Zavala Danish Psychiatric Society Association Psychiatric Association of Dr. Jeanett Bauer Ghana Psychiatric Dr. Farid Kacha Bosnia-Herzegovina Association Dominican Society of Dr. Sammy Ohene Argentinean Association of Dr. Izet Pajevic Psychiatry Psychiatrists Brazilian Association of Dr. Fior Solis de Mendez Hellenic Psychiatric Dr. Nestor Marchant Psychiatry Association (Greece) Ecuadorian Psychiatric Dr. J. Giouzepas Argentinean Psychiatrists Dr. Antonio Geraldo da Association Association Silva Dr. Ricardo Morla Bolona Hellenic Society of Dr. Alfred H. Cía Psychiatric Association of Neurology and Psychiatry Egyptian Psychiatric Rio de Janeiro State (Brazil) (Greece) Foundation for Association Dr. Costas Stefanis Interdisciplinary Dr. Fatima Vasconcellos Dr. Ahmed Mahmoud Fah- Investigation of Society of Psychiatry of Rio my Okasha Guatamalan Psychiatric Communication (Argentina) Grande do Sul (Brazil) Association Dr. Miguel Angel Materazzi Salvadorean Association of Dr. Sibyl Patricia Prado Dr. Lizaete Pessini Pezzi Psychiatry (El Salvador) Rosales Armenian Psychiatric Bulgarian Psychiatric Dr. Jose Miguel Fortin Association Association Honduran Society of Dr. Armen Soghoyan Estonian Psychiatric Psychiatry Dr. Temenuzka Mateva Association Dr. Holly Palacios The Royal Australian & Mental Health Association Dr. Andres Lehtmets New Zealand College of of Cambodia Hungarian Psychiatric Psychiatrists Ethiopian Psychiatric Association Dr. Sin Polu Association Dr. Maria Tomasic Dr. Tamas Kurimay Canadian Psychiatric Dr. Mesfin Araya Austrian Association Association Icelandic Psychiatric of Psychiatry and Finnish Psychiatric Association Dr. Nizar Ladha Association Psychotherapy Dr. Kristinn Tomasson Dr. Michael Musalek Society of Neurology, Dr. Jyrki Korkeila Psychiatry, and Indian Association for French Association of Azerbaijan Psychiatric Neurosurgery (Chile) Social Psychiatry Psychiatrists in Private Association Dr. David Rojas P. Dr. Rakesh Chadda Dr. Nadir Ismayilov Practice Chinese Society of Dr. Michel Marchand Indian Psychiatric Society Arab Gulf Psychiatric Psychiatry Dr. Roy Abraham French Association of Association Dr. Jingping Zhao Kallivayalil Dr. Mohamed Al-Haddad Psychiatry Hong Kong College of Dr. Bernard Gibello Indonesian Psychiatric Bangladesh Association of Psychiatrists Association Psychiatrists French Psychiatric Dr. Linda Lam Information Society Dr. Tun Kurniasih Dr. Md. Golam Rabbani Bastaman Colombian Society of Dr. Nicole Garret-Gloanec Barbados Association of Psychiatry Iranian Psychiatric International Society of Psychiatrists Dr. Jose Bornacelly Association Dr. Sharon Harvey Psycho-pathology of Costa Rican Psychiatric Expression (France) Dr. Gholamreza Mirsepassi Byelorussian Psychiatric Association Dr. Laurent Schmitt Iraqi Society of Psychiatrists Association Dr. Sisy Castillo-Ramirez Dr. Qassim Hadi Al-Awadi Dr. Roman A. Evsegneev Medical Psychologic Croatian Psychiatric Society (France) College of Psychiatry of Royal Society of Mental Association Dr. Mirabel Sarron Ireland Medicine of Belgium Dr. Vlado Jukic Dr. Anthony McCarthy Dr. Jean Bertrand The Psychiatric Evolution Cuban Society of (France) Israeli Psychiatric Society of Flemish Psychiatry Dr. Yves Thoret Association Neurologists & Psychiatrists Dr. Miguel Valdes Mier Dr. Zeev Kaplan (Belguim) Society of Georgian Dr. Geert Dom Cyprus Psychiatric Psychiatrists Italian Association for Association Dr. George Naneishvili Research in Schizophrenia Dr. Louis Kariolou Prof. Carlo Lorenzo Cazzullo

40 www.psychiatry.org PRESIDENTS OF INTERNATIONAL ALLIED ORGANIZATIONS

Italian Psychiatric Mexican Psychiatric Papua New Guinea Slovak Psychiatric Association Association (Asociación Psychiatric Association Association Dr. Eugenio Aguglia Psiquiátrica Mexicana A.C.) Dr. Umadevi Ambihaipahar Dr. Livia Vavrusova Dr. Fernando Lopez Munguia Jamaica Psychiatric Paraguayan Society of Psychiatric Association of Association Mexican Society of Psychiatry Slovenia Dr. Clayton Sewell Neurology and Psychiatry Dr. Andres Arce Dr. Peter Pregelj Dr. Juan Ignacio Rosales Japanese Society of Peruvian Psychiatric South African Society of Psychiatry and Neurology Belarusian Psychiatric Association Psychiatrists Dr. Haruo Kashima Association (Minsk) Dr. Aitor Castillo Dr. Ian Westmore Dr. Sergey Alexandrovich Jordanian Association of Philippine Psychiatric Korean Neuropsychiatric Psychiatrists Igumnov Association Association (South Korea) Dr. Walid Moh’d Shnaigat League for Mental Health Dr. Constatine Della Dr. Byoung-Hoon Oh from Republic of Moldova Kazakh Association Polish Psychiatric Spanish Association of of Psychiatrists and Dr. Mihail Hotineanu Association Neuropsychiatry Narcologists Mongolian Mental Health Dr. Janusz Heitzman Dr. Maria Fé Bravo Ortiz Professor Saltanat Association Portuguese Association of Spanish Society of Nurmagambetova Dr. Ayushjav Bayankhuu Psychiatry Psychiatry Kenya Psychiatric Montenegrin Psychiatric Dr. Jose C. Dias Cordeiro Dr. Jerónimo Saiz Association Association Portuguese Society of Sri Lanka College of Dr. Marx M. Okonji Dr. Lidija Injac-Stevovic Psychiatry and Mental Health Psychiatrists Kuwait Psychiatric Moroccan Society of Dr. Adriano S. Vaz-Serra Dr. Usha Gunawardhane Association Psychiatry Association of Free Sudanese Association of Dr. Essam A. Al-Ansari Dr. Fatima-Zahra Sekkat Psychiatrists of Romania Psychiatrists Kyrgyz Psychiatric Myanmar Medico- Dr. Aurel Romila Dr. Abdullah Abdelrahman Association Psychological Society Romanian Psychiatric Swedish Psychiatric Dr. Abjalal Begmatov Dr. Sao Sai Lon Association Association Latvian Psychiatric Psychiatrists’ Association Dr. Pompilia Dehelean Dr. Lise-Lotte Risö Association of Nepal Independent Psychiatric Bergerlind Dr. Elmars Terauds Dr. Surendra Sherchan Association of Russia Swiss Society of Psychiatry Lebanese Psychiatric Society Netherlands Psychiatric Professor Yuri Savenko (Schweiz Gesellschaft Association für Psychiatrie und Dr. Elie Karam Russian Society of Dr. Rutger Jan van der Psychotherapie - SGPP) Libyan Association of Psychiatrists Gaag Dr. Pierre Vallon Psychiatry, Neurology and Dr. Nikolay Nenanov Neurosurgery Nicaraguan Psychiatric Syrian Arab Association of Saudi Psychiatric Association Psychiatrists Dr. Ali Elroey Association Dr. Carlos Jose Fletes Dr. Pierre Chiniara Lithuanian Psychiatric Dr. Khalid Bazaid Association Gonzalez Taiwanese Society of Society of Psychopathology Psychiatry Dr. Alvydas Navickas Association of Psychiatrists and Mental Hygiene of in Nigeria Dr. Frank Huang-Chi Chou Luxembourguese Society of Dakar (Senegal) Psychiatry, Neurology and Dr. Owoidoho Udofia Professor Daouda Sow Psychiatric Association of Psychotherapy Thailand Norwegian Psychiatric Association of Psychiatric Dr. Chretien Jacoby Association Institutions of Serbia - UPUS Dr. Yongyud Wongpiromsam Psychiatric Association of Dr. Tone Skjerven Dr. Tatjana Voskresenski Tunisian Society of Macedonia (Republic of Psychiatry Pakistan Psychiatric Society Serbian Psychiatric Macedonia, FYROM) Dr. Rizwan Taj Association Dr. Rym Ghacherm Attia Dr. Antoni Novotni Palestinian Psychiatric Dr. Slavica Psychiatric Association of Malaysian Psychiatric Association Djukic-Dejanovic Turkey Association Dr. Doğan Yeşilbursa Dr. Bassam Ashhab Singapore Psychiatric Dr. Teck Hoe Yen Panamanian Society of Association Turkish Neuro-Psychiatric Mauritius Psychiatric Psychiatry Dr. Lee Ee-Lian Association Association Dr. Miguel Angel Cedeño Dr. Peykan G. Gökalp Dr. Jagessur Kumar Tello

165th Annual Meeting 41 PRESIDENTS OF INTERNATIONAL ALLIED ORGANIZATIONS

Uganda Psychiatric The Royal College of Venezuelan Society of Officers reported to the Association Psychiatrists Psychiatry American Psychiatric Dr. Fred Nsobya Kigozi Dr. Sue Bailey Dr. Néstor Macías Association Membership Department as of January Ukraine Scientific Society of Society of Psychiatry of Yemen Psychiatrists and 18, 2012. Neurologists, Psychiatrists Uruguay Neurologists Association and Narcologists Dr. Cecillia Idiarte Borda Dr. Abdelmagid S. Dr. Petro V. Voloshyn Association of Psychiatrists Al-Khulaidi Ukrainian Psychiatric of Uzbekistan Association Dr. Ulugbek Alimov Dr. Viktor Shumlyansky

APP Author Sessions at the 165th APA Annual Meeting Attend a Master Course at the 2012 American Psychiatric Association Annual Meeting and receive an accompanying reference as part of your admission!

Each book shown is included in the corresponding course!

Master Courses – Price for Each Master Course: Onsite: $375.00

Psychiatry in Review 2012 Essential Saturday, May 5 • 9:00am-4:00pm Pschopharmacology Director: Arden D. Dingle, M.D. Monday, May 7 • 9:00am - 4:00pm Co-Director: Robert Boland, M.D. Director: Alan Schatzberg, M.D. Co-Director: Charles DeBattista, M.D.,

Challenges in Psychodynamic Update on Pediatric Psychotherapy Psychopharmacology Saturday, May 5 • 9:00am-4:00pm Tuesday, May 8 • 9:00am - 4:00pm Director: Glen O. Gabbard, M.D. Director: Christopher J. Kratochvil, M.D.

Practical Cognitive- Behavior Therapy BOOKSTORE HOURS Sunday, May 6 • 9:00am - 4:00pm Director: Saturday, May 5 9:00am - 4:00pm Jesse H. Wright, M.D., Ph.D. Sunday, May 6 10:00am - 4:00pm Monday, May 7 10:00am - 4:00pm Tuesday, May 8 10:00am - 4:00pm

APA Members receive a 20% discount on APP titles and MITs receive a 25% discount, plus member discounts www.appi.org for journals as well as products on Email: [email protected] PsychiatryOnline.org. Phone: 1-800-368-5777 15% discount for non-members The First and Last Word in Psychiatry

Find us on Facebook and Twitter. Priority Code AH1222

42 www.psychiatry.org Special Acknowledgements This is for the main TOC. Keep on pasteboard with 2 points overlap into live area.

SPECIAL ACKNOWLEDGEMENTS

American Academy of Psychiatry and the Law: Investigators. co-support of the Manfred S. Guttmacher Award Lecture. Ortho-McNeil-Janssen Pharma Inc: support of American Association of Chairs of Departments the Committee of Asian-American student recruitment of Psychiatry: support of the APA/AACDP Research reception. Mentorship Award. Pennsylvania Departments of Psychiatry: American Psychiatric Association/Hurricane Di- support of the residents’ reception. saster Relief Fund: support of the Disaster Psychia- Pfizer, Inc: support of the APA/Pfizer M.D., Ph.D. Re- try Fellowship. search Fellowship. American Psychiatric Foundation: support of the Professional Risk Management Services, Inc.: APIRE Practice Research Network. co-support of the Manfred S. Guttmacher Award Lecture. Association of Women Psychiatrists: support of Scattergood Foundation: recognized for its collabo- the joint AWP/APA Women’s Caucus meeting, and co- ration with the 2012 Scientific Program Committee and support of the Alexandra Symonds Award Lecture. APA Ethics Committee chairpersons in the development Astra Zeneca: support of the George Tarjan Award. of an ethics track for the 2012 Annual Meeting and sup- port of “Mind Games” reception. Bristol-Myers Squibb Company: support of the President’s Dessert and Reception; the Solomon Carter Shire US, Inc.: support of the APA Child and Adoles- Fuller Award and reception; and the APA Fellowship on cent Psychiatry Fellowship. Public Psychiatry. Substance Abuse and Mental Health Services Center for Mental Health Services: support of the Administration (CMHS, CSAP, CSAT): sponsorship APA’s HIV-related education programs and materials. of the APA/SAMHSA Minority Fellowship Program. Estate of Agnes Purcell McGavin: support of the University of Nebraska: support of the Frank J. Me- Agnes Purcell McGavin Awards for Distinguished Career nolascino Award for Psychiatric Services for persons Achievement in Child and Adolescent Psychiatry, and with Mental Retardation/Developmental Disabilities. for Prevention. Estate of Dorothy C. Kempf: support of APA/Kempf Fund Award for Research Development in Psychobio- logical Psychiatry Awards. EARN ONLINE CME Estate of Judd Marmor, M.D.: support of the Judd @ APAeducation.org Marmor Award Lecture. Harding Foundation: partial support of the Oskar Pfister Award Lecture. Ittleson Foundation: support of the Blanche F. Ittle- son Award for Research in Child Psychiatry. Gill Foundation: co-support of the John Fryer Award. Lilly USA LLC: support of the APA/Lilly Psychiatric CME COURSES Research Fellowship; and the APA/Lilly Resident Re- search Awards., Chief Resident Leadership Program, In- Performance in Practice Modules ternational Dinner Symposium, and partial support of - Free to APA Members the American Psychiatric Foundation’s Annual Benefit. - Approved by ABPN for Part 4 MOC Co-support of the Simon Bolivar Award. - Three-stage Performance Improvement CME structure E/M Coding Course for Psychiatrists Merck & Co., Inc.: support of the resident poster - Free to APA Members session and the APA/Merck Early Academic Career Re- 8 Online Practice Guideline Courses - Earn up to 8 AMA PRA Category 1 Credits TM search Award. Buprenorphine for O ce Based Treatment of Opiate National Institute of Mental Health (NIMH): co- Dependent Patients - 8 Hour Training Program That Meets CSAT Requirements support of the APA/NIMH Vestermark Psychiatry Edu- And More... cator Award Lecture. My Transcript: A Tool for Recording Your CME - Record and Store Your CME Credits in One Easy to Access Location National Institute on Mental Health and Health Disparities: the Research Colloquium for Junior www.apaeducation.org

165th Annual Meeting 45 Disclosure Index This is for the main TOC. Keep on pasteboard with 2 points overlap into live area.

2012 ANNUAL MEETING DISCLOSURE INDEX AMERICAN PSYCHIATRIC ASSOCIATION CONTINUING MEDICAL EDUCATION POLICY ON FULL DISCLOSURE

he American Psychiatric Association requires dis- presentation). Disclosing to learners the relevant finan- closure by all program planners and presenters at cial relationships that were present and resolved assists TCME activities of any financial or other affiliation learners in assessing the potential for bias in the infor- with commercial organization(s) that may have a direct mation that is presented. The APA also requires verbal or indirect interest in the subject matter of the educa- disclosure of discussion of unlabeled uses of a commer- tional activity. A “financial interest” may include, but is cial product or investigational use of a product not yet not limited to: being an employee and/or being a share- approved for this purpose. holder in the organization; being on retainer with the The presenters and planners on the following pages organization; or having research or honoraria paid by indicated that either they or an immediate family mem- the organization. An “affiliation” may include holding a ber have a financial interest or other affiliation with a position on an advisory committee, speakers’ bureau or commercial entity producing, marketing, re-selling, or some other role or benefit to a supporting organization. distributing health care goods or services consumed by In compliance with the ACCME’s Standards for Com- or used on patients; the company name and affiliation mercial Support, the APA has a management of conflict is also listed. Providers of clinical service directly to pa- (MCI) process for all CME activities. This process en- tients are not considered to be commercial interests. sures that all conflicts of interest are identified, man- The second group of presenters and planners indicated aged and resolved prior to the educational activity. Ad- neither they nor an immediate family member has any ditionally, the prospective audience must be informed significant relationship to disclose. of the presenters’ or program planners’ affiliations with All presenters and planners must complete a disclo- every commercial interest by an acknowledgement in sure in order to participate in an APA CME activity. This the printed program and verbal or visual disclosure to disclosure listing includes the presenters of the Scien- participants at the session (disclosure by slide or over- tific Program and New Research Poster Sessions. head is required if audiovisual equipment is used for the

Special Attendee O er: Buy Today and Save $1000* APA Annual Meeting on Demand is a digital library of presentations from the 2012 American Psychiatric Association Annual Meeting with over 300 hours of educational content.

Features of APA Annual Meeting on Demand include: • Online access to content within 24 hours • NEW: Convenient USB drive for o ine viewing • Streaming content for viewing for most mobile devices • Downloadable audio MP3 fi les PHILADELPHIA • Over 50 Additional CME Credits Available Order in Philly or online at www.CMEonCall.com/APA Attendees: Enter your badge number or Promo Code “Philly2012”

Special attendee pricing expires May 9, 2012. * Savings vary depending on registration category 2012

APA 165TH ANNUAL MEETING • INTEGRATED CARE • PHILADELPHIA, PA • MAY 5-9, 2012

54 www.psychiatry.org DISCLOSURE INDEX

Stock/ Other Financial Grant/ Speaker’s Other Financial Interest Name Options Consultant Research Support Employee Bureau (specify) Adler, Lenard A Theravance, Alcobra, Shire, Eli Lilly, Chelsea Theravance Advisory Board, Shire Ltd. Therapeutics Advisory Board, NYU Recipient of royalty payments (as inventor) for license of adult ADHD scales and training materials. Agid, Ofer Novartis, Lilly Research, Janssen- Canada, Pfizer Canada, Sunovion Alam, Mohammed Takeda Alexopoulos, George S. J&J Eli Lilly Forest Forest, AstraZen- eca, Merck, Avanir Corporation Alphs, Larry D J&J Ortho-McNeil Janssen Scientific Affairs, LLC Alptekin, Koksal Janssen Cilag, Lund- Lundbeck Lundbeck, Abdi beck, Pfizer Inc. Ibrahim, AZ, Aventis, Eli Lilly, Janssen Cilag, Pfizer Inc., Sanofi Aventis Anton, Raymond F. Alkermes, GSK, Alkermes, GSK, Lundbeck, Lundbeck, Roche J&J, Schering Corporation, Diagnostics Abbott, Alcomed Inc. Appelbaum, Paul S. COVR, Inc. Atkins, Robert M. Aetna Aetna Baker, Ross A Otsuka Baldwin, David S Eli Lilly, Lundbeck, Lundbeck, Pfizer Inc. Eli Lilly speaking engagement, Pfizer Inc., Grunenthal Lundbeck speaking engagement, GmBH Pfizer Inc. speaking engagement, Servier speaking engagement Batki, Steven L. Alkermes Bauer, Michael Lundbeck, BMS, Stanley Medical Research BMS, AZ, Lilly, Lund- Otsuka, AZ, Lilly, Institute, NARSAD beck, GSK, Otsuka Servier Beezhold, Julian AZ, Lilly, Janssen Cilag, Lundbeck Benjamin, Sheldon Advanced Neuromodulation Brain Educators, LLC 1/3 owner- Systems, Inc. ship, author Beyer, John L. AZ, Forest, Janssen, Lilly Merck Bisaga, Adam Alkermes Black, Donald W. Psyadon, AZ

165th Annual Meeting 55 DISCLOSURE INDEX

Stock/ Other Financial Grant/ Speaker’s Other Financial Interest Name Options Consultant Research Support Employee Bureau (specify) Bogan, Richard K SleepMed Inc. Cephalon Inc., GSK, Cephalon Inc., Jazz ApniCure Industry funded research, Jazz Pharmacuetical, Pharmacuetical, Apnex Industry funded research, UCB Pharma, Inc., Sunovion, GSK Sensory Medical Industry funded ApniCure, Sunovion research, ResMed Industry funded research, Schwarz Industry funded research, Ventus Industry funded research, Actellion Industry funded research, Boehringer Ingelheim Industry funded research, Cepha- lon Inc. Industry funded research, GlaxoSmithKline Industry funded research, Jazz Pharmacuetical Industry funded research, Vanda Pharmaceuticals Industry funded research, Merck & Co., Inc. Indus- try funded research, Pfizer Inc. Industry funded research, Sepracor Inc. Industry funded research, Xenoport Industry funded research, Philips Industry funded research, Johnson & Johnson Industry funded research Bose, Anjana Forest Research Institute Bowden, Charles BMS, Sanofi Aventis, Abbott, GSK, Repligen, Jans- Schering Corporation, sen Research Foundation Pfizer Inc. Brams, Mathew Lilly, Novartis, McNeil, AZ, BMS, Forest, GSK R&D, Lilly, Shire US Inc., Shire US Inc. McNeil, Shire US Inc., Novar- Novartis, Pfizer Inc., tis, Sanofi Aventis, Lilly McNeil, AZ, Cephalon Inc. Brandt, Douglas M. Novartis Brenner, Jeff Lilly Brown, Richard P. Fisher Wallace, Humanetics Brown, Thomas E. Novartis, Lilly, Shire Lilly, Shire US Inc. Lilly US Inc. Buckley, Peter F. Janssen, Sepracor Inc., Pfizer Inc. Buckley, Peter F. Janssen Janssen, Pfizer Inc. Carpenter, Linda L. Abbott Medtronic, Inc., Neuronetics Inc., NeoSync Carpenter, William T. BMS, Shire Carson, William Otsuka Carter, Diana AZ Canada, Lundbeck Canada, Pfizer Canada Carter, Cameron S. Merck, Lilly, Pfizer Inc., Servier Case, Michael G Lilly Lilly Casey, Daniel E BMS, Dainippon Solvay, Abbott, BMS, Abbott, Roche, Jans- Janssen, Merck, sen, Merck, Pfizer Inc., Pfizer Inc. Wyeth Castilla-Puentes, Ruby C GSK, J&J PRD J&J PRD Chang, Kiki BMS, Lilly, GSK GSK Chang, Trina AZ, Cenerx, Euthymics Bioscience Inc., Forest, J&J, Pfizer Inc. Chung, Henry Takeda

56 www.psychiatry.org DISCLOSURE INDEX

Stock/ Other Financial Grant/ Speaker’s Other Financial Interest Name Options Consultant Research Support Employee Bureau (specify) Citrome, Leslie Noven Pharmaceutical, AZ Speakers Bureau and Research Valeant Pharmaceuti- Support, Pfizer Inc. Consultant, cals, Shire, Janssen, Speakers Bureau and Research Avanir Corporation, Support, Lilly Consultant Alexza, BMS, Alker- and Speakers Bureau, Merck mes, Otsuka, Lundbeck Consultant and Speakers Bureau, Canada Novartis Pharmaceutical, Sunovion Pharmaceuticals Inc. Coccaro, Emil F. Azevan Pharma Azevan Pharma Clayton, Anita Astellas Pharma US, Palatin Technologies, Inc., Bayer, Boehringer Pfizer Inc., Repligen, Takeda, Ingelheim, Dey Phar- Biosante maceutical LP, Lilly Coghill, David R Shire Shire, Janssen Cilag, Lilly Janssen Cilag, Shire, Janssen Cilag Adboard, Lilly Ad- Lilly, Novartis board, UCB Pharma, Inc. Adboard, Pfizer Inc. Adboard, Shire Adboard, Merck Adboard, Otsuka Adboard Cook, Ian A BMS, Pfizer Inc. Neuronetics Inc., Sepracor Neuronetics Inc. Inc., NeoSync, Seaside Therapeutics Coplan, Jeremy D. Pfizer Inc. Alexza, GSK, Pfizer Inc. BMS, AZ, GSK Corruble, Emmanuelle Lundbeck, Sanofi Eisai Inc. Aventis, Servier, BMS Currie, Alan Janssen Cilag Servier Registration fee, travel and accommodation expenses to attend ECNP in Paris, France. September 3-7th 2011 Cutler, Andrew J Addrenex, Shionogi Inc, Addrenex, Cephalon Inc., Ab- Janssen, Novartis, J&J PRD, Novartis, bott, AZ, BMS, GSK, Janssen, Abbott, AZ, BMS, Abbott, AZ, BMS, Jazz Pharmacuetical, J&J GSK, Lilly Research GSK, Janssen, Lilly PRD, Lilly Research Research Daniel, David G United BioSource Debattista, Charles Corcept Therapeu- CNS Response, Brain Lilly Research GSK, tics, Inc. Resource Ltd., Neuropace, Pfizer Inc., Cephalon GSK, Wyeth, Lilly Research, Inc., Wyeth, BMS, Cephalon Inc., Cyberonics AZ, Cyberonics Inc., Inc., Neuronetics, Novartis, Corcept Therapeu- AZ tics, Inc., Forest DelBello, Melissa Lilly, GSK, Merck, AZ Amylin, GSK, Lilly, Janssen, BMS, Merck J&J PRD, AZ, Forest, Pfizer Inc., Somerset Demitrack, Mark Neuronetics Inc. Deo, Rajat Boehringer Ingelheim Biotronik Dirks, Bryan Shire, J&J PRD Shire D’Mello, Dale Lilly AZ, Merck Doghramji, Karl Merck Pfizer Inc., UCB Pharma, Inc. Dougherty, Darin D. Medtronic, Inc. Forest, Lilly, Cyberonics Inc., Medtronic, Inc. Honoraria for Medtronic, Inc. training Edwards, John Forest Research Institute Evins, A. Eden Pfizer Inc., Boehringer Pfizer Inc., GSK Reed Medical Ingelheim Education Extein, Irl L. Eli Lilly, Merck, J&J BMS, Merck

165th Annual Meeting 57 DISCLOSURE INDEX

Stock/ Other Financial Grant/ Speaker’s Other Financial Interest Name Options Consultant Research Support Employee Bureau (specify) Ferrando, Stephen J. Merck Findling, Robert L Abbott, Addrenex, Abbott, Addrenex, AZ, BMS, BMS, J&J, Shire Alexza, AZ, Biovail Forest Research Institute, US Inc. Laboratories, Inc., GSK, J&J, Lilly Research BMS, Forest Research Merck, Otsuka, Pfizer Inc., Institute, GSK, J&J, Schering Corporation, Shire Lilly Research, Lun- US Inc., Supernus, Wyeth- dbeck, Merck & Co., Ayerst Pharmaceutical Inc., Novartis Pharma- Company ceuticals Corporation, Noven, Organon, Otsuka Pharmaceu- ticals, Physicians Post Graduate Press, Pfizer Inc., Roche Biosciences, Sanofi Aventis, Schering Corporation, Seaside Therapeutics, Sepracor Inc., Shire US Inc., Solvay Pharmaceu- ticals, Inc., Sunovion Pharmaceuticals Inc., Supernus, Trascept Pharm, Wyeth-Ayerst Pharmaceutical Company First, Michael B. TeleSage, RTI Health Lundbeck LINF faculty member Solutions Fleischhacker, Wolfgang F MedAvante Lundbeck, Roche Bio- Janssen, Alkermes, Eli Lilly, Lundbeck, Sunovion, sciences, BMS, Otsuka, Otsuka, Pfizer Inc. Janssen, Eli Lilly, United BioSource, Otsuka, AZ MedAvante, Sunovion, Merck, Janssen, Pfizer Inc. Fong, Timothy W. Reckitt Benckiser Pharmaceuticals, Cephalon Inc., Pfizer Inc., Forest Research Institute, Somaxon Foulds, Jonathan Pfizer Inc., Cypress Bioscience, GSK, Novartis Frank, Ellen Servier Vanda Guilford Publications Receive book royalties Frasch, Karel J AZ AZ Travel expenses, Janssen Cilag Travel expenses, Lilly Travel expenses, Janssen Cilag Speaker honoraria, BMS Travel expenses Fu, Dong-Jing J&J PRD Ortho-McNeil Janssen Scientific Affairs, LLC Gaebel, Wolfgang Lundbeck Janssen Cilag Symposia Support, Lilly Research Laboratories, a division of Lilly Symposia Support, Servier Symposia Support Garbely, Joseph AZ Gastfriend, David R. Alkermes Alkermes (Cambridge, MA) Gerbarg, Patricia L. Fisher Wallace, Humanetics

58 www.psychiatry.org DISCLOSURE INDEX

Stock/ Other Financial Grant/ Speaker’s Other Financial Interest Name Options Consultant Research Support Employee Bureau (specify) Ghaemi, S. Nassir Pfizer Inc. Sunovion research trial consulta- tion Ghate, Sameer BMS Gitlin, Michael BMS, Lilly, AZ Glick, Ira Janssen Pharmaceu- Janssen, Medivation, Otsuka, Boots Pharmaceu- AZ, Pfizer Inc. tica Inc. Lundbeck, Novartis, ticals, Pfizer Inc., Sunovion, Roche Biosciences Vanda, J&J, Lilly Research Takeda Goldberg, David P. Pfizer Inc. Goldberg, Joseph F. Lilly, Dey Pharmaceuti- AZ, Dey Pharmaceu- American Psychiatric Press cal LP tical LP, Merck, AZ Royalties Goldfinger, Stephen M. J&J PRD, Lilly, Teva Teva Pharmaceuticals Janssen Pharmaceutica Inc. Pfizer Inc. Members of my Pharmaceuticals department receive grant sup- port; Janssen Members of my department receive grant support, Alexza Lifelong friends with the company’s CFO, Teva Pharmaceuti- cals stockholder Goldman, Morris B. GSK Beechum Pharmaceu- ticals Goldstein, Benjamin American Psychiatric Asso- Purdue Pharma ciation, NARSAD, Pfizer Inc. Gommoll, Carl Forest Research Institute Goodkin, Karl Amgen Ortho-McNeil Janssen Merck Scientific Affairs, LLC Goodwin, Frederick K. Merck Gopal, Srihari J&J PRD J&J PRD Grant, Jon E. NIDA, Psyadon Pharmaceu- ticals Inc. Gray, Kevin M. Supernus, Merck Green, Alan I. Pfizer Inc., J&J, Lilly Research Laboratories, Mylan Janssen Pharmaceutica Inc. Greenberg, William Forest Research Institute Greenblatt, David J Transcept Pharmaceu- ticals Inc. Grossberg, George T. Forest, Novartis Forest Research Institute, BMS, Novartis, Janssen Re- search Foundation, Pfizer Inc. Haltzman, Scott D. Pfizer Inc., Forest, Organon, Lilly Research Laboratories, a division of Lilly Hamarman, Stephanie Merck, Eli Lilly, No- vartis, BMS, McNeil, Pam Lab LLC, Shire US Inc. Hammerness, Paul G. Shire US Inc., Ortho-McNeil Janssen Abbott CME/professional writing, Ortho-McNeil Janssen Scientific Affairs, LLC, Shire Lilly CME/professional writing, Scientific Affairs, LLC US Inc., Takeda, Cephalon Forest CME/professional writing Inc., Novartis, Forest, J&J, ElMindA, GSK Hammond, Christopher J. Shire Funding from an unrestricted educational grant from Shire to American Psychiatric Institute for Research and Education.

165th Annual Meeting 59 DISCLOSURE INDEX

Stock/ Other Financial Grant/ Speaker’s Other Financial Interest Name Options Consultant Research Support Employee Bureau (specify) Harbin, Henry Minster CNS Response, Pfizer Inc. Harvey, Philip D. J&J, En vivo, Pharma- Roche Biosciences Dr. Harvey NeuroBoost, Sunovion, also received royalties from Duke Abbott, Shire, Roche University. He is a consultant Biosciences with Genentech (a member of the Roche Group. The royalites with Duke University are not associ- ated with his consultancy with Genentech.) Heinrich, Thomas W. National Institutes of Health Hellerstein, David J Pfizer Inc., Lilly Henderson, Theodore A. CereScan Corp. The Synaptic Space Henderson, David C. Merck, Novartis Stanley Foundation, Ortho Massachusetts McNeil General Hospital Herman, Barry K. Sunovion Higgins, Napoleon B. AZ, BMS, Sunovion, Shire, Shionogi Inc, Otsuka, Janssen, AZ, Shire US Inc., GSK, McNeil Pharmaceutic Hillhouse, Todd Lundbeck Hollander, Eric Trascept Pharm Hulihan, Joseph J&J Ortho-McNeil Janssen Scientific Affairs, LLC Iosifescu, Dan V. CNS Response Forest Jacobson, Sandra A. Lilly Research Laboratories, salary support; clinical trials, BMS salary support: clinical trials, Avid salary support: clinical trials, Bayer salary support: clinical trials, Janssen Pharmaceutica Inc. salary support: clinical trials, American Psychiatric Publishing, Inc. royalties, Elan Pharma- ceuticals salary support; clinical trials, Eisai America, Inc. salary support; clinical trials, Pfizer Inc. salary support; clinical trials, Wyeth-Ayerst Research, Inc. salary support; clinical trials Jacqueline, Pesa A J&J Ortho-McNeil Janssen Scientific Affairs, LLC Jalpa, Doshi Shire Jang, Saeheon Janssen, Lundbeck Otsuka Janssen, Sanofi Aventis, AZ, GSK, Eli Lilly Janicak, Philip G. BMS, Neuronetics Inc. Otsuka, Neuronetics Inc., BMS, Otsuka, NeoStim, Sunovion Neuronetics Inc. Kalin, Ned H. Corcept Therapeu- Medivation, AZ, BMS, CME Outfitters tics, Inc., Cenerx Cenerx, Corcept Therapeutics, Inc., Elsevier Press, Lilly, Neuronetics, Otsuka, Sanofi Aventis, Wyeth

60 www.psychiatry.org DISCLOSURE INDEX

Stock/ Other Financial Grant/ Speaker’s Other Financial Interest Name Options Consultant Research Support Employee Bureau (specify) Kalman, Thomas P. Medivation, AstraZen- eca Pharmaceuticals, Bristol-Myers Squibb, Cenerx, Corcept Therapeutics, Inc., Elsevier Press, Eli Lilly and Company, Neuronetics, Otsuka Pharmaceuticals, Sanofi Aventis, Wyeth- Ayerst Pharmaceutical Company Kane, John M MedAvante Alkermes, Amgen, BMS, Cephalon Inc., Boehringer Ingelheim, Lilly, Janssen, J&J, Lundbeck, Merck, No- vartis, Otsuka, Pfizer Inc., Pierre Fabre, Proteus Karim, Reef Alkermes, Reckitt Benckiser Pharma- ceuticals Katon, Wayne J. Pfizer Inc., Forest Eli Lilly Advisory Board Keefe, Richard S Shire, Sanofi, Aventis, GSK, Novartis MATRICS Battery (BACS Symbol Solvay, Sunovion, Coding) Dr. Keefe receives royal- Takeda, Wyeth, Abbott, ties from the BACS testing battery Astellas Pharma US, and the MATRICS Battery (BACS Inc., Bioline, BrainCells, Symbol Coding). He is also a Inc., Bristol-Myers shareholder in NeuroCog Trials, Squibb, Cypress Bio- Inc., Durham NC. Duke University science, Eli Lilly, En holds the copyright for the SCoR vivo, Lundbeck, Merck & Co., Inc., Pfizer Inc., Roche Biosciences Kennedy, James L. Lilly Canada Honoraria Keshavan, Matcheri S. GSK Ketter, Terence A. Merck, Abbott, AZ, Abbott, BMS, GSK, Repligen, J&J PRD Spouse/stockholder Astellas Pharma US, Sepracor Inc., Wyeth, AZ, Nzeera Ketter, M.D., BMS Lecture Inc., Cephalon Inc., Cephalon Inc., Lilly, Pfizer Inc. Honoraria, Abbott Lecture Honorar- Lilly, Forest, Janssen, ia, Lilly Lecture Honoraria, Noven Jazz Pharmacuetical, Pharmaceutical Lecture Honoraria, Novartis, Organo Inc., Otsuka Lecture Honoraria, Pfizer Wyeth-Ayerst Phar- Inc. Lecture Honoraria, Johnson maceutical Company, and Johnson PRD Spouse/ Solvay Pharmaceu- employee Nzeera Ketter, M.D., ticals, Inc. , Valeant AstraZeneca Pharmaceuticals Pharmaceuticals, Lecture Honoraria, GlaxoSmith- Vanda Pharmaceu- Kline Lecture Honoraria ticals, Xenoport, Bristol-Myers Squibb, Dainippon Sumi- tomo Pharma Co., Ltd, GlaxoSmithKline Kiddoe, Jared Shire US Inc. Funding from an unrestricted educational grant from Shire to American Psychiatric institute for Research and Education Kiki, Chang D GSK, Eli Lilly, Merck, AZ, Lilly, GSK, BMS, Lilly BMS Kingdon, David G. Roche Biosciences AZ Kleber, Herbert D. Perdue, Alkermes Grunenthal GmBH SAB

165th Annual Meeting 61 DISCLOSURE INDEX

Stock/ Other Financial Grant/ Speaker’s Other Financial Interest Name Options Consultant Research Support Employee Bureau (specify) Kranzler, Henry R. Alkermes, Lundbeck, Merck Eli Lilly ACNP Alcohol Clinical Trials Roche Biosciences, Initiative Support, Janssen ACNP Glead, GSK Alcohol Clinical Trials Initiative Support, Schering-Plough, France ACNP Alcohol Clinical Trials Initiative Support, Lundbeck ACNP Alcohol Clinical Trials Initiative Support, Alkermes ACNP Alcohol Clinical Trials Initiative Support, GlaxoSmithKline ACNP Alcohol Clinical Trials Initiative Support, Abbott Laboratories ACNP Alcohol Clinical Trials Initiative Support, Johnson & Johnson ACNP Alcohol Clinical Trials Initiative Support Kratochvil, Christopher J. Lilly, Abbott, AZ, Pfizer Lilly, Abbott, Shire US Inc., Oxford Press Royalties, Wiley Inc. Somerset, AZ Editor Kyomen, Helen H. AZ, Bayer, BMS, Bayer, BMS, Lilly, Roche, UCB Merck, Lilly, Roche, Pharma, Inc., Wyeth, Pfizer GSK, Novartis, UCB Inc., National Institutes of Pharma, Inc. Health Lam, Raymond W Litebook Company, AZ Canada, Litebook Servier, Biovail Inc., GSK, Lundbeck, Company, Inc., Lundbeck, Laboratories, Inc. Takeda, AZ, Lilly, BMS Pfizer Canada, BMS, St. Jude Medical Lasser, Robert Shire Shire Lauriello, John Lilly, Sunovion Lavretsky, Helen Dey Pharmaceutical LP Lazarus, Arthur L. Shire US Inc. Shire US Inc. Leiser, Steven C Lundbeck Lerman, Caryn AZ, GSK, Pfizer Inc., Targacept Levin, Frances R. G W Pharmaceutical US World Med Levine, Stephen B. Biosante, Endoceutics, Palatin Technologies Lewy, Alfred J. Servier, Takeda Licinio, Julio DeCode Genetics Lieberman, Jeffrey Allon Therapeutics, Forest, Eli Lilly Advisory Board, Repligen Merck, Pfizer Inc. Patent, Bioline Advisory Lim, Russell F. AZ Educational Grant, Pfizer Inc. Educational Grant Lin, Jay Otsuka Lindenmayer, Jean-Pierre Shire US Inc., Merck AZ, Janssen, Sunovion, Lilly Research Otsuka, Hoffman- LaRoche Pharmaceuticals Links, Paul S. Eli Lilly Canada Lisanby, Sarah H. Brainsway Inc., The Stanley Magstim Equipment support, Medical Research Institute, Magventure Equipment support Neuronetics Inc. Loebel, Antony Sunovion Madaan, Vishal Avanir Corporation Pfizer Inc., Otsuka, Merck Madaan, Vishal Avanir Corporation Mago, Rajnish Otsuka, Forest Research Institute, Lilly, BMS

62 www.psychiatry.org DISCLOSURE INDEX

Stock/ Other Financial Grant/ Speaker’s Other Financial Interest Name Options Consultant Research Support Employee Bureau (specify) Malhi, Gin AZ, Servier, Lilly, Pfizer Inc., Janssen Cilag, Ingelheim- Boehringer Mao, Alice R. Lilly, BMS BMS, McNeil, Novar- tis, Shionogi Inc Marder, Stephen MedAvante BMS, Lundbeck, GSK, Novartis, Sunovion Wyeth, Schering Corporation, Roche Biosciences, Abbott, Astellas Pharma US, Inc., Amgen, Otsuka, Roche, Shire US Inc., Pfizer Inc. Markowitz, Michael A Janssen Scientific Affairs LLC Martin, Peter S BMS APA/BMS Public Psychiatry Fellowship Martinez, Larry Janssen Scientific Affairs LLC Mason, Barbara J. Addrenex, J&J, Merck Lohocla Research Corporation McCarron, Robert M. Eli Lilly, Merck Lippincott Book Editor McCarty, Dennis Alkermes McCracken, James T. PharmaNet, Inc., Seaside Therapeutics, Roche, Novartis, Roche Otsuka McDonald, William M. Cervelo Neurotherapeutics McDowell, David M. Pfizer, Inc. McElroy, Susan Lilly, Schering-Plough, Alkermes (Cambridge, MA), France, Alkermes AZ, Cephalon Inc., Lilly, (Cambridge, MA) Forest, Jazz Pharmacuetical, Orexigen, Pfizer Inc., Shire, Takeda Mcevoy, Joseph P Sunovion, Merck Sunovion, Lilly McGlynn, Lawrence Gilead Sciences McGorry, Patrick D. Janssen Cilag, Lilly, Janssen Cilag, AZ Pfizer Inc., AZ

165th Annual Meeting 63 DISCLOSURE INDEX

Stock/ Other Financial Grant/ Speaker’s Other Financial Interest Name Options Consultant Research Support Employee Bureau (specify) McIntyre, Roger S. Lilly, Janssen-Ortho Pharma- Janssen-Ortho Phar- Eli Lilly Advisory Board, Organon ceutica Inc., Shire US Inc. maceutica Inc., AZ, Advisory Board, Lundbeck Advisory Eli Lilly, Lundbeck, Board, Biovail Laboratories, Inc. Ad- Biovail Laboratories, visory Board, Biovail Laboratories, Inc., Wyeth Inc. Advisory Board, Pfizer Inc. Advisory Board, Shire Advisory Board, Schering-Plough, France Advisory Board, AstraZeneca Pharmaceuticals CME Activities, Bristol-Myers Squibb CME Activi- ties, France Foundation CME Activi- ties, CME Outfitters CME Activities, Solvay Pharmaceuticals, Inc. CME Activities, Postgraduate Press CME Activities, AstraZeneca Pharmaceu- ticals Advisory Board, Bristol-Myers Squibb Advisory Board, France Foundation Advisory Board, GlaxoS- mithKline Advisory Board, Janssen- Ortho Pharmaceutica Inc. Advisory Board, Solvay Pharmaceuticals, Inc. Advisory Board McIntyre, Roger Eli Lilly, Janssen-Ortho Janssen-Ortho Phar- AZ CME Activities, BMS CME Pharmaceutica Inc., Shire, maceutica Inc., AZ, Activities, France Foundation CME AZ, Lundbeck Eli Lilly, Lundbeck, Activities, I3CME CME Activities, Merck, Pfizer Inc. Physicians Post Graduate Press CME Activities, CME Outfitters CME Activities, Merck, CME Activities, Eli Lilly, AstraZeneca Pharmaceuticals Advisory Board, Bristol-Myers Squibb Advisory Board, France Foundation Advisory Board, GlaxoSmithKline Advisory Board, Janssen-Ortho Pharmaceu- tica Inc. Advisory Board, Eli Lilly Advisory Board, Organon Advisory Board, Lundbeck Advisory Board, Shire Pharmaceutical Develop- ment, Inc. Advisory Board, Merck & Co., Inc. Advisory Board Melmed, Raun D Novartis, Shire, Seaside Novartis, Shire, Therapeutics, BMS, Forest Shionogi Inc, BMS Research Institute Menza, Matthew A. BMS, Labopharm Inc, AZ, Boehringer Ingelheim, Ono Pharmaceuticals BMS, Forest, GSK, Lilly Research, Merck, Pfizer Inc., Sanofi Aventis, Sepracor Inc., Takeda Pharmaceutical, Wyeth-Ayerst Laboratories Meyer, Jonathan M Dainippon AZ, BMS, BMS, Pfizer Inc. Merck, AZ, Janssen- Janssen, Organon Inc., Ortho Pharmaceutica Pfizer Inc., Vanda, Inc., BMS Wyeth Mihajlovic, Aida Assure RX Mirski, Dario Otsuka Mischoulon, David BMS Pam Lab LLC, Amarin, Nordic Reed Medical Educa- Naturals, Ganeden tion, Nordic Naturals Misri, Shaila Lundbeck Canada, AZ Lundbeck Canada, Canada, Pfizer Canada Pfizer Canada, AZ Canada Moussaoui, Driss Sanofi Aventis, Servier, AZ

64 www.psychiatry.org DISCLOSURE INDEX

Stock/ Other Financial Grant/ Speaker’s Other Financial Interest Name Options Consultant Research Support Employee Bureau (specify) Mueller, Cynthia S J&J Ortho-McNeil Janssen Scientific Affairs, LLC Muser, Erik J&J Ortho-McNeil Janssen Scientific Affairs, LLC Husain, Mustafa Advanced Neuromodulation Systems, Inc., Neuronetics Inc., Cyberonics Inc. Nace, David K. McKesson Corp Nahas, Ziad H. Neuronetics Inc. Cyberonics Inc., Medtronic, Neuronetics Inc. Inc., Brainsway Inc, Neu- ronetics Inc. Narasimhan, Meera Lilly Forest, Janssen, Otsuka, Pfizer Inc. Nasr, Suhayl Eli Lilly, Pfizer Inc., BMS Nasrallah, Henry A AZ, Janssen, Merck, Janssen, Forest, Otsuka, AZ, Janssen, Merck, Novartis, Pfizer Inc., Pfizer Inc., Shire US Inc., Novartis, Pfizer Inc. Roche, Sunovion Lilly, Sunovion Nasrallah, Henry A Pfizer Inc., AZ, Jans- Janssen, Forest, Otsuka, AZ, Janssen, Merck, sen, Merck, Sharp Pfizer Inc., Shire US Inc. Sharp & Dohme, & Dohme, Novartis, Novartis, Pfizer Inc., Roche, Sunovion Sunovion Nemeroff, Charles B. Cenerx, Reevax Takeda Nova Del Pharma Inc. Board Pharmaceutical, of Directors, Cenerx Scientific PharmaNeuroBoost, Advisory Board Nova Del Pharma Inc. Newcorn, Jeffrey H. AZ, Lilly, Ortho-McNeil Lilly, Ortho-McNeil Janssen Janssen Scientific Af- Scientific Affairs, LLC, Shire, fairs, LLC Shire, Ridge- Ridgewood Pharmaceuticals wood Pharmaceuticals, Schering-Plough, France Ninan, Philip T. Pfizer Inc. Nunes, Edward V. Alkermes O’Brien, Charles Alkermes, Gilead Sciences, Embera Neu- roTherapeutics, Inc. Offord, Steve J Otsuka Olsen, Dale SIMmersion LLC President CEO Oquendo, Maria A. BMS Janssen Cilag, BMS, Pfizer Inc., Eli Lilly, Shire AZ Ostermeyer, Britta BMS, Evotec, J&J PRD, Pae, Chi-Un GSK, Lundbeck, AZ, Lilly, Otsuka, Pfizer Inc. Papakostas, George I Eli Lilly, Abbott, BMS, Forest, Pam Lab LLC, Pfizer AC Immune Honoraria for lectures, Pam Lab LLC Inc., BMS Abbott Honoraria for lectures, Eli Lilly Honoraria for lectures, Pam Lab LLC Honoraria for lectures, BMS Honoraria for lectures, GSK Honoraria for lectures, Lundbeck Honoraria for Lectures, Otsuka Pharmaceuticals Honoraria for Lectures, Pfizer Inc. Honoraria for Lectures

165th Annual Meeting 65 DISCLOSURE INDEX

Stock/ Other Financial Grant/ Speaker’s Other Financial Interest Name Options Consultant Research Support Employee Bureau (specify) Parameswaran, Sharat G. Janssen Pharmaceutica Inc. R25 MH086466-02 trainee stipend Parikh, Sagar V. BMS, Novartis, Pfizer Inc., AZ, Lilly Canada, Lundbeck Canada Parikh, Sagar V. Lundbeck Canada, Lilly Canada, BMS, AZ Canada, Novartis, Pfizer Canada Parks, Joseph J. Brain Resource Ltd. Patel, Amita R. Novartis, Pfizer Inc., AZ, BMS, Lilly, Forest Pehrson, Alan L Lundbeck Pena, Mario A Janssen Cilag Petersen, Ronald Elan, Pfizer Inc., Janssen Pharmaceu- tica Inc. Philipsen, Alexandra Janssen Cilag, Eli Lilly, Janssen Cilag, Eli Lilly, Novartis, Eli Lilly, Shire US Inc., Novartis Novartis Janssen Cilag Phillips, Katharine A Forest, Trascept Pharm Warren Alpert Medical School of Brown University Salary support, The Free Press Potential future royalties, Oxford Press Royalties, Guilford Publications Potential future royalties, US Food and Drug Administration (FDA) Grant research support and salary Pi, Edmond H. United Biosource Pikalov, Andrei Dainippon Pliszka, Steven R Shire Pope, Laura E Avanir Corporation Avanir Corpo- ration Price, Charles S. Synovion, AstraZen- eca, Pfizer, Merck Prince, Jefferson B. Shire US Inc. Sponsored CME Activity, Ortho McNeil Sponsored CME Activity Rahman, Zia BMS Rapaport, Mark H. Astellas Pharma US, CME Outfitters, CME Inc., BCI, J&J, Wyeth, Institute, Dainippon BrainCells, Inc, Quintiles, Pfizer Inc., Takeda Rasgon, Natalie L. Forest, Wyeth Forest, Wyeth Reifler, Burton V. SeniorBridge SeniorBridge Renner, John A. J&J PRD Reti, Irving Brainsway Inc, Neuronet- ics Inc. Reynolds, Charles BMS, Forest, Eli Lilly, Lilly Research Rivelli, Sarah Abbott, Astellas Pharma US, Inc. Robb, Adelaide McNeill Pediatrics, Bristol Myers, McNeil Bristol Myers, Janssen, GSK, Bristol Myers, McNeil Janssen, GSK, Pfizer Pediatrics, Forest, Merck, Supemus, Pediatrics, Lilly Lilly, Lundbeck Shinogi, Otsuka Otsuka

66 www.psychiatry.org DISCLOSURE INDEX

Stock/ Other Financial Grant/ Speaker’s Other Financial Interest Name Options Consultant Research Support Employee Bureau (specify) Robinson, Donald PGX Health, Dey Phar- maceutical LP, Forest Research Institute Robinson, Robert G. Avanir Corporation Roose, Steven P. Medtronics, Pfizer Inc. Rosenberg, Leon I Forest Research Institute clinical reseach studies, Lilly Research Laboratories, a division of Lilly clinical reseach studies, Otsuka clinical reseach studies Rosenquist, Peter B. Aspect Medical Systems, Inc., NeoSync, Neuronetics Rostain, Anthony L. Ortho-McNeil Janssen Scientific Affairs, LLC, Shire US Inc. Roth, Robert M Shire Rothschild, Anthony J. Lilly, Pfizer Inc., GSK Cyberonics Inc., Takeda Ruaño, Gualberto Genomas Inc President Rugino, Thomas A Lexicor LLC, Shire BMS BMS, Lilly, Shire, Forest Shire Research Institute, Lexicor LLC, Novartis Ryan, Deirdre AZ Canada, Lundbeck AZ Canada Canada, Pfizer Canada Sanchez, Connie Lundbeck Sanchez, Raymond Otsuka Sarwer, David Alergen NCE, Baronova National Institutes of Health Saveanu, Radu V. Novartis, GSK, Brain Resource Schatzberg, Alan F. Nova Del Pharma BrainCells, Inc, Cenerx, Corcept Therapeutics, Inc. Royalty Inc., Forest, Phar- Nova Del Pharma Inc., maNeuroBoost, En vivo, Takeda Synosia, Cenerx, Neurocrine, Corcept Therapeutics, Inc., Pfizer Inc., Merck, Brain Cells Inc Schiller, Mark J. CNS Response Schultz, S. Charles Biovail Laboratories, Otsuka, Rules Based Medi- Inc., Lilly cine Inc, AZ Sclar, David A BMS, Lilly, Pfizer Inc., Lilly, Pfizer Inc., GSK, Forest Dey Pharmaceutical LP Shaffer, David AFSP Shah, Asim Evotec, J&J PRD AZ Shannahoff-Khalsa, David WW Norton & Company royalties to books used in my courses Shear, M. Katherine AFSP Simon, Naomi M. Forest, GSK, Lilly Research Pfizer Inc. Speaking/CME/ Laboratories, Sepracor Inc. Consulting Simpson, Helen B. Janssen, Trascept Pharm Simpson, Helen Janssen, Trascept Pharm Siu, Cynthia O Pfizer Inc., Sunovion Small, Gary W. Dakim Novartis, Dakim, Novartis, Forest Forest, Schwabe, Lilly Research Laboratories, a division of Lilly

165th Annual Meeting 67 DISCLOSURE INDEX

Stock/ Other Financial Grant/ Speaker’s Other Financial Interest Name Options Consultant Research Support Employee Bureau (specify) Soares, Jair C. BMS, Repligen, GSK Beechum Pharmaceuticals, Forest, AZ Sockalingam, Sanjeev Lundbeck Canada Solanto, Mary Shire US Inc. Sprich, Susan Oxford Press I co-authored the therapist guide and client workbook entitled “Mastering Your Adult ADHD” published by Oxford University Press. I receive royalty payments from Oxford University Press. Stahl, Stephen M Janssen, Jazz Phar- Pharmasquire, BMS, Eli Lilly, Merck, Schering macuetical, Biovail, Lundbeck, Sanofi Aventis, Corporation, Pfizer Meda Corp, Alkermes, AZ, Boehringer Ingelheim, Inc., Wyeth SK Corporation, Sof- Cephalon Inc., Dainippon For- finova, Vivus, Allergan, est, Novartis, Pam Lab LLC, Sepracor Inc., Servier, Pfizer, Schering Corporation, Covance, BioMarin, Sepracor Inc., Shire US Inc., Meiji, Pierre Fabre, Wyeth-Ayerst Pharmaceuti- Prexa Pharmaceu- cal Company ticals, Propagate Pharma, Rexahn, Roy- alty Pharma, Cenerx, Eisai Inc., Merck & Co., Inc., Otsuka Phar- maceuticals, Pfizer Canada, PGxHealth, Schering Corporation, AstraZeneca Phar- maceuticals, Arena Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb, Cypress Bioscience, Dainippon Sumitomo Pharma Co., Ltd, Eli Lilly and Company, Forest Laboratories, Inc., GlaxoSmithKline, Labopharm Inc, Lundbeck, Neuronet- ics Inc., Marinus Pharmaceuticals, No- vartis Pharmaceuticals Corporation, Pam Lab LLC, Pfizer Inc., Sanofi Pharmaceuticals, Inc. , Shire Pharmaceuti- cal Development, Inc., Wyeth-Ayerst Pharmaceutical Com- pany, Wyeth-Ayerst Laboratories, Vanda Pharmaceuticals, Solvay Pharmaceuti- cals, Inc. Starace, Anju Forest Research Institute Starks, Steven AZ Recipient of a Diversity Leader- ship Fellowship (funded by the above organization) Stigler, Kimberly A. BMS, Lilly, Forest Research Institute, Ortho-McNeil Janssen Scientific Affairs, LLC, Janssen

68 www.psychiatry.org DISCLOSURE INDEX

Stock/ Other Financial Grant/ Speaker’s Other Financial Interest Name Options Consultant Research Support Employee Bureau (specify) Sullivan, Patrick SAB Eli Lilly Sullivan, Maria A. Reckitt Benckiser Pharma- ceuticals, Alkermes Summers, Richard F. Biogen Suppes, Trisha Pfizer Inc., AZ, Sunovion Jones and Bartlett Royalties Surman, Craig B. Shire US Inc., Takeda, McNeil, Shire US Inc., Takeda McNeil, Novartis, JanssenCanada Sponsored talks, McNeil Shire US Inc. Shire US Inc. Educational and Survey Funding Swartz, Holly Navigant, Scimed Servier (honorarium) Swartz, Marvin S. Novartis Lilly Swerdlow, Neal R. Neurocrine Tamminga, Carol A. PureTech Ventures, Pfizer Inc. Expert Witness Lilly, Sunovion, Merck Thase, Michael E Otsuka, Pfizer Inc., Lilly, Osuka, Forest Merck, Shire US Inc., Forest Trimble, Michael Pfizer Inc., Sanofi Aventis, Janssen Cilag Turkington, Douglas Janssen Cilag, BMS Turkoz, Ibrahim J&J J&J PRD Van Ameringen, Michael Lilly Canada, Shire, Lilly Canada, Pfizer Inc., Lundbeck Canada, Labopharm Inc, Pfizer JanssenCanada, Wyeth Valeant Pharmaceu- Inc., Valeant Pharma- Canada ticals, Janssen- ceuticals Canada, Pfizer Inc. Vieta, Eduard Eli Lilly, Forest Re- search Institute, GSK, Servier, Schering- Plough, France, Solvay, Takeda, Wyeth, AZ, BMS, Janssen Cilag, Jazz Pharmacuetical, Johnson & Johnson, Lundbeck, Novartis Pharmaceuticals Corporation, Organon, Otsuka Pharmaceuti- cals, Pfizer Inc., Pierre Fabre, Sanofi Aventis Walkup, John T. Guilford Publications Royalties, Pfizer Inc. Free drug and placebo for completed NIMH study, Eli Lilly Free drug and placebo for completed NIMH study, Abbott Free drug for completed NIMH study, Walsh, B. Timothy AZ Weiden, Peter Merck Roche, Ortho-McNeil Janssen Merck, Pfizer Inc., Ortho-McNeil Janssen Scientific Affairs, LLC, Roche, Sunovion, Novartis, Scientific Affairs, LLC, Sunovion, Novartis Ortho-McNeil Sunovion, Novartis Janssen Scientific Affairs, LLC

165th Annual Meeting 69 DISCLOSURE INDEX

Stock/ Other Financial Grant/ Speaker’s Other Financial Interest Name Options Consultant Research Support Employee Bureau (specify) Weisler, Richard Pharmacia & Upjohn Otsuka, Pfizer Inc., Organon Inc., Otsuka, Otsuka, Pharmacia Company, Inc., Pharmacia & Upjohn Pharmacia & Upjohn Com- & Upjohn Company, Burroughs-Wellcome Company, Inc., Repli- pany, Inc., Repligen, Sandoz Inc., Sanofi-Synthe- Pharmaceutical gen, Sanofi-Synthelabo Pharmaceuticals Corporation, labo Pharmaceuti- Company, Dainippon Pharmaceuticals, Sanofi Aventis, Sanofi- cals, Inc., Schwabe, Inc., Schwabe, Solvay, Synthelabo Pharmaceuticals, Solvay, Synaptic, Synaptic, Vela, Wyeth, Inc., Schwabe, Sepracor Vela, Wyeth, Organon Abbott, AstraZen- Inc., Shire, Solvay, Takeda, Inc., Abbott, AZ, eca Pharmaceuticals, TAP Pharmaceuticals, Biovail, Laboratories, Biovail Laboratories, UCB Pharma, Inc., Abbott Inc., Bristol-Myers Inc., Bristol-Myers Laboratories, AstraZeneca Squibb, Burroughs- Squibb, Burroughs- Pharmaceuticals, Biovail Wellcome Pharma- Wellcome Pharmaceu- Laboratories, Inc., Bristol- ceutical Company, tical Company, Ciba Myers Squibb, Burroughs- Ciba Geigy Corpora- Geigy Corporation, Wellcome Pharmaceutical tion, Pharmaceutical Pharmaceutical Company, Cephalon Inc., Division, Forest Division, Cortex Ciba Geigy Corporation, Phar- Research Institute, Pharmaceutical, Forest maceutical Division, Corcept GlaxoSmithKline, Research Institute, Therapeutics, Inc., Eisai Janssen Cilag, John- GlaxoSmithKline, Jans- Inc., Eli Lilly and Company, son and Johnson sen Cilag, Lundbeck Forest Research Institute, PRD, Lundbeck GlaxoSmithKline, Janssen Cilag, Johnson and Johnson PRD, Lundbeck, Merck & Co., Inc., McNeil Pharmaceuticals, National Institute of Mental Health, Neurochem, Novartis Pharmaceuticals Corporation Weissman, Myrna M. MultiHealth Systems Inc. Receive royalties Wernert, John J. Sunovion Williams, Jill M. Pfizer Inc. Pfizer Inc. Williams, Janet B MedAvante Williamson, Johnny Novartis Wise, Thomas N. Eli Lilly Wisner, Katherine L Lilly Novartis donation of active and placebo estradiol patches for an NIMH funded randomized controlled trial Wong, Bruce J Otsuka Wright, Jesse H. Empower Interactive Takeda Xu, Jane Sunovion Young, Joel L Cyberonics Inc., Lilly, Novar- Novartis, AZ, Avanir Eli Lilly Advisory boards, Novartis tis, Otsuka, Pfizer Inc., Shire Corporation, BMS, Advisory boards, Shire Advisory Lilly, Forest, Merck, boards, Shionogi Inc. Advisory Shire, Shionogi Inc. boards Young, L. Trevor AZ, Lilly Youngstrom, Eric A. BMS travel support Zajecka, John PamLabs, Otsuka, Ab- McNeil, Takeda, Otsuka, Otsuka, Eli Lilly, bott, Eli Lilly, Novartis AZ, Boehringer Ingelheim, BMS, PamLabs, AZ BMS, Cyberonics Inc., GSK, McNeil, PamLabs, Novartis Pharmaceuticals Corporation, Pfizer Inc. Zatzick, Douglas F. National Institutes of Health Ziegler, Penelope P. Medicom Worldwide Inc.

70 www.psychiatry.org DISCLOSURE INDEX THE FOLLOWING PRESENTERS INDICATED NEITHER THEY NOR AN IMMEDIATE MEMBER OF THEIR FAMILY HAVE ANY SIGNIFICANT RELATIONSHIP TO DISCLOSE

Abbass, Allan A. Ayuso, Jose L. Bhatt, Smita Campbell, Frank Abbey, Susan E. Azeem, Muhammad Waqar Bhugra, Dinesh Campo-Arias, Adalberto Abi-Dargham, Anissa Baca-Garcia, Enrique Bindal, Ankur Cannon, Tyrone D. Abizadeh, Jasmin Back, Sudie Bjork, James M. Cao, Xiaohua Abraham, Henry D Bagby, R. Michael Bjorkenstam, Charlotte Capaldi, Vincent F Abrams, Karen M. Bahnson, Brenda A. Bjorkenstam, Emma Caplan, Arthur Abuzzahab, Faruk S Bahroo, Bhagwan A Blair, Ellen W Captain, Farrokh K. Acharya, Monika Baile, Walter F. Blanch, Jordi Caravella, Rachel Ackerman, Marra Bailey, Rahn K. Blanchard, Jack J. Carlat, Daniel J. Adelson, Stewart L. Bailey, Brigitte Blanco-Jerez, Carlos Carlson, Cindy Agarwal, Vishesh Bailey, Sue Blanco-Lutzen, Sally Carlton, Richard M. Aggarwal, Richa Balan, Yener A Bland, D. Anton Carnes , Patrick Aggarwal, Rashi Balasubramaniam, Meera Blinder, Barton J. Caroff, Stanley N. Aguilar-Gaxiola, Sergio Bales, Dawn L. Bloch, Michael H. Carvalhal, Adriana Ahmad, Mohit Balfour, Margaret Block, Jerald J. Casey, David A. Ahmed, Iqbal Ball, Valdesha Blow, Frederic Cassano, Paolo Ahmed, Sadaf Balon, Richard Blum, Joshua Cassin, Stephanie Ahmed, Ameena T. Balt, Steven Blum, Nancee S. Castellano, F. Xavier Ahmedani, Brian K. Barber, Jacques P. Blum, Steve Castilla-Puentes, Wilma I Ahuja, Amir K Barber, Mary E. Bobish, Jena L Cerimele, Joseph Ak, Mehmet Barnas, Gretchen G Boche, Benjamin Cerny, Cathleen A. Akil, Mayada Barnett, Nancy Bodèn, Robert Certa, Kenneth M. Aklin, Will Barnhill, John W. Boisseau, Christina L. Cha, Danielle S Alao, Adekola Baron, David A. Boland, Robert J. Chadha, Puja Alarcon, Renato D. Baron, Steven H. Bonnie, Richard J. Chan, Carlyle H. Alatise, Adeniyi Barrett, Marna Book, Howard E. Chander, Geetanjali Alberati, Daniela Barsky, Arthur J. Book, Sarah Chanen, Andrew M. Aldea, Ivan O Bartlik, Barbara Booty, Andrew Chang, Denise Alexander, Regi T. Barton, Jonathan Bordnick, Patrick S. Chapel, Sunny Alexander, Danielle Barzman, Drew Bornstein, Robert F. Charach, Alice Alexander, Cara J Bateman, Anthony W. Borsook, David Chauhan, Mohit Alexander, Randolph Batista, Sharon M. Bostwick, Jolene R. Chawla, Monica Alexander, Mary Jane Baum, Antonia L. Boutros, Nash N. Chawla, Jatinder M Alexeenko, Lada Baum-Baicker, Cynthia Bradley, John C. Cheatle, Martin D. Alfonso, Cesar A. Bauza, Pedro Brady, Kathleen Cheema, Mohsin A Allred, Patricia Baweja, Raman Bree, Dan Chen, Lian Yu Althoff, Robert R. Bazzi, Lama Breitbart, William Chen, Cory K. Alverio-Pares, Carlos M Beahrs, John O. Brendel, David Cheng, Jason E Amen, Daniel G. Beardslee, William R. Brinkley, Trimaine M. Cheong, Josepha A Amin, Rohul Beck, Judith S. Brodkey, Amy C. Chiarelli (U.S. Army Retired), An, Na-Young Becker, Daniel F. Brodsky, Beth S. General Peter W. Anderson, Allan A. Beeber, Alan R. Brooks, Beth Ann Chilton, Julie A Anderson, Tanya R. Beiling, Peter Brouette, Thomas E. Chilton, Julie A. Anderson, Elijah Bell, Carl C. Broussard, Beth Chiu, Simon Anderson, Otis Bell, Morris D. Brown, Gregory K. Cho, Seongjin Annas, George D Belmonte, David C. Brown-Nyseth, Victoria L Choi, Hyungin Anspikian, Ara Belnap, Barri Brownridge, Andrea M Choi, Octavio Anzia, Joan M. Benders-Hadi, Nikole S. Buchanan, Susan Choice, Tanishia Apfebaum, Sergio D Benedek, David M. Buck, David Choi-Kain, Lois W. Appareddy, Vijayalakshmi Benedek, Elissa P. Buckstein, Oscar G. Chopra, Amit Apter, Gisele Benedek, David Bulbena, Antonio Chowdhury, Noshin Arango, Juan C Benson, Timothy Burd, Ronald M. Christmas, June J. Arnaout, Bachaar Berko, Anat Burkey, Matthew D Chung, In Won Aronson, Mara Berkson, Sarah Y Burnett Sr., Arthur L. Chung, Chung Yeub Arora, Prerna Berlin, Jon S. Busner, Joan Ciccone, Donald S Arroyo, William Berman, Ellen M. Bustamante, Pedro M. Cinar, Mehmet Alper Ashley, Kenneth B. Bernstein, Carol A. Buxbaum, Joseph Ciraulo, Domenic Aslan, Selcuk Berrettini, Wade H Buyse, Valerie J. Cisse, Aminata Atdjian, Sylvia Best, Michael Cabaj, Robert P Clarke, Diana E. Attia, Evelyn Bestha, Durga Cabaniss, Deborah Clarkin, John F. Aurora, Rozy Betts, Keith Cagande, Consuelo C. Clayton, Paula J. Avasthi, Ranjan Bhalla, Ish Cain, Tonier Clements, Julie A. Avellaneda Ojeda, Andres A Bhat, Venkataramana Campbell, William H. Coffey, M. Justin Axelson, Alan Bhatia, Kamal Campbell, William Coffey, C. Edward

165th Annual Meeting 71 DISCLOSURE INDEX

Cogollo, Zuleima DiBernardo, Allitia Fisher, Caroline Gogineni, R. Rao Cohen, Carl I. Dicker, Rachel Fishkind, Avrim B. Gogtay, Nitin Cohen, Mary Ann Dickerson, Daniel L. Fitelson, Elizabeth M. Goin, Marcia K. Cohen, Mitchell J. M. Dickstein, Leah J. Fitzgerald, David Goisman, Robert M. Coia, Denise Diebold, Carroll J. Flosnik, Dawn L Gold, Liza H. Combs, Mark Dimsdale, Joel E. Flynn, David Golden, Jane Compton, Michael T. Dingle, Arden D. Foidel, Sarah Goldman, Marina Corchado, Lisa Direk, Nese Fonagy, Peter Goldsmith, Scott J. Cornelius, Jack R. Dooley, Patricia Forester, Brent P. Goodman, Marianne Cortes, Jacqueline Dougherty, Kathleen C. Forgey, Marcy J. Goodman, Marianne S. Courchesne, Eric Douglas, Steven Forgey, Marcy Goodman, Wayne Cournos, Francine Douglas, Kelly Forman, Marc Goodwin, Ericka L. Courtet, Philippe Drake, Robert E. Forstein, Marshall Gordon, Kimberly Cowley, Deborah S. Drescher, Jack Fossati, Andrea Gordon, Edward Cozza, Kelly L. Drury, Stacy S. Foubister, Nicole A. Gordy, Tracy R Crapanzano, Kathleen Druss, Benjamin G. Fox, Andrea Gorelick, David A. Creedon, Jennifer Du, Ye B. França, Milena Goschin, Simona Creelman, Wayne L. Duda, Roger Francis, Michael M Gotlib, Ian Crisp-Han, Holly Dudley, Richard G. Frank, Julia Gourevitch, Raphael Cristancho, Mario A Duffy, Farifteh F. Frank, Julia B. Granacher, Robert P. Crocker, Benjamin Dupont, Robert L. Frankenburg, Frances R. Grassi, Luigi Crocq, Marc Antoine Duquette, Patrice M. Franklin, Martin E. Greden, John F. Crome, Erica M Durham, Michelle Frascella, Joseph Greenberg, Benjamin D. Crone, Catherine C. Durmaz, Onur Freedman, Jacob L. Greer, Brendan Crosier, Amanda Earley, Paul H Freedman, Robert Gregory, Robert J. Crow, Katy Edgcomb, David B Fretwell, Heather M. Griffin, Marilyn Crowley, Brian Ehret, Megan J. Fried, Stephen M. Griffith, James L. Cucchiaro, Josephine Einarson, Adrienne Fried, Joanna Grosjean, Bernadette M. Cuffe, Steven P. Eisen, Jane Friedman, Matthew J. Grossberg, Paul Cutler, Janis L. Eist, Harold I. Frometa, Ayme Gunderson, John G. Cyriac, Thomas Eknoyan, Donald P. Frosch, Emily Gupta, Amit D Silva, Sahana K. El Gabalawi, Fayez Frye, Mark Gupta, Anuj D Souza, Neisha A. Elizondo, Paul M. Fryman, Jayce A Gupta, Aarti Daley, Christopher Ellison, James M. Fuentes, Manuel E. Gupta, Swapnil Dalkilic, Alican Elman, Igor Fulk, Michelle Gur, Raquel E. Dallaire (Ret’d), Senator, Elsheshai, Adel M Fusco, Gina Guschwan, Marianne T. LGen the Hon. Romeo A. Engel, Charles C. Gabay, Pablo M Gyulai, Laszlo Dalseth, Natasha Engstrom, Frederick W. Gabbard, Glen O. Habeych, Miguel E. Daub, Suzanne Erlich, Matthew D. Gage, Shana Habl, Samar Davidoff, Donald A. Euler, Dillon Gallagher, Sean Haddjeri, Nasser Davine, Jon S Evans, Elizabeth Gaman , Alexandru Hafter Gray, Sheila Davis, Jeri Evans, Arthur C. Gambheera, Harishchandra Haglund, Margaret Davis, Mary Helen Everett, Anita S. Garber, Mandy Hahn, David Daviss, Steven R. Faden, Vivian Garcia-Aracena, Elena F Hales, Deborah J. Day, Susan Falcone, Tatiana Garcia-Toro, Mauro Hales, Robert E Dayanandam, Eswar Kumar Falk, Katherine Gardner, Ann Hall, James Dazzi, Sergio Falk, Dan Gastelum, Emily Haller, Deborah L. De Figueiredo, John M. Fallon, Brian A. Geboy, Alexander G Hallman, Ilze S. Dedesma, Ronit K Farmer, Carrie M. Geller, Jeffrey Halper, James Deen, Serina R. Faulkner, Larry R. George, Lisa St. Halpern , Abraham L. Deepan, Singh Fauman, Beverly J. Geschwind, Daniel Halverson, Jerry L. Degruy, Frank Fawcett, Jan Ghaffar, Sadia Hamkins, SuEllen DeJong, Sandra M. Fayad, Sarah M. Gibbs, Jerome M. Hammer, Paul S. Del Busto, Elena T. Fedovskiy, Kaney K. F. Gielen, Konstant Han, Jaesu Dell’Osso, Bernardo Feffer, Kfir Gildengers, Ariel Han, Kyoungho DeMaria, Rita Feldman, Lance Gillean, John A Hanlon , Colleen A. Demars, Cathy Fernandez, Antony Gillece, Joan Hanrahan, David M De-Melo-Neto, Valfrido L Ferrer, Aderezza Gilmer, Evan Hanson, Annette Denninger, John W. Fetterolf, Frank A Ginory, Almari Harding, Kelli Desai, Abhilash K. Feusner, Jamie Girgis, Christina Harmandayan, Maria Desai, Nitigna V Filbey, Francesca Gise, Leslie H. Harrington, Colin J. Desbeaumes Jodoin, Veronique Filmyer, Dawn Giwa, Aishat Harris, Toi B. Detke, Holland C Fine, Carla Glick, Rachel L. Harsh, John Deutsch, Stephen I Fink, Paul J Glick, Jeremy Harvanko, Arit Dewan, Mantosh J. Fink, Per C. Glick, Hannah Harvey, Renee Dhillon, Vikram Finnegan, Nora Godleski, Linda S. Hashem, Ryan Dhopesh, Vasant P. Fiorillo, Andrea Goethe, John W. Hasija, Deepa Diamond, Diana Firdous, Begum Goforth, Harold W. Hasin, Deborah S.

72 www.psychiatry.org DISCLOSURE INDEX

Hassano, Mayuri Isenberg, Keith Kay, Jerald Kuramoto, S. Janet Hatters-Friedman, Susan Ivashinenko, Dimitry Kay, Abigail Lachance, Laura Hatti, Shivkumar S. Ivbijaro, Gabriel Kayser, Robert A. Lackamp, Jeanne M. Hawa, Raed Iyer, Aparna Keith, Patricia LaCroix, Camille A. Hawkins, Alric D. Izediuno, Ifeanyi Keitner, Gabor I. LaGarde, Elise Hazlett, Erin A. Izenwasser, Sari Kellermann, Sirid Lakshmana Balaji, Arjun Heilig, Markus Jackson, James S. Kellner, Charles Lam, Sherrell T Helms, Joseph M. Jacobs, Petra Kelly, Meredith A. Lambert, Kristen M. Hemmings, Sian Jain, Gaurav Kelly, Patrick Lancaster, Michael Henderson, Schuyler W. Jain, Abhishek Kelsoe, John R. Langan, Julie Hendriks, Margaret H Jain, Sargam Kennedy, Robert S. Langheim, Frederick JP Henry, Cassis Jalali Roudsari, Mohsen Kennedy, Cheryl Ann Lanius, Ruth A. Herazo, Edwin Jalees, Shah Kent, Laura K. Lansky, Madeleine Hermann, Alison D. Jamadar, Sharna Kern, John S. Lapidus, Manana Hermanstyne, Keith Jamison, Kay Redfield Kernberg, Otto F. LaRiviere, Lori L Herpertz, Sabine Janofsky, Jeffrey Kertzner, Robert M. Lattimer, Cheri Herrman, Helen E. Jaycox, Lisa Kesebir, Sermin Lavania, Sagar Heru, Alison M. Jee Hoon , Sohn Keuroghlian, Alex S. Lawson, William B Hickey, Anita H. Jehi, Lara Khan, Christina T. Lazar, Sara Hickman, Matt Jensen, Brenda Khan, Arif Lazarevic, Sonya Hill, Marjorie Jeste, Shafali S. Khan, Mohammad L Lazarus, Jeremy A. Hilty, Donald M. Jeste, Dilip V. Khan, Jamsheed H Leary, Kimberlyn Hindi, Amjad Jilani, Zebunisa A. Khushalani, Sunil D. Lecours, Maurice Hipolito, Maria Mananita S Jimenez, Carolina Kidd, Jeremy D Lee, Jeewon Hobday, Gabrielle Jimenez, Ester Kim, Yong-Ku Lee, Kang Joon Hochfeld, Marla Jindal, Monika Kim, Hyun Lee, Jongha Hoffman, Perry D. Joanne, Fertig Kim, BoAh Lee, Seungyup Hogue, Aaron John, Rakesh Kim, Chul-Eung Lee, Allison M Holleman, Kevin John, Nadyah J. Kim, Haebin Lee, Min-Soo Holler, Rhea Johnson, Robert W. Kim, Wonwoo Lee, Elliot Holtzman, Niki S Johnson, Sarah Kim , Jin-Nah Lee, Chuan-Mei Hopenwasser, Karen Johnson, Bankole A. Kimmel, Susan Legha, Rupinder K. Hopwood, Christopher J. Joly, Olivia M. King, Nicole M. Leichter, Josh Horan, William P. Jones, Billy E. King, Howard Leichter, Franz Horgan, John G. Jones, Kristina Kirson, Noam Leichter, Kathy Hornbaker, Michelle Joseph, Robert C. Kissane, David W. Leifman, Steve Horne, Christopher B Jovanovic, Nikolina Kissell, Robin L. Leigh, Hoyle Horseman, Casia Jun, Tae-Youn Kljenak, Diana Leight Wesley, Kristin Horvitz-Lennon, Marcela Jung, Sungwon Koenigsberg, Harold W. Leon, Alejandra L. Houri, Alaa K Jung, Hyun Jin Koffman, Robert L. Leon-Andrade, Carlos A. Howe, Edmund G. Junquera, Patricia Kogan, Richard Lester, Natalie Huang, Hsinte M Justice, Ledro Koh, Steve Leung, Margaret W. Huebner, Robert B. Kaasenbrood, Adrianus J. A. Kolli, Venkata B. Levander, Eric Huffine, Charles W. Kabat-Zinn, Jon Kolodner, Robert M. Leventhal, Bennett L. Hunter, Jon J. Kahlon, Harnek Komrad, Mark S. Levine, Jack Hunzeker, Adam L Kalaf, Juliana Koob, George F. Levkovich, Natalie Huprich, Steven Kalman, Thomas P. Kool, Simone Levounis, Petros Huremovic, Damir Kampman , Kyle M. Kopelowicz, Alex Levy, Steven Hurst, Donald Kandel, Eric R. Kopp, Melanie Levy, Kenneth N. Hussain, Maria Kanel, Keith Kotwicki, Raymond Lewis, Marshall E. Hussaini, Syed Q Kansara, Neha Koyuncu, Ahment Li, Jianying Hutchinson, Kent Kanukuntla, Tulasi Kozloff, Nicole Liebert, John A Hutner, Lucy A. Kanwar, Jyoti Kraemer, Helena C. Lifton, Robert J. Hwang, Heesung Kapetanovic, Suad Krakowski, Menahem I. Lin, Iris H Hwang, Soonjo Kaplan, Allan Kramer, Milton Lin, Chieh-Hsin Hyler, Steven E. Kaplan, Dorothy Kraus, Louis J. Linares, Francisco Hyman, Steven E. Karam, Elie G. Krishna, Nithin Lineberry, Timothy Hyun, Aerin M. Karim, Syed A Krogsgaard Bording, Malene Linehan, Marsha M. Hyun-Chung, Jang Kasckow, John Kroll, David S. Lipsitt, Don R. Iarovici, Doris M Kasick, David P. Krystal, Andrew Litten, Raye Z. Ice, Susan Kass, Erica P. Krystal, John H. Little, Karley Y. Iftene, Felicia Kasuba, Bryce E Kubie, John L. Livesley, John Iglewicz, Alana Kataoka, Sheryl Kudler, Harold Lloyd, Robert B Ingenhoven, Theo Kates, Nick Kulkarni, Chetana Lluberes, Nubia G Iqbal, Mudassar Kathol, Roger G. Kulkarni, Gaurav Lobach, Liudmila Iren Akbiyik , Derya Katz, Craig L. Kumar, Yingying S Lock, James Irwig, Michael Katzman, Gary Kumar, Sanaz Lomax, James Isaac, Mohan Kaufmann, Michael W. Kupfer, David J. Lopez, David L.

165th Annual Meeting 73 DISCLOSURE INDEX

Lorenzo, Diana A McCormick, Laurie M. Muttineni, Jyotsna Pandey, Ghanshyam N. Lott, David McDonnell, David P Myers, Wade Pandya, Anand Lovern, Robert E McDowell, Anna Myers, Michael F. Pappalardo, Stephen Low, Nancy C McDuff, David Na, Kyoung-Sae Pardes, Herbert Lowenkopf, Eugene L. McGovern, Mark P. Nadeem, Ferhana Parens, Henri Lu, Francis McGraw, Deven C. Nadelson, Carol Parida, Suprit Lubarsky, Katherine E McGuire, Lauren Nader, Michael A. Parikh, Rajesh M. Lukasik, Daniel T. McIntosh, Christopher A. Nagalla, Madhavi Parikshit, Deshmukh Lukens, Jonathan McIntyre, Kathryn Nair, Beena Paris, Joel Luo, John McKay, James R. Nakamura, Mitsuhiro Parish, Brooke Lusins, John O McKinney, Jacki Nam, Jiwon Park, Min-Cheol Lusskin, Shari I. McKnight, Curtis A. Napoli, Joseph C. Park, Yong-Chon Lux, Joseph Z. McLay, Robert Nardi, Antonio E Parmar, Varinderjit S Luyten, Patrick McLellan, A. Thomas Narrow, William E. Parsons, Sarah E. Lynch, Alison C. McLeod-Bryant, Stephen A. Nascimento, Antonio L Pasic, Jagoda MacDonald III, Angus McMillan, Gary A. Nash, Maureen C. Patel, Shirish Mack, Avram H. McQuistion, Hunter L. Nastasi, Robert Patel, Rupal Madabushi, Jayakrishna S. McVoy, Molly K. Natarajan, Nirupama A Patel, Harshad C Madan, Pavan K Mehl-Madrona, Lewis Nawka, Alexander Pato, Carlos Magro, Todd Melek, Stephen P. Neale, Benjamin Pato, Michele T. Mahal, Satinder K Mercader, Carolina Nelsen, Andrea Patten, Scott Mahendran, Rathi Meyer, Phil Nelson, Christopher S. Patterson, Gloria Mainguy, Barbara J. Meyers, Nicholas M. Nelson, Charles Paul, Steven Maitland, Melissa Mian, Ayesha Nemiary, Deina Peel, Deborah Majeed, Muhammad H Michels, Robert Nerval, Dorly Peele, Roger Majeed, Kiran Miciano, Armando S Neuhut, Samuel Peglow, Stephanie l Majeed, Salman Miclutia, Ioana Valentina M New, Antonia S. Penciu, Cristian Malaspina, Dolores Mikesell, Lauren C Newkirk, Cassandra F. Pender, Vivian B. Maldonado, Jose R. Mikkola, Eeva Newman, Joseph P. Penn, Joseph Malik, Mazhar Miklowitz, David J. Newmark, Thomas S. Penska, Keith Malik, Abid Milburn, Christopher A. Ng, Bernardo Peracha, Feriha N. Malmquist, Carl P. Millegan, Jeffrey Nica, Sorin Perez Rodriguez, M. Mercedes Mangurian, Christina V. Miller, Ashley K. Niedermier, Julie Perez-Rodriguez, Mercedes Mannelli, Paolo Miller, Dinah Niedtfeld, Inga Perlman, Barry B. Manring, John Miller, Laura Nieto, Rodrigo Perry, John C. Manschreck, Theo Miller, Benjamin Norris, Lorenzo Pessar, Linda F. Marambage, Kapila A Miller, Gregory A. Norris, Donna M. Peteet, John R. Marazziti, Donatella Minervino, Alfredo Jose Notman, Malkah T. Petitjean, Francois C. Marchionni, Christine Mintz, David L. Noursi, Samia D. Petrovic-Dovat, Lidija Marcu, Jahan Mistler, Lisa A. Novick, Andrew M Phillips, James E. Mariani, John J. Mitsuishi, Fumi Nuland, Sherwin Photos, Valerie I. Marienfeld, Carla B. Mittal, Dinesh Nunes, Sandra Odebrecht Vargas Pierre, Joseph M. Marijnissen, Radboud Moamai, Javad Nurenberg, Jeffry R Pies, Ronald W. Marin, Alina Moffic, Steven O Connor, Stephen Pike, Kathleen M. Markota, Matej Mojtabai, Ramin O Dowd, Mary Pinals, Debra Markov, Dimitri D Mollica, Roberto O Hara, Ruth Pincus, Aaron L. Markowitz, John C. Money, Nisha N. O Reardon, Johnny Pincus, Harold A. Marks, Saul I. Monin, Joan O Reardon, John Pine, Daniel Marsch, Lisa A. Montoya, Ivan D. O’Donnell, Lolita Plakun, Eric M. Martin, Glenn A. Moon, Young S Ogundeji, Olufemi Plovnick, Robert M. Martin , Sonya L . Mooney, Larissa Oh, Esther E. Pogarell, Oliver Martinez, Diana Moore, Andrea J. Okusaga, Olaoluwa Pogge, David L Martinez, Octavio N. Moore, Michelle B. Olarte, Silvia W. Pollack, David A. Martinez-Saravia, Rosario I Moreira-Almeida, Alexander Oldham, John M. Pontius, Edward Massey, Suena H Morley, James F. Oleshansky, Marvin Porr, Valerie Mathews, Annette Morrato, Elaine Oleskey, Christopher J. Porter, Michael Mathur, Nivedita Moscicki , Eve K. Olsen, Christina K Post, Jerrold M. Matlin, Samantha Mosnaim, Aron D Olson, Kelly Powell, Samantha Matthys, Sarah C Mousa, Sylvia Ordorica, Patricia I. Powell, Steven W Mauldin, Sheila Mrazek, David A. Osher, Fred C. Powers, Rebecca A. May, Catherine S. Munir, Farah Osofsky, Howard J. Powsner, Seth Mayberg, Helen S. Munk-Jørgensen, Povl Osofsky, Joy D. Price, Marilyn Mayer, Laurel Munoz, Rodrigo A. Osser, David N. Primeau, Michelle Maytan, Margaret Musher, Jeremy S. Oviedo, Heidi C Primm, Annelle B. Mazaheri, Sara Muskin, Philip R. Owen, Richard R Privitera, Michael R. McClintock, Shawn Musso, Giovanna M Pain, Clare Pumariega, Andres J. McCloskey, Michael S. Muszynski, Irvin Palazzo, M.Carlotta Pumphrey, Dara N McClure, Deimante Muth, Shawn Palmer, Brian A. Qazi, Farhana

74 www.psychiatry.org DISCLOSURE INDEX

Quang-Dang, Uyen-Khanh Ronningstam, Elsa Schwartz, Joseph M Sliwa, Jennifer K Rackley, Sandra Rooney, Melissa H. Schwartz, Lauren H Smith, Darryl C. Radke, Alan Q. Rosen, Anna H. Schwartz, Harold I. Smith, Mariann W. Ragab, Sherif A. Rosen, Donald E. Sean, Kerrigan Smith, Delaney Rajagopalan, Krithika Rosen, Brooke Seawell, Monifa Snyder, Kristen Ramani, Meena Rosenberg, Ronald C Sederer, Lloyd I. Sobanski, Thomas Ramchand, Rajeev Rosenberg, Ken Seedat, Soraya Sobreiro , Matldes Ramos, Pamela Rosenthal, Joshua Seidman, Larry J. Sofair, Jane B. Ramsay, Russell Rosnick, Phillida Seigler, David Soliman, Sherif Ramtekkar, Ujjwal P Rothe, Eugenio M. Selvarajah, Jennifer Solomon, Phyllis Raney, Lori Rothenberg, Kasia G Selzer, Jeffrey A. Solomon, Barry S. Rankin, Susan Rowley, Robert Senis, Elaine Son, Ji Hyun Ranz, Jules Roy-Byrne, Peter P. Sepah, Torang S. Sonawalla, Shamsah B. Rao, Nyapati R. Ruiz, Amanda Serby, Michael J Sorel, Eliot Rasic, Daniel T Ruiz, Pedro Serrano, Neftali Sorensen, Helle O Raskind, Murray A. Ruocco, Anthony C. Servis, Mark Sperber, Jacob E. Rathod, Shanaya Rushing , Susan E. Shackelford, James R. Spiegel, David Ratzliff, Anna Russakoff, L. Mark Shah, Shaneel Spiegel, David R. Ravindran, Rohini Russom, Elsa Shah , Amy Spinelli, Margaret Ray, Kevin Rutter, Michael Shahmoon Shanok, Rebecca Sprott, Richard A. Real, Lawrence A. Ryan, Anne T. Shannon, Scott Spurgeon, Joyce A. Reardon, Claudia L. Rychik, Abe M. Shapiro, Edward R. Srabstein, Jorge Reardon, James D. Rynn, Moira Shapov, Arlenne Srivastava, Shefali Recupero, Patricia R. Ryu, Helen H Sharfstein, Steven S. St. Victor, Guitelle Reddy, Sparsha Sabbag, Samir Sharp, Carla Staab, Jeffrey P. Reddy, Sridhar Sabnis, Deepika Shats, Polina Stablein, Donald Reed, Lawrence I. Sabo, Alex N. Shaw, Dana E. Stanley, Barbara H. Reed, Thomas A Sabol, Deana M Shaw, Billina R. Stefansson, Jon Reed, Brian C. Sachdeva, Shilpa Sheff, Elisabeth Steffens, David C. Regier, Darrel A. Sachs, Gary Shehu-Brovina, Shqipe Stein, Elliot Reich, James Sadler, John Z. Shelby, Aikiesha Steinglass, Joanna E. Reid, William H. Sadock, Benjamin J. Sheline, Yvette I. Stejskal, William J. Reiman, Amanda Saeed, Sy A. Shelton, Richard Stern, Harriet Reinhardt, Michael Safar, Laura Shelton, P. G. Stern, Robert G Reiss, Neele Sahai, Vishwani Shervington, Denese O. Stewart, Colin E Resnick, Phillip J. Saitz, Richard Shim, Ruth S. Stewart, S. Evelyn Reutfors, Johan Salmon, Joanna Shim, Inbo Stoddard, Frederick J. Riba, Michelle B. Sampson, Shirlene M. Shin, Cheolmin Stortelder, Frans F. Ribeiro, Philip L Sanders, Renata Shoyinka, Sosunmolu O Stotland, Eve Rich, Brendan A. Sanders, Erica M Shriqui, Christian L Stotland, Nada L. Richards, Lawrence K. Sanders, Kathy M. Shrivastava, Amresh Streltzer, Jon Rieman, Joseph Sangkyung , Lee Shu, Janet E Stroup, Thomas S. Riggs, Paula D. Santander, Jaime Shulman, Matisyahu Y Stuber, Margaret L. Ripoll, Luis H. Saranga, Reshmi Shuster, Jr., John L. Stuller, Elizabeth Ripperger-Suhler, Jane Sargent, John A. Siever, Larry J. Subramaniam, Geetha Ritchie, Elspeth C. Sargent, Susan C. Silk, Kenneth R. Sudak, Donna M. Rizvi, Asim A Sarhan, Walid Y. Silva, Robert Suetsugi, Masatomo Rizwan, Iqbal Sarmiento, Dennis Silverman, Joel J. Suliman, Sharain Rizzo, Albert Satre, Derek D. Silverman, Merav H. Sullivan, Matthew C Roach, Deidra Saunders, Ramotse Silverman, Bernard L Suokas, Jaana T Robert, Hsiung C. Savage, Sara Silverman, Alice Surmeli, Tanju Roberts, Laura W. Saxon, Andrew J. Simon, Lori Susman, Virginia L. Roberts, James Sayadipour, Amirali Simon, Robert I. Sutcliffe, James Roberts, Rosalind Scasta, David L. Simopoulos, Eugene F. Svab, Igor Robillard, Matt T Schadé, Annemiek Simpson, Scott A. Swanson, Jeffrey W. Robinowitz, Carolyn B. Schak, Kathryn M. Simpson, William Swedo, Susan E. Robinson, Gail E. Scheiber, Stephen C. Singh, Garima Szarek, Bonnie L. Roby, David S. Schell, Terry L. Singh, Pratima Szegedi, Armin Roca, Robert P. Schmahl, Christian Sinha, Rajita Szigethy, Eva Roddy, Giselle Schmidt, Chester W. Sisti, Dominic Szymczak, Peter Rodin, Gary M. Schmitz, Joy Sivrioglu, Yusuf Tae-Yeong, Jeong Rodriguez, Mercedes P. Schneider, Brett J. Skiandos, Anna Tafet, Gustavo E. Rodriguez-Villa, Ana Marie Schneider, M. Bret Skipper, Gregory Taintor, Zebulon Rogers, Kenneth M Schneiderman, Gerald Sklar, Pamela Tak, Youn Rogers, Hollister B. Schnurr, Paula Sklarew, Bruce Takacs, Cindy Rohrbaugh, Robert Schubmehl, James Q. Skodol, Andrew E. Takamura, Michael M. Romanowicz, Magdalena Schuermeyer, Isabel N. Slaughter, Bill Takeshita, Junji Ronis, Robert J. Schwartz, Victor I Sleemi, Aamar R Talbott, John A.

165th Annual Meeting 75 DISCLOSURE INDEX

Tamburrino, Marijo B Towns, Daniel S. van Oppen, Patricia Winer, Lucy M. Tampi, Rajesh R. Tran, David van Wel, E. Bas Woesner, Mary Tan, Adrienne Trangle, Michael A. Vanderlip, Erik R. Wolinsky, Debra Tandon, Rajiv Tranguch, Anthony J. Vanderpool, Donna Womack, Rosalyn Tangen, Rebecca K. Trinh, Nhi-Ha T. Vatsalya, Vatsalya Won, Eunsoo Tanielian, Terri L. Trinidad, Anton C Vaughan, Barney Wong, Jillian W Tanis, Thachell Trivedi, Jitendra Kumar Vela, Ricardo M. Woods, Douglas W. Tasleem, Hina Tross, Susan Veras, Andre B Woolley, Stephen B. Tawk, Rima Tsai, Gary Verduin, Marcia L. Wright, Jean H. Taylor, Jacob L Tsai, Shang- Ying Vergne, Derick Wrzosek, Marika I. Taylor-Desir, Monica Tsuang, John W. Verhagen, Peter J. Wu, Li-Tzy Teater, Julie Tucker, Phebe M Veronika, Stock M Wu, Joseph C. Tebes, Jacob K. Turecki, Gustavo Vidal, Carolina Wu, Renrong Tejani, Emily Tuttle, Ralph E Villagomez, Amelia K. Wu, Chai Templeton, Bryce Twemlow, Stuart W. Vinson, Sarah Wulsin, Lawson R. Terroni, Luisa M N Tyagi, Himanshu Vohringer, Paul A Wynn, Gary Tesar, George E. Tylim, Isaac Volkow, Nora Wynn, Gary H. Thakkar, Vatsal Uga, Aghaegbulam H Volpp, Serena Y. Yadack, Audra M Tharian, Priyanka Ujkaj, Manjola Vyas, Umesh Yager, Joel Thomas, Tiffany Ulwelling, William Wagner, Karen D. Yagudayeva, Raisa Thomas, Jean M. Unutzer, Jurgen Walaszek, Art Yao, Michael Thompson, Trevor Upton, Monique L. Walseman, Kathryn Yapici Eser, Hale Thompson, Kenneth S. Ursano, Robert J. Walsh, Leorah M Yarasi, Naveen K Thompson, Jeff Uzoma, Hyacinth N. Ward, Mary Yarbrough, Eric Thompson, Peter M. Vahia, Ipsit Warikoo, Nisha Yaseen, Zimri Tiamson-Kassab, Maria Vaks, Yakir K Warner, Christopher H Yellowlees, Peter Tillman, Jane G. Valenstein, Helen R Waseem, Mehnaz Yen, Shirley Tolchin, Joan G. Valladares Juarez, Elia M Watanabe, Norio Yen, Jennifer Tolchin, Matthew A. Van De Kerkhof, Noortje Watanabe, Margaret R. Yeomans, Frank E. Torrey, Fuller Van Dorn, Richard A. Waterman, G. Scott Yeung, Albert Totten, Julie van Luijn, Johannes B. Watkins, Katherine E. Yeung, Paul Watson, Amy C. Yohanan, Monique V. Watson, Clarence Yoho, Scott D Weber, Samuel Young, Robert C. Webster, Cecil R. Yu, Van Wedig, Michelle M. Yunyoung, Kwon Weerasekera, Priyanthy Zanarini, Mary C. American Psychiatric Association Weinberger, Daniel Zaraa, Solomon Weine, Stevan Zdanys, Kristina Weinstein, Sally Zeller, Scott L. INTEGRATED CARE • PHILADELPHIA, MAY 5-9, 2012 Weinstock, Robert Zhang, Kerang Weisman, Henry W. Zhang, Yuanfen Weisner, Constance M. Ziajko, Lauretta Weiss, Kenneth J. Zilber, Claire Weiss, Meredith Zimmerman, Mark Werner, Lisa M Zimmermann, Mia West, Joyce C. Zisook, Sidney West, Sara G. Zuber, Nicole A. Wetherington, Cora L. Zucker, Kenneth J. White, Chris Whiteley, Laura B. Wick, Paul H. Widge, Alik Are you an Early Wilhelm, Sabine Wilkinson, Willy Willenbring, Mark L. Career ? Williams, Mark D. Williams, Jason B. Come and meet your local and national ECP Williams, Emily leaders and representatives at the APA Annual Meeting in Williams, Donald H. Philadelphia, PA. Discuss the most important issues facing Williams, Eric R. Williams, Scott young psychiatrists today. Williams, Nancy Monday, May 7, 2012. 4:00 p.m. - 5:00 p.m. Williams, Sarah Room 407, Level 4, Philadelphia Marriott Downtown Williams, Kristi S Williams, Arthur R Wills, Cheryl D. Wilner, Philip J.

76 www.psychiatry.org Program Book This is for the main TOC. Keep on pasteboard with 2 points overlap into live area.

2012 ANNUAL MEETING 165TH ANNUAL MEETING • PHILADELPHIA, PA • MAY 5-9, 2012

Program Book

CONTENTS

Format Descriptions ...... 80

Daily Attendance Log ...... 82

Saturday’s Program ...... 85

Sunday’s Program ...... 99

Monday’s Program ...... 117

Tuesday’s Program ...... 137

Wednesday’s Program ...... 157

Topic Index ...... 167 © Richard Cummins/CORBIS© Richard Format Descriptions Format Descriptions This is for themain TOC. Keep on pasteboard with 2 points overlap into This is for theProgGuide TOC. Keep on pasteboard with 2 live area. points overlap into live area.

FORMAT DESCRIPTIONS

Advances In Series Courses/Master Courses These sessions are intended to highlight important new Courses are designed to emphasize learning experiences advances occurring in the field of psychiatry involving that actively involve participants and include the selected disorders or treatments. Some of these sessions ­opportunity for informal exchange with the faculty. are chaired by editors of recent textbooks published by ­Offered in four-hour (half-day), six-hour (full-day), and the American Psychiatric Publishing, Inc. (APPI), and eight-hour (full-day) sessions, courses either ­review ­feature selected chapter authors from these texts. The ­basic concepts in a special subject area or present books discussed at these sessions may be purchased at ­advanced material on a circumscribed topic. Attendees the APPI bookstore or online. During the Advances in must be registered for the meeting and purchase tickets Research Session, leading clinical researchers present the to attend. latest developments in research. Other types of advances Focus live! in sessions include topics designed to provide psychia- trists with the latest in clinical developments in other These 90-minute sessions allow attendees to test their areas of medicine. The intent is to give the audience an knowledge using an interactive Audience Response update from a physician in a particular specialty. These System (ARS), offering a new and entertaining way to sessions will help attendees keep pace with the rapidly learn. By using the ARS, attendees will feel like they are expanding knowledge base and technology in various involved in a small group consultation with an expert branches of medicine. clinician, even though the session is being attended by a large number of people. Experts, who served as Case Conferences guest editors of FOCUS, will lead lively multiple choice During these 90-minute sessions, clinical material is question-based discussions, and the audience will enter presented by videotape or the treating therapist. One or their answers using hand-held devices. The results are more experts then discuss the case. instantly tallied and projected on the screen. Forums ! These sessions are open to APA members only. A blue registration badge or an APA membership card is These are flexible presentations that afford an oppor- required for admittance. tunity to highlight and select topics that are of timely interest to psychiatrists and other mental health

INTERNATIONAL DISCUSSION GROUPS AT THE APA 165TH ANNUAL MEETING Philadelphia Marriott Downtown, Philadelphia, Pennsylvania

Join us at the APA international discussion groups. These discussions afford psychiatrists the opportunity to meet and discuss relevant medical and mental health issues pertinent to the world. These groups are open to all Annual Meeting attendees and chaired by APA members.

Sunday, May 6, 2012 Monday, May 7, 2012

2:30 – 4:30pm 2:00 – 4:00pm Africa Discussion Group South Asia Discussion Group Room 410, Level 4 Room 410, Level 4

2:30 – 4:30pm Those interested in mental health issues in Latin America may Europe Discussion Group wish to attend the American Society of Hispanic Psychiatrists Room 411, Level 4 allied organization meeting Saturday, May 5 from 10:00 AM to 8:30 PM at the Loews Philadelphia Hotel, Commonwealth Hall, B,C,D. Further information is available in the Directory of Activities. Cocktail hour at 6:00 PM for ASHP members only.

80 www.psychiatry.org professionals. Speakers and panel members are chosen the presentation of each paper. There is no formal by the Scientific Program Committee for their expertise discussant. and leadership in the field. Seminars Lectures Seminars are designed to emphasize in-depth learning Lectures feature a small number of distinguished speak- experiences that actively involve participants and in- ers discussing scientific and cultural topics, many of clude the opportunity for informal exchange with the which will extend our understanding beyond the usual presenters. Offered in four-hour (half-day) ­sessions, limits of clinical psychiatry. The Scientific Program seminars either review basic concepts in a special sub- Committee invites the lecturers. Award lectures are ject area or present advanced material on a circum- ­selected by the various APA Award Boards and/or Coun- scribed topic. cils. All award lecturers are approved by the Board of Small interactive sessions Trustees. This 90-minute format allows small groups to meet in- New research formally with either selected experts in psychiatry to This format allows for presentation of very recent find- discuss topics chosen by the expert; to obtain consulta- ings. Posters, which are visual, are self-explanatory tions for problems in research from senior researchers; presentations. Two poster sessions on Monday will be or utilize clinical material offered by the attendee and designated as Young Investigators’ Poster Sessions, hear, clinically-based seminars presented by outstand- which will contain poster presentations from young ing educators. Small Interactive Sessions are reserved ­investigators, residents, medical students, and research for residents only. These sessions are limited to 50 or clinical fellows. ­attendees on a first-come, first-served basis. Scientific and clinical reports Symposia/Presidential Scientific and Clinical Reports are oral presentations Symposia are two or three-hour sessions consisting of of papers prepared for submission before publica- four to six presentations that are thematically linked tion. In this 90-minute format, reports are grouped and focus on a specific topic relevant to clinical psychia- by topic, with discussion from the audience following try. They are designed to provide comprehensive treat- ment on a topic or discussion of the topic from several points of view by the participants and stimulate discus- sion with the audience. American Psychiatric Association Workshops (media) PROGRAM HIGHLIGHTS Workshops are 90-minute sessions, which typically INTEGRATED CARE • PHILADELPHIA, MAY 5-9, 2012 ­involve brief presentations from individual panel mem- bers, followed by the opportunity for lively and infor- mative discussion. This format provides for substantial MILITARY TRACK audience participation and should be highly interactive. For Mental Health Professionals Media Workshops are three-hour sessions where a FORUM: ­feature-length film is shown and discussed. Combat-Related PTSD: Injury or Disorder? John M. Oldham, M.D., M.S.

CASE CONFERENCE: PTSD and the U.S. Soldier Today Col. Elspeth C. Ritchie, M.D., MPH

SYMPOSIA: Army Psychiatrists in the Combat Zone: Personal Experiences and Reflections Col. Elspeth C. Ritchie, M.D., MPH

ADVANCES IN SERIES: Advances in Posttraumatic Stress Disorder Chairs: Gary Wynn, M.D. and David Benedek, M.D.

SMALL INTERACTIVE WORKSHOP: Psychological Effects of the Long War: Strategies for Mitigation Chair: Col. Elspeth C. Ritchie, M.D., MPH and Col. John C. Bradley, M.D.

WORKSHOPS: Treatment of PTSD and Depression in DOD: Taking Lessons Learned from the Trenches into Your Practice and the Community Capt. Paul S. Hammer, M.D.

Integrating Psychiatric and General Medical Care: Military and Civilian Models Daniel Herrera Sheila Hafter-Gray, M.D. A complete list of Military Sessions is available on our website: www.psych.org/program. Also, be sure to pick up the Military Brochure at the on-site kiosk. Historic District © Andrea Burolla

165th Annual Meeting 81 Daily Attendance Log Daily Attendance Log This is for the main TOC. Keep on pasteboard with This is for the ProgGuide TOC. Keep on pasteboard 2 points overlap into live area. with 2 points overlap into live area.

DAILY LOG FOR ATTENDANCE AT CME SESSIONS 165th Annual Meeting of the American Psychiatric Association May 5-9, 2012 • Philadelphia, PA

! This form is for your records and not for All scientific sessions listed in the Annual Meeting submission. Use this page to keep track of your Program Book are designated for AMA PRA attendance. Reporting is on an honor basis, claim one Category 1 Credits™, except for New Research Poster credit for each hour of participation. Sessions.

Date / Time Title of Session # of Hours

Total

82 www.psychiatry.org APP Advances In Sessions at the 165th APA Annual Meeting Advances In Sessions provide meeting attendees with an opportunity to gain in-depth information on clinical and research advances in specific areas of psychiatry. These 3-hour didactic lecture series feature well-known experts presenting clinical and research findings and allowing time for questions and answers. No registration is necessary for these sessions.

Advances in Addiction Advances in Motivational Psychopharmacology Interviewing Sunday, May 6 • 8:00am-11:00am Monday, May 7 • 2:00pm-5:00pm Henry Kranzler, M.D., and Petros Levounis, M.D., M.A., and Domenic A. Ciraulo, M.D. Bachaar Arnout, M.D.

Advances in PTSD Advances in Child Sunday, May 6 • 12:30pm-4:00pm Psychopharmacology David M. Benedek, M.D., and Tuesday, May 8 • 9:00am-12:00pm Gary M. Wynn, M.D. Robert Findling, M.D., and Molly McVoy, M.D.

Advances in Mentalization- Based Therapy Monday, May 7 • 9:00am-12:00pm APP Bookstore Anthony Bateman, M.D., and Be sure to stop by the APP bookstore to check Peter Fonagy, Ph.D. out APP’s latest selections, from the newest textbooks, clinical manuals, and journals, to electronic products for your mobile devices.

BOOKSTORE HOURS www.appi.org Saturday, May 5 9:00am - 4:00pm Email: [email protected] Sunday, May 6 10:00am - 4:00pm Monday, May 7 10:00am - 4:00pm Phone: 1-800-368-5777 Tuesday, May 8 10:00am - 4:00pm The First and Last Word in Psychiatry

Find us on Facebook and Twitter. Priority Code AH1220

165th Annual Meeting 83 Saturday’s Program Saturday’s Program This is for the main TOC. Keep on pasteboard This is for the ProgGuide TOC. Keep on with 2 points overlap into live area. pasteboard with 2 points overlap into live area.

2012 ANNUAL MEETING

SATUR DAY MAY 5

165th Annual Meeting 85 8:00 A.M. Sessions Seminar 2 Lecture 8:00 A.M. - 12:00 P.M. Course Room 119A, Level 1 Lecture 1 Pennsylvania Convention Center 9:00 A.M. - 10:30 A.M. ! Course Descriptions are Evidence-Based Psychodynamic Terrace Ballroom IV, Level 4 available in the Course Brochure. Therapy: A Clinician's Guide Pennsylvania Convention Center You can pick up a Course 4 Brochure and purchase a course Deep Brain Stimulation: ticket in the Course Enrollment Directors: Rethinking Depression and Its Area located in Exhibit Halls C-E, Richard F. Summers, M.D. Treatment SATURDAY, MAY 5 Level 2, Pennsylvania Convention Jacques P. Barber, Ph.D. APA Frontiers of Science Lecture Series Center. Admission to all courses, 1 including Master Courses is by ticket only. Course 3 Speaker: 8:00 A.M. - 5:00 P.M. Helen S. Mayberg, M.D. Room 102A, Level 1 Pennsylvania Convention Center Chair: Course 1 Jair C. Soares, M.D. 8:00 A.M. - 12:00 P.M. Office-Based Buprenorphine Room 121B, Level 1 Treatment of Opioid-Dependent Pennsylvania Convention Center Patients Scientific and Clinical Report

Brain Stimulation Therapies in Director: Psychiatry Petros Levounis, M.D., M.A. SCR 1 9:00 A.M. - 10:30 A.M. Faculty(s): Director: Room 109B, Level 1 Ziad H. Nahas, M.D. John A. Renner, M.D. Andrew J. Saxon, M.D. Pennsylvania Convention Center Faculty(s): Linda L. Carpenter, M.D. AIDS/HIV Darin D. Dougherty, M.D. Mustafa Husain, M.D. 9:00 A.M. Sessions Chair: Meera Vaswani, M.D. Forum SCR01-1. Contributory Effects of Course 2 Childhood Trauma to White 8:00 A.M. - 12:00 P.M. Forum 1 Matter Tract Injury in Human Room 125, Level 1 Immunodeficiency Virus in Infected Pennsylvania Convention Center 9:00 A.M. - 10:30 A.M. and Uninfected Women Room 117, Level 1 Soraya Seedat, M.D., Ph.D. Pennsylvania Convention Center How to Detect, Prevent, and SCR01-2. Mental Health Outcomes Treat Bullying Related Morbidity for Orphans by AIDS Compared to Along the Lifespan DSM-5: Research and Development Orphans by Other Means Director: 7 Carla Sharp, Ph.D. Jorge Srabstein, M.D. SCR01-3. The Outpatient Clinic for Chair: HIV and Mental Health: Patients’ David J. Kupfer, M.D. Characteristics and Comparison Seminar 1 Presenter(s): With Homosexual Non-HIV Infected 8:00 A.M. - 12:00 P.M. Darrel A. Regier, M.D., M.P.H. Patients Room 112A, Level 1 Lawson R. Wulsin, M.D. Annemiek Schadé, M.D., Ph.D. Pennsylvania Convention Center David P. Goldberg, D.M., D.P.M. William E. Narrow, M.D., M.P.H. Sexual Compulsivity and Addictions

Director: ! Program changes are printed ! All scientific sessions listed Ken Rosenberg, M.D. each day in the Daily Bulletin in the Annual Meeting Program which can be picked up in the Book are designated for AMA Faculty(s): Pennsylvania Convention Center. PRA Category 1 Credits™, Patrick Carnes, Ph.D. A mobile application will also be except for New Research Poster Ken Rosenberg, M.D. available. Sessions.

86 www.psychiatry.org Workshop Chair: BIO

Napoleon B. Higgins, M.D. 5 MAY SATURDAY, Presenter(s): Helen S. Workshop 1 Carl C. Bell, M.D. Mayberg, M.D. 9:00 A.M. - 10:30 A.M. Rahn K. Bailey, M.D. , is Profes- Room 102B, Level 1 Kenneth S. Thompson, M.D. sor of Psychia- Pennsylvania Convention Center William B. Lawson, M.D., Ph.D. try and Neurol- ogy and the Update on Parasomnias: a Dorothy Fuqua Review for Psychiatric Practice Workshop 5 Chair in Psychi- atry Imaging and Therapeutics in 9:00 A.M. - 10:30 A.M. the School of Medicine at Emory Chairs: Room 109A, Level 1 University. Her research program Dimitri D. Markov, M.D. Pennsylvania Convention Center Marina Goldman, M.D. uses to study brain mechanisms mediating depression Presenter(s): Workshop on Integration pathogenesis and antidepressant Dimitri D. Markov, M.D. of Primary Care, Preventive treatment response. She pio- Karl Doghramji, M.D. Services, and Assertive neered the development of deep Abigail Kay, M.D., M.A. Community Treatment Teams brain stimulation for treatment- resistant depressed patients. Dr. Chairs: Mayberg is a Board Certified Neu- Workshop 2 Erik R. Vanderlip, M.D. rologist, is a member of the Insti- Nancy Williams, M.D. 9:00 A.M. - 10:30 A.M. tute of Medicine of the National Room 104A, Level 1 Academies, the Dana Alliance, and Pennsylvania Convention Center the NARSAD Scientific Advisory Workshop 6 Board; is active in the Society for Management Strategies for 9:00 A.M. - 10:30 A.M. Neuroscience, Society of Biological Antisocial Personality Disorders Room 110B, Level 1 Psychiatry, American Neurological Pennsylvania Convention Center Association, American College 2 4 of Neuropsychopharmacology, A Historical Overview of the and the Organization for Human Chair: Inception of Moral Treatment in Brain Mapping; and serves on the Donald W. Black, M.D. Psychiatry editorial boards of Human Brain APA/The Scattergood Foundation Mapping, , Workshop 3 Neuroimaging, Brain Stimula- Chair: tion, Neuroinformatics, and Brain 9:00 A.M. - 10:30 A.M. David S. Roby, M.D. Structure and Function. Room 106A/B, Level 1 APA Frontiers of Science Lecture Pennsylvania Convention Center Presenter(s): Series David S. Roby, M.D. Lecture 1: 9-10:30 a.m. Reefer Madness? The Role of Psychiatry in the Evolution of Marijuana as a Medical Treatment Workshop 7 Chair: 9:00 A.M. - 10:30 A.M. Christopher A. Milburn, M.D., M.S. Room 111A, Level 1 Presenter(s): Pennsylvania Convention Center Kenneth M. Certa, M.D. Robert L. Dupont, M.D. Training for the Future: ! SESSION TRACKS Addressing Community 1 Anxiety & Mood Disorders Psychiatry Workforce Shortages Workshop 4 and Health Care Reform 2 Personality Disorders Through Resident Training in 9:00 A.M. - 10:30 A.M. Public Psychiatry Room 107A, Level 1 3 Psychopharmacology Pennsylvania Convention Center 4 Psychotherapy Chairs: Prevention of Mental Health 5 Schizophrenia and Matthew D. Erlich, M.D. Sequelae: Evidence-Based Other Psychotic Disorders Sharat G. Parameswaran, M.D. Practices in Protection, 6 NIAAA Presenter(s): Prevention, and Intervention in Fumi Mitsuishi, M.D., M.S. African-American Population 7 DSM-5 Michael Yao, M.D., M.P.H. APA Caucus of Black Psychiatrists Jules Ranz, M.D.

165th Annual Meeting 87 Media Workshop Symposium 2 3. Perspectives on the Use of Psychotropic Medications in 9:00 A.M. - 12:00 P.M. Children in Canada Room 103B, Level 1 Media Workshop 1 Alice Charach, M.D. Pennsylvania Convention Center 9:00 A.M. - 12:00 P.M. 4. Perspectives on the Use of Room 119B, Level 1 Scope, Current Evidence, and Psychotropic Medications in Pennsylvania Convention Center Innovative Approaches in Children in New Zealand Managing PTSD in the Military P. G. Shelton, M.D. The Celluloid Closet: A 1 3 4 Documentary About the Development of Gay Movie Chair: Symposium 4 SATURDAY, MAY 5 Characters and Its Relation to Farifteh F. Duffy, Ph.D. 9:00 A.M. - 12:00 P.M. the Coming-Out Process Discussant(s): Room 107B, Level 1 Robert J. Ursano, M.D. Pennsylvania Convention Center Chairs: Eric Yarbrough, M.D. 1. Epidemiology and Treatment of A Primer on Prevention in Christopher A. McIntosh, M.D., M.Sc. PTSD Associated With Combat: A Psychiatry Critical Look at the Evidence Presenter(s): Gary H. Wynn, M.D. 5 Eric Yarbrough, M.D. 2. Psychopharmacologic Treatment Chair: for PTSD Michael T. Compton, M.D., M.P.H. David M. Benedek, M.D. Symposium 1. An Introduction to Prevention 3. Understanding the Evidence on Principles Evidence-Based Psychotherapy for Symposium 1 Ruth S. Shim, M.D., M.P.H. PTSD 2. Considering Schizophrenia From a 9:00 A.M. - 12:00 P.M. Paula Schnurr, Ph.D. Prevention Perspective Room 103A, Level 1 4. Disseminating Effective, Integrated Michael T. Compton, M.D., M.P.H. Pennsylvania Convention Center Mental Health and Primary Care 3. Prevention Services for PTSD and Depression One-Stop Psychiatric Shopping: in the U.S. Military Frederick JP Langheim, M.D., Ph.D. How to Integrate Medication Charles C. Engel, M.D., M.P.H. 4. Substance Abuse Prevention and Psychotherapy in Your Rebecca A. Powers, M.D. Practice 5. DOD/APIRE PTSD Care 3 4 Dissemination Project 5. A Primer on Prevention in Farifteh F. Duffy, Ph.D. Psychiatry Chair: Christopher J. Oleskey, M.D., M.P.H. Daniel J. Carlat, M.D. Symposium 3 1. Integrative Strategies in Treating 9:00 A.M. - 12:00 P.M. Symposium 5 Eating Disorders Room 103C, Level 1 9:00 A.M. - 12:00 P.M. Joel Yager, M.D. Pennsylvania Convention Center Room 108A/B, Level 1 2. Exploring the Meaning of Pennsylvania Convention Center Medications Cross Cultural Issues in the Use of Psychotropic Medications in David L. Mintz, M.D. Personality Disorders: DSM-5 Children and Beyond 3. Combining CBT and APA Council on Children, Adolescents Pharmacotherapy in Brief Sessions and Their Families 2 7 Jesse H. Wright, M.D., Ph.D. 3 Chairs: 4. A Private Psychiatric Practice in Steven Huprich, Ph.D. Rural Vermont: A Return to the Old Chair: Robert F. Bornstein, Ph.D. Frontier David A. Mrazek, M.D. Alice Silverman, M.D. Discussant(s): Discussant(s): Nicole A. Zuber, M.D. Andrew E. Skodol, M.D. Billina R. Shaw, M.D. 1. Framing the Debate for DSM-5 APA 2012 Annual ! Personality Disorders Meeting On Demand 1. Perspectives on the Use of Psychotropic Medications in Steven Huprich, Ph.D. • Special onsite pricing Children in the United States 2. Proposed Revisions for DSM-5 • Earn CME Credit for top David A. Mrazek, M.D. lectures and symposia online Personality Disorders: A Process • For more information: 2. Perspectives on the Use of Focused Critique and Suggestions Psychotropic Medications in for Future Work Groups Children in the United Kingdom Robert F. Bornstein, Ph.D. Sue Bailey, M.D.

88 www.psychiatry.org 3. Is There Sufficient Empirical Symposium 7 4. Pharmacotherapy of Alcohol Support for the Proposed Dependence in Serious and SATURDAY, MAY 5 MAY SATURDAY, Changes for DSM-5 in Diagnosing 9:00 A.M. - 12:00 P.M. Persistent Mental Illness Personality Disorders? Room 120B, Level 1 Steven L. Batki, M.D. Mark Zimmerman, M.D. Pennsylvania Convention Center

4. Does Neurobiology Support Spectrum Disorders: The Symposium 9 Dimensional Diagnosis of Syndromal Overlap of Anxiety, Personality Disorders? Affective Symptoms, and 9:00 A.M. - 12:00 P.M. Joel Paris, M.D. Medical Comorbidity Room 121A, Level 1 Pennsylvania Convention Center 5. DSM-5 Personality Disorders and 1 Beyond Financing Sustainable John Livesley, M.D. Chairs: Interdisciplinary Care in Jeremy D. Coplan, M.D. Psychiatric and General Medical Singh Deepan, M.B.B.S Settings Symposium 6 Discussant(s): 9:00 A.M. - 12:00 P.M. Myrna M. Weissman, Ph.D. Chair: Room 120A, Level 1 Jeremy D. Coplan, M.D. Roger G. Kathol, M.D. Pennsylvania Convention Center 1. Joint Hypermobility and Anxiety: 1. Clinical and Systems-Level Models The Connective Issue for Improving Care on the Primary The Long-Term Course of Antonio Bulbena, M.D., M.Sc. Care/Mental Health Interface Borderline Personality Disorder: Benjamin G. Druss, M.D., M.P.H. 16-Year Findings From the 2. The ALPIM Syndrome: Anxiety of McLean Study of Adult the Mind and Body Part I 2. The High Cost of Comorbid Chronic Development Singh Deepan, M.B.B.S Medical and Behavioral Conditions: An Opportunity for Creative 2 3. Beyond the Serotonin Hypothesis: Payment Reform for Integrated Mitochondria and Inflammation Medical-Behavioral Care Chair: in Major Depression and Affective Stephen P. Melek Mary C. Zanarini, Ed.D. Spectrum Disorders Discussant(s): Ann Gardner, M.D., Ph.D. 3. Carved In, Carved out and Cut Up: Kenneth R. Silk, M.D. The Status Quo of Current Funding Schemes for Integrated Psychiatric 1. Attainment and Stability of Symposium 8 Treatment and Primary Care Symptomatic Remission and Anita S. Everett, M.D. Recovery Among Patients with BPD 9:00 A.M. - 12:00 P.M. and Axis II Comparison Subjects: A Room 120C, Level 1 4. Integrated Claims Adjudication 16-Year Follow-Up Study Pennsylvania Convention Center as a Strategy for Reversing the Mary C. Zanarini, Ed.D. Negative Effects of Comorbid Integrating the Full Spectrum General Medical and Psychiatric 2. Predictors of Suicide Attempts in of Alcohol and Other Drug Disorders Patients With BPD Over 16 Years of Problems in Psychiatric and Roger G. Kathol, M.D. Prospective Follow-Up Primary Care Michelle M. Wedig, Ph.D. U.S. National Institute on Alcohol Abuse 3. Utilization of Inpatient and and Alcoholism ! Obtain your Certificate of Outpatient Medical Services 1 3 5 6 Attendance for the 2012 APA by Patients with BPD and Axis Annual Meeting at www.psych. II Comparison Subjects Over a Chair: org/AnnualMeetingCME Decade of Prospective Follow-Up Robert B. Huebner, Ph.D. Alex S. Keuroghlian, M.D., M.Sc. 1. Treating Patients With First- 4. Subtypes of Identity Disturbance Episode Psychosis and Alcohol and and Their Impact on the Course of Other Drug Use Disorders ! SESSION TRACKS Borderline Personality Disorder Robert E. Drake, M.D. 1 Anxiety & Mood Disorders Over 16 Years of Prospective 2. The Importance of Integrating Follow-Up 2 Personality Disorders Alcohol Treatment Within Mental Valerie I. Photos, Ph.D. Health Care 3 Psychopharmacology 5. Opioid Use Among Patients with Constance M. Weisner, D.P.H., 4 Psychotherapy BPD Followed Prospectively for a M.S.W. Decade: Description and Prediction 5 Schizophrenia and 3. Screening and Treatment of Other Psychotic Disorders Frances R. Frankenburg, M.D. Alcohol Use Among Depression Patients 6 NIAAA Derek D. Satre, Ph.D. 7 DSM-5

165th Annual Meeting 89 Course Course 7 Seminar 3 9:00 A.M. - 4:00 P.M. 9:00 A.M. - 4:00 P.M. Room 126B, Level 1 Room 123, Level 1 ! Course Descriptions are Pennsylvania Convention Center Pennsylvania Convention Center available in the Course Brochure. You can pick up a Course Basic Concepts in The International Medical Brochure and purchase a course Administrative Psychiatry I Graduate Institute ticket in the Course Enrollment Directors: Area located in Exhibit Halls C-E, American Association of Nyapati R. Rao, M.D., M.S. Level 2, Pennsylvania Convention Psychiatric Administrators Jacob E. Sperber, M.D. Center. Admission to all courses, SATURDAY, MAY 5 including Master Courses is by Directors: Faculty(s): ticket only. Barry K. Herman, M.D. John Manring, M.D. Douglas M. Brandt, M.D. Jacob E. Sperber, M.D. Joan M. Anzia, M.D. Faculty(s): Damir Huremovic, M.D., M.P.P. L. Mark Russakoff, M.D. Course 4 Priyanthy Weerasekera, M.D., M.Ed. Shivkumar S. Hatti, M.D., M.B.A. Mantosh J. Dewan, M.D. 9:00 A.M. - 4:00 P.M. Sy A. Saeed, M.D., M.S. Antony Fernandez, M.D. Room 121C, Level 1 David K. Nace, M.D. Jeffrey Goldberg, D.O. Pennsylvania Convention Center Hesham M Hamoda, M.D. Integrating Behavioral Health Master Course 1 Rashi Aggarwal, M.D. and Primary Care: Practical Andres Sciolla 9:00 A.M. - 4:00 P.M. Skills for the Consultant Team Salman Akhtar, M.D. Room 118A-C, Level 1 Psychiatrist Milton Kramer, M.D. Pennsylvania Convention Center R. Rao Gogineni, M.D. Ramotse Saunders, M.D. Directors: 2012 Psychiatry Review Lori Raney, M.D. Jurgen Unutzer, M.D., M.P.H. The American College of 10:00 A.M. Sessions Faculty(s): Psychiatrists John S. Kern, M.D. New Research Poster Anna Ratzliff, M.D., Ph.D. Directors: Arden D. Dingle, M.D. NR Poster Session 1 Course 5 Robert J. Boland, M.D. 10:00 A.M. - 11:30 A.M. 9:00 A.M. - 4:00 P.M. Faculty(s): Exhibit Hall C-E, Level 2 Room 124, Level 1 Richard Balon, M.D. Pennsylvania Convention Center Pennsylvania Convention Center Sandra M. DeJong, M.D. Natalie Lester, M.D. Resident Poster Competition Kundalini Yoga Meditation for Avram H. Mack, M.D. — Patient-Oriented and Anxiety Disorders Including Vishal Madaan, M.D. Epidemiology OCD, Depression, Attention Anthony L. Rostain, M.D., M.A. Deficit Hyperactivity Disorder, Mark Servis, M.D. and Posttraumatic Stress Marcia L. Verduin, M.D. 11:00 A.M. Sessions Disorder Forum 1 Master Course 2 Director: 9:00 A.M. - 4:00 P.M. Forum 2 David S. Shannahoff-Khalsa Room 122A/B, Level 1 11:00 A.M. - 12:30 P.M. Pennsylvania Convention Center Room 117, Level 1 Course 6 Pennsylvania Convention Center Challenges in Psychodynamic 9:00 A.M. - 4:00 P.M. Psychotherapy Room 126A, Level 1 Alcohol Screening and Brief Pennsylvania Convention Center 4 Intervention for Youth: The NIAAA Practitioner's Guide Neuropsychiatric Masquerades: Director: U.S. National Institute on Alcohol Abuse Medical and Neurological Glen O. Gabbard, M.D. and Alcoholism Disorders That Present With Faculty(s): 6 Psychiatric Symptoms Mantosh J. Dewan, M.D. Chair: Academy of Valdesha Ball, M.D. Vivian Faden, Ph.D. Gabrielle Hobday, M.D. Director: Holly Crisp-Han, M.D. Presenter(s): Jose R. Maldonado, M.D. Vivian Faden, Ph.D.

90 www.psychiatry.org Lecture Workshop BIO SATURDAY, MAY 5 MAY SATURDAY, Lecture 2 Workshop 8 Robert E. Hales, M.D., 11:00 A.M. - 12:30 P.M. 11:00 A.M. - 12:30 P.M. M.B.A., is Room 113A-C, Level 1 Room 104A, Level 1 Joe P. Tupin Pennsylvania Convention Center Pennsylvania Convention Center Endowed Chair and Professor Communicating Psychiatric Helping Patients Who Drink and Chair of Knowledge: From Kites to Too Much: Using the NIAAA Psychiatry and Kindle Clinician's Guide Behavioral Sciences at the Davis APA Judd Marmor Award Lecture U.S. National Institute on Alcohol Abuse School of Medicine, University and Alcoholism of California. Dr. Hales served Speaker: 6 as Chief of Psychiatry and Direc- Robert E. Hales, M.D., M.B.A. tor of Research at the California Pacific Medical Center and then Chair: Chair: Mark L. Willenbring, M.D. joined the University of California Stuart C. Yudofsky, M.D. psychiatry faculty, becoming chair Presenter(s): in 1998. He has published exten- Mark L. Willenbring, M.D. sively and is Editor-in-Chief of the Scientific and Clinical Report books division at American Psy- chiatric Publishing for which he SCR 2 Workshop 9 coedited three major textbooks. He is Past President of the As- 11:00 A.M. - 12:30 P.M. 11:00 A.M. - 12:30 P.M. sociation for Academic Psychiatry, Room 109B, Level 1 Room 106A/B, Level 1 which honored him with the 2006 Pennsylvania Convention Center Pennsylvania Convention Center Educator Award for his lifetime contributions to psychiatric Attention Spectrum Disorders The Ethics of Patient-Targeted Googling education. He was a member of Chair: APA/The Scattergood Foundation the DSM-IV Task Force, is Deputy Joseph Berger, M.D. Editor of The Journal of Neuro- psychiatry and Clinical Neurosci- SCR02-1. Prevalence of ADHD and Chair: ences, and is a Distinguished Life Comorbid Psychiatric Disorders David Brendel, M.D., Ph.D. Fellow of the American Psychiatric in a Veterans Administration Presenter(s): Association. Outpatient Clinic David Brendel, M.D., Ph.D. Robert A. Kayser, M.D. Judd Marmor Award Lecture SCR02-2. Adult Attention-Deficit/ Lecture 2: 11:00 a.m. – 12:30 p.m. Hyperactivity Disorder and Anxiety Workshop 10 Disorders: Prevalence in a Clinical 11:00 A.M. - 12:30 P.M. Sample Room 107A, Level 1 Michael Van Ameringen, M.D. Pennsylvania Convention Center 1 Workshop 11 Health Care Reform and SCR02-3. Duration of Action of 11:00 A.M. - 12:30 P.M. Lisdexamfetamine Dimesylate in Psychiatry Training for Primary Care Physicians: What to Teach, Room 109A, Level 1 Children and Adolescents With Pennsylvania Convention Center Attention Deficit/Hyperactivity How to Teach, Where to Teach Disorder Electronic Health Records David R. Coghill, M.D. Chairs: Hoyle Leigh, M.D. (EHRs): What to Look for When 3 Jon Streltzer, M.D. Selecting an EHR for Your Practice ! SESSION TRACKS Presenter(s): The APA Committee on Electronic Don R. Lipsitt, M.D., M.A. Health Records 1 Anxiety & Mood Disorders Beena Nair, M.D. 2 Personality Disorders Seth Powsner, M.D. Chairs: Steven R. Daviss, M.D. 3 Psychopharmacology Robert M. Plovnick, M.D., M.S. 4 Psychotherapy Presenter(s): 5 Schizophrenia and Zebulon Taintor, M.D. Obtain your Certificate of Other Psychotic Disorders ! Edward Pontius, M.D. Attendance for the 2012 APA 6 NIAAA Lori Simon, M.D. Annual Meeting at www.psych. Roger Duda, M.D. 7 DSM-5 org/AnnualMeetingCME

165th Annual Meeting 91 Workshop 12 1:00 P.M. Sessions Lecture 4 11:00 A.M. - 12:30 P.M. 1:30 P.M. - 3:00 P.M. Room 110B, Level 1 Course Terrace Ballroom IV, Level 4 Pennsylvania Convention Center Pennsylvania Convention Center

Addressing Addiction Among ! Course Descriptions are Dialectical Behavior Therapy: Women: A USA Perspective available in the Course Brochure. Where It Started, Where It Went, You can pick up a Course Where It May Be Now, and Chair: Brochure and purchase a course Where Are We Going? Pedro Ruiz, M.D. ticket in the Course Enrollment APA Frontiers of Science Lecture Series Area located in Exhibit Halls C-E, 4 SATURDAY, MAY 5 Presenter(s): Level 2, Pennsylvania Convention Annelle B. Primm, M.D., M.P.H. Center. Admission to all courses, Patricia Junquera, M.D. Speaker: including Master Courses is by Marsha M. Linehan, Ph.D. Michelle Primeau, M.D. ticket only. Chair: Workshop 13 Kenneth R. Silk, M.D. 11:00 A.M. - 12:30 P.M. Course 8 Room 111A, Level 1 1:00 P.M. - 5:00 P.M. Lecture 5 Pennsylvania Convention Center Room 121B, Level 1 1:30 P.M. - 3:00 P.M. Pennsylvania Convention Center Evidence-Based Integrative Commonwealth Hall B/C/D, Second Treatments for Anxiety, Floor Melatonin and Light Treatment Depression, and Trauma in Mass Loews Hotel Philadelphia of SAD, Sleep and Other Body Disasters Clock Disorders APA Caucus on Alternative and Teaching Illness Self- Complimentary Medicine 1 Management to Improve the Integration of Care among 1 3 4 Director: Hispanics Alfred J. Lewy, M.D., Ph.D. APA Simon Bolivar Award Lecture Chairs: Helen Lavretsky, M.D., M.S. Speaker: Patricia L. Gerbarg, M.D. Course 9 Alex Kopelowicz, M.D. Presenter(s): 1:00 P.M. - 5:00 P.M. Patricia L. Gerbarg, M.D. Room 125, Level 1 Chairs: Richard P. Brown, M.D. Pennsylvania Convention Center Daniel B. Martinez, M.D. Jose E. De La Gandara, M.D. Neuroanatomy of Emotions

Director: Scientific and Clinical Report ! Program changes are printed Ricardo M. Vela, M.D. each day in the Daily Bulletin which can be picked up in the SCR 3 Pennsylvania Convention Center. Lecture 1:30 P.M. - 3:00 P.M. A mobile application will also be Room 109B, Level 1 available. Pennsylvania Convention Center Lecture 3 1:30 P.M. - 3:00 P.M. Biological Studies of Brain Functioning ! SESSION TRACKS Room 115A-C, Level 1 Pennsylvania Convention Center 1 Anxiety & Mood Disorders Chair: Understanding Patients With Elias Shaya, M.D. 2 Personality Disorders Borderline Personality Disorder SCR03-1. Brain-Derived Neurotrophic 3 Psychopharmacology APA International Psychiatrist Lecture Factor Moderates Effects of Job 4 Psychotherapy Series Stress on the Severity of Alcohol 2 Drinking in Korean 20s Office 5 Schizophrenia and Workers Other Psychotic Disorders Speaker: BoAh Kim, M.D. 6 NIAAA Sabine C. Herpertz, M.D. SCR03-2. Significant Association 7 DSM-5 Between IQ and Degree of Overall Chair: Cortical Gyrification Robert M. McCarron, D.O. Venkataramana Bhat, M.D.

92 www.psychiatry.org BIOS SATURDAY, MAY 5 MAY SATURDAY, Sabine C. Marsha Alejandro ­Herpertz, M.D., ­Linehan, (Alex) is Chair of Psychia- Ph.D., is Pro- ­Kopelowicz, try and Director of fessor of Psy- M.D., is Profes- the Department of chology and sor and Vice- General Psychiatry Adjunct Profes- Chair of the De- at the Centre for sor of Psychia- partment of Psychosocial Medi- try and Behav- Psychiatry and cine, University of Heidelberg. Previ- ioral Sciences at the University of Biobehavioral Sciences, David Geffen ously she held an appointment as Washington. She is also Director of School of Medicine, UCLA. He is also Professor of Experimental Psychopa- the Behavioral Research and Therapy Medical Director of the San Fernando thology at RWTH Aachen University, Clinics, a consortium of research Mental Health Center and Chief of after which she moved to Rostock projects developing new treatments Psychiatry at Olive View-UCLA Medi- University as Chair of Psychiatry and and evaluating their efficacy for se- cal Center. He has been a frequent Director of the department. Her re- verely disordered and suicidal popula- lecturer on biobehavioral treatment search focuses on borderline and an- tions. She studies the application of and psychiatric rehabilitation tech- tisocial personality disorder, emotion behavioral models to suicidal behav- niques and has written more than regulation and social cognition, using iors, drug abuse, and borderline per- 100 articles and book chapters on functional magnetic resonance imag- sonality disorder, and develops mod- these subjects. His current projects ing and electrophysiology as methods els for transferring science-based focus on culturally adapting the fam- for neurobiological research, and treatments to the clinical community. ily psychoeducation approach for a neuropsychology and experimental Dr. Linehan has published extensive- Mexican-American population and a psychopathology. She has written ly; written four books, including two multi-site study comparing a long- several books on the neurobiology treatment manuals; and serves on a acting, injectable antipsychotic medi- of personality disorders as well as on number of editorial boards. The cation with oral atypical antipsychot- psychotherapy. American Association of Suicidology ic agents. created an award in her name for out- APA International Psychiatrist APA Simon Bolivar Award Lecture standing research in the treatment of Lecture Series Lecture 5: 1:30 - 3:00 p.m. suicidal behavior. Lecture 3: 1:30 – 3:00 p.m. APA Frontiers of Science Lecture Series Lecture 4: 1:30 – 3:00 p.m.

SCR03-3. Impaired Semantic SCR04-3. Should the Diagnostic Had Inappropriate or Abusive Object Recall From Features in Criteria for Bipolar Disorder Care in Residential Treatment as Schizophrenia and Bipolar Disorder Be Broadened?: Implications Adolescents Sharna Jamadar, Ph.D. From Longitudinal Studies of 1 1 5 Subthreshold Conditions Mark Zimmerman, M.D. Chair: Charles W. Huffine, M.D. SCR 4 1 SCR04-4. Misuse of the Mood Presenter(s): 1:30 P.M. - 3:00 P.M. Disorders Questionnaire as a Case- Rebecca K. Tangen, M.S.W. Room 111B, Level 1 Finding Measure and a Critique of Shawn Muth Pennsylvania Convention Center the Concept of Using a Screening Scale for Bipolar Disorder Workshop 15 Bipolar Disorder 1 Mark Zimmerman, M.D. 1:30 P.M. - 3:00 P.M. 1 Chair: Room 104A, Level 1 David Preven, M.D. Pennsylvania Convention Center SCR04-1. The Clinical Demographics Workshop of the Mayo Clinic Bipolar Disorder Computer-Assisted Cognitive- Biobank Behavior Therapy for Workshop 14 Manuel E. Fuentes, M.D. Depression 1 1:30 P.M. - 3:00 P.M. 1 4 Room 102B, Level 1 SCR04-2. Diagnostic Stability of DSM- Pennsylvania Convention Center Chairs: IV Clinical Diagnosis of Bipolar Jesse H. Wright, M.D., Ph.D. Disorder Psychiatrist's Response to Michael E. Thase, M.D. Bonnie L. Szarek, R.N. Young Adult Patients Who Have 1 7

165th Annual Meeting 93 Presenter(s): Workshop 19 Presidential Symposium Gregory K. Brown, Ph.D. 1:30 P.M. - 3:30 P.M. Joyce A. Spurgeon, M.D. Room 111A, Level 1 Presidential Symposium 1 Pennsylvania Convention Center 2:00 P.M. - 5:00 P.M. Workshop 16 Room 108A/B, Level 1 Don’t You Want to Be a Real Pennsylvania Convention Center 1:30 P.M. - 3:00 P.M. Doctor? Overcoming Career Room 107A, Level 1 Development Challenges Teaching Psychodynamic Pennsylvania Convention Center Faced by Asian Americans in Psychiatry in the 21st Century Psychiatry 2012 Revision of APA Caucus of Asian-American 4 SATURDAY, MAY 5 the Schizophrenia Psychiatrists Psychopharmacology Algorithm Chairs: From the Harvard South Shore Chairs: Carol C. Nadelson, M.D. Psychiatry Program Sharat G. Parameswaran, M.D. John M. Oldham, M.D., M.S. 3 5 Paul Yeung, M.D., M.P.H. Discussant(s): Presenter(s): Robert Michels, M.D. Chair: Francis Lu, M.D. 1. Establishing a Therapeutic David N. Osser, M.D. Russell F. Lim, M.D. Dialogue: The Specifics Presenter(s): Esther E. Oh, M.D. Steven Levy, M.D. Mohsen Jalali Roudsari, M.D. Ye B. Du, M.D., M.P.H. 2. Teaching Psychotherapy Theo Manschreck, M.D., M.P.H. Deborah Cabaniss, M.D. 3. Everyone Is a Psychoanalyst Richard F. Summers, M.D. Workshop 17 2:00 P.M. Sessions 4. Making It So: Creating a 1:30 P.M. - 3:00 P.M. Psychodynamic Research Clinic Room 109A, Level 1 Media Workshop Kimberlyn Leary, Ph.D., M.P.A. Pennsylvania Convention Center Presidential Symposium 2 Promoting Emotional and Media Workshop 2 Physical Safety During 2:00 P.M. - 5:00 P.M. 2:00 P.M. - 3:30 P.M. Residency: Being Prepared for Room 114 Lecture Hall, Level 1 Room 119B, Level 1 Life Threatening Emergencies Pennsylvania Convention Center Pennsylvania Convention Center Mindfulness-Based Practices Chairs: Lucy Ozarin, M.D.: An Inspiring Curtis A. McKnight, M.D. in the Treatment of Stress and Life of one who Continues on David P. Kasick, M.D. Psychiatric Illness Her Path of Learning and Giving Presenter(s): 1 4 Curtis A. McKnight, M.D. Chair: Julie Teater, M.D. Leah J. Dickstein, M.D., M.A. Chair: Julie Niedermier, M.D. Kathy M. Sanders, M.D. Presenter(s): 1. Mindfulness-Based Stress Leah J. Dickstein, M.D., M.A. Reduction (MBSR): What It Is and Gary A. McMillan, M.A., M.S. Workshop 18 Its Clinical Applications for Stress, 1:30 P.M. - 3:00 P.M. Pain, and Chronic Illness Room 110B, Level 1 New Research Poster Jon Kabat-Zinn, Ph.D. Pennsylvania Convention Center 2. Mindfulness-Based Cognitive Therapy (MBCT) in the Treatment NR Poster Session 2 Clinical Wisdom in and Prevention of Relapse in Major Psychotherapy: A Philosophical 2:00 P.M. - 3:30 P.M. Recurrent Depression and Qualitative Report Exhibit Hall C-E, Level 2 Peter Beiling, Ph.D. APA/The Scattergood Foundation Pennsylvania Convention Center 3. Probing the Molecular Mechanism 4 of Mind-Body Practices With Resident Poster Competition — Genomic and Translational Community Service, Curriculum Chair: Techniques Development and Educational, Arthur Caplan, Ph.D. John W. Denninger, M.D., Ph.D. Psychosocial and/or Biomedical Presenter(s): Research 4. Changes in Neural Structure Cynthia Baum-Baicker, Ph.D. and Function Associated With Dominic Sisti, Ph.D. Mindfulness Training Programs Sara Lazar, Ph.D.

94 www.psychiatry.org Symposium 3. DSM-5 Field Trials in Academic or 2. Palliative Psychotherapy – When Large Clinical Settings: Summary the Prognosis Seems Bleak SATURDAY, MAY 5 MAY SATURDAY, and Implications Lorenzo Norris, M.D. Symposium 10 Diana E. Clarke, Ph.D., M.Sc. 3. Case Presentation I 2:00 P.M. - 5:00 P.M. 4. Dimensional Measures in Amanda Crosier, M.D. Room 103A, Level 1 Psychiatric Diagnosis: Results 4. Case Presentation II Pennsylvania Convention Center From the DSM-5 Field Trials Sanaz Kumar, M.D. William E. Narrow, M.D., M.P.H. Social Stress and Drug Addiction in Preclinical and 5. Testing DSM-5 in Routine Symposium 14 Clinical Studies: Sex/Gender Clinical Practice Settings: Trials, Matters in Effects on Brain Tribulations, and Triumphs 2:00 P.M. - 5:00 P.M. and Behavior and Treatment Eve K. Moscicki, Sc.D., M.P.H. Room 107B, Level 1 Implications Pennsylvania Convention Center U.S. National Institute on Drug Abuse Symposium 12 When Your Patient Is a Parent: Chairs: 2:00 P.M. - 5:00 P.M. Supporting the Family and Samia D. Noursi, Ph.D. Room 103C, Level 1 Addressing the Needs of Cora L. Wetherington, Ph.D. Pennsylvania Convention Center Children

Discussant(s): Rebound and Recovery in the 1 Rajita Sinha, Ph.D. Athlete Chairs: 1. Monkey Models of Social International Society for Sport Alison M. Heru, M.D. Stress and Cocaine Abuse: Sex Psychiatry Ellen M. Berman, M.D. Differences Michael A. Nader, Ph.D. Chair: Discussant(s): Antonia L. Baum, M.D., M.D. 2. Social Stress Differentially Affects Ellen M. Berman, M.D. Drug Reward in Adolescent Male Discussant(s): 1. Overview of Needs of the Children and Female Rats Antonia L. Baum, M.D., M.D. of Parents With Mental Illness Sari Izenwasser, Ph.D. Alison M. Heru, M.D. 1. Doping in Sports: What's on the 3. From Picture to Practice: The Role Horizon? 2. Clinical Implications of Evidence- of Gender and Affect on the Neural David A. Baron, D.O. Based Preventive Interventions for Response to Social Stress in Families With Parental Depression Cocaine Users 2. Sexual Harassment and Abuse William R. Beardslee, M.D. in Sports: What It Is, How to Colleen A. Hanlon, Ph.D. 3. A Family Perspective from Julie Prevent It. 4. Sex Difference in Reactivity to Totten, President and Founder of Saul I. Marks, M.D. Laboratory Induced Stress and Families for Depression Awareness Drug Cues 3. Psychological Impact of Injury on Julie Totten, M.B.A. Sudie Back, Ph.D. the Athlete Thomas S. Newmark, M.D. Symposium 15 Symposium 11 4. Doping in Elite Cycling: A Psychiatric Perspective on Causes, 2:00 P.M. - 5:00 P.M. 2:00 P.M. - 5:00 P.M. Consequences, Recovery and Room 117, Level 1 Room 103B, Level 1 Rehabilitation Pennsylvania Convention Center Pennsylvania Convention Center Alan Currie, M.B.B.S Pros and Cons of SPECT Brain Field Trial Testing of Proposed Imaging: What Is the Status of Revisions to DSM-5: Findings Symposium 13 the Science? and Implications 2:00 P.M. - 5:00 P.M. American Psychiatric Institute for Room 106A/B, Level 1 Chairs: Research and Education Pennsylvania Convention Center Theodore A. Henderson, M.D., Ph.D. 7 Joseph C. Wu, M.D. Time-Limited Psychotherapy Chairs: 1. Capturing Mental Illness in a Brain for Cancer: From Diagnosis to David J. Kupfer, M.D. Scan: Dream or Reality? Remission or End of Life Darrel A. Regier, M.D., M.P.H. Anissa Abi-Dargham, M.D. 1. DSM-5 Field Trials: New Methods, Chairs: 2. SPECT Imaging in Psychiatric New Insights Anton C. Trinidad, M.D. Practice: Ready for Prime Time? Helena C. Kraemer, Ph.D. Lorenzo Norris, M.D. Jair C. Soares, M.D. 2. DSM-5 Field Trials in Academic or 1. Assessment and Treatment of 3. Brain SPECT Imaging Is Large Clinical Settings: Detailed Cancer Patients for Time-Limited Immediately Useful in Clinical Findings for Schizophrenia, Psychotherapy: Who’s Appropriate Practice Depression, and ADHD at What Stage? Daniel G. Amen, M.D. Darrel A. Regier, M.D., M.P.H. Anton C. Trinidad, M.D.

165th Annual Meeting 95 4. Bringing SPECT Functional 2. Implementing STEPPS in Different Symposium 19 Neuroimaging Into Perspective Service Settings in the United 2:00 P.M. - 5:00 P.M. Theodore A. Henderson, M.D., Ph.D. Kingdom Renee Harvey, M.A. Room 120C, Level 1 Pennsylvania Convention Center Symposium 16 3. STEPPS in the Netherlands: The Efficacy in a Group of Philosophical and Pragmatic 2:00 P.M. - 5:00 P.M. Dutch Patients With Borderline Problems for DSM-5 Room 119A, Level 1 Personality Disorder and With Pennsylvania Convention Center Borderline Personality Features 7 E. Bas van Wel, M.D. : Informing Chairs: 4. STEPPS Treatment of Inpatients Joel Paris, M.D. SATURDAY, MAY 5 Clinical Practice With Mood Disorders and Co- James E. Phillips, M.D. occurring Borderline PD Diagnosis: Chairs: Discussant(s): Preliminary Results From a One- Robert I. Simon, M.D. Michael B. First, M.D. Year Follow-Up Study Liza H. Gold, M.D. Andrea Fossati, M.D., Ph.D. 1. The Ideology Behind DSM-5 1. Looking Beyond Patients’ Denial Joel Paris, M.D. of Suicidal Ideation: Assessing Symposium 18 2. The Conceptual Status of DSM Observable Evidence-Based Risk Diagnoses Factors 2:00 P.M. - 5:00 P.M. James E. Phillips, M.D. Robert I. Simon, M.D. Room 120B, Level 1 3. Considering the Economy of DSM Pennsylvania Convention Center 2. Disability Evaluations: A Model for Alternatives John Z. Sadler, M.D. Assessment Narcissistic Personality Disorder Liza H. Gold, M.D. in DSM-5: Impact on Research, 4. What Are the Benefits and Risks of Conservatism? 3. Neuroimaging in Forensic Diagnosis, and Treatment G. Scott Waterman, M.D. Psychiatry: Current Status and 1 2 4 Future Directions 5. The Pragmatic Context of Robert P. Granacher, M.D., M.B.A. Chair: Psychiatric Diagnosis Elsa Ronningstam, Ph.D. Joseph M. Pierre, M.D. 4. Correctional Psychiatry Joseph Penn, M.D. Discussant(s): Kenneth N. Levy, Ph.D. Symposium 20 5. The Internet and Psychiatry: An Update on Legal and Ethical 1. Narcissistic Personality Disorder in 2:00 P.M. - 5:00 P.M. Considerations DSM-5 Room 121A, Level 1 Patricia R. Recupero, M.D., J.D. Andrew E. Skodol, M.D. Pennsylvania Convention Center 6. Child Forensic Psychiatry: 21st 2. Finding Common Denominators: Understanding the Association New Paradigms for Investigating Century Practice Relational Disturbances in Cheryl D. Wills, M.D. of Depression, Depressive Personality, and Hypersensitive Borderline Personality Disorder (Vulnerable) Narcissism 2 Symposium 17 Steven Huprich, Ph.D. Chair: 3. Narcissistic Grandiosity and 2:00 P.M. - 5:00 P.M. Lois W. Choi-Kain, M.D., M.Ed. Room 120A, Level 1 Narcissistic Vulnerability: Clinical Pennsylvania Convention Center Examples, Current Research, and Discussant(s): Implications for DSM-5 John G. Gunderson, M.D. STEPPS (Systems Training for Aaron L. Pincus, Ph.D. Peter Fonagy, M.D., Ph.D. Emotional Predictability and 4. Narcissistic Personality Disorder: 1. Attachment and Cognition in BPD: Problem Solving): Treating An Interactive Exploratory Problems in Integrating Complex Borderline Personality Disorder Diagnostic Process Information in Emotionally in Diverse Settings Around the Elsa Ronningstam, Ph.D. Stimulated Attachment Contexts Globe Lois W. Choi-Kain, M.D., M.Ed. 5. Transference-Focused 2. Rejection Sensitivity as a 1 2 4 Psychotherapy for Narcissistic Distinguishing Feature of Personality Disorder Chair: Borderline Personality Disorder Diana Diamond, Ph.D. Donald W. Black, M.D. Valerie I. Photos, Ph.D. 1. Overview of STEPPS Treatment 3. Empathy, Attachment, and Program and Its Implementation in Borderline Personality: Correctional Settings (Prisons and Genetic, Neurobiological, and Community Corrections) Developmental Perspectives Nancee S. Blum, M.S.W., L.C.S.W. Luis H. Ripoll, M.D.

96 www.psychiatry.org 4. Emerging Investigational BIOS Paradigms for the Empirical Study SATURDAY, MAY 5 MAY SATURDAY, of Rejection Sensitivity Carol Bankole Alex S. Keuroghlian, M.D., M.Sc. T­amminga, Johnson, M.D., Ph.D., 5. Neuroimaging of Social Exclusion M.D., is Profes- D.Sc. in Borderline Personality Disorder sor and Chair of , is Alum- Anthony C. Ruocco, Ph.D. the Department ni Professor and Chair of of Psychiatry, the Depart- and Chief of ment of Psychiatry and Neuro­ 3:30 P.M. Sessions Translational Neuroscience Re- behavioral Sciences at the University search in Schizophrenia at the Lecture of Virginia and is Professor in the University of Texas Southwest- Departments of Neuroscience and ern Medical School. She holds Medicine. Dr. Johnson’s clinical ex- Lecture 6 the Communities Foundation of pertise is in addiction and biological and forensic psychiatry. He uses neu- 3:30 P.M. - 5:00 P.M. Texas Chair in Brain Science, the Lou and Ellen McGinley Distin- roimaging, neuropharmacology, and Room 113A-C, Level 1 molecular genetics techniques in his Pennsylvania Convention Center guished Chair, and the McKenzie Chair in Psychiatry. She directs research of the psychopharmacology of medications for treating addic- Schizophrenia as a Learning research on understanding the tions. His many honors include the and Memory Disorder disease mechanisms of schizo- Distinguished Senior Scholar of Dis- APA Distinguished Psychiatrist Lecture phrenia and on developing im- tinction Award from the National Series proved treatments. At the Uni- Medical Association and the Ameri- 5 versity of Texas she developed can Psychiatric Association’s Distin- a clinical research laboratory, a guished Psychiatrist Lecturer Award. Speaker: He is a Fellow in the Royal College of Carol A. Tamminga, M.D. human postmortem brain col- lection, and an in vivo human Psychiatrists, the American College of Neuropsychopharmacology, and Chair: imaging laboratory for normal Distinguished Fellow of the Ameri- Lucy A. Epstein-Hutner, M.D. and schizophrenia research. Dr. Tamminga serves on sev- can Psychiatric Association. eral boards, is a member of the NIAAA Guest Lecture Lecture 7 NIMH National Advisory Coun- Lecture 7: 3:30 – 5:00 p.m. 3:30 P.M. - 5:00 P.M. cil and is a member of the Insti- Room 115A-C, Level 1 tute of Medicine of the National Pennsylvania Convention Center Academies. She cofounded and directs the International Con- Musings on Decades of Progress in Alcoholism gress on Schizophrenia Research, Treatment Research and lectures nationally and in- U.S. National Institute on Alcohol Abuse ternationally on treatments in and Alcoholism schizophrenia. 6 APA Distinguished Psychiatrist Lecture Series Speaker: Lecture 6: 3:30 – 5:00 p.m. Bankole A. Johnson, M.D., Ph.D.

Chair: SCR05-1. Is Antidepressant Use in Richard N. Rosenthal, M.D. SCR 6 Bipolar Disorder Associated With Higher Readmission Rates? 3:30 P.M. - 5:00 P.M. Megan J. Ehret, Pharm.D. Room 111B, Level 1 Pennsylvania Convention Center Scientific and Clinical Report 1 3 Borderline Personality SCR05-2. Increased Life Events in Disorders, Diagnostic Issues SCR 5 Bipolar II Patients Participating in Bipolar Biobank 3:30 P.M. - 5:00 P.M. Chair: Mohit Chauhan, M.B.B.S Renato D. Alarcon, M.D., M.P.H. Room 109B, Level 1 Pennsylvania Convention Center 1 SCR06-1. Is Dimensional Scoring of Borderline Personality Disorder Bipolar Disorders Part 2 Only Important for Subthreshold Obtain your Certificate of Chair: ! Levels of Severity? Attendance at: www.psych.org/ Joseph Berger, M.D. AnnualMeetingCME Mark Zimmerman, M.D. 2

165th Annual Meeting 97 SCR06-2. Distinguising Bipolar II and Workshop 23 Presenter(s): Borderline Personality Disorder: A Erica P. Kass, M.D. 3:30 P.M. - 5:00 P.M. Review of Current Literature Sonya L . Martin, M.D., M.A. Room 109A, Level 1 Katy Crow Alison D. Hermann, M.D. Pennsylvania Convention Center 1 2 Meredith A. Kelly, M.D. Jason E. Cheng, M.D. SCR06-3. Borderline Personality Responding to the Impact of Disorder and Atypical Depression: Suicide on Clinicians Controversies and Convergences Workshop 25 Ana Marie Rodriguez-Villa Chair: Eric M. Plakun, M.D. 3:30 P.M. - 5:00 P.M. 1 2 Room 111A, Level 1

SATURDAY, MAY 5 Presenter(s): Pennsylvania Convention Center Jane G. Tillman, Ph.D. Workshop Joining the Ranks of as a Civilian Workshop 24 Contractor: Lessons Learned Workshop 20 3:30 P.M. - 5:00 P.M. 3:30 P.M. - 5:00 P.M. Room 110B, Level 1 Chair: Room 102B, Level 1 Pennsylvania Convention Center Elspeth C. Ritchie, M.D., M.P.H. Pennsylvania Convention Center Presenter(s): Making the Most of Your Chief Christopher S. Nelson, M.D. Understanding Genetics: It’s Not Year: Chief Residents’ Forum I Elspeth C. Ritchie, M.D., M.P.H. Just Mendelian Anymore Chairs: Chair: Margaret Haglund, M.D. Michele T. Pato, M.D. Rosalyn Womack, D.O. Presenter(s): Michele T. Pato, M.D.

Workshop 21 EARN ONLINE CME 3:30 P.M. - 5:00 P.M. Room 104A, Level 1 @ APAeducation.org Pennsylvania Convention Center

Children of Psychiatrists

Chairs: Michelle B. Riba, M.D., M.S. Leah J. Dickstein, M.D., M.A. Presenter(s): Helen R Valenstein, B.A. Eve Stotland, Esq. Hannah Glick Jeremy Glick CME COURSES

Workshop 22 Performance in Practice Modules

3:30 P.M. - 5:00 P.M. - Free to APA Members Room 107A, Level 1 - Approved by ABPN for Part 4 MOC - Three-stage Performance Improvement CME structure Pennsylvania Convention Center E/M Coding Course for Psychiatrists Promoting Improved - Free to APA Members Integration: The Role of 8 Online Practice Guideline Courses

Collaborative Health Care in TM - Earn up to 8 AMA PRA Category 1 Credits Today’s Society Buprenorphine for O ce Based Treatment of Opiate Dependent Patients Chair: Peter S. Martin, M.D., M.P.H. - 8 Hour Training Program That Meets CSAT Requirements And More... Presenter(s): My Transcript: A Tool for Recording Your CME Marilyn Griffin, M.D. - Record and Store Your CME Credits in One Easy to Access Location Margaret Balfour, M.D., Ph.D. www.apaeducation.org 98 www.psychiatry.org Sunday’s Program Sunday’s Program This is for themain TOC. Keep on pasteboard with 2 This is for the ProgGuide TOC. Keep on pasteboard with points overlap into live area. 2 points overlap into live area.

2012 ANNUAL MEETING

SUNDAY MAY 6

165th Annual Meeting 99 8:00 A.M. Sessions Scientific and Clinical Report BIO Case Conferences Judge Steven SCR 7 Leifman is at the forefront of ! These sessions are open 8:00 A.M. - 9:30 A.M. a public policy to APA members only. A blue Room 109B, Level 1 movement to registration badge or an APA Pennsylvania Convention Center reduce the membership card is required for number of peo- admittance. Collaborative Care ple with mental illness in prison, and to develop Chair: alternatives that offer treatment Derya Iren Akbiyik, M.D. and support recovery. He serves Case Conference 1 SCR07-1. Do Psychopharmacologists as Associate Administrative Judge 8:00 A.M. - 9:30 A.M. Speak to Psychotherapists About in the Miami-Dade County Court Room 118A-C, Level 1 Their Mutual Patients? A Survey of Criminal Division and as Special Pennsylvania Convention Center Practicing Clinicians Advisor on Criminal Justice and Thomas P. Kalman, M.D., M.S. Mental Health for the Supreme Court of Florida. He Chairs the A Case of Bipolar Spectrum 3 4 Depression Eleventh Judicial Circuit of Flor- (APA Members Only) SCR07-2. Assessing the Practices ida’s Mental Health Committee, and Perceptions of Dually-Trained Cochairs the Miami-Dade County Chair: Physicians: A Pilot Study Mayor’s Mental Health Task Force, Michael E. Thase, M.D. Gaurav Jain, M.D. and serves on a statewide task SUNDAY, MAY 6 force to improve Florida’s mental SCR07-3. Characteristics of Patients Presenter(s): health system. He has over two Enrolled in a Collaborative Care Michael E. Thase, M.D. dozen awards and honors, is a Pilot for Patients With Chronic member of the National Leader- Medical Illness and Depression ship Forum for Behavioral Health, and/ or Harmful Drinking Lecture and is on the Board of Directors of Henry Chung, M.D. the American Psychiatric Founda- tion. He has developed a course Lecture 8 Small Interactive Session explaining how judges can divert 8:00 A.M. - 9:30 A.M. defendants with mental illness Room 115A-C, Level 1 into treatment rather than jail. Pennsylvania Convention Center Small Interactive Session 1 Patient Advocacy Award Lecture Lecture 8: 8-9:30 a.m. The Criminalization of Mental 8:00 A.M. - 9:30 A.M. Illness Room 107A, Level 1 APA Patient Advocacy Award Lecture Pennsylvania Convention Center Sports Psychiatry: Helping Speaker: Workshop Teams Manage Suicide and Steve Leifman, J.D. Sudden Death in Athletes Workshop 26 Chair: David McDowell, M.D. Chair: 8:00 A.M. - 9:30 A.M. David McDuff, M.D. Room 101, Level 1 Pennsylvania Convention Center Small Interactive Session 2 Pain in the Nursing Home: A 8:00 A.M. - 9:30 A.M. Mental Health Concern ! SESSION TRACKS Room 109A, Level 1 Pennsylvania Convention Center 1 Anxiety & Mood Disorders Chairs: Mara Aronson, M.S., R.N. 2 Personality Disorders Meet the Author of the Amita R. Patel, M.D. Evidence-Based Guide to 3 Psychopharmacology Antidepressant Medications 4 Psychotherapy 1 3 ! Program changes are printed 5 Schizophrenia and each day in the Daily Bulletin Other Psychotic Disorders Chair: which can be picked up in the Anthony J. Rothschild, M.D. 6 NIAAA Pennsylvania Convention Center. A mobile application will also be 7 DSM-5 available.

100 www.psychiatry.org Workshop 27 Workshop 31 Symposium 8:00 A.M. - 9:30 A.M. 8:00 A.M. - 9:30 A.M. Room 102A, Level 1 Room 110B, Level 1 Symposium 21 Pennsylvania Convention Center Pennsylvania Convention Center 8:00 A.M. - 11:00 A.M. The Internet as a Weapon: Legal, Incarceration of Black Females: Room 103B, Level 1 Educational, and Psychiatric Casualties and Collateral Pennsylvania Convention Center Perspectives on Cyberbullying Damage From "the War on Drugs" and Other Nonviolent The Future of Psychiatric Chair: Offences Diagnosis: Updates on Patricia R. Recupero, M.D., J.D. APA Caucus of Black Psychiatrists Proposed Diagnostic Criteria for Presenter(s): DSM-5 (Part I) Laura B. Whiteley, M.D. Chairs: American Psychiatric Institute for Anne T. Ryan, Ed.D. Napoleon B. Higgins, M.D. Research and Education Patricia R. Recupero, M.D., J.D. Stephen A. McLeod-Bryant, M.D. 2 7 Presenter(s): 6 MAY SUNDAY, Chairs: Workshop 28 Aikiesha Shelby, M.D. Monique L. Upton, M.D. Darrel A. Regier, M.D., M.P.H. 8:00 A.M. - 9:30 A.M. David J. Kupfer, M.D. Room 102B, Level 1 1. Neurodevelopmental Pennsylvania Convention Center Advances In Series Disorders, Including Autism Spectrum Disorder, Intellectual CBASP, an Evidence-Based Developmental Disorder and Psychotherapy for the Treatment Advances In Series 1 Learning Disorder of the Chronically Depressed 8:00 A.M. - 11:00 A.M. Susan E. Swedo, M.D. Patient Room 108A/B, Level 1 2. The Developmental Perspective 1 4 Pennsylvania Convention Center and DSM-5 Daniel Pine, M.D. Chair: Advances in Addiction Sherif A. Ragab, M.D. Psychopharmacology 3. Developmental Considerations: Looking Forward and Looking Back Presenter(s): 3 Eric Levander, M.D., M.P.H. David Shaffer, M.D. Rhea Holler, Psy.D. Chairs: 4. Evolution of a New Model of Henry R. Kranzler, M.D. Personality Disorders for DSM-5 Workshop 29 Domenic A. Ciraulo, M.D. Andrew E. Skodol, M.D. 8:00 A.M. - 9:30 A.M. 1. Overview of Medications 5. Neurocognitive Disorders Development Room 104A, Level 1 Ronald Petersen, M.D., Ph.D. Pennsylvania Convention Center Domenic A. Ciraulo, M.D. 2. Medications to Treat Alcohol Symposium 22 The ABC’s of Applied Behavioral Dependence Analysis (ABA) for Autism and Henry R. Kranzler, M.D. 8:00 A.M. - 11:00 A.M. other Educational Interventions Room 103C, Level 1 3. Medications to Treat Nicotine Pennsylvania Convention Center Chair: Dependence Alice R. Mao, M.D. Caryn Lerman, Ph.D. The Contributions of Brain 4. Medications to Treat Opioid Imaging to the Study of Workshop 30 Dependence Psychosis John A. Renner, M.D. 5 8:00 A.M. - 9:30 A.M. 5. Medications to Treat Cocaine and Room 106A/B, Level 1 Chair: Pennsylvania Convention Center Other Stimulant Dependence Kyle M. Kampman, M.D. Raquel E. Gur, M.D., Ph.D. Do Cognitive Psychology and 6. Medications to Treat Cannabis 1. The Kraepelinian Schizophrenia- Neuroscience Have Anything to Dependence Bipolar Disorder Divide: What Do Teach Us About Morality? Frances R. Levin, M.D. the Neuroimaging Studies Tell Us? Matcheri S. Keshavan, M.D. Chair: 2. Understanding and Treating Carl I. Cohen, M.D. Impaired Cognition and Emotion in Presenter(s): Schizophrenia John L. Kubie, Ph.D. Cameron S. Carter, M.D. Ramotse Saunders, M.D. Amjad Hindi, M.D.

165th Annual Meeting 101 3. Alterations in Working and 2. Stress Innoculation and Resilience Discussant(s): Declarative Memory Circuitry in the in a Primate Model Antonia S. New, M.D. Psychosis Prodrome Alan F. Schatzberg, M.D. 1. Impulsive Behavior in Pathological Larry J. Seidman, Ph.D. 3. Preventing the Onset of Gambling: a Behavioral Addiction 4. Brain Function in Psychosis-Prone Depression in High-Risk Children: Carlos Blanco-Jerez, M.D., Ph.D. Youth and Schizophrenia A Novel Experimental Approach 2. Searching for Endophenotypes in Raquel E. Gur, M.D., Ph.D. Ian Gotlib, Ph.D. BPD: a Focus on Self-Reported and 4. The Neurobiology of Child Abuse Behavioral Impulsivity Symposium 23 and Neglect: Impact on the M. Mercedes Perez-Rodriguez, M.D., Ph.D. Withdrawn Pathophysiology and Treatment of Mood Disorders 3. Impulsivity and Intermittent Charles B. Nemeroff, M.D., Ph.D. Explosive Disorder: Making Sense Symposium 24 of Inconsistent Findings Michael S. McCloskey, Ph.D. 8:00 A.M. - 11:00 A.M. Symposium 26 Room 111B, Level 1 4. Assessment of Predictors of High- Pennsylvania Convention Center 8:00 A.M. - 11:00 A.M. Risk Mixed-Diagnosis Suicidal Room 119A, Level 1 Veterans Patient Suicide in Residency Pennsylvania Convention Center Marianne S. Goodman, M.D. Training 5. ADHD and Impulsivity: Bipolar Disorder: State-of-the- Longitudinal Course, Comorbidity, Chairs: Art Treatments and Impairments Related to Meredith A. Kelly, M.D. 1 3 4 Persistence Into Adulthood Joan M. Anzia, M.D.

SUNDAY, MAY 6 Jeffrey H. Newcorn, M.D. Chair: Discussant(s): Michael Gitlin, M.D. Sidney Zisook, M.D. Edward R. Shapiro, M.D. Discussant(s): Symposium 28 1. Resident Experience of Patient Mark Frye, M.D. 8:00 A.M. - 11:00 A.M. Suicide 1. New Developments in the Grand Ballroom Salon G Uyen-Khanh Quang-Dang, M.D. Treatment of Acute : Clinical Philadelphia Marriott Downtown 2. How "Collateral Damage: The and Methodological Issues First Annual Member in Psychiatrist's Response to Suicide" Roger S. McIntyre, M.D. Training/ Early Career Came About and What It Is 2. Treatment Options for Acute Psychiatrist Leadership Forum Supposed to Provide Depression in Bipolar Disorder James Lomax, M.D. Michael Bauer, M.D., Ph.D. Chairs: 3. Patient Suicide in Residency 3. Maintenance Treatment of Bipolar Joyce A. Spurgeon, M.D. Training Disorder Sarah Johnson, M.D. Christina V. Mangurian, M.D. Michael Gitlin, M.D. 1. APA's Structure and Leadership 4. Institutional Responses to Patient Carol A. Bernstein, M.D. Suicide: The UCSF Model 4. The Treatment of Complex Bipolar Andrew Booty, M.D. Disorder 2. How Mentorship Can Be a Gin Malhi, M.D. Powerful Tool for the Local District Branches Symposium 25 5. Adjunctive Psychosocial Nada L. Stotland, M.D., M.P.H. Interventions for Bipolar Disorder 3. How to Submit Presentations to 8:00 A.M. - 11:00 A.M. David J. Miklowitz, Ph.D. Room 114 Lecture Hall, Level 1 the Annual Meeting Pennsylvania Convention Center Mary Helen Davis, M.D. Symposium 27 Can Major Depression Be 8:00 A.M. - 11:00 A.M. Symposium 29 Prevented? New Insights From Room 120A, Level 1 Basic and Clinical Studies Pennsylvania Convention Center 8:00 A.M. - 11:00 A.M. 1 Room 120C, Level 1 Impulsivity and Behavioral Pennsylvania Convention Center Chairs: Dysinhibition Across Psychiatric Alan F. Schatzberg, M.D. Disorders: Pathological Promoting Resilience, Recovery, Ned H. Kalin, M.D. Gambling, Personality Social Inclusion, and Behavioral 1. Using the Nonhuman Primate Disorders, Suicide, and ADHD Health Equity: A Historical and Contemporary Profile of Developmental Model of Anxious 2 Temperament to Conceptualize Philadelphia New Approaches to Early Chair: Interventions Antonia S. New, M.D. Chair: Ned H. Kalin, M.D. Annelle B. Primm, M.D., M.P.H.

102 www.psychiatry.org 1. The Cosmopolitan Canopy: Race Symposium 31 Course 11 and Civility in Everyday Life in Philadelphia 8:00 A.M. - 11:00 A.M. 8:00 A.M. - 12:00 P.M. Elijah Anderson, Ph.D. Room 121B, Level 1 Room 121C, Level 1 Pennsylvania Convention Center Pennsylvania Convention Center 2. Resilience in Action: A Presentation by Youth M.O.V.E. Current Models of Collaborative Mentalization Based Treatment Philadelphia Care for Borderline Personality Marc Forman, M.D. Disorder: Introduction to Clinical 3. Resilience in Action: A Chair: Practice Presentation by Youth M.O.V.E. Amy C. Brodkey, M.D. 2 Philadelphia Discussant(s): Randolph Alexander Jurgen Unutzer, M.D., M.P.H. Directors: Anthony W. Bateman, M.D. 4. Reducing Disparities in Access 1. A Pilot Study Embedding Peter Fonagy, M.D., Ph.D. to Treatment for Justice-Involved Behavioral Health Providers in an Academic Patient Centered Individuals Diagnosed With Severe 6 MAY SUNDAY, Mental Illness Medical Home Practice Course 12 Jean H. Wright, Psy.D. Susan Day, M.D. 8:00 A.M. - 12:00 P.M. 5. Transforming a Behavioral 2. Integration of Primary and Behavioral Health Care in a Multi- Room 123, Level 1 Health System to a Recovery and Pennsylvania Convention Center Resilient-Oriented System of Care: Site Federally Qualified Health Improved Healthcare and Health Center Amy C. Brodkey, M.D. Motivation and Change: Equity in Philadelphia The Theory and Practice of Arthur C. Evans, Ph.D. 3. Integrating Health Care by Reverse Motivational Interviewing Colocation APA Council on Addiction Psychiatry Lawrence A. Real, M.D. 4 Symposium 30 4. Veterans Healthcare 8:00 A.M. - 11:00 A.M. Administration: Primary Care Directors: Room 121A, Level 1 Mental Health Integration Central Petros Levounis, M.D., M.A. Pennsylvania Convention Center Arkansas Veterans Healthcare Bachaar Arnaout, M.D. System Faculty(s): Medication Use for Treating Patricia Allred, M.D. Marianne T. Guschwan, M.D. Alcohol Dependence 5. MHIP: The Washington State Gary Katzman, M.D. U.S. National Institute on Alcohol Abuse Mental Health Integration Program Carla B. Marienfeld, M.D. and Alcoholism Jurgen Unutzer, M.D., M.P.H. 1 3 4 6 Course 13 Chairs: Course 8:00 A.M. - 12:00 P.M. Raye Z. Litten, Ph.D. Room 124, Level 1 Fertig Joanne, Ph.D. ! Course Descriptions are Pennsylvania Convention Center 1. Quetiapine for the Treatment of available in the Course Brochure. Clinician's Guide to Assessing Alcohol Dependence You can pick up a Course and Managing Behavior Fertig Joanne, Ph.D. Brochure and purchase a course Disturbances in Patients With ticket in the Course Enrollment 2. Gabapentin Treatment of Alcohol Dementia With an Emphasis on Area located in Exhibit Halls C-E, Dependence and Alcohol-Related Those With Moderate to Severe Level 2, Pennsylvania Convention Disturbances in Mood and Sleep Symptoms Barbara J. Mason, Ph.D. Center. Admission to all courses, including Master Courses is by Director: 3. Novel Targets From the Dark Side ticket only. Maureen C. Nash, M.D., M.S. of Dependence on Alcohol: Focus on the Brain Stress Systems CRF, Faculty(s): Dynorphin, and Vasopressin Sarah Foidel, OTR/L George F. Koob, Ph.D. Course 10 4. Extended-Release Naltrexone 8:00 A.M. - 12:00 P.M. for the Treatment of Alcohol Room 112A, Level 1 Dependence Pennsylvania Convention Center ! All scientific sessions listed David R. Gastfriend, M.D. in the Annual Meeting Program Mindfulness: Practical Book are designated for AMA Applications for Psychiatry PRA Category 1 Credits™, except for New Research Poster Director: Sessions. Susan E. Abbey, M.D.

165th Annual Meeting 103 Course 14 Seminar 4 Seminar 8 8:00 A.M. - 12:00 P.M. 8:00 A.M. - 12:00 P.M. 8:00 A.M. - 12:00 P.M. Room 201C, Level 2 Room 111A, Level 1 Room 501, Level 5 Pennsylvania Convention Center Pennsylvania Convention Center Philadelphia Marriott Downtown

The Detection of Malingered Mind! Lessons From the Brain Losing a Patient to Suicide Mental Illness Director: Director: Director: Philip T. Ninan, M.D. Michael F. Myers, M.D. Phillip J. Resnick, M.D. Faculty(s): Course 15 Seminar 5 Frank Campbell, Ph.D., M.S.W. Carla Fine, M.S. 8:00 A.M. - 12:00 P.M. 8:00 A.M. - 12:00 P.M. Grand Ballroom Salon D, Level 5 Room 112B, Level 1 Philadelphia Marriott Downtown Pennsylvania Convention Center 9:00 A.M. Sessions Culturally Appropriate Best Financial Practices for Course Assessment Revealed: The Fiscally Solvent Delivery of DSM-IV-TR Outline for Cultural Integrated Care Formulation Demonstrated With Course 18 Videotaped Case Vignettes Director: 9:00 A.M. - 4:00 P.M. Roger G. Kathol, M.D. Directors: Room 125, Level 1

SUNDAY, MAY 6 Russell F. Lim, M.D. Faculty(s): Pennsylvania Convention Center Francis Lu, M.D. Stephen P. Melek Susan C. Sargent, M.B.A. Treatment of Schizophrenia Chris White, M.D., J.D. Course 16 3 5 8:00 A.M. - 12:00 P.M. Director: Grand Ballroom Salon I, Level 5 Seminar 6 Philip G. Janicak, M.D. Philadelphia Marriott Downtown 8:00 A.M. - 12:00 P.M. Faculty(s): Room 203B, Level 2 Mood Disorders in Later Life Rajiv Tandon, M.D. Pennsylvania Convention Center Philip G. Janicak, M.D. 1 Morris B. Goldman, M.D. Seeing the Forest and the Trees: Stephen Marder, M.D. Directors: An Approach to Biopsychosocial James M. Ellison, M.D., M.P.H. Formulation Yusuf Sivrioglu, M.D. Course 19 Faculty(s): Director: James M. Ellison, M.D., M.P.H. William H. Campbell, M.D., M.B.A. 9:00 A.M. - 4:00 P.M. Donald A. Davidoff, Ph.D. Room 126A, Level 1 Brent P. Forester, M.D. Pennsylvania Convention Center Joanna Salmon, Ph.D., M.B.A. Seminar 7 Kundalini Yoga Meditation 8:00 A.M. - 12:00 P.M. Techniques for Schizophrenia, Course 17 Registration II, Level 5 the Personality Disorders, and Philadelphia Marriott Downtown 8:00 A.M. - 12:00 P.M. Autism Grand Ballroom Salon K, Level 5 Writing, Blogging, and 1 2 5 Philadelphia Marriott Downtown Podcasting About Psychiatry for the Public: A Guide for the Director: Current Procedural Terminology Perplexed David S. Shannahoff-Khalsa Coding and Documentation APA Committee on RBRVS, Codes and Reimbursement Directors: ! SESSION TRACKS Steven R. Daviss, M.D. 1 Anxiety & Mood Disorders Annette Hanson, M.D. Director: 2 Personality Disorders Ronald M. Burd, M.D. Faculty(s): 3 Psychopharmacology Dinah Miller, M.D. Faculty(s): 4 Psychotherapy Ronald M. Burd, M.D. 5 Schizophrenia and Allan A. Anderson, M.D. Other Psychotic Disorders David K. Nace, M.D. NIAAA Chester W. Schmidt, M.D. 6 Jeremy S. Musher, M.D. 7 DSM-5 Tracy R. Gordy, M.D.

104 www.psychiatry.org Course 20 Course 23 Lecture 10 9:00 A.M. - 4:00 P.M. 9:00 A.M. - 4:00 P.M. 10:00 A.M. - 11:30 A.M. Room 126B, Level 1 Grand Ballroom Salon C, Level 5 Terrace Ballroom IV, Level 4 Pennsylvania Convention Center Philadelphia Marriott Downtown Pennsylvania Convention Center

Basic Concepts in Psychodynamic Resilience as a Dynamic Administrative Psychiatry II Psychopharmacology: Applying Concept American Association of Psychiatric Practical Psychodynamics APA International Psychiatrist Lecture Administrators to Improve Pharmacologic Series 1 Outcomes With Treatment Resistant Patients Speaker: Directors: 3 4 Michael Rutter, M.D. Douglas M. Brandt, M.D. Wayne L. Creelman, M.D. Director: Chair: David L. Mintz, M.D. Patricia I. Ordorica, M.D.

Faculty(s): 6 MAY SUNDAY, Robert M. Atkins, M.D., M.P.H. Faculty(s): Alan Axelson, M.D. David Flynn, M.D. William H. Reid, M.D., M.P.H. Samar Habl, M.D. Arthur L. Lazarus, M.D., M.B.A. Barri Belnap, M.D. Jeri Davis, M.B.A.

Master Course 3 BIO Course 21 9:00 A.M. - 4:00 P.M. Katherine 9:00 A.M. - 4:00 P.M. Room 122A/B, Level 1 L. Wisner Room 203A, Level 2 Pennsylvania Convention Center M.D., M.S., Pennsylvania Convention Center is Professor Practical Cognitive Behavior of Psychiatry, Essentials of Assessing and Therapy Obstetrics/Gy- necology and Treating Attention Deficit 1 4 Hyperactivity Disorder in Adults Reproductive Sciences, Epidemiol- and Children ogy and Women’s Studies at the Director: University of Pittsburgh School Jesse H. Wright, M.D., Ph.D. Director: of Medicine and Director of the Thomas E. Brown, Ph.D. Faculty(s): Women’s Behavioral HealthCARE Robert M. Goisman, M.D. program at the Western Psychiat- Faculty(s): Donna M. Sudak, M.D. ric Institute and Clinic, University Jefferson B. Prince, M.D. Judith S. Beck, Ph.D. of Pittsburgh Medical Center. She Anthony L. Rostain, M.D., M.A. also serves as an investigator at the Magee-Womens Research In- stitute. Dr. Wisner researches the Course 22 10:00 A.M. Sessions psychiatric treatment of women of childbearing age. She is a recog- 9:00 A.M. - 4:00 P.M. Lecture Grand Ballroom Salon B, Level 5 nized expert in the treatment of Philadelphia Marriott Downtown depression during pregnancy and Lecture 9 the postpartum period and is a Davanloo's Intensive Short- strong advocate for development Term Dynamic Psychotherapy in 10:00 A.M. - 11:30 A.M. of somatic nondrug treatment op- Clinical Practice Room 115A-C, Level 1 tions for depression during child- Pennsylvania Convention Center bearing to increase the choices 4 available to women. Dr. Wisner is Perinatal Psychiatry: Reflections board-certified in general, child, Directors: Over Three Decades of Research and adolescent psychiatry. She James Q. Schubmehl, M.D. APA Alexandra Symonds Award Lecture is a Distinguished Fellow of the Alan R. Beeber, M.D. American Psychiatric Association Speaker: and is often called on to consult Katherine L Wisner, M.D., M.S. for government agencies. Dr. Wis- ner received the Woman in Science Chairs: Award from the American Medical ! Obtain your Certificate of Gail E. Robinson, M.D. Women’s Association in 2011. Eva M. Szigethy, M.D., Ph.D. Attendance for the 2012 APA APA Alexandra Symonds Award Annual Meeting at www.psych. Lecture org/AnnualMeetingCME Lecture 9: 10-11:30 a.m.

165th Annual Meeting 105 New Research Poster BIOS Sir Michael Milton NR Poster Session 3 Rutter, M.D., Kramer, is Professor of M.D., is Con- 10:00 A.M. - 11:30 A.M. Developmental sultant in Psy- Exhibit Hall C-E, Level 2 Psychopathology chiatry at Beth Pennsylvania Convention Center at the Institute of Israel Medical Psychiatry, Kings Center and St. Young Investigators College. He is a Luke’s-Roosevelt Hospital. He was long-time Consultant at the Maud- formerly director of psychiatric re- sley Hospital. He has studied the search at Maimonides Medical Cen- Scientific and Clinical Report genetics of autism as well as the de- ter and Clinical Professor of Psychia- velopment of diagnostic and screen- try at New York University. While at ing measures for autism, antisocial the University of Mississippi he was SCR 8 behavior, and school and family Director of the country’s first Divi- influences on children’s behavior. He sion of Somnology and later opened 10:00 A.M. - 11:30 A.M. has a special interest in the interplay the sleep and dream laboratory at Room 109B, Level 1 between genetic and psychosocial the VA hospital in Cincinnati. Dr. Pennsylvania Convention Center risk factors. Dr. Rutter led a major Kramer was a founding member of study into the effect of early severe what is now the Academy of Sleep Depression deprivation on Romanian orphans Medicine. His lifetime of research in adopted into Britain. He was Deputy sleep and dreams has been recog- Chair: Chairman of the Wellcome Trust nized by the International Associa- SUNDAY, MAY 6 Derya Iren Akbiyik, M.D. from 1999 to 2004, is a Fellow of the tion for the Study of Dreams of SCR08-1. Why Do Some Depressed Royal Society, and a Founding Fellow which he is Past President. Dr. Kram- Outpatients Who Are in Remission of the Academia Europaea and the er is well-known for his writings According to the Hamilton Academy of Medical Sciences. about dreams and the diagnosis and Depression Rating Scale Not APA International Psychiatrist Lec- treatment of sleep disorders. Consider Themselves to Be in ture Series APA George Tarjan Award Lecture Remission? Lecture 10: 10-11:30 a.m. Lecture 11: 12:30 – 2:00 p.m. Mark Zimmerman, M.D. 1 SCR08-2. Evaluation of Postpartum Workshop Workshop 34 Depressive Disorders Dimitry Ivashinenko, M.D. 10:00 A.M. - 11:30 A.M. Workshop 32 Room 102B, Level 1 1 Pennsylvania Convention Center SCR08-3. Light Treatment in African- 10:00 A.M. - 11:30 A.M. American Versus Caucasian Room 101, Level 1 Better Integration of Patients With Seasonal Affective Pennsylvania Convention Center International Medical Graduates in Psychiatry by Understanding Disorder Psychiatrist Workforce Shortage: Hyacinth N. Uzoma, M.B.B.S Their Journey Through Challenges and Solutions Application, Residency and 1 Chairs: Beyond Alan Q. Radke, M.D., M.P.H. Small Interactive Session Joseph J. Parks, M.D. Chairs: Lama Bazzi, M.D. Renata Sanders, M.D. Small Interactive Session 3 Workshop 33 Presenter(s): 10:00 A.M. - 11:30 A.M. 10:00 A.M. - 11:30 A.M. Lada Alexeenko, M.D. Room 107A, Level 1 Room 102A, Level 1 Renata Sanders, M.D. Pennsylvania Convention Center Pennsylvania Convention Center Suprit Parida, M.D. Lama Bazzi, M.D. Implementing Interpersonal and Quality Improvement: What It Shaneel Shah, M.B.B.S Social Rhythm Therapy Across a Means for Psychiatrists Michael Reinhardt, M.D. Range of Clinical Settings Chair: 1 4 Claudia L. Reardon, M.D. Chair: Presenter(s): Ellen Frank, Ph.D. Art Walaszek, M.D. John M. Oldham, M.D., M.S. Jerry L. Halverson, M.D. Robert M. Plovnick, M.D., M.S. 106 www.psychiatry.org Workshop 35 Presenter(s): Case Conferences Margaret W. Leung, M.D., M.P.H. 10:00 A.M. - 11:30 A.M. John O. Lusins, M.D., M.S. Room 104A, Level 1 Colin E. Stewart, M.D. ! These sessions are open Pennsylvania Convention Center Kristina Zdanys, M.D. to APA members only. A blue registration badge or an APA Psychiatry on the Forefront: membership card is required for Increasing Access to Care in the admittance. Disaster Setting 12:30 P.M. Sessions Chairs: Catherine S. May, M.D. APA Case Conference 2 Elspeth C. Ritchie, M.D., M.P.H. 12:30 P.M. - 2:00 P.M. Presenter(s): Room 103A, Level 1 Brooke Parish, M.D. APA Annual Business Pennsylvania Convention Center Catherine S. May, M.D.

Meeting 6 MAY SUNDAY, David M. Benedek, M.D. Treating Complicated Grief (APA Members Only) 12:30 P.M. – 1:30 P.M. Workshop 36 Ballroom B, Level 3 1 4 Pennsylvania Convention Center 10:00 A.M. - 11:30 A.M. Chair: Room 106A/B, Level 1 Call to Order M. Katherine Shear, M.D. Pennsylvania Convention Center John M. Oldham, M.D., M.S. Presenter(s): President Mild Traumatic Brain M. Katherine Shear, M.D. Injury: Assessment and Memorial to Deceased Initial Management With Members Announcement of Lecture Neuropharmacology Election Rules 3 Eliot Sorel, M.D. Chair, Committee of Tellers Lecture 11 Chair: David Fitzgerald, M.D. Reports to Membership 12:30 P.M. - 2:00 P.M. Roger Peele, M.D. Room 115A-C, Level 1 Secretary Pennsylvania Convention Center Workshop 37 David Fassler, M.D. My Interest and Experience 10:00 A.M. - 11:30 A.M. Treasurer in Working with International Room 109A, Level 1 Ann Marie T. Sullivan, M.D. Medical Graduates [IMGs] Pennsylvania Convention Center Speaker APA George Tarjan Award Lecture Mindfulness for the Next R. Scott Benson, M.D. Speaker: Generation: The Koru Program Speaker-Elect Milton Kramer, M.D. for Teaching Mindfulness John Oliver Gaston, M.D. and Meditation to University Chair, Committee on By-Laws Chairs: Students and Other Emerging Marie-Claude Rigaud, M.D., M.P.H. Adults Robert Kelly, M.D. Fructuoso R. Irigoyen, M.D. Chair, Elections Committee Chairs: Joseph Ezra V. Rubin, M.D. Hollister B. Rogers, M.D. Chair, Membership Committee Margaret Maytan, M.D., M.A. James H. Scully, Jr., M.D. Medical Director ! SESSION TRACKS Workshop 38 Chairs of Councils 1 Anxiety & Mood Disorders 10:00 A.M. - 11:30 A.M. (written reports only) Personality Disorders Room 110B, Level 1 2 Pennsylvania Convention Center Annual Forum 3 Psychopharmacology 4 Psychotherapy A Resident Leader's Tool Kit Adjournment American Psychiatric Leadership 5 Schizophrenia and Fellowship Program Other Psychotic Disorders Chair: 6 NIAAA Sarah M. Fayad, M.D. 7 DSM-5

165th Annual Meeting 107 Scientific and Clinical Report Small Interactive Session Chairs: Gail E. Robinson, M.D. Karen M. Abrams, M.D. SCR 9 Small Interactive Session 4

12:30 P.M. - 2:00 P.M. 12:30 P.M. - 2:00 P.M. Workshop 42 Room 109B, Level 1 Room 107A, Level 1 Pennsylvania Convention Center Pennsylvania Convention Center 12:30 P.M. - 2:00 P.M. Room 104A, Level 1 Diagnostic Issues The Vitality of Psychodynamic Pennsylvania Convention Center Psychotherapy Chair: Management of Patients With Renato D. Alarcon, M.D., M.P.H. 4 Alcohol and Co-Occurring Disorders: Problems and SCR09-1. Patients With Intellectual Chair: Solutions Disability and Personality Jerald Kay, M.D. Disorders: Closer to Personality U.S. National Institute on Alcohol Abuse Disorders or Intellectual Disability? and Alcoholism Regi T. Alexander, M.D. Workshop 1 6 2 Chair: SCR09-2. The Frequency of Comorbid Workshop 39 Geetanjali Chander, M.D. Axis I Diagnosis in Social Anxiety 12:30 P.M. - 2:00 P.M. Disorder Patients Presenter(s): Ahment Koyuncu, M.D. Room 101, Level 1 Geetanjali Chander, M.D. Pennsylvania Convention Center Sarah Book, M.D. SUNDAY, MAY 6 1 SCR09-3. Assessment of Mixed Integrating Psychotherapy Depression in Bipolar Depression and Psychopharmacology: Workshop 43 Utilizing a Modified Hypomania The Psychiatrist’s Role in the 12:30 P.M. - 2:00 P.M. Diagnosis and Treatment of Checklist Room 109A, Level 1 Sexual Dysfunction Manuel E. Fuentes, M.D. Pennsylvania Convention Center 3 4 SCR 10 Writing for the Lay Public: Chair: Pointers From a Psychiatrist 12:30 P.M. - 2:00 P.M. Eugene F. Simopoulos, M.D. Writer, Investigative Journalist, Room 111B, Level 1 Presenter(s): and the Trainee Perspective Pennsylvania Convention Center Michael Irwig, M.D. Chairs: Epidemiology Serina R. Deen, M.D., M.P.H. Workshop 40 David J. Hellerstein, M.D. Chair: Elias Shaya, M.D. 12:30 P.M. - 2:00 P.M. Presenter(s): SCR10-1. Improving Access and Room 102A, Level 1 Stephen M. Fried Efficient Care for Patients Pennsylvania Convention Center David J. Hellerstein, M.D. With Psychiatric Illnesses in an Serina R. Deen, M.D., M.P.H. Child Abuse in Children From Academic Teaching Medical Center Afro-Caribbean, Asian and Michael W. Kaufmann, M.D. Hispanic Households: What Workshop 44 SCR10-2. Characterization of Persons It Looks Like and How to 12:30 P.M. - 2:00 P.M. Receiving Primary Care Services in Approach It Room 110B, Level 1 a Mental Health Clinic Pennsylvania Convention Center James R. Shackelford, M.D. Chair: Jared Kiddoe, M.D., M.A. SCR10-3. National Telemental Health How Does She Do It All? Outcomes in 98,609 Patients Presenter(s): Balancing Family, Life, and Linda S. Godleski, M.D. Caroline Fisher, M.D., Ph.D. Career Jared Kiddoe, M.D., M.A. ! APA 2012 Annual Chairs: Meeting On Demand Silvia W. Olarte, M.D. Workshop 41 Leah J. Dickstein, M.D., M.A. • Special onsite pricing 12:30 P.M. - 2:00 P.M. • Earn CME Credit for top Presenter(s): Room 102B, Level 1 lectures and symposia online Toi B. Harris, M.D. Pennsylvania Convention Center • For more information: Silvia W. Olarte, M.D. Alice R. Mao, M.D. Prevention of Harm From Eva M. Szigethy, M.D., Ph.D. Stalking

108 www.psychiatry.org Workshop 45 Workshop 49 Chairs: Annette M. Matthews, M.D. 12:30 P.M. - 2:00 P.M. 12:30 P.M. - 2:00 P.M. Robert M. McCarron, D.O. Room 111A, Level 1 Room 123, Level 1 Pennsylvania Convention Center Pennsylvania Convention Center Presenter(s): Sarah Rivelli, M.D. Group Schema Therapy for CPT Coding and Documentation Thomas W. Heinrich, M.D. Borderline Personality Disorder Update Margaret W. Leung, M.D., M.P.H. 2 4 APA Committee on RBRVS, Codes and Robert M. McCarron, D.O. Reimbursement 1. Medical/Psychiatry Updates: Just Chair: What the Psychiatrist Needs to Heather M. Fretwell, M.D. Chair: Know Ronald M. Burd, M.D. Presenter(s): Sarah Rivelli, M.D. Neele Reiss, M.S. Presenter(s): 2. Endocrinology: A Clinically L. Mark Russakoff, M.D. Relevant Review of Medical and Joseph M Schwartz, M.D.

Psychiatric Conditions 6 MAY SUNDAY, Workshop 46 Junji Takeshita, M.D. Thomas W. Heinrich, M.D. 12:30 P.M. - 2:00 P.M. Sarah E. Parsons, D.O. Room 112A, Level 1 Edward Gordon, M.D. 3. Medical/Psychiatric Updates for Pennsylvania Convention Center the Psychiatrist Margaret W. Leung, M.D., M.P.H. Workshop 50 When Physicians Die by Suicide: 4. "Ouch!" Chronic Lower Back Pain: What Can We Learn From Their 12:30 P.M. - 2:00 P.M. What the Psychiatrist Needs to Loved Ones? Room 124, Level 1 Know…. Pennsylvania Convention Center Robert M. McCarron, D.O. Chair: Michael F. Myers, M.D. A Terrible Melancholy: Presenter(s): Depression in the Legal Advances In Series Margaret R. Watanabe, M.D., Ph.D. Profession Dan Bree, M.S. Anna H. Rosen, M.D. Chair: Advances In Series 2 Lawson R. Wulsin, M.D. Carla Fine, M.S. 1:00 P.M. - 4:00 P.M. Presenter(s): Room 108A/B, Level 1 Workshop 47 Lawson R. Wulsin, M.D. Pennsylvania Convention Center Daniel T. Lukasik, Esq. 12:30 P.M. - 2:00 P.M. Advances in Posttraumatic Room 112B, Level 1 Stress Disorder Pennsylvania Convention Center 1:00 P.M. Sessions 1 3 4 Evaluation and Treatment of the Complex Eating Disordered New Research Poster Chairs: Patient Gary H. Wynn, M.D. David M. Benedek, M.D. NR Poster Session 4 Chairs: 1. Epidemiology Susan Ice, M.D. 1:00 P.M. - 3:00 P.M. Charles C. Engel, M.D., M.P.H. Alican Dalkilic, M.D., M.P.H. Exhibit Hall C-E, Level 2 2. Psychotherapy Presenter(s): Pennsylvania Convention Center Paula Schnurr, Ph.D. David Hahn, M.D. New Research — Mood Disorders 3. Pharmacotherapy David M. Benedek, M.D. Workshop 48 Gary H. Wynn, M.D. 12:30 P.M. - 2:00 P.M. Advances In Medicine 4. Complimentary and Alternative Room 121C, Level 1 Medicine Pennsylvania Convention Center Advances In Medicine 1 Gary H. Wynn, M.D. The Art of Narrative Psychiatry: 1:00 P.M. - 4:00 P.M. 5. Clinical Practice Guidelines Integrating the Values and Room 118A-C, Level 1 David M. Benedek, M.D. Strategies of Narrative Pennsylvania Convention Center Psychotherapy With Psychiatric Practice Medical Mysteries and Practical ! Obtain your Certificate of Med Psych Updates: Is It Attendance for the 2012 APA 3 4 "Medical,” “Psychiatric” or a Annual Meeting at www.psych. Chair: Little of Both…? org/AnnualMeetingCME SuEllen Hamkins, M.D.

165th Annual Meeting 109 Media Workshop 2. Proposed Changes in the DSM- Symposium 34 5 Section on Major Depressive Disorders 1:00 P.M. - 4:00 P.M. Room 106A/B, Level 1 Media Workshop 3 Jan Fawcett, M.D. Pennsylvania Convention Center 1:00 P.M. - 4:00 P.M. 3. Updates From the Mood Disorders Room 119B, Level 1 Workgroup for DSM-5: Bipolar A Comprehensive Model Pennsylvania Convention Center Disorder for Mental Health Tobacco Trisha Suppes, M.D., Ph.D. Recovery in New Jersey “Here One Day:” A Film About 4. Update on Proposed DSM-5 Bipolar Disorder and Suicide Changes for Anxiety Disorders and Chair: 1 Obsessive-Compulsive and Related Jill M. Williams, M.D. Disorders 1. A Comprehensive Model for Mental Chairs: Katharine A. Phillips, M.D. Health Tobacco Recovery in New Kathy Leichter 5. Proposed Trauma and Stress- Jersey: Introduction and Overview Michael F. Myers, M.D. Related Disorders for DSM-5 of the Model Presenter(s): Matthew J. Friedman, M.D., Ph.D. Mia Zimmermann, M.P.H. Kathy Leichter 2. Innovations in Tobacco Franz Leichter Dependence Education and Josh Leichter Symposium 33 Intervention: The Choices Program Stephen M. Goldfinger, M.D. 1:00 P.M. - 4:00 P.M. Patricia Dooley, M.A. Ira Glick, M.D. Room 103C, Level 1 3. Environmental Changes Needed Pennsylvania Convention Center in the Mental Health System to SUNDAY, MAY 6 Symposium Support Treatment Efforts Clinical and Administrative Jill M. Williams, M.D. Aspects of the DSM-5 Personality Disorders 4. Clinical Treatment Approaches for Symposium 32 Association for Research in Personality Smokers With Mental Illness 1:00 P.M. - 4:00 P.M. Disorders Jonathan Foulds, Ph.D. Room 103B, Level 1 2 7 Pennsylvania Convention Center Symposium 35 Chair: The Future of Psychiatric James Reich, M.D., M.P.H. 1:00 P.M. - 4:00 P.M. Diagnosis: Updates on Room 107B, Level 1 Proposed Diagnostic Criteria for Discussant(s): Pennsylvania Convention Center DSM-5 (Part II) Andrew E. Skodol, M.D. American Psychiatric Institute for 1. Personality Disorders: the DSM-1 Integrative Psychiatry for Research and Education to DSM-5 Crosswalk Treatment of Mood and Anxiety 1 5 7 Donald W. Black, M.D. Disorders Across the Life Cycle 2. Validators of Proposed DSM-5 1 Chairs: Personality Disorders David J. Kupfer, M.D. Larry J. Siever, M.D. Chair: Darrel A. Regier, M.D., M.P.H. Helen Lavretsky, M.D., M.S. 3. Personality and Outcome of Axis I 1. Anticipating DSM-5: The Psychosis Disorders After DSM-5 1. The Use of Mind-Body Chapter James Reich, M.D., M.P.H. Interventions for Treatment and William T. Carpenter, M.D. Prevention of Later-Life Mood 4. Dimensional Diagnostic Disorders Classification of Personality Helen Lavretsky, M.D., M.S. Disorder: Implications for 2. Natural Remedies and Acupuncture SESSION TRACKS Psychotherapy ! John Livesley, M.D. for Mood Disorders: Review of the Evidence 1 Anxiety & Mood Disorders 5. Unintended and Nonpsychiatric David Mischoulon, M.D., Ph.D. 2 Personality Disorders Consequences of a Change in Diagnosis 3. Trance and Treatment: Minding 3 Psychopharmacology Kenneth R. Silk, M.D. Mood and Anxiety 4 Psychotherapy David R. Spiegel, M.D. 4. CAM: Implications for Mood and 5 Schizophrenia and Other Psychotic Disorders Anxiety Disorders Mark H. Rapaport, M.D. 6 NIAAA 5. Integrative Psychiatry for Pediatric 7 DSM-5 Mood Disorders Scott Shannon, M.D.

110 www.psychiatry.org Symposium 36 Symposium 38 Psychopathy Versus Other Externalizing Disorders 1:00 P.M. - 4:00 P.M. 1:00 P.M. - 4:00 P.M. Joseph P. Newman, Ph.D. Room 114 Lecture Hall, Level 1 Room 119A, Level 1 Pennsylvania Convention Center Pennsylvania Convention Center 3. Dopamine, Cognitive Function, and Cocaine Characterization and Borderline Personality Disorder Joy Schmitz, Ph.D. Treatment of Early Stages of and the Mood Disorders 4. Cognition as a Target for Nicotine Schizophrenia Spectrum: Co-Morbidity, Dependence Treatment 3 5 Confusion, and Controversy Caryn Lerman, Ph.D. 1 2 Chairs: S. Charles Schulz, M.D. Chair: Symposium 40 Matcheri S. Keshavan, M.D. Lois W. Choi-Kain, M.D., M.Ed. 1:00 P.M. - 4:00 P.M. 1. Adolescent Brain Development, Discussant(s): Room 120B, Level 1 Premorbid Impairments, and Risk S. Nassir Ghaemi, M.D., M.P.H. Pennsylvania Convention Center 6 MAY SUNDAY, for Schizophrenia 1. The Importance of Considering Matcheri S. Keshavan, M.D. Integrated Psychiatry: Primary Borderline Personality Disorder Care Services in Houston, Texas 2. Altered Functional and Structural When Interpreting Studies of the Brain Developmental Trajectories Validity of the Bipolar Spectrum Chair: in Youth at Clinical Risk for Mark Zimmerman, M.D. Britta Ostermeyer, M.D. Psychosis 2. Phenotype, Endophenotype, and John M. Oldham, M.D., M.S. Tyrone D. Cannon, Ph.D. Genotype Comparisons Between 1. Foundation and Overview of the 3. Early Intervention in Psychiatry: Borderline Personality Disorder Community Behavioral Health Lessons From Psychosis and Major Depressive Disorder Program (CBHP) Patrick D. McGorry, M.D., Ph.D. Marianne S. Goodman, M.D. Britta Ostermeyer, M.D. 4. Update on Medication Approaches 3. Atypical Depression: Mood 2. The CBHP Psychiatrist: The Good, to Early-Stage Schizophrenia Disorder, Borderline Personality the Bad, and How we Improved S. Charles Schulz, M.D. Disorder, or Both? Asim Shah, M.D. Lois W. Choi-Kain, M.D., M.Ed. 3. The CBHP Primary Care Physician: 4. Interaction of BPD and Affective Symposium 37 Experiences and Barriers to Disorders: 10-Year Follow-Up Integrated Care 1:00 P.M. - 4:00 P.M. John G. Gunderson, M.D. Room 117, Level 1 Brian C. Reed, M.D. Pennsylvania Convention Center 4. The Guidelines for Integrated Symposium 39 Care by the State of Texas and Neurobiological Mechanisms in 1:00 P.M. - 4:00 P.M. Integrated Care Within Health Care Borderline Personality Disorder for the Homeless Room 120A, Level 1 2 Pennsylvania Convention Center David Buck, M.D., M.P.H.

Chairs: Neurobehavioral and Symposium 41 Christian Schmahl, M.D. Pharmacological Approaches to Harold W. Koenigsberg, M.D. Target Cognitive Remediation in 1:00 P.M. - 4:00 P.M. 1. Oxytocin Modulates Threat Drug-Addiction Room 120C, Level 1 Hypersensitivity in BPD U.S. National Institute on Drug Abuse Pennsylvania Convention Center Sabine C. Herpertz, M.D. 4 The Widening Scope of 2. Alterations in Default Mode Chairs: Psychodynamic Psychiatry Network Connectivity During Pain Will Aklin, Ph.D. American Academy of Psychoanalysis Processing in BPD Ivan D. Montoya, M.D., M.P.H. and Dynamic Psychiatry Ruth A. Lanius, M.D., Ph.D. Discussant(s): 4 3. Training in Cognitive Reappraisal Morris D. Bell, Ph.D. to Reduce Negative Affect in Chair: Borderline Personality Disorder: 1. Cognitive Enhancement and Joan G. Tolchin, M.D. Behavioral and FMRI Findings Remediation Strategies to Improve Discussant(s): Harold W. Koenigsberg, M.D. Smoking Cessation Outcomes Sergio Dazzi, M.D. A. Eden Evins, M.D., M.P.H. 4. Pain-Mediated Affect Regulation in 1. Dynamic Psychotherapy: BPD 2. Matching Cognitive Remediation Terminable and Interminable Inga Niedtfeld, M.A. to the Distinct Cognitive Deficits Carolyn B. Robinowitz, M.D. Associated With Substance- Abusing Prisoners With

165th Annual Meeting 111 2. Using the Telephone in 1. The Relationship of Attachment Lecture Psychodynamic Treatments Style to Expressed Emotion and Joan G. Tolchin, M.D. Caregiver Burden in Bipolar Disorder 3. Male to Female Transsexual: Lecture 12 Allison M. Lee, M.D. Considerations of the 2:30 P.M. - 4:00 P.M. Psychodynamic Psychotherapy 2. Attachment Processes in Older Room 113A-C, Level 1 During the Transgender Adult Caregiving Relationships Pennsylvania Convention Center Transformation Joan Monin, Ph.D. David L. Lopez, M.D. 3. The Last Act: Implications of Workplace in Mental 4. The Doorman’s Friend: A Attachment Security With Life- and General Healthcare Fundamental Thought Experiment Threatening Disease Settings: Development and That Distinguishes Between Gary M. Rodin, M.D. Concepts Unconscious and Conscious AAPL/APA Manfred S. Guttmacher 4. Distinct but Overlapping Neural Mental Process Award Lecture Networks Subserve Depression Matthew A. Tolchin, M.D. and Insecure Attachment: Speaker: Subcortical Activity Distinguishes Michael R. Privitera, M.D., M.S. Symposium 42 Early Versus Late Attachment 1:00 P.M. - 4:00 P.M. Zimri Yaseen, M.D. Chair: Room 121A, Level 1 5. Attachment’s Relationship to the Marilyn Price, M.D. Pennsylvania Convention Center Attitudes, Stress, and Behavior of Daughters Caring for a Parent With Psychiatrists Working With the Dementia Scientific and Clinical Report SUNDAY, MAY 6 United Nations Cory K. Chen, Ph.D. World Psychiatric Association SCR 11 Chair: 2:30 P.M. - 4:00 P.M. Vivian B. Pender, M.D. 2:30 P.M. Sessions Room 109B, Level 1 Discussant(s): Forum Pennsylvania Convention Center Pedro Ruiz, M.D. Genetic Studies 1. International Psychiatry: Lessons From Tanzania ! FOCUS: The Journal of John W. Barnhill, M.D. Lifelong Learning in Psychiatry Chair: Tel: 800-368-5777 Meera Vaswani, M.D. 2. The International Psychoanalytical SCR11-1. High Prevalence and Association as an N.G.O. of the Signficant Pharmacokinetic U.N. Implications of the Cyp2c19 Isaac Tylim, Psy.D. Forum 3 Gain-of-Function Allele *17 in 3. Chairing the NGO Committee on 2:30 P.M. - 4:00 P.M. Psychotropic-Treated Patients the Status of Women Room 103A, Level 1 Gualberto Ruaño, M.D., Ph.D. Vivian B. Pender, M.D. Pennsylvania Convention Center 3 4. Field Work in a Psychiatric Clinic in The Future Is Now: The Evolving SCR11-2. Toxoplasma Gondii Tanzania Role of Psychiatry in the Antibody Titers and History of Sargam Jain, M.D. Integration of Behavioral Health Suicide Attempts in Patients With 5. A Psychiatrist in Haiti and Primary Care Schizophrenia Madeleine Lansky, M.D. Olaoluwa Okusaga, M.D. 6. Well-Being for U.N. Staff: A Project Chair: 5 Lori Raney, M.D. Phillida Rosnick, Ph.D. SCR11-3. The Effects of Triallelic Presenter(s): Serotonin Transporter Gene and Symposium 43 Lori Raney, M.D. Stressful Life Events on Depression Jurgen Unutzer, M.D., M.P.H. in Patients With Alcohol 1:00 P.M. - 4:00 P.M. Roger G. Kathol, M.D. Dependence Room 121B, Level 1 Benjamin G. Druss, M.D., M.P.H. Jang Hyun-Chung, M.D. Pennsylvania Convention Center 1 Attachment Security and Its Implications for Psychiatry 1 ! Obtain your Certificate of Attendance for the 2012 APA Chairs: Annual Meeting at www.psych. Allison M. Lee, M.D. org/AnnualMeetingCME Gary M. Rodin, M.D.

112 www.psychiatry.org BIO Small Interactive Session Chair: Steven S. Sharfstein, M.D., M.P.A. Michael R. Presenter(s): Small Interactive Session 5 Privitera, Mark J. Schiller, M.D. M.D., M.S. , 2:30 P.M. - 4:00 P.M. John J. Wernert, M.D. is Associate Room 107A, Level 1 Leslie H. Gise, M.D. Professor in the Pennsylvania Convention Center Department of Psychiatry, Uni- Mentalizing in Mental Health Workshop 53 versity of Roch- Practice ester School of Medicine and Den- 2:30 P.M. - 4:00 P.M. tistry. He has been a consultant to 2 4 Room 102B, Level 1 hospital medical and surgical units Pennsylvania Convention Center in the areas of mood disorders and Chairs: psychosomatic medicine. His work Anthony W. Bateman, M.D. Psychotherapy Update for the in psychiatric education and train- Peter Fonagy, M.D., Ph.D. Practicing Psychiatrist SUNDAY, MAY 6 MAY SUNDAY, ing has been recognized by several 4 awards, ­including American Psy- chiatric Association’s Irma Bland Workshop Chair: Award and the Nancy C.A. Roeske Priyanthy Weerasekera, M.D., M.Ed. Award. Dr. Privitera Cochaired a University of Rochester Workplace Workshop 51 Violence Committee for more than 2:30 P.M. - 4:00 P.M. Workshop 54 6 years. This experience, along Room 101, Level 1 2:30 P.M. - 4:00 P.M. with The First International Con- Pennsylvania Convention Center Room 104A, Level 1 ference on Workplace Violence in Pennsylvania Convention Center the Healthcare Sector, fostered the Psychiatric Factors in Bariatric development of his award winning Surgery: Assessment and Bedlam Revisited: Society, book, Workplace Violence in Mental Beyond Psychiatry, and Severely and General Healthcare Settings. Mentally Ill Individuals Chair: AAPL/APA Manfred S. 5 Guttmacher Award Lecture Sanjeev Sockalingam, M.D. Lecture 12: 2:30 – 4:00 p.m. Presenter(s): Chair: Sanjeev Sockalingam, M.D. Ken Rosenberg, M.D. Raed Hawa, M.D. Presenter(s): Stephanie Cassin, Ph.D. SCR 12 Ken Rosenberg, M.D. Paul J Fink, M.D. 2:30 P.M. - 4:00 P.M. Workshop 52 John A. Talbott, M.D. Room 111B, Level 1 Fuller Torrey, M.D. Pennsylvania Convention Center 2:30 P.M. - 4:00 P.M. Jeffrey Lieberman, M.D. Room 102A, Level 1 Geriatric Psychiatry Pennsylvania Convention Center Workshop 55 Chair: Public Law 111-148 (The Patient 2:30 P.M. - 4:00 P.M. Elias Shaya, M.D. Protection and Affordable Room 109A, Level 1 SCR12-1. Event Related Potentials as a Care Act) Is Deeply Flawed and Pennsylvania Convention Center Biomarker for Alzheimer's Disease: Should Be Repealed: Views From the Left and the Right The Cognision ERP System The Sigma Enigma: The Role of David A. Casey, M.D. Sigma Receptors in the Current SCR12-2. The Interplay Between ! SESSION TRACKS Practice of Psychopharmacology Neuroticism and Atherosclerosis 3 in Late-Life Depression Supports a 1 Anxiety & Mood Disorders Hypothesis of Vascular Apathy 2 Personality Disorders Chair: Radboud Marijnissen, M.D. Damir Huremovic, M.D., M.P.P. 3 Psychopharmacology 1 Presenter(s): Psychotherapy SCR12-3. Olanzapine as a Rapidly and 4 Guitelle St. Victor, M.D. Strikingly Effective Augmenting 5 Schizophrenia and Sadaf Ahmed, M.D. Strategy for Antidepressant- Other Psychotic Disorders Madhavi Nagalla, M.D. Resistant Geriatric Outpatients NIAAA With Major Depressive Disorder 6 Irl L. Extein, M.D. 7 DSM-5 1 3

165th Annual Meeting 113 Workshop 56 Workshop 59 4:30 P.M. Session 2:30 P.M. - 4:00 P.M. 2:30 P.M. - 4:00 P.M. Room 110B, Level 1 Room 121C, Level 1 Opening Session Pennsylvania Convention Center Pennsylvania Convention Center 4:30 P.M. - 6:30 P.M. Making the Most of Your Chief How Girls, Mothers, and Mother- Terrace Ballroom Fourth Floor Year: Chief Residents’ Forum II Daughter Relationships Can Pennsylvania Convention Center Thrive Through Adolescence: Chairs: Updates From the Mother- Opening Session and a Margaret Haglund, M.D. Daughter Project Conversation Between Aaron T. Alison D. Hermann, M.D. Beck, M.D. and Glen O. Gabbard, Chair: M.D. Workshop 57 SuEllen Hamkins, M.D. Cognitive Therapy and 2:30 P.M. - 4:00 P.M. Psychodynamic Therapy: More Room 111A, Level 1 Workshop 60 Alike Than Different? Pennsylvania Convention Center See description on next page. 2:30 P.M. - 4:00 P.M. Evaluation and Management of Room 123, Level 1 7:00 P.M. Sessions Patients With Excessive Daytime Pennsylvania Convention Center Sleepiness in Psychiatric Media Workshop What Psychiatrists Need to Practice Know About APA Council on Addiction Psychiatry Media Workshop 4 Chairs: SUNDAY, MAY 6 Dimitri D. Markov, M.D. 7:00 P.M. - 10:00 P.M. Chair: Marina Goldman, M.D. Grand Ballroom Salon F, Level 5 John A. Renner, M.D. Philadelphia Marriott Downtown Presenter(s): Dimitri D. Markov, M.D. Presenter(s): John A. Renner, M.D. Kings Park: Stories From an Karl Doghramji, M.D. David Borsook, M.D., Ph.D. American Mental Institution Abigail Kay, M.D., M.A. Igor Elman, M.D. Chair: Jean-Pierre Lindenmayer, M.D. Workshop 58 Workshop 61 Presenter(s): 2:30 P.M. - 4:00 P.M. 2:30 P.M. - 4:00 P.M. Lucy M. Winer Room 112A, Level 1 Room 124, Level 1 Benjamin J. Sadock, M.D. Pennsylvania Convention Center Pennsylvania Convention Center Jean-Pierre Lindenmayer, M.D.

Legal, Risk, and Ethical Ethics and Diagnosis: The Considerations in the Age of Medicalization of Predicaments ! APA 2012 Annual Technology and Online Social APA/The Scattergood Foundation Meeting On Demand Networking • Special onsite pricing Chair: • Earn CME Credit for top Chair: Marc Forman, M.D. lectures and symposia online Kristen M. Lambert, J.D., M.S.W. Presenter(s): • For more information: Presenter(s): Marc Forman, M.D. Claire Zilber, M.D. Dominic Sisti, Ph.D. © G. Widman for GPTMC© G. Widman

114 www.psychiatry.org 4:30 P.M. Session

Opening Session

American Psychiatric Association Annual Meeting Opening Session and a Conversation Between Aaron T. Beck, M.D. and Glen O. Gabbard, M.D.

4:30 P.M.-6:30 P.M. Cognitive Therapy and Psychodynamic Terrace Ballroom Fourth Floor Therapy: More Alike Than Different? Pennsylvania Convention Center A Conversation Between Aaron T. Beck, M.D. Call to Order

and Glen O. Gabbard, M.D. 6 MAY SUNDAY, John M. Oldham, M.D., M.S. APA President Moderated by John M. Oldham, M.D., M.S.

Presentation of Check to Philadelphia Mental Health Published research on psychotherapy has increasingly Center demonstrated its effectiveness as an evidence-based John M. Oldham, M.D., M.S. treatment for many psychiatric disorders, in categories Introduction of Stage Guests ranging from mood and anxiety disorders to personality John M. Oldham, M.D., M.S. disorders. But psychotherapy, even “manualized,” Report from the Scientific standardized psychotherapy, comes in many varieties. Not Program Committee uncommonly, adherents to one form of psychotherapy or Kenneth R. Silk, M.D. another advocate for its unique effectiveness, as if the Chairperson, Scientific Program Committee field is a racetrack where there is only one winner. In this spirit, the most frequent “either/or” comparison is between Introduction of Presidents and Representatives of United cognitive therapy and psychodynamic therapy, often viewed States and International Allied as radically different treatment approaches. Organizations John M. Oldham, M.D., M.S. A rare opportunity will be presented in a unique Opening Session event at the Annual Meeting of the American Introduction of the President for the Presidential Address Psychiatric Association in May, 2012, in which two masters Robert Michels, M.D. of psychotherapy will discuss the commonalities and differences between these two well-established forms of Presidential Address John M. Oldham, M.D., M.S. treatment. Without powerpoints and without scripts, Drs. Aaron Beck and Glen Gabbard will take their seats for an Introduction of the President- informal armchair conversation about these different yet Elect for the Response to the Presidential Address overlapping forms of psychotherapy. Henry A. Nasrallah, M.D. Aaron T. Beck, M.D. University Professor Emeritus of Psychiatry, University of Response of the President-Elect Pennsylvania, Perelman School of Medicine Dilip V. Jeste, M.D. Glen O. Gabbard, M.D. Introduction of Special Program Professor of Psychiatry at SUNY Upstate Medical University in John M. Oldham, M.D., M.S. Syracuse, NY, and Clinical Professor of Psychiatry at Baylor College of Medicine in Houston, TX John M. Oldham, M.D., M.S. Senior Vice President and Chief of Staff, The Menninger Clinic; Professor and Executive Vice Chair, Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine; and President, American Psychiatric Association

165th Annual Meeting 115 Certificate of Attendance How do you obtain it?

Get your certificate in person or online.

To receive your certificate in person: CME Certificate of Attendance Booth complete the general evaluation form at the Located in Exhibit Hall C–E CME Certificate of Attendance Booth located Hours of Operation: in Exhibit Hall C–E in the Convention Center Saturday May 5 12pm–5:00pm Sunday May 6 7:30am–5:00pm Types of Certificate Monday May 7 7:30am–5:00pm • Certificate of Credit for physicians Tuesday May 8 7:30am–5:00pm • Certificate of Attendance for non-physicians Wednesday May 9 7:30am–5:00pm

Certificate is Available During or After the Meeting

To receive your Certificate Online: Accreditation & Designation complete the online evaluation at: psych.org/annualmeetingCME The American Psychiatric Association (APA) is accredited by the Accreditation Council for The website will remain active until Continuing Medical Education to provide August 10, 2012. continuing medical education for physicians. The American Psychiatric Association Follow these simple steps: designates this live activity for a maximum of 50 AMA PRA Category 1 CreditsTM. Physicians should only claim credit 1. Use your 6-digit badge number to access commensurate with the extent of their the General Evaluation form participation in the activity. 2. Complete the Evaluation The scientific program offers a variety of sessions that meet the criteria for AMA PRA 3. Confirm your personal details Category 1 CreditTM. 4. Enter the number of credits earned For questions, contact the 5. Email the certificate to yourself American Psychiatric Association 6. Print certificate for your records Department of CME E-mail: [email protected] Monday’s Program Monday’s Program This is for themain TOC. Keep on pasteboard with This is for theProgGuide TOC. Keep on pasteboard 2 points overlap into live area. with 2 points overlap into live area.

2012 ANNUAL MEETING

MONDAY MAY 7

165th Annual Meeting 117 8:00 A.M. Sessions Course 27 Course 31 8:00 A.M. - 12:00 P.M. 8:00 A.M. - 12:00 P.M. Course Room 204C, Level 2 Grand Ballroom Salon K, Level 5 Pennsylvania Convention Center Philadelphia Marriott Downtown

! Course Descriptions are Advances in Neuropsychiatry: Disaster Psychiatry available in the Course Brochure. The Neuropsychiatry of Emotion APA Committee on Psychiatric You can pick up a Course and Its Disorders Dimensions of Disasters Brochure and purchase a course ticket in the Course Enrollment Director: Directors: Area located in Exhibit Halls C-E, C. Edward Coffey, M.D. Anand Pandya, M.D. Level 2, Pennsylvania Convention Frederick J. Stoddard, M.D. Center. Admission to all courses, Faculty(s): including Master Courses is by Matthew A. Menza, M.D. Faculty(s): ticket only. Michael Trimble, M.D. David M. Benedek, M.D. M. Justin Coffey, M.D. Kristina Jones, M.D., M.A. Robert G. Robinson, M.D.

Course 24 Seminar Course 28 8:00 A.M. - 12:00 P.M. 8:00 A.M. - 12:00 P.M. Room 201A, Level 2 Seminar 9 Pennsylvania Convention Center Grand Ballroom Salon A, Level 5 Philadelphia Marriott Downtown 8:00 A.M. - 12:00 P.M. Exploring Technologies in Room 112A, Level 1 Psychiatry ECT Practice Update for the Pennsylvania Convention Center American Association for Technology in General Psychiatrist Psychiatry 1 Counter-Intuitives in Medical Ethics Directors: Director: Robert S. Kennedy, M.A. Laurie M. McCormick, M.D. Director: John Luo, M.D. Edmund G. Howe, M.D., J.D. Faculty(s): Faculty(s): Charles Kellner, M.D. Carlyle H. Chan, M.D. Andrew Krystal, M.D. Seminar 10 Laurie M. McCormick, M.D. Peter B. Rosenquist, M.D. 8:00 A.M. - 12:00 P.M. Course 25 Donald P. Eknoyan, M.D. Room 112B, Level 1 MONDAY, MAY 7 Pennsylvania Convention Center 8:00 A.M. - 12:00 P.M. Room 201B, Level 2 Course 29 Treating Medical Students and Pennsylvania Convention Center Physicians 8:00 A.M. - 12:00 P.M. The Psychiatrist as Expert Grand Ballroom Salon B, Level 5 Directors: Witness Philadelphia Marriott Downtown Michael F. Myers, M.D. Leah J. Dickstein, M.D., M.A. Director: Street Drugs and Mental Phillip J. Resnick, M.D. Disorders: Overview and Faculty(s): Treatment of Dual Diagnosis Penelope P. Ziegler, M.D. Patients William B. Lawson, M.D., Ph.D. Course 26 8:00 A.M. - 12:00 P.M. Director: John W. Tsuang, M.D. Seminar 11 Room 204A, Level 2 Pennsylvania Convention Center Faculty(s): 8:00 A.M. - 12:00 P.M. Larissa Mooney, M.D. Room 203A, Level 2 Advanced Assessment and Timothy W. Fong, M.D. Pennsylvania Convention Center Treatment of Attention Deficit Reef Karim, M.D. Hyperactivity Disorder Recovery: How to Transform Your Clinical Practice Effectively and Efficiently Director: Program changes are printed Thomas E. Brown, Ph.D. ! each day in the Daily Bulletin Director: Faculty(s): which can be picked up in the Shirish Patel, M.D. Jefferson B. Prince, M.D. Pennsylvania Convention Center. Anthony L. Rostain, M.D., M.A. A mobile application will also be available.

118 www.psychiatry.org Seminar 12 Case Conferences Presenter(s): General Peter W. Chiarelli, U.S. Army 8:00 A.M. - 12:00 P.M. (Ret’d) Grand Ballroom Salon D, Level 5 ! These sessions are open LGen. Romeo A. Dallaire, Canadian Philadelphia Marriott Downtown to APA members only. A blue Army (Ret’d), Senator (Canada) registration badge or an APA Robert J. Ursano, M.D. Emergency Psychiatry: Theory to membership card is required for Matthew J. Friedman, M.D., Ph.D. Practice admittance. American Association for Emergency Psychiatry Lecture Case Conference 3 Director: Rachel L. Glick, M.D. 9:00 A.M. - 10:30 A.M. Lecture 13 Room 103A, Level 1 Faculty(s): 9:00 A.M. - 10:30 A.M. Pennsylvania Convention Center Rachel L. Glick, M.D. Room 113A-C, Level 1 Jon S. Berlin, M.D. "Doctor, Would You Please Kill Pennsylvania Convention Center Scott L. Zeller, M.D. Me?": What Are the Boundaries Seth Powsner, M.D. Why Should Psychiatrists Care of Self-Determination and Avrim B. Fishkind, M.D. About Neuroscience Suicide? APA Distinguished Psychiatrist Lecture (APA Members Only) Series Seminar 13 Chairs: Speaker: 8:00 A.M. - 12:00 P.M. Philip R. Muskin, M.D., M.A. Mayada Akil, M.D. Grand Ballroom Salon J, Level 5 Elizabeth Evans, M.D. Philadelphia Marriott Downtown Chair: Presenter(s): Kenneth R. Silk, M.D. Laura W. Roberts, M.D., M.A. Narrative Hypnosis for Deborah Cabaniss, M.D. Psychiatry: Emphasis on Pain BIO Philip R. Muskin, M.D., M.A. 7 MAY MONDAY, Management Mayada Akil, 4 Focus Live! M.D., is Senior Director: Advisor to the Lewis Mehl-Madrona, M.D., Ph.D. NIMH Direc- ! FOCUS: The Journal of tor. She is also Faculty(s): Lifelong Learning in Psychiatry Professor of Barbara J. Mainguy, M.A., M.F.A. Tel: 800-368-5777 Psychiatry at Georgetown University School of Medicine and Focus Live 1 Director of Outpatient Programs 9:00 A.M. Sessions in the Department of Psychiatry at 9:00 A.M. - 10:30 A.M. Georgetown University Hospital. Advances In Medicine Room 118 A-C, Level 1 Since joining the Director’s office at Pennsylvania Convention Center NIMH, she has led several efforts Advances In Medicine 2 Schizophrenia related to research and neurosci- ence education of psychiatrists. 9:00 A.M. - 10:30 A.M. Moderators: She currently organizes “Brain Room 119A, Level 1 Deborah J. Hales, M.D. Camp,” an annual meeting that Pennsylvania Convention Center Mark H. Rapaport, M.D. brings psychiatrists in training in contact with leading neuro- Presenter(s): Top 10 Medical Articles of 2011: scientists and she is developing A Comprehensive and Practical Peter F. Buckley, M.D. Brian Miller, M.D. a neuroscience curriculum for Review of What We Need to psychiatrists. Dr. Akil is the recipi- Know ent of several awards including the Health and Human Services Secre- Speaker: Forum tary’s Award for Distinguished Ser- Monique V. Yohanan, M.D., M.P.H. Forum 4 vice, the NIMH Director’s Award Chair: for Significant Achievement, Robert J. Boland, M.D. 9:00 A.M. - 10:30 A.M. and the Louis F. Rittelmeyer, Jr., Room 107B, Level 1 Teacher of the Year Award from the Pennsylvania Convention Center Georgetown University Hospital Combat-Related PTSD: Injury or Department of Psychiatry. Disorder? APA Distinguished Psychiatrist Lecture Series Chairs: Lecture 13: 9-10:30 a.m. John M. Oldham, M.D., M.S.

165th Annual Meeting 119 Lecture 14 SCR 14 Workshop 63 9:00 A.M. - 10:30 A.M. 9:00 A.M. - 10:30 A.M. 9:00 A.M. - 10:30 A.M. Terrace Ballroom IV, Level 4 Room 111B, Level 1 Room 102B, Level 1 Pennsylvania Convention Center Pennsylvania Convention Center Pennsylvania Convention Center

The Chariot and the Couch: Inpatient Psychiatry Waste in Psychiatry: An Western Psychotherapeutic Overview of the Problem and Models and Eastern Insights Chair: Some Suggested Solutions APA Frontiers of Science Lecture Series Iqbal Ahmed, M.D. Chair: SCR14-1. Clinical and Demographic 4 Sunil D. Khushalani, M.D. Profile of Repeatedly Violent Speaker: Patients in an Acute Psychiatric Presenter(s): Matcheri S. Keshavan, M.D. Hospital: a One-Year Retrospective Steven S. Sharfstein, M.D., M.P.A. Study Robert P. Roca, M.D., M.P.H. Chair: Rozy Aurora, M.D. Nalini Juthani, M.D. SCR14-2. The Impact of Hospitalists in Workshop 64 Psychiatry Julian Beezhold, M.D. 9:00 A.M. - 10:30 A.M. New Research Poster Room 104A, Level 1 SCR14-3. Inpatient Psychiatric Care: Pennsylvania Convention Center NR Poster Session 5 Consequences of Short LOS Harold I. Schwartz, M.D. True Integrated Care: The Role 9:00 A.M. - 10:30 A.M. of Combined Training in Family- Exhibit Hall C-E, Level 2 Medicine Psychiatry and Internal Pennsylvania Convention Center Small Interactive Session Medicine Psychiatry in the Era of Integration Young Investigators Small Interactive Session 6 Chairs: 9:00 A.M. - 10:30 A.M. Erik R. Vanderlip, M.D. Scientific and Clinical Report Room 107A, Level 1 Alison C. Lynch, M.D. Pennsylvania Convention Center Presenter(s): SCR 13 Robert M. McCarron, D.O. APA Meet the Author Session— Lawson R. Wulsin, M.D. 9:00 A.M. - 10:30 A.M. Women in Psychiatry: Personal Room 109B, Level 1 Perspectives Pennsylvania Convention Center Workshop 65 MONDAY, MAY 7 Chair: Longitudinal Course of Donna M. Norris, M.D. 9:00 A.M. - 10:30 A.M. Borderline Personality Disorder Room 106A/B, Level 1 Pennsylvania Convention Center Chair: Workshop Yener Balan, M.D. Factors Affecting Provision of Workshop 62 Psychotherapy by American and SCR13-1. The Course of Anxiety Canadian Psychiatrists Disorders in Patients With 9:00 A.M. - 10:30 A.M. 3 4 Borderline Personality Disorder Room 101, Level 1 and Axis II Comparison Subjects: A Pennsylvania Convention Center Chairs: 10-Year Follow-Up Study Joyce C. West, Ph.D., M.P.P. Merav H. Silverman, Post-Mortem Approaches to John C. Perry, M.D., M.P.H 1 2 Psychiatric Neuropathology: Eric M. Plakun, M.D. Logistical, Legal, and SCR13-2. The Relationship Between Allan A. Abbass, M.D. Neuropathological Issues Childhood Adversity and Dysphoric Joyce C. West, Ph.D., M.P.P. Inner States Among Borderline Chair: Patients Followed Prospectively for Karley Y. Little, M.D. 10 Years ! SESSION TRACKS Lawrence I. Reed, Ph.D. Presenter(s): 1 Anxiety & Mood Disorders Rosalind Roberts, M.D. 2 2 Personality Disorders Peter M. Thompson, M.D., M.S. 3 Psychopharmacology SCR13-3. Personality Trait Changes 4 Psychotherapy in Patients With Borderline ! Obtain your Certificate of 5 Schizophrenia and Personality Disorder and Other Attendance for the 2012 APA Other Psychotic Disorders Personality Disorders Over 16 Years Annual Meeting at www.psych. 6 NIAAA Christopher J. Hopwood, Ph.D. org/AnnualMeetingCME 7 DSM-5 2

120 www.psychiatry.org BIO Workshop 67 Advances In Research 9:00 A.M. - 10:30 A.M. Matcheri Room 110B, Level 1 ­Keshavan, Advances In Research 1 Pennsylvania Convention Center M.D., is 9:00 A.M. - 12:00 P.M. Stanley Cobb Transformational Leadership Room 108A/B, Level 1 Professor of to Improve Mental Health Pennsylvania Convention Center Psychiatry at Care Delivery in Minority and the Beth Is- Underserved Populations Advances in Research rael Deaconess American Psychiatric Leadership 5 Medical Center, Harvard Medical Fellowship Program School. He is also Vice-Chair for Chair: the department’s Public Psychia- Chairs: Herbert Pardes, M.D. try Division and Senior Psychiat- Tanya R. Anderson, M.D. ric Advisor for the Massachusetts Napoleon B. Higgins, M.D. 1. Schizophrenia: Advancing Mental Health Center. He inves- Knowledge With a Paradigm Shift tigates the neurodevelopmental Presenter(s): William T. Carpenter, M.D. Brigitte Bailey, M.D. basis of schizophrenia and early 2. Neuromodulation in Psychiatric intervention. His work in the neu- Daniel L. Dickerson, D.O., M.P.H. Tatiana Falcone, M.D. Practice robiology of psychosis, especially Sarah H. Lisanby, M.D. as it pertains to first episode psy- Toi B. Harris, M.D. chotic disorders, has resulted in Serena Y. Volpp, M.D., M.P.H. 3. Alzheimers Disease: Genes, over 350 publications. He is a dis- Diagnostics, and Therapeutic Advances tinguished Fellow of the American Workshop 68 Psychiatric Association; a Fellow Steven Paul, M.D. 9:00 A.M. - 10:30 A.M. of the Royal College of Physicians, 4. Update on Treatment of Unipolar Canada; and a Fellow of the Royal Room 111A, Level 1 Depression College of Psychiatrists, UK. Dr. Pennsylvania Convention Center

Steven P. Roose, M.D. 7 MAY MONDAY, Keshavan is the Editor-in-Chief of the Asian Journal of Psychiatry Transition to Practice and and serves on the editorial boards Transitions in Practice: A Advances In Series for Acta Neuropsychiatrica and Workshop for Members-In- Schizophrenia Research. Training (MITs) and Early Career APA Frontiers of Science Lecture Psychiatrists (ECPs) Advances In Series 3 Series Lecture 14: 9-10:30 a.m. Chair: 9:00 A.M. - 12:00 P.M. Chetana Kulkarni, M.D. Room 122A/B, Level 1 Presenter(s): Pennsylvania Convention Center Deepika Sabnis, M.D. Advances in Mentalization Workshop 66 Anna Skiandos, D.O. Michael M. Takamura, M.D. Based Therapy 9:00 A.M. - 10:30 A.M. Joyce A. Spurgeon, M.D. 2 4 Room 109A, Level 1 Brenda Jensen, M.D. Pennsylvania Convention Center Chairs: Anthony W. Bateman, M.D. Addressing Mental Health Workshop 69 John G. Gunderson, M.D. Care Disparities Through 1. Psychopathology and Mentalizing Inter­dis­ciplinary Training in 9:00 A.M. - 10:30 A.M. Peter Fonagy, M.D., Ph.D. Integrated Health Care, Cultural Room 126B, Level 1 Competence, and Family Systems Pennsylvania Convention Center 2. Mentalizing Interventions in Everyday Clinical Practice Chair: American Board of Psychiatry Anthony W. Bateman, M.D. Octavio N. Martinez, M.D., M.P.H. and Neurology Update: Certification in Psychiatry and 3. Integrating General Psychiatric Presenter(s): Its Management With MBT and DBT Cindy Carlson, Ph.D. Lois W. Choi-Kain, M.D., M.Ed. Jane Ripperger-Suhler, M.D. Chairs: 4. Effectiveness of MBT: An Patricia Keith, Ph.D. Larry R. Faulkner, M.D. Independent Replication Study Prerna Arora, M.A. Beth Ann Brooks, M.D., M.S. and Other Evidence From the Presenter(s): Netherlands Robert J. Ronis, M.D., M.P.H. Dawn L. Bales, M.A., M.Sc. 5. Training and the Development of an MBT Service for BPD Robin L. Kissell, M.D.

165th Annual Meeting 121 Media Workshop Symposium 45 4. Changing Practice With Research: It Ain’t Just Dissemination 9:00 A.M. - 12:00 P.M. A. Thomas McLellan, Ph.D. Room 103C, Level 1 Media Workshop 5 Pennsylvania Convention Center 9:00 A.M. - 12:00 P.M. Symposium 47 Room 119B, Level 1 Schizophrenia and Bipolar Pennsylvania Convention Center Disorder Spectrum: New 9:00 A.M. - 12:00 P.M. Findings and Clinical Room 120B, Level 1 Beginners: Conundrums of Implications Pennsylvania Convention Center Human Bonding, Young and Old, 1 3 5 LGBT, and Otherwise Inventing the Neck: Connecting Chairs: Body, Mind, World From the Top Chairs: S. Charles Schulz, M.D. Down and the Bottom Up Petros Levounis, M.D., M.A. Carol A. Tamminga, M.D. Jack Drescher, M.D. Chair: 1. Phenotyping Across the Psychosis Kenneth S. Thompson, M.D. Presenter(s): Spectrum: Schizophrenia, Mary E. Barber, M.D. Schizoaffective and Psychotic Discussant(s): Bipolar Disorder David A. Pollack, M.D. Carol A. Tamminga, M.D. Andrea Fox, M.D., M.P.H. Symposium 2. Genetic Predisposition, 1. Improving Behavioral Health Endophenotypes, and New Care in Primary Care: Partners in Treatment Strategies for Integrated Care Symposium 44 Schizophrenia and Bipolar Keith Kanel, M.D. Disorder 9:00 A.M. - 12:00 P.M. 2. Psychosocial Pediatrics for the Room 103B, Level 1 Robert Freedman, M.D. New Millenium Pennsylvania Convention Center 3. Update From the Mood Disorders Howard King, M.D. Workgroup for DSM-5: Boundaries 3. Focusing Health Care: The Camden The Future of Psychiatric of Bipolar and Schizophrenia Experience Diagnosis: Updates on Disorders Jeff Brenner, M.D. Proposed Diagnostic Criteria for Trisha Suppes, M.D., Ph.D. DSM-5 (Part III) 4. The Convergence of 4. Integrating Health Care by American Psychiatric Institute for Psychopharmacotherapy for Crossing the Professional Line: Research and Education Schizophrenia and Bipolar Peer Support Specialists and the 7 Disorder Journey to Wellness Philip G. Janicak, M.D. Marshall E. Lewis, M.D. MONDAY, MAY 7 Chairs: Darrel A. Regier, M.D., M.P.H. 5. Pursuing Wellness From Head to David J. Kupfer, M.D. Toe: A Seeker’s Perspective Symposium 46 Lisa St. George, M.S.W. 1. DSM-5 Proposals for Somatic 9:00 A.M. - 12:00 P.M. Symptom Disorders Room 120A, Level 1 Joel E. Dimsdale, M.D. Pennsylvania Convention Center Symposium 48 2. DSM-5 Classification of Sleep- 9:00 A.M. - 12:00 P.M. Wake Disorders Innovative Substance Abuse Room 120C, Level 1 Charles Reynolds, M.D. Research Findings: What are the Pennsylvania Convention Center Barriers to Implemention? 3. Neuroscience and Substance Use Psychiatry and the Role of Disorders in DSM-5 Chairs: Charles O’Brien, M.D., Ph.D. Psychiatrists as Leaders in the Frances R. Levin, M.D. Field of Medicine in Terms of 4. Eating Disorders in DSM-5 John J. Mariani, M.D. Health Policy and the Changes B. Timothy Walsh, M.D. 1. Genetics and Pharmacogenetics of in Health Care Delivery Drug and Alcohol Dependence 5. Report on the Sexual and Gender Henry R. Kranzler, M.D. Chairs: Identity Disorders Workgroup Rahn K. Bailey, M.D. Kenneth J. Zucker, Ph.D. 2. The Impact of Functional Imaging on Clinical Practice: Promises and Jeremy A. Lazarus, M.D. Pitfalls Discussant(s): ! Program changes are printed Diana Martinez, M.D. Dilip V. Jeste, M.D. each day in the Daily Bulletin 3. Computer-Delivered Therapy for 1. The Role of Psychiatrists as which can be picked up in the Addiction: State of the Science Leaders in Healthcare Pennsylvania Convention Center. and Opportunities for Embedding Rahn K. Bailey, M.D. A mobile application will also be Technology-Based Therapeutic available. Tools in Systems of Care 2. The Role of Professional Medical Lisa A. Marsch, Ph.D. Associations in Representing

122 www.psychiatry.org the Interests of Physicians to the 2. Bereavement-Related and 2. Information Gathering: How to Stay Government and Private Sector Nonbereavement-Related up to Date With the Most Current Jeremy A. Lazarus, M.D. Depressions: A Comparative Field Literature in Perinatal Psychiatry 3. Healthcare Reform and Changes in Study in Lebanon Elizabeth M. Fitelson, M.D. Healthcare Delivery in the Future Elie G. Karam, M.D. 3. Acute Management of the Obstetric Annelle B. Primm, M.D., M.P.H. 3. The Discriminant Validity of DMS- Patient IV Bereavement Exclusion for the Lucy A. Epstein-Hutner, M.D. Symposium 49 Diagnosis of Major Depression: 4. Medication Treatments for the Results of Naturalistic Real-World Perinatal Psychiatric Population 9:00 A.M. - 12:00 P.M. Studies in France Adrienne Einarson, R.N. Room 121A, Level 1 Emmanuelle Corruble, M.D., Ph.D. Pennsylvania Convention Center 5. Perinatal Consultation: 4. Characteristics and 3-Year Psychotherapeutic Treatment Use of Technology for Research, Course of Bereavement- Options Treatment, and Evaluation of Related Depressive Episodes: A Kristin Leight Wesley, M.D. Alcohol Dependence Longitudinal Community-Based 6. The Formulation: Putting It All U.S. National Institute on Alcohol Abuse Study in the United States Together and Alcoholism Ramin Mojtabai, M.D., Ph.D. Laura Miller, M.D. 6 Symposium 51 Chair: Symposium 53 Dan Falk, Ph.D. 9:00 A.M. - 12:00 P.M. 9:00 A.M. - 12:00 P.M. 1. Computer-Delivered Interventions: Room 121C, Level 1 Room 124, Level 1 A Stepped Care Approach for Pennsylvania Convention Center Pennsylvania Convention Center Problem Drinkers William Campbell, M.S. Impact of Psychiatric Disorder The Black Community and Its on HIV Management 2. Virtual Reality Skills Training LGBT Members 1 3 5

for Health Care Professionals 7 MAY MONDAY, in Alcohol Screening and Brief Chair: Chair: Intervention Billy E. Jones, M.D., M.S. Marshall Forstein, M.D. Dale Olsen, Ph.D. Discussant(s): 3. Virtual Reality Skills Training 1. Central Nervous System June J. Christmas, M.D. Complications for Health Care Professionals 1. Being Black and Lesbian, Gay, Stephen J. Ferrando, M.D. in Alcohol Screening and Brief Bisexual or Transgendered Intervention: Part 2 2. Mood Disorders and HIV Richard G. Dudley, M.D. Paul Grossberg, M.D. Lawrence McGlynn, M.D. 2. The Current Science of LGBT and 4. Virtual Reality Applications for 3. Psychosis and HIV Mental Health Alcohol and Drug Abuse Francine Cournos, M.D. Kenneth B. Ashley, M.D. Patrick S. Bordnick, Ph.D. 5. Biosensors for Alcohol Treatment 4. HIV and Anxiety Disorders 3. Is There More Homophobia in the Research and Practice: An Update Mary Ann Cohen, M.D. Black Community? Nancy Barnett, Ph.D. 5. Sleep Disorders and HIV Marjorie Hill, Ph.D. Mary O Dowd, M.D. Kelly Douglas, Ph.D. 4. The Black Community and LGBT Symposium 50 6. HIV and Pain Members: The Role for Behavioral 9:00 A.M. - 12:00 P.M. Marshall Forstein, M.D. Scientists Room 121B, Level 1 Jerome M. Gibbs, Ph.D. Pennsylvania Convention Center Symposium 52 Grief or Major Depression? That 9:00 A.M. - 12:00 P.M. Symposium 54 Is the Question Room 123, Level 1 9:00 A.M. - 12:00 P.M. 1 Pennsylvania Convention Center Room 125, Level 1 Chairs: Fundamentals of the Perinatal Pennsylvania Convention Center Sidney Zisook, M.D. Psychiatric Consultation M. Katherine Shear, M.D. Addressing the Mental Health 3 4 Needs of Returning Service Discussant(s): Personnel and Veterans Ronald W. Pies, M.D. Chairs: Paula J. Clayton, M.D. Aerin M. Hyun, M.D., Ph.D. 1 Olivia M. Joly, M.D. 1. The Bereavement Exclusion for the Chair: Diagnosis of Major Depression: 1. Risk/Benefit Decision Making and Terri L. Tanielian, M.A. Background and Rationale the Perinatal Consultation Alana Iglewicz, M.D. Margaret Spinelli, M.D.

165th Annual Meeting 123 Discussant(s): Course Course 34 Elspeth C. Ritchie, M.D., M.P.H. 9:00 A.M. - 4:00 P.M. 1. Prevalence of PTSD and ! Course Descriptions are Room 202B, Level 2 Depression Over Time Among Iraq Pennsylvania Convention Center and Afghanistan Veterans available in the Course Brochure. Terry L. Schell, Ph.D. You can pick up a Course Brochure and purchase a course Trauma-Informed Care: 2. Prevalence and Correlates of ticket in the Course Enrollment Principles and Implementation Drinking Behaviors Among Area located in Exhibit Halls C-E, Previously Deployed Military and Director: Level 2, Pennsylvania Convention Sylvia Atdjian, M.D. Matched Civilian Populations Center. Admission to all courses, Rajeev Ramchand, Ph.D. including Master Courses is by Faculty(s): 3. Health-Care Seeking Among ticket only. Joan Gillece, Ph.D. Previously Deployed Military Tonier Cain Personnel: Barriers to and Preferences for Treatment Lisa Jaycox, Ph.D. Course 32 Course 35 4. Can Measures of Post-Concussive 9:00 A.M. - 4:00 P.M. 9:00 A.M. - 4:00 P.M. Syndrome Distinguish Traumatic Room 102A, Level 1 Room 203B, Level 2 Brain Injury From Posttraumatic Pennsylvania Convention Center Pennsylvania Convention Center Psychiatric Problems? Terri L. Tanielian, M.A. Autism Spectrum Disorders: A Practical Approach to Risk Diagnostic Classification, Assessment Neurobiology, Biopsychosocial Symposium 55 Interventions, and Director: William H. Campbell, M.D., M.B.A. 9:00 A.M. - 12:00 P.M. Pharmacologic Management Room 126A, Level 1 3 Pennsylvania Convention Center Course 36 Directors: Dysconnectivity of the Brain in Kimberly A. Stigler, M.D. 9:00 A.M. - 4:00 P.M. Addiction and Pain Alice R. Mao, M.D. Room 204B, Level 2 Pennsylvania Convention Center U.S. National Institute on Drug Abuse Faculty(s): Chairs: Mathew Brams, M.D. Adult Sexual Love and Infidelity Eric Courchesne, Ph.D. James M. Bjork, Ph.D. 4 Joseph Frascella, Ph.D., M.S. James Sutcliffe, Ph.D. Stephanie Hamarman, M.D. MONDAY, MAY 7 Director: Discussant(s): Jennifer Yen, M.D. Stephen B. Levine, M.D. Nora Volkow, M.D. Julie A. Chilton, M.D. 1. Revealing the Brain’s Circuit Diagrams via Resting State Master Course 4 Functional Connectivity Course 33 9:00 A.M. - 4:00 P.M. F. Xavier Castellano, M.D. 9:00 A.M. - 4:00 P.M. Grand Ballroom Salon E, Level 5 2. Functional and Structural Room 201C, Level 2 Philadelphia Marriott Downtown Connectivity in Chronic Marijuana Pennsylvania Convention Center and Tobacco Smokers Essential Psychopharmacology Francesca Filbey, Ph.D. Can’t Work or Won’t Work? 3. Phenotype/Genotype-Dependent Psychiatric Disability 3 Evaluations Brain Circuit Alterations in Nicotine Directors: Dependence Alan F. Schatzberg, M.D. Director: Elliot Stein, Ph.D. Charles Debattista, M.D. Liza H. Gold, M.D. 4. Functional Connectivity of Reward Faculty(s): Faculty(s): Responsivity and Disinhibition Terence A. Ketter, M.D. Marilyn Price, M.D. Angus Macdonald, Ph.D. Kiki Chang, M.D. William J. Stejskal, Ph.D. Natalie L. Rasgon, M.D., Ph.D. 5. Functional Connectivity in Pain and Donna Vanderpool, J.D., M.B.A. Opioid Analgesic Dependence Charles Debattista, M.D. Ira Glick, M.D. David Borsook, M.D., Ph.D. ! Program changes are printed each day in the Daily Bulletin which can be picked up in the Pennsylvania Convention Center. A mobile application will also be available.

124 www.psychiatry.org 11:00 A.M. Sessions Lecture Lecture 16 11:00 A.M. - 12:30 P.M. Advances In Medicine Terrace Ballroom IV, Level 4 Lecture 15 Pennsylvania Convention Center Advances In Medicine 3 11:00 A.M. - 12:30 P.M. Room 113A-C, Level 1 Mice, Men, and Mental Illness: 11:00 A.M. - 12:30 P.M. Pennsylvania Convention Center Animal Models of Cognitive Room 119A, Level 1 and Negative Symptoms of Pennsylvania Convention Center A Life in Moods Schizophrena APA Guest Lecture Series APA Adolf Meyer Award Lecture Pain Medicine: An Evolving 5 Field for Psychiatry Speaker: Kay Redfield Jamison, Ph.D. Speaker: Speaker: Eric R. Kandel, M.D. Martin D. Cheatle, Ph.D. Chair: Michael F. Myers, M.D. Chair: Chair: John M. Oldham, M.D., M.S. Donald, M. Hilty, M.D.

Focus Live! BIOS Kay Redfield Eric R. ! FOCUS: The Journal of Jamison, ­Kandel, Lifelong Learning in Psychiatry Ph.D., is the M.D., is Pro- Tel: 800-368-5777 Dalio ­Family fessor at Co- Professor in lumbia Univer- Mood Disor- sity; Fred Kavli

ders, Professor Professor and 7 MAY MONDAY, Focus Live 2 of Psychiatry Director, Kavli 11:00 A.M. - 12:30 P.M. at the Johns Hopkins University Institute for Brain Science; and a Room 118 A-C, Level 1 School of Medicine, and Codirec- ­Senior Investigator at the Howard Pennsylvania Convention Center tor of the Johns Hopkins Mood Hughes Medical Institute. Dr Kan- Disorders Center. She is a coauthor del’s research focuses on biophysics/ Anxiety of Manic Depressive Illness: Bipolar ion channels, synapses and circuits, Disorders and Recurrent Depres- neurobiology of learning and memo- Moderators: sion, the definitive book on the ry, models of psychiatric disorders, Deborah J. Hales, M.D. topic. Dr. Jamison is one of the and neurogenetics. He specializes Mark H. Rapaport, M.D. country’s most famous writers in molecular biology of long-term about manic-depressive illness. memory storage. His research Presenter(s): Her memoir about her experiences theme combines behavioral, cellular, R. Bruce Lydiard, M.D. with manic-depressive illness, An and molecular biological approaches Unquiet Mind, was on The New York to delineate the changes that under- Times Best Seller List for over 5 lie simple forms of learning and Forum months and translated into twenty- memory. Dr. Kandel has received 13 five languages. Her other books have honorary degrees, is a member of won widespread acclaim, including the National Academy of Sciences as Forum 5 her most recent, Nothing Was the well as the National Science Acad- 11:00 A.M. - 12:30 P.M. Same. In addition to many profes- emies of German and France. In Room 103A, Level 1 sional honors, she was selected as ­addition to multiple international Pennsylvania Convention Center one of five individuals for the public awards, he received the US National television series “Great Minds of Medal of Science. In 2000 he was Witness to an Extreme Century Medicine,” and chosen by Time awarded the Nobel Prize for Physiol- magazine as a “Hero of Medicine.” ogy or Medicine. Chairs: R. Rao Gogineni, M.D. APA Guest Lecture Series Adolf Meyer Award Lecture Abraham L. Halpern, M.D. Lecture 15: 11:00 -12:30 p.m. Lecture 15: 11:00 -12:30 p.m. Presenter(s): Robert J. Lifton, M.D. Steven S. Sharfstein, M.D., M.P.A. Henri Parens, M.D.

165th Annual Meeting 125 New Research Poster SCR16-2. New Zealand Mental Health: Workshop 72 An American Perspective James D. Reardon, M.D. 11:00 A.M. - 12:30 P.M. NR Poster Session 6 Room 104A, Level 1 SCR16-3. A Retrospective Analysis of Pennsylvania Convention Center 11:00 A.M. - 12:30 P.M. Healthcare Utilization in Psychiatric Exhibit Hall C-E, Level 2 Outpatients in a Staff Model HMO: Update on Screening and Brief Pennsylvania Convention Center Applications of a Pharmacogenetic Intervention (SBI): What we Algorithm Know and Don’t Know About Schizophrenia and Other Aida Mihajlovic, M.D., M.S. SBI Psychotic Disorders 3 U.S. National Institute on Alcohol Abuse and Alcoholism Scientific and Clinical Report 6 Small Interactive Session Chair: SCR 15 Richard Saitz, M.D. 11:00 A.M. - 12:30 P.M. Small Interactive Session 7 Presenter(s): Room 109B, Level 1 11:00 A.M. - 12:30 P.M. Emily Williams, Ph.D. Pennsylvania Convention Center Room 107A, Level 1 Mark L. Willenbring, M.D. Pennsylvania Convention Center Individual Therapy as Treatment Workshop 73 Treatment-Resistant Chair: Depression: Clinical Guidelines 11:00 A.M. - 12:30 P.M. Yener Balan, M.D. for Treatment and Prevention Room 106A/B, Level 1 SCR15-1. Challenges in the Treatment Pennsylvania Convention Center of a Physician Patient With 1 3 4 Integrative Group Therapy for Psychosis Chair: Adult Patients With ADHD: How Jacob L. Freedman, M.D. John F. Greden, M.D. Can We Make It Effective? 5 SCR15-2. Adolescence and the 4 Workshop Reorganization of Infant Chair: Development: a Neuro- Alina Marin, M.D., Ph.D. Psychoanalytic Model Frans F. Stortelder, M.D. Workshop 70 Presenter(s): 11:00 A.M. - 12:30 P.M. Elaine Senis, M.S.W. 4 Susan Buchanan, Ph.D. SCR15-3. The Clinical Relevance Room 101, Level 1 MONDAY, MAY 7 Giselle Roddy, R.N. and Application of the Real Pennsylvania Convention Center Relationship in Patient Treatment DSM-5 and the Prisons Workshop 74 Patrice M. Duquette, M.D. 4 7 11:00 A.M. - 12:30 P.M. Room 109A, Level 1 SCR15-4. An introduction to Chairs: Pennsylvania Convention Center Psymentology, a new Persian Rodrigo A. Munoz, M.D. Ethnopsychiatric Method for the Amanda Ruiz, M.D. Virgins, Vixens and Vampires: Treatment of Mentally ill Patients The Art of Edvard Munch Mohammad Shekari Yazdi, M.D., Presenter(s): Marcia K. Goin, M.D., Ph.D. Ph.D. Chairs: Harold I. Eist, M.D. Linda F. Pessar, M.D. SCR 16 Mariann W. Smith, M.A. 11:00 A.M. - 12:30 P.M. Workshop 71 SESSION TRACKS Room 111B, Level 1 11:00 A.M. - 12:30 P.M. ! Pennsylvania Convention Center Room 102B, Level 1 1 Anxiety & Mood Disorders Pennsylvania Convention Center Mental Health Care in Other 2 Personality Disorders Countries Women in Psychiatry: Pregnancy 3 Psychopharmacology and Parenthood Chair: 4 Psychotherapy Elias Shaya, M.D. Chair: 5 Schizophrenia and SCR16-1. Mental Health Interventions Delaney Smith, M.D. Other Psychotic Disorders in Non-Psychiatric Settings: Presenter(s): 6 NIAAA Examples From a Youth Clinic in Delaney Smith, M.D. Geneva, Switzerland Cathleen A. Cerny, M.D. 7 DSM-5 Shqipe Shehu-Brovina, M.D. Susan Hatters-Friedman, M.D.

126 www.psychiatry.org Workshop 75 12:30 P.M. Sessions Course 39 11:00 A.M. - 12:30 P.M. 1:00 P.M. - 5:00 P.M. Room 110B, Level 1 Forum Room 204C, Level 2 Pennsylvania Convention Center Pennsylvania Convention Center Forum 6 Psychiatrists and Pharma: How Management of Psychiatric Should They Interact? 12:30 P.M. - 2:00 P.M. Disorders in Pregnant and APA/The Scattergood Foundation Room 114, Level 1 Postpartum Women Pennsylvania Convention Center Chair: 1 3 4 Paul S. Appelbaum, M.D. The Mind and Music of Directors: Presenter(s): Beethoven Shaila Misri, M.D. Paul S. Appelbaum, M.D. Diana Carter, M.D. Chair: Richard Kogan, M.D. Faculty(s): Deirdre Ryan, M.D. Workshop 76 Shari I. Lusskin, M.D. 11:00 A.M. - 12:30 P.M. Room 111A, Level 1 1:00 P.M. Sessions Pennsylvania Convention Center Course 40 Course 1:00 P.M. - 5:00 P.M. Medical Conditions Mimicking Grand Ballroom Salon B, Level 5 Psychiatric Disorders Versus Course Descriptions are Philadelphia Marriott Downtown Psychiatric Disorders Mimicking ! available in the Course Brochure. Medical Conditions - Diagnostic You can pick up a Course Transference-Focused and Treatment Challenges Brochure and purchase a course Psychotherapy for Borderline APA Council on Psychosomatic Medicine ticket in the Course Enrollment Personality Disorder and Geriatric Psychiatry Area located in Exhibit Halls C-E, 2 4 7 MAY MONDAY, Level 2, Pennsylvania Convention Chairs: Center. Admission to all courses, Directors: Catherine C. Crone, M.D. including Master Courses is by Frank E. Yeomans, M.D., Ph.D. Lorenzo Norris, M.D. ticket only. Otto F. Kernberg, M.D. Presenter(s): Faculty(s): Sahana K. D Silva, M.D., M.S. John F. Clarkin, Ph.D. Melissa Maitland, M.D. Kathryn J. Walseman, M.D. Course 37 Jason B. Williams, M.D. 1:00 P.M. - 5:00 P.M. Course 41 Room 201A, Level 2 1:00 P.M. - 5:00 P.M. Pennsylvania Convention Center Workshop 77 Grand Ballroom Salon K, Level 5 Philadelphia Marriott Downtown 11:00 A.M. - 12:30 P.M. Repetitive Head Injury in Sports Room 126B, Level 1 and Other Life Activities: A Intermediate CPT Coding: Pennsylvania Convention Center Psychiatric Perspective: What to Evaluation and Management Know and How to Treat (E/M) Codes in Depth The Different Faces of Global APA Committee on RBRVS, Codes and Director: Mental Health: Current Reimbursement Initiatives, Future Directions Michele T. Pato, M.D. American Association of Community Faculty(s): Director: Psychiatrists Steven H. Baron, Ph.D. Ronald M. Burd, M.D. David A. Baron, D.O. Chairs: Faculty(s): Sosunmolu O. Shoyinka, M.D. Ronald M. Burd, M.D. David K. Nace, M.D. Mandy Garber, M.D., M.P.H. Course 38 Allan A. Anderson, M.D. Presenter(s): 1:00 P.M. - 5:00 P.M. Jeremy S. Musher, M.D. Craig L. Katz, M.D. Room 202A, Level 2 Chester W. Schmidt, M.D. Robert Rohrbaugh, M.D. Pennsylvania Convention Center Clare Pain, M.D. Interpersonal Psychotherapy (IPT) ! Obtain your Certificate of 1 4 Attendance for the 2012 APA Annual Meeting at www.psych. Director: org/AnnualMeetingCME John C. Markowitz, M.D.

165th Annual Meeting 127 Seminar 14 Seminar 18 1:30 P.M. Sessions 1:00 P.M. - 5:00 P.M. 1:00 P.M. - 5:00 P.M. Room 112A, Level 1 Room 204A, Level 2 Advances In Medicine Pennsylvania Convention Center Pennsylvania Convention Center Advances In Medicine 4 EEG in Psychiatry Practice Integrative Treatments for Cognitive Enhancement, 1:30 P.M. - 3:00 P.M. Directors: Traumatic Brain Injury, ADHD, Room 119A, Level 1 Nash N. Boutros, M.D. Sexual Enhancement, and Pennsylvania Convention Center Oliver Pogarell, M.D. Life-Stage Issues for Men and Women Advances in Medicine: Palliative Seminar 15 1 Medicine 1:00 P.M. - 5:00 P.M. Directors: Chairs: Room 112B, Level 1 Patricia L. Gerbarg, M.D. John L. Shuster, Jr., M.D. Pennsylvania Convention Center Richard P. Brown, M.D. Catherine C. Crone, M.D. Kathryn J. Walseman, M.D. Integrating Mental Health Faculty(s): Services Within Primary Care Richard P. Brown, M.D. Setting: Effective Strategies and Patricia L. Gerbarg, M.D. Case Conferences Practical Tips Seminar 19 Director: ! These sessions are open Nick Kates, M.B.B.S 1:00 P.M. - 5:00 P.M. to APA members only. A blue Grand Ballroom Salon A, Level 5 registration badge or an APA Faculty(s): Philadelphia Marriott Downtown membership card is required for Jon S. Davine, M.D. admittance. A Developmental Approach Seminar 16 to Contemporary Issues in Psychotherapy With Gay Men 1:00 P.M. - 5:00 P.M. Case Conference 4 Room 201B, Level 2 4 Pennsylvania Convention Center 1:30 P.M. - 3:00 P.M. Directors: Room 103A, Level 1 Robert M. Kertzner, M.D. How to Give a More Effective Pennsylvania Convention Center Marshall Forstein, M.D. Lecture: Punch, Passion, and Polish Faculty(s): Early Intervention and MONDAY, MAY 7 Stewart L. Adelson, M.D. Continuity of Care for the Early- Director: Stage Schizophrenic Person Phillip J. Resnick, M.D. (APA Members Only) Seminar 20 3 5 1:00 P.M. - 5:00 P.M. Seminar 17 Grand Ballroom Salon D, Level 5 Chair: 1:00 P.M. - 5:00 P.M. Philadelphia Marriott Downtown S. Charles Schulz, M.D. Room 203A, Level 2 Presenter(s): Pennsylvania Convention Center Performance of the Mental S. Charles Schulz, M.D. Status Examination: John Lauriello, M.D. Psychiatric Consultation in Assessment of Frontal Cortical Peter Weiden, M.D. Long-Term Care: Advanced Functioning Seminar Director: 3 Stephen I. Deutsch, M.D., Ph.D. ! SESSION TRACKS Directors: Faculty(s): Anxiety & Mood Disorders Abhilash K. Desai, M.D. Stephen I. Deutsch, M.D., Ph.D. 1 George T. Grossberg, M.D. David R. Spiegel, M.D. 2 Personality Disorders 3 Psychopharmacology ! APA 2012 Annual Meeting On Demand 4 Psychotherapy • Special onsite pricing 5 Schizophrenia and • Earn CME Credit for top Other Psychotic Disorders lectures and symposia online 6 NIAAA • For more information: 7 DSM-5

128 www.psychiatry.org Lecture Scientific and Clinical Report Small Interactive Session

Lecture 17 SCR 17 Small Interactive Session 8 1:30 P.M. - 3:00 P.M. 1:30 P.M. - 3:00 P.M. 1:30 P.M. - 3:00 P.M. Room 108A/B, Level 1 Room 109B, Level 1 Room 107A, Level 1 Pennsylvania Convention Center Pennsylvania Convention Center Pennsylvania Convention Center

Rethinking Bipolar Disorder: Metabolic Syndrome and Top 10 Geriatric Psychiatry Where We’ve Been, Where We Related Problems Issues for the General Are, Where We Need to Go Psychiatrists Chair: APA Distinguished Psychiatrist Lecture Derya Iren Akbiyik, M.D. Series Chair: SCR17-1. Is Posttraumatic Stress Josepha A. Cheong, M.D. Speaker: Disorder Associated With David J. Kupfer, M.D. Increased Risk of Metabolic Syndrome Among Inpatients With Small Interactive Session 9 Chair: Mood Disorders? Dilip V. Jeste, M.D. 1:30 P.M. - 3:00 P.M. John W. Goethe, M.D. Room 109A, Level 1 1 Pennsylvania Convention Center SCR17-2. Predictors of Monitoring BIO Maximizing the Treatment of Metabolic Parameters in Response for Depression David J. Kup- Adolescents on Antipsychotics fer, M.D., is Sameer Ghate, M.P.H. Chair: Thomas Detre 3 Richard Shelton, M.D. Professor in the Department of SCR17-3. Monitoring Metabolic Side MONDAY, MAY 7 MAY MONDAY, Psychiatry, Uni- Effects of Atypical Antipsychotics in Workshop versity of Pitts- People With Intellectual Disability burgh School Priyanka Tharian of Medicine. Dr. Kupfer studies 3 Workshop 78 long-term treatment strategies 1:30 P.M. - 3:00 P.M. for recurrent mood disorders, the SCR 18 pathogenesis of depression, and Room 101, Level 1 the relationship between biomark- 1:30 P.M. - 3:00 P.M. Pennsylvania Convention Center ers and depression. A prolific Room 111B, Level 1 Advocating for Your Patients in writer, Dr. Kupfer has authored or Pennsylvania Convention Center an Era of Health Care Reform coauthored more than a thousand articles, books, and book chapters. Non-pharmacologic Treatment APA Council on Advocacy and In recognition of his contributions of Depression Government Relations to the field, he received the Insti- Chair: Chair: tute of Medicine’s 1998 Rhoda Jerry L. Halverson, M.D. and Bernard Sarnat International Derya Iren Akbiyik, M.D. Prize in Mental Health and was SCR18-1. FMRI Guidance Enhances Presenter(s): the 2010 Litchfield Lecturer at Targeting of Transcranial Magnetic Jerry L. Halverson, M.D. the Department of Psychiatry at Stimulation (TMS) Ara Anspikian, M.D. Oxford University. Dr. Kupfer was David A. Gorelick, M.D., Ph.D. Nicholas M. Meyers elected to the Institute of Medi- Robert P Cabaj, M.D. cine of the National Academies. SCR18-2. Tai Chi Treatment for He is the Founding President Depressed Chinese Americans: A of the International Society of Pilot Study Workshop 79 Albert Yeung, M.D., Sc.D. Bipolar Disorders and chairs the 1:30 P.M. - 3:00 P.M. American Psychiatric Association 1 Room 102B, Level 1 Task Force for . DSM-5 SCR18-3. Healing the Mind: The Role Pennsylvania Convention Center APA Distinguished Psychiatrist of Spirituality in Depression Lecture Series Elsa Russom, M.D. The Metrics of Suicide Lecture 17: 1:30 – 3:00 p.m. 1 Chair: M. Justin Coffey, M.D. Presenter(s): Brian K. Ahmedani, Ph.D., M.S.W. C. Edward Coffey, M.D. M. Justin Coffey, M.D.

165th Annual Meeting 129 Workshop 80 Workshop 83 2:00 P.M. Sessions 1:30 P.M. - 3:00 P.M. 1:30 P.M. - 3:00 P.M. Room 104A, Level 1 Room 111A, Level 1 New Research Poster Pennsylvania Convention Center Pennsylvania Convention Center NR Poster Session 7 High-Yield Cognitive Behavior "Maybe You Should See Therapy for Brief Sessions Someone…": The Challenges of 2:00 P.M. - 3:30 P.M. 4 Referring Resident Colleagues Exhibit Hall C-E, Level 2 to Mental Health and Substance Pennsylvania Convention Center Chair: Abuse Treatment Donna M. Sudak, M.D. New Research — Treatment and Chairs: Services Presenter(s): Marra Ackerman, M.D. Donna M. Sudak, M.D. Margaret Haglund, M.D. Jesse H. Wright, M.D., Ph.D. Judith S. Beck, Ph.D. Presenter(s): Advances In Series David A. Casey, M.D. Rachel Caravella, M.D. Richard F. Summers, M.D. Scott J. Goldsmith, M.D. Advances In Series 4 Workshop 81 Jeffrey A. Selzer, M.D. 2:00 P.M. - 5:00 P.M. Alison D. Hermann, M.D. Terrace Ballroom IV, Level 4 1:30 P.M. - 3:00 P.M. Laura K. Kent, M.D. Room 106A/B, Level 1 Pennsylvania Convention Center Pennsylvania Convention Center Advances in Motivational Workshop 84 Antipsychotics in the Medically Interviewing Ill 1:30 P.M. - 3:00 P.M. 4 Room 120A, Level 1 3 Pennsylvania Convention Center Chairs: Petros Levounis, M.D., M.A. Chair: Vishal Madaan, M.D. Treatment of PTSD and Bachaar Arnaout, M.D. Depression in DOD: Taking 1. Using Motivational Interviewing Presenter(s): Lessons Learned from the in a Research Context to Answer Durga Bestha, M.B.B.S Trenches into Your Practice and Important Clinical Questions and Jayakrishna S. Madabushi, M.D. the Community Guide Treatment Venkata B. Kolli, M.B.B.S 1 3 4 Deborah L. Haller, Ph.D. 2. Training in Motivational MONDAY, MAY 7 Chair: Workshop 82 Paul S. Hammer, M.D. Interviewing Edward V. Nunes, M.D. 1:30 P.M. - 3:00 P.M. Presenter(s): Room 110B, Level 1 Paul S. Hammer, M.D. 3. Motivational Interviewing Pennsylvania Convention Center Approaches to Challenges of HIV Susan Tross, Ph.D. Applying Recovery and Trauma- Workshop 85 Informed Care Principles to an Inpatient Psychiatric Setting 1:30 P.M. - 3:00 P.M. Media Workshop APA/The Scattergood Foundation Room 126B, Level 1 Pennsylvania Convention Center Chair: Media Workshop 6 Gina Fusco, M.D. Bullying: Prevention and Intervention: An Overview 2:00 P.M. - 5:00 P.M. Presenter(s): AAOL Room 119B, Level 1 Gina Fusco, M.D. Pennsylvania Convention Center Joseph Garbely, M.D. Chair: Mark Combs, M.D. David L. Scasta, M.D. Sixty-Five Years After World War Cindy Takacs, M.D. Presenter(s): II: A Family Secret Louis J. Kraus, M.D. Chair: Debra Pinals, M.D. Gerald Schneiderman, M.D. Cheryl D. Wills, M.D. David L. Scasta, M.D. Presenter(s): Gregory A. Miller, M.D., M.B.A. Gerald Schneiderman, M.D.

130 www.psychiatry.org Presidential Symposium Symposium Symposium 58 2:00 P.M. - 5:00 P.M. Room 107B, Level 1 Presidential Symposium 3 Symposium 56 Pennsylvania Convention Center 2:00 P.M. - 5:00 P.M. 2:00 P.M. - 5:00 P.M. Room 122A/B, Level 1 Room 103B, Level 1 Integrating Primary Care, Pennsylvania Convention Center Pennsylvania Convention Center Mental Health, and Public Health: European and American New Approaches to Integration Mythbusters: Untangling Perspectives of Mental Health and Medical Psychiatric Myths From Truths Health Services Chairs: 3 Eliot Sorel, M.D. 1 Chair: Igor Svab, M.D., Ph.D. Chairs: Sparsha Reddy, M.D. Discussant(s): Wayne J. Katon, M.D. 1. MAOI Myths: Things I Learned in David A. Pollack, M.D. Jurgen Unutzer, M.D., M.P.H. Medical School That Turned Out 1. Integrating Primary Care & Mental 1. Nationwide Integration of Not to Be Quite True Health: European Perspectives Behavioral Health Screening and Philip R. Muskin, M.D., M.A. Gabriel Ivbijaro, M.D. Intervention for Trauma-Related 2. The Myth of Antipsychotics That Disorders in Acute Care Medical 2. Primary Care Psychiatry: The U.K. Antipsychotics Work for Delirium: Settings Perspective True? Or Just Wishful Thinking? Douglas F. Zatzick, M.D. Dinesh Bhugra, M.B.B.S, Ph.D. Robert J. Boland, M.D. 2. The Mental Health Integration 3. Making Common Cause: How 3. Which Labs to Check: From B12 to Program: A Statewide Effort to a Partnership With Psychiatry Thyroid Improve Mental Health Care for Could Make Primary Health Care John W. Barnhill, M.D. Safety-Net Patients Complete Frank Degruy, M.D.

Jurgen Unutzer, M.D., M.P.H. 4. Indications for Neuroimaging in 7 MAY MONDAY, Psychiatric Patients 3. Approaches to Integrating Health 4. Integrating Primary Care Colin J. Harrington, M.D. Care in Specialty Mental Health and Mental Health: Serving Settings Underserved Populations Benjamin G. Druss, M.D., M.P.H. Symposium 57 Sergio Aguilar-Gaxiola, Ph.D., M.D. 4. Disseminating Effective Integrated 2:00 P.M. - 5:00 P.M. Mental Health and Primary Care Room 103C, Level 1 Symposium 59 Services for PTSD and Depression Pennsylvania Convention Center 2:00 P.M. - 5:00 P.M. in the U.S. Military Charles C. Engel, M.D., M.P.H. Beyond DSM-5: Shifting Room 113A-C, Level 1 Paradigms in Schizophrenia Pennsylvania Convention Center 5. Cost-Effectiveness of a Multicondition Collaborative Care 5 Clinical Neuromodulation: What Intervention Chairs: Every Clinician Needs to Know Wayne J. Katon, M.D. Matcheri S. Keshavan, M.D. Chair: Henry A. Nasrallah, M.D. 6. The Diamond Project: Improving Sarah H. Lisanby, M.D. Outcomes for Depression in Carol A. Tamminga, M.D. Primary Care and Changing the 1. Paradigm Shifts in Clinical 1. Clinical Neuromodulation: Present Model of Reimbursement for That Conceptualization of Realities and Future Promise Care Schizophrenia Sarah H. Lisanby, M.D. Mark D. Williams, M.D. Rajiv Tandon, M.D. 2. State of The Art of TMS: Evidence 2. Shifting Paradigms in the Based Practice ! SESSION TRACKS Epidemiology of Schizophrenia John O’Reardon, M.D. Dolores Malaspina, M.D. 1 Anxiety & Mood Disorders 3. State of the Art Convulsive 3. The Simple Truth About the Genetic Therapy: ECT and MST 2 Personality Disorders Complexity of Schizophrenia Mustafa Husain, M.D. Daniel Weinberger, M.D. 3 Psychopharmacology 4. DBS for OCD: Current 4 Psychotherapy Status, Research Needs, and ! Program changes are printed Recommendations 5 Schizophrenia and each day in the Daily Bulletin Benjamin D. Greenberg, M.D., Ph.D. Other Psychotic Disorders which can be picked up in the 5. Cognitive Outcomes With Clinical Pennsylvania Convention Center. 6 NIAAA Brain Stimulation A mobile application will also be Shawn McClintock, Ph.D. 7 DSM-5 available.

165th Annual Meeting 131 Symposium 60 Treating Perinatal Mood and Symposium 63 Anxiety Disorders 2:00 P.M. - 5:00 P.M. Julia B. Frank, M.D. 2:00 P.M. - 5:00 P.M. Room 117, Level 1 Room 121A, Level 1 Pennsylvania Convention Center 2. Acculturation and Demoralization Pennsylvania Convention Center in Immigrant America Privacy John M. De Figueiredo, M.D., Sc.D. Double Trouble: Co-occurrence Update 3. Cultural Contents and Dynamics of of Alcoholism and Psychiatric American Association for Technology in the Psychotherapeutic Encounter Disorders Psychiatry Renato D. Alarcon, M.D., M.P.H. U.S. National Institute on Alcohol Abuse and Alcoholism Chairs: 4. Existential Inquiry: Brief Zebulon Taintor, M.D. Psychotherapy for Countering 1 2 6 Glenn A. Martin, M.D. Demoralization in Chronic Illness Chair: Discussant(s): James L. Griffith, M.D. Alan I. Green, M.D. Deborah Peel, M.D. 5. A Psychodynamic Psychotherapy 1. Alcoholism and Anxiety Disorders 1. Privacy as Health IT Enabler: Are Curriculum for Medical Students Domenic A. Ciraulo, M.D. we There Yet? Janis L. Cutler, M.D. 2. Depression and Alcohol Use Deven C. McGraw, J.D., M.P.H. Disorders Kathleen Brady, M.D., Ph.D. 2. Health Information Exchanges Symposium 62 3. Integrating Addiction Treatment or the Healthy Exchange of 2:00 P.M. - 5:00 P.M. Services in Mental Health and Information: Can It Be Done While Primary Care Settings: Application Protecting our Patients’ Privacy Room 120C, Level 1 of Benchmark Measures of Interests? Pennsylvania Convention Center Program Capability Glenn A. Martin, M.D. Ethics and Medical Leadership Mark P. McGovern, Ph.D. 3. Open-Source Software as Shared 4. An Epidemiological Update Chairs: Infrastructure: A Novel Strategy on Alcohol and Psychiatric Michael F. Myers, M.D. to Enhance Data Interoperability Comorbidity: Personality Disorders, Leah J. Dickstein, M.D., M.A. While Improving Information Longitudinal Course, and Meta- Privacy in EHRs and HIEs 1. Ethical Leadership in Medicine Structure of Common Disorders Robert M. Kolodner, M.D. Leah J. Dickstein, M.D., M.A. Deborah S. Hasin, Ph.D. 4. APA 2012: Balancing Privacy With 2. Ethical Leadership for the Convenience and Utility in Health Profession of Medicine Symposium 64 Networks: Merging of HIEs, PHRs, Jeremy A. Lazarus, M.D. and Social Media 2:00 P.M. - 5:00 P.M. MONDAY, MAY 7 3. Women Psychiatrists in Leadership Steven R. Daviss, M.D. Room 121B, Level 1 Roles: Change and Ethics Pennsylvania Convention Center 5. Trends and Consequences in Donna M. Norris, M.D. Breaches of Protected Health Information 4. Ethical Challenges Facing Chief Psychiatrists as Activists: On Zebulon Taintor, M.D. Residents Being Part of the Solution Sherif A. Ragab, M.D. Chair: 5. Ethical Leadership Issues for Annelle B. Primm, M.D., M.P.H. Symposium 61 Program Directors in Psychiatry 1. Psychiatric Activism and Women's Michael F. Myers, M.D. 2:00 P.M. - 5:00 P.M. Reproductive Rights Room 120B, Level 1 Nada L. Stotland, M.D., M.P.H. Pennsylvania Convention Center 2. The Politics of Sexual Science a The Psychotherapy of Gay Psychiatrist's Report From the Trenches of the Culture Wars Hope: Back to the Future ! SESSION TRACKS in Celebrating the 50th Jack Drescher, M.D. Anniversary of Persuasion and 1 Anxiety & Mood Disorders 3. Psychiatrists as Leaders in Post Healing 2 Personality Disorders Disaster Emotional Resiliency 4 Recovery 3 Psychopharmacology Denese O. Shervington, M.D., M.P.H. Chairs: 4 Psychotherapy 4. The Range of Interventions in Julia B. Frank, M.D. Traumatized Communities Renato D. Alarcon, M.D., M.P.H. 5 Schizophrenia and Other Psychotic Disorders Bruce Sklarew, M.D. Discussant(s): 5. "Do the Right Thing" NIAAA Thomas N. Wise, M.D. 6 Carl C. Bell, M.D. 1. Integrating Evolutionary Science 7 DSM-5 6. Democracy, Voices and Psychiatry and Meaningful Psychotherapy: Kenneth S. Thompson, M.D.

132 www.psychiatry.org Symposium 65 4. Suicide Loss Survivors and 2. Eating in Eating Disorders: What Is Complicated Grief Important? 2:00 P.M. - 5:00 P.M. Sidney Zisook, M.D. Laurel Mayer, M.D. Room 121C, Level 1 Pennsylvania Convention Center 3. CBT and Beyond: New Treatments Symposium 67 for Eating Disorders Trauma, PTSD, and HIV: Joanna E. Steinglass, M.D. Psychodynamic and Educational 2:00 P.M. - 5:00 P.M. 4. Lost in Translation: Integrating Approaches to Adherence in a Room 124, Level 1 Culture in Eating Disorders Community Medical Setting Pennsylvania Convention Center Kathleen M. Pike, Ph.D. American Academy of Updates on Screening and Treatment of the Psychological Psychoanalysis and Dynamic Symposium 69 Psychiatry Effects of the Wars in Iraq and 1 4 Afghanistan 2:00 P.M. - 5:00 P.M. 1 3 4 Room 126A, Level 1 Chair: Pennsylvania Convention Center Cesar A. Alfonso, M.D. Chair: Elspeth C. Ritchie, M.D., M.P.H. Integrated Approaches to the Discussant(s): Care of Patients With Borderline Cesar A. Alfonso, M.D. Discussant(s): Personality Disorder 1. Development of a Trauma and Christopher H Warner, M.D. 2 3 4 PTSD Curriculum to Meet the 1. Screening and Intervention Needs of HIV Clinicians and their John C. Bradley, M.D. Chairs: Patients Andrew E. Skodol, M.D. 2. Providing Psychiatric Treatment in Sharon M. Batista, M.D. Harold W. Koenigsberg, M.D. War Zones: Perspectives From a 2. Psychodynamics of Trauma, PTSD, Combat Stress Control Psychiatrist Discussant(s): and Non-Adherence to Medical in Iraq and Afghanistan Peter Fonagy, M.D., Ph.D. Care in Persons with HIV and AIDS Jerald J. Block, M.D. 7 MAY MONDAY, Mary Ann Cohen, M.D. 1. Affective Instability: Toward an 3. Our Patients With Trauma Are 3. The Pacific Psychological Health Integration of Neuroscience and Nonadherent to Medical Care: An Task Force: Building Partnerships Psychological Perspectives Innovative Approach to Education to Enhance Psychological Health Harold W. Koenigsberg, M.D. Care in the Pacific Region in an AIDS Clinic 2. BPD Adversely Affects the Course Carroll J. Diebold, M.D. Maria Tiamson-Kassab, M.D. of Axis I Disorders: An Integrated 4. Results and Outcomes of a Trauma, 4. Pharmacotherapy for PTSD Perspective on Assessment and PTSD, and HIV Training Program David M. Benedek, M.D. Prognosis Andrew E. Skodol, M.D. Phil Meyer, L.C.S.W. 5. Building Community Deployment Mental Health Competence and 3. APA Practice Guidelines for Symposium 66 Capacity Through DOD/VA/State BPD: Integrating Psychotherapy and Community Partnerships and Psychopharmacological 2:00 P.M. - 5:00 P.M. Harold Kudler, M.D. Management Room 123, Level 1 John M. Oldham, M.D., M.S. Pennsylvania Convention Center 6. Psychological Effects of the Long War Strategies for Mitigation 4. Collaborative Treatment of Patients Complicated Grief and DSM-5: A Elspeth C. Ritchie, M.D., M.P.H. With BPD Stress-Response Syndrome Kenneth R. Silk, M.D. 1 7 Symposium 68 5. Recent Empirical Findings on Chairs: BPD and Their Implications for 2:00 P.M. - 5:00 P.M. Naomi M. Simon, M.D., M.Sc. Integrated Care Charles Reynolds, M.D. Room 125, Level 1 Kenneth N. Levy, Ph.D. Pennsylvania Convention Center Discussant(s): Matthew J. Friedman, M.D., Ph.D. Integrated Treatment of Eating Paula J. Clayton, M.D. Disorders: What to Ask and 1. The Bereavement V-Code as an Aid What to Do to Prevention of Complicated Grief 4 M. Katherine Shear, M.D. ! All scientific sessions listed 2. Assessment and Diagnosis of Chair: in the Annual Meeting Program Joanna E. Steinglass, M.D. Complicated Grief Book are designated for AMA Charles Reynolds, M.D. 1. When a Patient Is in Your PRA Category 1 Credits™, 3. Complicated Grief: Differential Office: Initial Assessment and except for New Research Poster Diagnosis and Comorbidity Management of Eating Disorders Sessions. Naomi M. Simon, M.D., M.Sc. Evelyn Attia, M.D.

165th Annual Meeting 133 3:30 P.M. Sessions BIO SCR 21 3:30 P.M. - 5:00 P.M. B . Timothy Room 120A, Level 1 Walsh, M.D., Lecture 18 Pennsylvania Convention Center is Ruane 3:30 P.M. - 5:00 P.M. Professor of Pe- TBI Resources and Co-occuring Room 108A/B, Level 1 diatric Psycho- Disorders Pennsylvania Convention Center pharmacology at the College The Persistent Enigma of Chair: of Physicians Gary H. Wynn, M.D. Anorexia Nervosa and Surgeons of Columbia Univer- APA Distinguished Psychiatrist Lecture sity and Director of the Division SCR21-1. DCoE for Psychological Series of Clinical Therapeutics at the New Health and Traumatic Brain Injury: York State Psychiatric Institute. Resources and Programs Speaker: Dr. Walsh established the Eating Lolita O’Donnell, M.D. B. Timothy Walsh, M.D. Disorders Research Unit at the SCR21-2. Sleep Dysfunction: the TBI Chair: Institute and under his leadership and Psychological Health Co- Donald M. Hilty, M.D. it has developed into one of the occurring Disorders Dilema world’s leading academic eating Dorothy Kaplan, M.D. disorders programs. The program Scientific and Clinical Report conducts groundbreaking work on the development of new treat- Small Interactive Session ment methods and on biological SCR 19 and psychological abnormalities Small Interactive Session 10 3:30 P.M. - 5:00 P.M. that contribute to the develop- Room 109B, Level 1 ment and perpetuation of eating 3:30 P.M. - 5:00 P.M. Pennsylvania Convention Center disorders. Dr. Walsh has served Room 107A, Level 1 as president of the Academy for Pennsylvania Convention Center Impulse Control Disorders Eating Disorders and of the Eat- ing Disorders Research Society. What Is Bullying and Why Is Chair: He has been honored by awards It Such a Problem in Schools, David Preven, M.D. from these organizations as well Workplaces, and Home Posing as from the National Eating Disor- as Domestic Violence SCR19-1. Relationship Between ders Association, and the Associa- Plasma Clomipramine Levels and tion for Behavioral and Cognitive Chair: OCD Symptoms in Adult Patients Therapies. He heads theDSM-5 Stuart W. Twemlow, M.D. Donatella Marazziti, M.D. Eating Disorders Work Group. MONDAY, MAY 7 1 3 APA Distinguished Psychiatrist Small Interactive Session 11 SCR19-2. Prevalence of Stalking in Lecture Series General Medical Practice L18: 3:30 – 5:00 p.m. 3:30 P.M. - 5:00 P.M. Kathleen C. Dougherty, M.D. Room 109A, Level 1 Pennsylvania Convention Center SCR19-3. The Long-Term Treatment of Obsessive-Compulsive Disorder SCR20-2. A Correlation of the APA Meet the Author Session — With SSRIs and Clomipramine Psychosocial Distress Status Laboratory Medicine: A Case- With and Without Benzodiazepines and the Physical Performance Based Discussion Jyotsna Muttineni, M.D., M.S. of Individuals With Poly-Trauma 1 3 History: Two Years and Chronic Chair: Pain Sandra A. Jacobson, M.D. Armando S. Miciano, M.D. SCR 20 1 4 Workshop 3:30 P.M. - 5:00 P.M. SCR20-3. The Use of a Novel Multi-Coil Room 111B, Level 1 RTMS Device for the Treatment of Pennsylvania Convention Center Fibromyalgia Pain: Results of a Workshop 86 Feasibility Study 3:30 P.M. - 5:00 P.M. Pain Management M. Bret Schneider, M.D. Room 101, Level 1 Chair: Pennsylvania Convention Center Joseph Berger, M.D. Discharged to Shelter: The SCR20-1. Understanding Fatigue: The Obtain your Certificate of Complex Relationship Between ! Theory and Practice of Attendance for the 2012 APA Homeless Psychiatry Depression and Sleep Annual Meeting at www.psych. Michael Best, org/AnnualMeetingCME Chair: 1 Dillon Euler, M.D.

134 www.psychiatry.org 5:30 P.M. Session

Convocation

Convocation of Distinguished Fellows and the William C. Menninger Memorial Convocation Lecture

5:30 – 6:30 p.m. William C. Menninger Memorial Terrace Ballroom I-III, Level 4 Convocation Lecture Pennsylvania Convention Center Presiding: Edward M. Kennedy, Jr. John M. Oldham, M.D., M.S., Mr. Kennedy is the President president and co- founder of Marwood Grand Marshals: Paul J. Fink, M.D, Group & Co., a Michael J. Vergare, M.D. healthcare-focused financial services firm Marshals: with offices in New Donna M. Sudak, M.D. York City, Washington, D.C., and London Michael E. Thase, M.D specializing in proprietary healthcare Introduction of Distinguished Life Fellows research, asset management and private Dilip V. Jeste, M.D. equity advisory services. Previously, Mr. President-Elect Kennedy served as an Associate and Induction of Distinguished Fellows later as Counsel to the law firm of Wiggin Dilip V. Jeste, M.D., & Dana located in New Haven, CT. Mr. 7 MAY MONDAY, President-Elect Kennedy’s health law practice focused primarily on state and federal regulatory Introduction of Fellows and Life Fellows and reimbursement issues affecting John M. Oldham, M.D., M.S. hospitals, homecare agencies, long-term Introduction of Fifty-Year Distinguished Life Fellows, care providers, physicians, and mental Fifty-Year Life Members health providers. In addition, Mr. Kennedy John M. Oldham, M.D., M.S. served as Director of Legal and Regulatory Introduction of International Distinguished Fellows Affairs at the Connecticut Hospital John M. Oldham, M.D., M.S. Association, counseling acute care providers and policy-makers on a wide Presentation of Awards John M. Oldham, M.D., M.S. variety of emerging health care issues. Mr. Kennedy has also Presidential Commendations been an active leader ! All Distinguished Life Distinguished Service Awards in the civil rights Fellows, Distinguished movement for persons Fellows, Life Fellows, Presentation of Distinguished Service Awards with disabilities. In his International Fellows, APA John M. Oldham, M.D., M.S. disability law practice, Members, and Registered Introduction of the Membership Committee he advised companies Guests Are Invited to Attend. Chairperson and Award Board Chairpersons about how to best John M. Oldham, M.D., M.S. expand opportunities for persons with APA Human Rights Award disabilities and how to avoid liability under the Americans with Disabilities Act. He APF Blanche F. Ittleson Award for Research in Child Psychiatry APF/Kempf Fund Award for Research continues to serve on the corporate and Development in Psychobiological Psychiatry advisory boards of numerous disability organizations and lectures nationwide on APA/Lilly Resident Research Awards topics relating to health and disability law. Agnes Purcell McGavin Award for a Distinguished Mr. Kennedy received an undergraduate Career in Child and Adolescent Psychiatry degree from Wesleyan University, a Agnes Purcell McGavin Award for Prevention master’s degree from Yale University’s APF Isaac Ray Award School of Forestry and Environmental Studies, and a law degree from the APF Jack Weinberg Memorial Award for Geriatric Psychiatry University of Connecticut School of Law.

165th Annual Meeting 135 Presenter(s): Workshop 90 5:30 P.M. Session Van Yu, sM.D. 3:30 P.M. - 5:00 P.M. Joanna Fried, M.D. Room 110B, Level 1 Anuj Gupta, M.D. Convocation Pennsylvania Convention Center Hina Tasleem, M.B.B.S 5:30 P.M. - 6:30 P.M. Collaborating for Change: Terrace Ballroom, Fourth Floor Workshop 87 Training Families to Become Pennsylvania Convention Center Clinical Allies so as to Improve 3:30 P.M. - 5:00 P.M. BPD Treatment Outcomes Convocation of Distinguished Fellows and the William Room 102B, Level 1 2 Pennsylvania Convention Center C. Menninger Memorial Chair: Convocation Lecture Successful Career Planning for Valerie Porr, M.A. See description on previous page. Women APA Womens Caucus Presenter(s): Valerie Porr, M.A. Chairs: 7:00 P.M. Sessions Gail E. Robinson, M.D. Workshop 91 Carol C. Nadelson, M.D. Media Workshop 3:30 P.M. - 5:00 P.M. Room 111A, Level 1 Workshop 88 Pennsylvania Convention Center Media Workshop 7 3:30 P.M. - 5:00 P.M. 7:00 P.M. - 10:00 P.M. Room 104A, Level 1 Using a Checklist to Grand Ballroom Salon F, Level 5 Pennsylvania Convention Center Characterize and Impact Philadelphia Marriott Downtown Antipsychotic Prescribing Psychiatry in the Courts: Hot Patterns: Data From and Unmourned Loss in “Saraband”: Issues Implications of the New York Ingmar Bergman’s Last Film APA Committee on Judicial Action State Office of Mental Health SHAPEMED Project Chair: Chair: 3 Bruce Sklarew, M.D. Paul S. Appelbaum, M.D. Presenter(s): Chairs: Annelle B. Primm, M.D., M.P.H. Presenter(s): Sharat G. Parameswaran, M.D. Bruce Sklarew, M.D. Paul S. Appelbaum, M.D. Matthew D. Erlich, M.D. Robert Weinstock, M.D. Presenter(s):

MONDAY, MAY 7 Jeffrey Janofsky, M.D. Lloyd I. Sederer, M.D. Gregory A. Miller, M.D., M.B.A. Workshop 89 Cassis Henry, M.D. Thomas S. Stroup, M.D., M.P.H. 3:30 P.M. - 5:00 P.M. Room 106A/B, Level 1 Pennsylvania Convention Center Workshop 92 The Mental Health Parity Act: 3:30 P.M. - 5:00 P.M. Making it Work for You and Your Room 126B, Level 1 Patients Pennsylvania Convention Center

Chairs: Prescribing Psychotropic Paul H. Wick, M.D. Medication for Geriatric Presenter(s): Patients: Pearls and Pitfalls Anita S. Everett, M.D. APA Council on Psychosomatic Medicine Irvin Muszynski and Geriatric Psychiatry Julie A. Clements, J.D. 3 Barry B. Perlman, M.D. Henry Harbin, M.D. Chairs: Claudia L. Reardon, M.D. Helen H. Kyomen, M.D., M.S. James M. Ellison, M.D., M.P.H. Presenter(s): Iqbal Ahmed, M.D. Helen H. Kyomen, M.D., M.S. G. Widman for GPTMC Betsy Ross House

136 www.psychiatry.org Tuesday’s Program Tuesday’s Program This is for themain TOC. Keep on pasteboard with 2 This is for theProgGuide TOC. Keep on pasteboard points overlap into live area. with 2 points overlap into live area.

2012 ANNUAL MEETING

TUE SDAY MAY 8

165th Annual Meeting 137 8:00 A.M. Sessions Seminar 21 Lecture 21 8:00 A.M. - 12:00 P.M. 9:00 A.M. - 10:30 A.M. Course Room 202B, Level 2 Room 114 Lecture Hall, Level 1 Pennsylvania Convention Center Pennsylvania Convention Center

! Course Descriptions are Understanding the Person Racial and Ethnic Influences available in the Course Brochure. Behind the Illness: An Approach on Mental Health: The Evolving You can pick up a Course to Psychodynamic Formulation Evidence Brochure and purchase a course APA Solomon Carter Fuller Award ticket in the Course Enrollment Director: Lecture Area located in Exhibit Halls C-E, William H. Campbell, M.D., M.B.A. Level 2, Pennsylvania Convention Speaker: Center. Admission to all courses, James S. Jackson, Ph.D. including Master Courses is by ticket only. 9:00 A.M. Sessions Chair: Michele Reid, M.D. Case Conferences Course 42 Lecture 22 These sessions are open ! 9:00 A.M. - 10:30 A.M. 8:00 A.M. - 12:00 P.M. to APA members only. A blue Terrace Ballroom IV, Level 4 Room 201B, Level 2 registration badge or an APA Pennsylvania Convention Center Pennsylvania Convention Center membership card is required for admittance. ADHD in Adults - From Clinical Developmental Risk for Anxiety Research to Clinical Practice and Depression: A Translational Neuroscience Approach 3 4 APA Distinguished Psychiatrist Lecture Case Conference 5 Series Director: 9:00 A.M. - 10:30 A.M. Craig B. Surman, M.D. Room 103A, Level 1 Speaker: Faculty(s): Pennsylvania Convention Center Ned H. Kalin, M.D. Paul G. Hammerness, M.D. Dementia With Behavioral Chair: Disturbance Jair C. Soares, M.D. Course 43 (APA Members Only) 8:00 A.M. - 12:00 P.M. 3 New Research Poster Room 202A, Level 2 Pennsylvania Convention Center Chair: David A. Casey, M.D. NR Poster Session 8 Risk Assessment for Violence 9:00 A.M. - 10:30 A.M. Exhibit Hall C-E, Level 2 Director: Lecture Pennsylvania Convention Center Phillip J. Resnick, M.D. New Research — Psychiatric Lecture 20 Subspecialities Course 44 9:00 A.M. - 10:30 A.M. 8:00 A.M. - 12:00 P.M. Room 113A-C, Level 1 Room 204B, Level 2 Pennsylvania Convention Center Scientific and Clinical Report TUESDAY, MAY 8 Pennsylvania Convention Center Does Psychodynamic SCR 22 Cognitive-Behavior Therapy for Psychotherapy Have a Future as Severe Mental Illness a Psychotherapeutic Modality? 9:00 A.M. - 10:30 A.M. A Future Perspective on Past Room 109B, Level 1 4 5 Outcomes Pennsylvania Convention Center APA Frontiers of Science Lecture Series Director: Pregnancy and Post-Partum Jesse H. Wright, M.D., Ph.D. Speaker: Chair: Faculty(s): Peter Fonagy, M.D., Ph.D. Michael E. Thase, M.D. Yener Balan, M.D. Douglas Turkington, M.D. Chair: SCR22-1. Intra-Familial Study of David G. Kingdon, M.D. Annette M. Matthews, M.D. Pregnancy Complications in Attention-Deficit/ Hyperactivity Disorder Venkataramana Bhat, M.D. 138 www.psychiatry.org BIOS Peter Fonagy, James S. Ned H. Kalin, M.D., Ph.D, Jackson, M.D., is Hed- F.B.A., is Freud Ph.D., is Daniel berg Professor Memorial Profes- Katz Distin- and Chair of the sor of Psychoanal- guished Univer- Department of ysis and Head of sity Professor Psychiatry at the Research De- of Psychology the University partment of Clini- and Professor of Wisconsin cal, Educational and Health Psychol- of Health Behavior and Health Educa- School of Medicine and Public Health. ogy at University College London; tion in the School of Public Health He is also Director of the Health Chief Executive of the Anna Freud and Director and Research Professor Emotions Research Institute and Pro- Centre, London; and Consultant to of the Institute for Social Research, at fessor in the Department of Psychol- the Child and Family Programme the University of Michigan. He is also ogy at the University of Wisconsin. at the Menninger Department of Director of the Research Center for Dr. Kalin is an affiliate scientist at the Psychiatry and Behavioral Sciences at Group Dynamics, the Program for Re- Wisconsin Regional Primate Center the Baylor College of Medicine. He search on Black Americans, and the and the Harlow Primate Laboratory. is a clinical psychologist and train- Center for Afro-American and African His research centers on uncovering ing and supervising analyst in the Studies at the university. His re- mechanisms that relate stress to the British Psycho-Analytical Society in search focuses on issues of racial and development of psychopathology and child and adult analysis. His clinical ethnic influences on life course devel- to understanding which mechanisms interests center on issues of border­ opment, attitude change, reciprocity, cause some children to be vulnerable line psychopathology, violence, and social support, and coping and health for the development of anxiety and early attachment relationships. His among blacks. He was named to the depression. He also treats patients work attempts to integrate ­empirical NIH Advisory Council to the Director who suffer from anxiety and depres- ­research with psychoanalytic and is a member of the Institute of sion that are refractory to standard theory. A major focus of Dr. Fonagy’s Medicine of the National Academies. treatment. ­research has been a dynamic thera- APA Solomon Carter Fuller Award APA Distinguished Psychiatrist peutic approach, called Mentalization Lecture Lecture Series Based Therapy. Lecture 21: 9:00-10:30 a.m. Lecture 22: 9:00 - 10:30 a.m. APA Frontiers of Science Lecture Series Lecture 20: 9:00 – 10:30 a.m.

SCR22-2. Antipsychotics During Small Interactive Session 13 Pregnancy: Relation to Fetal and ! Program changes are printed Maternal Metabolic Effects 9:00 A.M. - 10:30 A.M. each day in the Daily Bulletin Robert Bodèn, M.D., Ph.D. Room 109A, Level 1 which can be picked up in the 8 MAY TUESDAY, Pennsylvania Convention Center Pennsylvania Convention Center. 3 A mobile application will also be SCR22-3. Does New Jersey’s Screening The Interplay of Love and available. Law Increase the Detection of Aggression Postpartum Depression? 2 Jane B. Sofair, M.D. Chair: Otto F. Kernberg, M.D. Workshop 94 Small Interactive Session 9:00 A.M. - 10:30 A.M. Room 102A, Level 1 Workshop Pennsylvania Convention Center Small Interactive Session 12 9:00 A.M. - 10:30 A.M. Workshop 93 Building Resilience: Responding Room 107A, Level 1 to College Student Mental 9:00 A.M. - 10:30 A.M. Health Needs Pennsylvania Convention Center Room 101, Level 1 Pennsylvania Convention Center Sports Psychiatry: Strategies Chair: Doris M Iarovici, M.D. for Life Balance & Peak Treating Behavioral Performance (MTA) Disturbances in Dementia in the Presenter(s): Era of Black-Box Warnings Hollister B. Rogers, M.D. Chair: Leah J. Dickstein, M.D., M.A. David McDuff, M.D. Chair: Victor I. Schwartz, M.D. Rajesh R. Tampi, M.D., M.S.

165th Annual Meeting 139 Workshop 95 Workshop 98 Chair: Vasant P. Dhopesh, M.D. 9:00 A.M. - 10:30 A.M. 9:00 A.M. - 10:30 A.M. Room 102B, Level 1 Room 111A, Level 1 Presenter(s): Pennsylvania Convention Center Pennsylvania Convention Center Stanley N. Caroff, M.D. James F. Morley, M.D., Ph.D. Primary Care Behavioral Health Cognitive Behavioral Strategies Integration: Roles of the Key for Weight Loss Workshop 102 Team Members 4 9:00 A.M. - 10:30 A.M. Chair: Chair: Room 126B, Level 1 Lori Raney, M.D. Sarah Johnson, M.D. Pennsylvania Convention Center Presenter(s): Presenter(s): Lori Raney, M.D. Joyce A. Spurgeon, M.D. A Tale of Two Specialities: The Frank Degruy, M.D. Casia Horseman, M.D. Integration of Oncology and Benjamin Miller, Psy.D. Psychiatry Workshop 99 Chairs: Workshop 96 9:00 A.M. - 10:30 A.M. Sarah E. Parsons, D.O. Mary Helen Davis, M.D. 9:00 A.M. - 10:30 A.M. Room 111B, Level 1 Pennsylvania Convention Center Room 104A, Level 1 Presenter(s): Pennsylvania Convention Center Julie A. Chilton, M.D. Brief Psychotherapeutic Strategies to Enhance Medi-Medi: A Ghost Story Psychopharmacological Advances In Series Treatments Chair: Rodrigo A. Munoz, M.D. 3 4 Advances In Series 5 Presenter(s): Chairs: Roger Peele, M.D. R. Rao Gogineni, M.D. 9:00 A.M. - 12:00 P.M. Brian Crowley, M.D. Amit Gupta, M.D. Room 108A/B, Level 1 Harold I. Eist, M.D. Pennsylvania Convention Center Presenter(s): Donna M. Sudak, M.D. Advances in Child Workshop 97 Psychopharmacology 9:00 A.M. - 10:30 A.M. Workshop 100 1 3 5 Room 110B, Level 1 9:00 A.M. - 10:30 A.M. Pennsylvania Convention Center Room 112A, Level 1 Chairs: Pennsylvania Convention Center Molly K. McVoy, M.D. Incarceration of Black Males: Robert L. Findling, M.D. The Effects of Untreated Bipolar, Bootcamp for Burnout: 1. Treatment of ADHD and Disruptive ADHD, and Substance Abuse Strategies to Promote Behavior Disorders Disorders Resilience and Wellness for Solomon Zaraa, D.O. APA Caucus of Black Psychiatrists Psychiatrists Association of Women Psychiatrists 2. Treatment of Pediatric Mood 1 Disorders Tiffany Thomas, M.D. Chairs: Chairs: Napoleon B. Higgins, M.D. Eva M. Szigethy, M.D., Ph.D. 3. Psychopharmacology of Autism

TUESDAY, MAY 8 Ericka L. Goodwin, M.D. Patricia I. Ordorica, M.D. and PDD Molly K. McVoy, M.D. Presenter(s): Presenter(s): Otis Anderson, M.D. Stacy S. Drury, M.D., Ph.D. 4. Treatment of Pediatric Anxiety Rahn K. Bailey, M.D. Christina T. Khan, M.D., Ph.D. Disorders Johnny Williamson, M.D. Eva M. Szigethy, M.D., Ph.D. Moira Rynn, M.D. Napoleon B. Higgins, M.D. 5. Early-Onset Psychotic Disorders, Timothy Benson, M.D. Workshop 101 Evaluation, and Treatment Nitin Gogtay, M.D. 9:00 A.M. - 10:30 A.M. All scientific sessions listed ! Room 112B, Level 1 in the Annual Meeting Program Pennsylvania Convention Center Book are designated for AMA PRA Category 1 Credits™, Update on Movement Disorders: except for New Research Poster Clinical Features and Diagnosis Sessions. 3

140 www.psychiatry.org Symposium 71 Media Workshop ! SESSION TRACKS 9:00 A.M. - 12:00 P.M. 1 Anxiety & Mood Disorders Room 103C, Level 1 Media Workshop 8 Pennsylvania Convention Center 2 Personality Disorders 9:00 A.M. - 12:00 P.M. 3 Psychopharmacology Room 119B, Level 1 Updates on Reproductive Issues Pennsylvania Convention Center in Women’s Mental Health 4 Psychotherapy 3 5 Schizophrenia and The Cycle of Inner-City Violence Other Psychotic Disorders in Bunuel’s “Los Olvidados” Chair: Gisele Apter, M.D., Ph.D. 6 NIAAA Chair: 7 DSM-5 Bruce Sklarew, M.D. Discussant(s): Carol C. Nadelson, M.D. Presenter(s): 1. Violence Against Women and Annelle B. Primm, M.D., M.P.H. Promoting Mental Health Bruce Sklarew, M.D. Helen E. Herrman, M.D., M.B. 6. Preventing Terrorist Recruitment Through Promoting Family and 2. Abortion Trauma: Deconstructing Community Resilience in Muslim the Myth Symposium Diasporas Nada L. Stotland, M.D., M.P.H. Stevan Weine, M.D. 3. Emotional Aspects of Assisted Symposium 70 Reproductive Technology Symposium 73 9:00 A.M. - 12:00 P.M. Malkah T. Notman, M.D. Room 103B, Level 1 4. Decision Making Regarding 9:00 A.M. - 12:00 P.M. Pennsylvania Convention Center Psychopharmacology in Pregnancy Room 107B, Level 1 and Postpartum Pennsylvania Convention Center The Role of Psychiatrists in the Gail E. Robinson, M.D. Prevention of Violence at the 5. Therapeutic Management, Complementary and Alternative Level of Nations, Communities, Psychotropic Medication and the Medicine Relevant to Psychiatry and Individuals Postpartum 1 5 Gisele Apter, M.D., Ph.D. Chair: Chairs: Elspeth C. Ritchie, M.D., M.P.H. Sue Bailey, M.D. Symposium 72 1. Complementary and Alternative John M. Oldham, M.D., M.S. 9:00 A.M. - 12:00 P.M. Medicine: Integrative Health Care for Psychiatry and Neurology 1. Violence and Schizophrenia: Room 106A/B, Level 1 Nisha N. Money, M.D. Therapeutic Variations and Pennsylvania Convention Center Different Societal Influences Result 2. Medical Acupuncture's New in Variable Expression Between the The Changing Face of Terrorism Potential in Psychological Health 8 MAY TUESDAY, U.S. and Other Countries Joseph M. Helms, M.D. Chair: Peter F. Buckley, M.D. 3. Treating Pain and PTSD With Jerrold M. Post, M.D. Acupuncture 2. Public Mental Health and Violence: Discussant(s): Links, Challenges, and Solutions Robert L. Koffman, M.D., M.P.H. John O. Beahrs, M.D. Dinesh Bhugra, M.B.B.S, Ph.D. 4. The Therapeutic Use of Animals in 1. Mothers of the Mujahideen: Why Medicine and Psychiatry 3. Building an Alliance for a Safer They Kill Elspeth C. Ritchie, M.D., M.P.H. Future: A Public Health Approach Farhana Qazi, M.A. to Addressing Violence and 2. The Smarter Bomb: Women and Reducing Health Inequalities in Symposium 74 Children in Palestinian Terrorism Scottish Society Anat Berko, Ph.D. 9:00 A.M. - 12:00 P.M. Denise Coia, M.D. 3. Trauma and Vulnerability to Room 117, Level 1 4. Violence and Mental Illness: Extremist Violence Pennsylvania Convention Center Putting Theory Into Practice in a Schuyler W. Henderson, M.D., M.P.H. Local Community Research Advances in 4. Lone Wolves, Radicalization Sue Bailey, M.D. Psychiatric Pharmacogenomics Online, and the Virtual Community of Hatred 1 3 Jerrold M. Post, M.D. ! Obtain your Certificate of Chair: 5. Walking Away: The Disengagement Attendance for the 2012 APA David A. Mrazek, M.D. Annual Meeting at www.psych. and Deradicalization of Terrorists 1. Personalized Treatment of org/AnnualMeetingCME John G. Horgan, Ph.D. Bipolar Disorder: Advances in

165th Annual Meeting 141 the Pharmacogenetics of Lithium Symposium 76 Symposium 78 Response John R. Kelsoe, M.D. 9:00 A.M. - 12:00 P.M. 9:00 A.M. - 12:00 P.M. Room 120B, Level 1 Room 121A, Level 1 2. Progress Toward Use of Pennsylvania Convention Center Pennsylvania Convention Center Pharmacogenetic Information to Avoid Antipsychotic-Induced Genetic and Epigenetic Factors Personalized Medicine: An Tardive Dyskinesia and Weight in Suicidal Behavior: Effects of Update Gain Early and Late Environmental U.S. National Institute on Alcohol Abuse James L. Kennedy, M.D. Stressors and Alcoholism 3. Pharmacogenomics in the Search 1 3 6 for New ADHD Treatment Targets Chairs: James T. McCracken, M.D. Chair: Maria A. Oquendo, M.D. 4. Increasing the Precision of the Markus Heilig, M.D., Ph.D. Pharmacogenomic Prediction of Enrique Baca-Garcia, M.D., Ph.D. 1. The Role of Pharmacogenetics in Antidepressant Response 1. Developmental Vulnerability to Treating Alcohol Dependence With David A. Mrazek, M.D. Suicidal Behavior Philippe Courtet, M.D., Ph.D. Ondansetron Bankole A. Johnson, M.D., Ph.D. Symposium 75 2. The Role of Life Events in Precipitating Suicide Attempts and 2. SSRIS: Widely Prescribed 9:00 A.M. - 12:00 P.M. Completed Suicide Medications That May Adversely Room 119A, Level 1 M. Mercedes Perez-Rodriguez, M.D., Affect a Subgroup of Alcoholics Pennsylvania Convention Center Ph.D. Henry R. Kranzler, M.D. Developments in Forensic 3. Epigenetic Regulation of Genes 3. Alcohol Dependence and Psychiatry in the United States Involved in Stress Response by Personalized Medicine: Leveraging and France: Vive La Difference! Early-Life Adversity: Implications Neurobiological Phenotypes to on Suicide Risk Uncover Genetic Predictors Gustavo Turecki, M.D., Ph.D. Chairs: Kent Hutchinson, M.D. John A. Talbott, M.D. 4. A Prospective Study of the Role of 4. Functional Polymorphism of Francois C. Petitjean, M.D. Life Events in Precipitating Suicidal the Mu Opioid Receptor Gene Behavior 1. A New Law for Psychiatric (OPRM1) Influences Reinforcement Treatment in France: First Maria A. Oquendo, M.D. Learning in Humans Impressions After Nine Months Elliot Stein, Ph.D. Francois C. Petitjean, M.D. Symposium 77 2. Outlier Commitment Groups 9:00 A.M. - 12:00 P.M. Symposium 79 Carl P. Malmquist, M.D. Room 120C, Level 1 9:00 A.M. - 12:00 P.M. 3. Data on Involuntary Psychiatric Pennsylvania Convention Center Hospitalizations in France Prior to Room 121B, Level 1 Pennsylvania Convention Center the July 2011 Law Moral Treatment to Recovery: Raphael Gourevitch, M.D., Ph.D. The Ivy League Hospitals Look American Psychiatry and Human at Contemporary Ethical Issues 4. Mental Health Law Reform in the Rights in the 21st Century: in Psychiatry United States Services to Special Populations Richard J. Bonnie, J.D. Chair: American Association for Social 5. What Do We Know About Virginia L. Susman, M.D. Psychiatry Compulsory Community Treatment? Discussant(s): Chair: Marc Antoine Crocq, M.D. Steven S. Sharfstein, M.D., M.P.A. Andres J. Pumariega, M.D. TUESDAY, MAY 8 1. A Historic Overview of the 6. Compare and Contrast the New 1. Human Rights and Racial/Ethnic Inception of Moral Treatment French Civil Commitment Law With Disparities David S. Roby, M.D. Civil Commitment Practices in the Andres J. Pumariega, M.D. United States 2. Confidentiality of Mental Health 2. Human Rights and Mental Health Jeffrey Janofsky, M.D. Records After Death Patricia R. Recupero, M.D., J.D. of Women Beverly J. Fauman, M.D. 3. Distinctive Competencies APA 2012 Annual ! Frederick W. Engstrom, M.D. 3. Human Rights and Services to Meeting On Demand 4. Safe and Satisfied Patients, Circa Special Populations: Children and • Special onsite pricing 2012 Youth • Earn CME Credit for top Philip J. Wilner, M.D. Consuelo C. Cagande, M.D. lectures and symposia online • For more information: 5. Superintendent of the Asylum to 4. Addressing Health Disparities in Recovery Coach: The Psychiatrist’s Immigrant and Refugee Children in Role the United States Virginia L. Susman, M.D. Eugenio M. Rothe, M.D. 142 www.psychiatry.org Symposium 80 Symposium 82 Symposium 83 9:00 A.M. - 12:00 P.M. 9:00 A.M. - 12:00 P.M. 9:00 A.M. - 12:00 P.M. Room 121C, Level 1 Room 123, Level 1 Room 124, Level 1 Pennsylvania Convention Center Pennsylvania Convention Center Pennsylvania Convention Center

Update on HIV and AIDS Integrated Care and the Assessment of Substance Use Psychiatry Future of Psychiatry: Teaching Disorder Patient Outcomes Academy of Psychosomatic Medicine Psychiatry Residents and Based on Longitudinal Registry/ 3 Fellows to Work at the Interface EMR Data of Mental Health and Primary U.S. National Institute on Drug Abuse Chair: Care Mary Ann Cohen, M.D. American Association of Directors of Chair: Petra Jacobs, M.D. Psychiatric Residency Training Discussant(s): 1. Overview of Methodologies Mary Ann Cohen, M.D. Chairs: Used to Assess Large Registry 1. HIV Through the Life Cycle: Deborah S. Cowley, M.D. Databases Childhood, Adolescence, and Robert M. McCarron, D.O. Donald Stablein, Ph.D. Reproductive Health Discussant(s): 2. Substance Use Disorders and Suad Kapetanovic, M.D. Jurgen Unutzer, M.D., M.P.H. Comorbid Psychiatric Disorders 2. HIV Through the Life Cycle: Aging Barry S. Solomon, M.D., M.P.H. Among Young Psychiatric Patients: of HIV Population 1. Training Challenges for Residents Findings From a Large Electronic Adriana Carvalhal, M.D., Ph.D. in Psychosomatic Medicine Posed Health Records Database 3. Update on HIV and AIDS Psychiatry by New Models of Health Care Li-Tzy Wu, D.Sc., M.A. Psychopharmacologic Approaches Delivery: Integrated Care and the 3. Presentation of European and Care “Medical Home” Australian Cohorts That Assess the Kelly L. Cozza, M.D. Marshall Forstein, M.D. Risk and Associated Influences on 4. Psychiatric Disorders 2. Training Challenges for Residents Mortality During and After Opioid Jordi Blanch, Ph.D. and Fellows in Psychosomatic Treatments Matt Hickman, M.S.C., Ph.D. 5. Multimorbid Medical Illness: Non- Medicine Posed by New Models of HIV and HIV-Related Health Care Delivery: Integrated 4. Presentation of EMR System in Joseph Z. Lux, M.D. Care and the “Medical Home” Italy and Outcome Studies Using Robert C. Joseph, M.D., M.S. Its Data 6. Update on HIV and AIDS Roberto Mollica, M.D. Psychiatry: Palliative and End of 3. Mental Health Integration in a Life Care Pediatric Primary Care Clinic: 5. Using National VA Patient Harold W. Goforth, M.D. Providing Care and Cross-Training Databases and Registries to Pediatric and Child Psychiatry Evaluate Care and Outcomes Residents for Patients With Mental and Symposium 81 Emily Frosch, M.D. Substance Use Disorders 4. Impact of Integrated Psychiatry- Frederic Blow, Ph.D. 9:00 A.M. - 12:00 P.M. 8 MAY TUESDAY, Room 122A/B, Level 1 Primary Medical Care Training on Pennsylvania Convention Center Resident Comfort With General Symposium 84 Medical Concerns in Patients With 9:00 A.M. - 12:00 P.M. Mental Disorders Improving Quality of Care for Room 125, Level 1 Kristen Snyder, M.D. Patients With Psychiatric Illness: Pennsylvania Convention Center Combining and Integrating 5. Integrated Care and the Future of Psychopharmacological, Psychiatry: Educating Psychiatrists Mentalizing: Current Core Individual, and Family Therapy to Work at the Interface of Mental Concepts 3 4 Health and Primary Care Jaesu Han, M.D. 4 Chairs: 6. Using an Elective Rotation in Alison M. Heru, M.D. Chair: an Integrated Care Program to Howard E. Book, M.D. Ira Glick, M.D. Foster Development of Resident 1. Mentalizing: Current Key 1. Combining Pharmacotherapy With Psychiatrist Consulting Skills Constructs Other Modalities Anna Ratzliff, M.D., Ph.D. Alan F. Schatzberg, M.D. Howard E. Book, M.D. 2. How Mentalization Contributes to 2. Combining Individual Therapy With Program changes are printed Good Psychiatric Management Other Modalities ! each day in the Daily Bulletin Glen O. Gabbard, M.D. John G. Gunderson, M.D. which can be picked up in the 3. A Role for Mentalizing in 3. Family Intervention by Psychiatrists Pennsylvania Convention Center. Psychiatric and Medical Education as a Routine Component of Patient A mobile application will also be Jon J. Hunter, M.D. Care available. Gabor I. Keitner, M.D.

165th Annual Meeting 143 4. Generic Mentalization-Based Director: Master Course 5 Interventions: How to Foster Anthony L. Rostain, M.D., M.A. a Mentalizing Stance in Your 9:00 A.M. - 4:00 P.M. Patients Faculty(s): Room 201C, Level 2 Patrick Luyten, Ph.D. Alexandra Philipsen, M.D. Pennsylvania Convention Center Russell Ramsay, Ph.D. Mary Solanto, Ph.D. Update on Pediatric Symposium 85 Susan Sprich, Ph.D. Psychopharmacology 9:00 A.M. - 12:00 P.M. 3 Room 126A, Level 1 Course 46 Pennsylvania Convention Center Director: 9:00 A.M. - 4:00 P.M. Christopher J. Kratochvil, M.D. Psychosocial Treatments for Room 203A, Level 2 Pediatric Bipolar Disorder: Pennsylvania Convention Center Faculty(s): Improving the Prognosis Christopher J. Kratochvil, M.D. Beyond Medications Systems Training for Emotional John T. Walkup, M.D. Predictability and Problem Karen D. Wagner, M.D., Ph.D. 1 4 Solving (STEPPS) Treatment Chair: Program for Borderline Darryl C. Smith, M.D., M.P.H. Personality Disorder 1. Anything Besides Medication? 2 11:00 A.M. Sessions An Overview of Alternatives to Pharmacotherapy in the Treatment Director: Forum of Pediatric Bipolar Disorder Donald W. Black, M.D. Darryl C. Smith, M.D., M.P.H. Faculty(s): 2. The Assessment of Children and Nancee S. Blum, M.S.W., L.C.S.W. Forum 7 Adolescents With Bipolar Disorder 11:00 A.M. - 12:30 P.M. Eric A. Youngstrom, Ph.D. Course 47 Terrace Ballroom IV, Level 4 3. Functional Impairment, Stress, Pennsylvania Convention Center and Psychosocial Intervention in 9:00 A.M. - 4:00 P.M. Bipolar Disorder Room 203B, Level 2 The Addiction Performance David J. Miklowitz, Ph.D. Pennsylvania Convention Center Project Presents Long Day's 4. A Child and Family-Focused CBT Journey Into Night A Psychodynamic Approach for Pediatric Bipolar Disorder: U.S. National Institute on Drug Abuse to Treatment-Resistant Mood Development and Preliminary Disorders: Breaking Through Results Chair: Treatment-Resistance by Sally Weinstein, Ph.D. Nora Volkow, M.D. Focusing on Comorbidity and Axis II Presenter(s): Course 1 4 Charles O’Brien, M.D., Ph.D. Herbert D. Kleber, M.D. Director: Dianne Wiest, Actress ! Course Descriptions are Eric M. Plakun, M.D. available in the Course Brochure. You can pick up a Course Faculty(s): Brochure and purchase a course Edward R. Shapiro, M.D. Lecture ticket in the Course Enrollment David L. Mintz, M.D. Area located in Exhibit Halls C-E, Donald E. Rosen, M.D. Level 2, Pennsylvania Convention Lecture 23 TUESDAY, MAY 8 Center. Admission to all courses, Course 48 11:00 A.M. - 12:30 P.M. including Master Courses is by Room 113A-C, Level 1 ticket only. 9:00 A.M. - 4:00 P.M. Room 204A, Level 2 Pennsylvania Convention Center Pennsylvania Convention Center Basic Sciences and Course 45 Yoga of the East and West: Interviewing Skills: Educational Conundrums? 9:00 A.M. - 4:00 P.M. Experiential Breath Work, APA/NIMH Vestermark Award Lecture Room 201A, Level 2 Movement, and Meditation Pennsylvania Convention Center Directors: Speaker: Evidence Based Group and Patricia L. Gerbarg, M.D. Bryce Templeton, M.D. Individual Psychosocial Richard P. Brown, M.D. Treatments for Adult ADHD: Chair: Faculty(s): Sandra G. Sexson, M.D. Theory and Practice Richard P. Brown, M.D. 3 4 Patricia L. Gerbarg, M.D. 144 www.psychiatry.org BIOS Bryce Michael E. Steven E. ­Templeton, Porter, ­Hyman, M.D., M.D., M.Ed., is M.B.A., Ph.D., is Distin- Professor Emeri- is Bishop Wil- guished Service tus at Drexel liam Lawrence Professor of University. Dr. University Pro- Stem Cell and Templeton has fessor at Har- Regenerative extensive experi- vard Business Biology at Harvard University and a ence developing new methodologies School. An authority on company visiting scholar at the Broad Institute for the evaluation of knowledge, strategy and the competitiveness of of Harvard and MIT. Dr. Hyman re- skills, problem solving ability and nations and regions, his work is wide- cently completed a decade of service competencies of students, residents, ly recognized by governments, corpo- as Provost of Harvard University. and practicing physicians. His career rations, nonprofits, and academic in- From 1996 to 2001 he served as Di- includes16 years at the National stitutions across the globe. His work rector of NIMH, where he empha- Board of Medical Examiners, where has redefined thinking about compet- sized investment in emerging genetic he helped organize both the NBME itiveness, economic development, ec- technologies and neuroscience and Part II exam and several special board onomically distressed urban commu- initiated a series of large clinical trials exams. Earlier in his career he worked nities, environmental policy, and the performed in “real world” popula- for the Public Health Service at a fed- role of corporations in society. Dr. tions. Before his government service eral prison in California and on the Porter studies problems in health he was the first faculty Director of consultation service at the University care, and his book, Redefining Health Harvard University’s interdisciplinary of Pittsburgh. He was recently award- Care, develops a new framework for Mind, Brain, and Behavior Initiative ed The Vestermark Psychiatry Educa- transforming the value delivered by and Director of Psychiatry Research tor Award, the top national award for the health care system, with implica- at Massachusetts General Hospital. excellence, leadership, and creativity tions for providers, health plans, em- He is a member of the Institute of in education from the American Psy- ployers, and government. He has also Medicine of the National Academies, chiatric Association and the National developed a curriculum for universi- a Fellow of the American College of Institute of Mental Health. ties, medical schools, and profession- Neuropsychopharmacology, and a al education programs for health pro- Distinguished Life Fellow of the APA/NIMH Vestermark Award fessionals around the world. Dr. American Psychiatric Association. Lecture Porter has advised numerous leading Lecture 23: 11:00 -12:30 p.m. APA Distinguished Psychiatrist US and international companies and Lecture Series plays an active role in US economic Lecture 25: 11:00 -12:30 p.m. policy with the Executive Branch and Congress.

APA Guest Lecture Series Lecture 24: 11:00 -12:30 p.m. TUESDAY, MAY 8 MAY TUESDAY,

Lecture 24 APA Distinguished Psychiatrist Lecture Scientific and Clinical Report Series 11:00 A.M. - 12:30 P.M. Room 114 Lecture Hall, Level 1 7 SCR 23 Pennsylvania Convention Center Speaker: 11:00 A.M. - 12:30 P.M. Room 109B, Level 1 Value-Based Mental Health Care Steven E. Hyman, M.D. Pennsylvania Convention Center Delivery Chair: APA Guest Lecture Series Professional Issues Dilip V. Jeste, M.D. Speaker: Chair: Michael E. Porter, M.B.A., Ph.D. David Preven, M.D. New Research Poster SCR23-1. Burnout Among Psychiatrists Chair: and Pediatricians at LAC and USC Chair Gregory W. Dalack, M.D. NR Poster Session 9 Medical Center Torang S. Sepah, M.D. Lecture 25 11:00 A.M. - 12:30 P.M. Exhibit Hall C-E, Level 2 1 11:00 A.M. - 12:30 P.M. Pennsylvania Convention Center Room 115A-C, Level 1 SCR23-2. Learning From a Case-Based Pennsylvania Convention Center Workshop for Interprofessional New Research — Biological Audience Psychiatry, Neuroscience, Diana Kljenak, M.D. Can We Safely Deliver the Genetics, and Other DSM‑5 Into the 21st Century? 2

165th Annual Meeting 145 SCR23-3. Psychotherapy Practices of Small Interactive Session 15 Presenter(s): Psychiatrists in the United States: Kathryn S. McIntyre, M.D. Patterns, Trends, and Reported 11:00 A.M. - 12:30 P.M. Mitchell J. M. Cohen, M.D. Barriers to Psychotherapy Room 109A, Level 1 Joyce C. West, Ph.D., M.P.P. Pennsylvania Convention Center Workshop 106 3 4 Meet the Author Session: 11:00 A.M. - 12:30 P.M. Cognitive Behavior Therapy for Room 104A, Level 1 Children and Adolescents SCR 24 Pennsylvania Convention Center 11:00 A.M. - 12:30 P.M. 3 4 Room 111B, Level 1 Extended Treatment for Alcohol Chair: Pennsylvania Convention Center Use Disorders: An Update Eva M. Szigethy, M.D., Ph.D. U.S. National Institute on Alcohol Abuse Psychosomatic and Alcoholism 6 Chair: Workshop Daniel Chapman, Ph.D. Chair: SCR24-1. Frequency of Depression and Workshop 103 James R. McKay, Ph.D. Anxiety in Dissociative Conversion Disorder Patients Reporting at a 11:00 A.M. - 12:30 P.M. Presenter(s): Tertiary Care Psychiatric Facility of Room 101, Level 1 James R. McKay, Ph.D. Fauji Foundation Pennsylvania Convention Center Mazhar Malik, M.B.B.S Role of Gender and Culture in Workshop 107 1 Professional Psychiatry 11:00 A.M. - 12:30 P.M. SCR24-2. The Relationship of Room 110B, Level 1 Health Anxiety to State Anxiety, Chair: Pennsylvania Convention Center Depression, Somatic Symptom Nyapati R. Rao, M.D., M.S. Burden, and Disability in a Presenter(s): Resolving Ethical Challenges Tertiary Psychosomatic Medicine Rashi Aggarwal, M.D. and Promoting Mental Health Population Vijayalakshmi Appareddy, M.D. Recovery Jeffrey P. Staab, M.D., M.S. Joan M. Anzia, M.D. APA/The Scattergood Foundation 1 Toi B. Harris, M.D. SCR24-3. Developing an Emergency Chair: Phyllis Solomon, Ph.D. Psychiatry Consultation Sevice Workshop 104 Within a C-L Program: Impact and Presenter(s): Change 11:00 A.M. - 12:30 P.M. Phyllis Solomon, Ph.D. Henry W. Weisman, M.D. Room 102A, Level 1 Jonathan Lukens, M.D. Pennsylvania Convention Center Small Interactive Session A Primer on Psychotherapy in Workshop 108 the Medically Ill 11:00 A.M. - 12:30 P.M. Small Interactive Session 14 4 Room 111A, Level 1 Pennsylvania Convention Center 11:00 A.M. - 12:30 P.M. Chair: Room 107A, Level 1 Sanjeev Sockalingam, M.D. Great Performances: Pennsylvania Convention Center Presenter(s): Malingering in Fiction Sanjeev Sockalingam, M.D.

TUESDAY, MAY 8 Posttraumatic Stress Disorder Raed Hawa, M.D. Chair: Open Forum: Come Discuss Susan E. Abbey, M.D. Sherif Soliman, M.D. PTSD With the Editors of the Adrienne Tan, M.D. Recent Text ‘Clinical Manual for Presenter(s): Management of PTSD’ Cathleen A. Cerny, M.D. Workshop 105 Susan Hatters-Friedman, M.D. 1 Sara G. West, M.D. 11:00 A.M. - 12:30 P.M. Sherif Soliman, M.D. Chairs: Room 102B, Level 1 David M. Benedek, M.D. Pennsylvania Convention Center Gary H. Wynn, M.D. ! Program changes are printed The Cobbler's Children: Dealing each day in the Daily Bulletin With Mental Illness in Our Own which can be picked up in the Families Pennsylvania Convention Center. A mobile application will also be Chair: available. Julia B. Frank, M.D.

146 www.psychiatry.org Workshop 109 1:00 P.M. Sessions Course 51 11:00 A.M. - 12:30 P.M. 1:00 P.M. - 5:00 P.M. Room 112A, Level 1 Course Room 202B, Level 2 Pennsylvania Convention Center Pennsylvania Convention Center ! Course Descriptions are Strengthening Resilience and available in the Course Brochure. Good Psychiatric Management Developing Posttraumatic You can pick up a Course (GPM) for Borderline Growth in Children, Adults, Brochure and purchase a course Personality Disorder: What and Communities Following ticket in the Course Enrollment Every Psychiatrist Should Know Disasters Area located in Exhibit Halls C-E, 2 Level 2, Pennsylvania Convention Chair: Center. Admission to all courses, Director: Howard J. Osofsky, M.D., Ph.D. including Master Courses is by John G. Gunderson, M.D. ticket only. Presenter(s): Faculty(s): Joy D. Osofsky, Ph.D. Brian A. Palmer, M.D., M.P.H. Michelle B. Moore, Psy.D., M.Ed. Paul S. Links, M.D. Rebecca Shahmoon Shanok, M.D. Course 49 1:00 P.M. - 5:00 P.M. Seminar 22 Workshop 110 Room 201B, Level 2 1:00 P.M. - 5:00 P.M. Pennsylvania Convention Center 11:00 A.M. - 12:30 P.M. Room 204B, Level 2 Room 112B, Level 1 Pennsylvania Convention Center Pennsylvania Convention Center The Expert Witness in Psychiatric Malpractice Cases The Four Pillars of Healthcare Ethical Dilemmas in Psychiatric Integration: Practice, Workforce, Practice Director: Payment and Policy Phillip J. Resnick, M.D. Ethics Committee APA/The Scattergood Foundation

Chair: Directors: Burton V. Reifler, M.D. Course 50 Natalie Levkovich Presenter(s): 1:00 P.M. - 5:00 P.M. Faculty(s): Wade Myers, M.D. Room 202A, Level 2 Neftali Serrano, Psy.D. Harriet Stern, M.D. Pennsylvania Convention Center Sean Gallagher, Ph.D. William Arroyo, M.D. Benjamin Miller, Psy.D. Elissa P. Benedek, M.D. Healthy Brain Aging: Evidence Suzanne Daub, L.C.S.W. Mark S. Komrad, M.D. Based Methods to Preserve and Improve Brain Health

Workshop 111 Director: 8 MAY TUESDAY, George T. Grossberg, M.D. 1:30 P.M. Sessions 11:00 A.M. - 12:30 P.M. Room 126B, Level 1 Faculty(s): Advances In Medicine Pennsylvania Convention Center Abhilash K. Desai, M.D. Advances In Medicine 5 TMS Beyond the FDA Label: Consensus Guidelines for Best 1:30 P.M. - 3:00 P.M. Clinical Practice Room 114 Lecture Hall, Level 1 Pennsylvania Convention Center 1 Update on Sleep Disorders: Chair: SESSION TRACKS What's New Under the Moon Irving Reti, M.B.B.S ! 1 Anxiety & Mood Disorders Presenter(s): Speaker: Irving Reti, M.B.B.S 2 Personality Disorders Karl Doghramji, M.D. Sarah H. Lisanby, M.D. 3 Psychopharmacology Chairs: Linda L. Carpenter, M.D. Catherine C. Crone, M.D. Shirlene M. Sampson, M.D., M.S. 4 Psychotherapy Amanda Crosier, M.D. Husain Mustafa, M.D. 5 Schizophrenia and John O’Reardon, M.D. Other Psychotic Disorders

6 NIAAA 7 DSM-5

165th Annual Meeting 147 Case Conferences BIO SCR 26 Sherwin B. 1:30 P.M. - 3:00 P.M. ! These sessions are open Nuland, M.D., Room 111B, Level 1 to APA members only. A blue FACS, retired Pennsylvania Convention Center registration badge or an APA in 2009 as Clin- Schizophrenia Part 2 membership card is required for ical Professor of admittance. Surgery at the Chair: Yale School of Daniel Chapman, Ph.D. Medicine but SCR26-1. Drug Compliance and Case Conference 6 continues to teach bioethics and Associated Outcomes in medical history at Yale. He serves 1:30 P.M. - 3:00 P.M. Schizophrenia Patients Before on the Executive Committee of and After the Initiation of Depot Room 103A, Level 1 Yale’s Interdisciplinary Center for Pennsylvania Convention Center Antipsychotic Agents Bioethics and is a member of the Steve J. Offord, Ph.D. Board of Directors of the Hastings PTSD and the US Soldier Today Center, the nation’s first Bioethics SCR26-2. Clinical Deficits Underlying (APA Members Only) think tank, of which he is also a the Denial of Aggression and 1 Fellow. He began writing full-time Symptoms in Patients With in 1992 and has written exten- Schizophrenia Randomized Chairs: sively for professional and general to Clozapine, Olanzapine, and Elspeth C. Ritchie, M.D., M.P.H. audiences. His book How We Die Haloperidol Marvin Oleshansky, M.D. was on the New York Times Best Menahem I. Krakowski, M.D., Ph.D. Presenter(s): Seller List for 34 weeks. It won a 3 5 National Book Award, and was a Jerald J. Block, M.D. SCR26-3. Primary Polydipsia in a finalist for the 1995 Pulitzer Prize. Brett J. Schneider, M.D. Chronic Psychiatric Outpatient His most recent book, The Soul of Michelle Hornbaker, M.D. Population Medicine: Tales From the Bedside, Felicia Iftene, M.D., Ph.D. was published in 2009. He is a Fel- Lecture low of the American Academy for 5 the Advancement of Science. APA Guest Lecture Series Small Interactive Session Lecture 26 Lecture 26: 1:30 - 3:00 p.m. 1:30 P.M. - 3:00 P.M. Terrace Ballroom IV, Level 4 Small Interactive Session 16 Oral Antipsychotics Among U.S. Pennsylvania Convention Center 1:30 P.M. - 3:00 P.M. and Non-Medicare Room 107A, Level 1 Populations The Goodness of the Physician: Pennsylvania Convention Center From Hippocrates to Hi-Tech Bruce J. Wong, M.D. APA Guest Lecture Series 3 5 TMS and ECT in Clinical SCR25-2. Glycine Reuptake Inhibitor Practice: Q & A Speaker: (GRI) Enhances NMDA Receptor Sherwin B. Nuland, M.D. 1 Activity: A Novel Approach to the Treatment of Schizophrenia Chair: Chair: Daniela Alberati, Ph.D. John O’Reardon, M.D. Michael F. Myers, M.D. 3 5 SCR25-3. Metformin for Treatment of Workshop TUESDAY, MAY 8 Scientific and Clinical Report Antipsychotic-Induced Amenorrhea and Weight Gain in Female Patients With First-Episode Workshop 112 SCR 25 Schizophrenia: A Randomized, 1:30 P.M. - 3:00 P.M. Double Blind Study 1:30 P.M. - 3:00 P.M. Room 101, Level 1 Renrong Wu, M.D., Ph.D. Room 109B, Level 1 Pennsylvania Convention Center Pennsylvania Convention Center 3 5 Small, Medium, or Large? Schizophrenia Part 1 A Panel Discussion With Psychiatrists From Three Chair: College Campuses Adel Gabriel, M.D. ! Obtain your Certificate of Attendance for the 2012 APA Chairs: SCR25-1. Epidemiology of Annual Meeting at www.psych. Farah Munir, D.O. Schizophrenia Patients Initiating org/AnnualMeetingCME Long-Acting Injectable Versus Susan Kimmel, M.D.

148 www.psychiatry.org Presenter(s): Workshop 116 Presenter(s): Farah Munir, D.O. Deborah J. Hales, M.D. 1:30 P.M. - 3:00 P.M. Susan Kimmel, M.D. Beth Ann Brooks, M.D., M.S. Room 110B, Level 1 Michelle Fulk, D.O. Robert J. Ronis, M.D., M.P.H. Pennsylvania Convention Center

Workshop 113 Lost in Translation: Taking Cultural Sensitivity From Theory 1:30 P.M. - 3:00 P.M. to the Bedside Room 102A, Level 1 2:00 P.M. Sessions APA Council on Medical Education and Pennsylvania Convention Center Lifelong Learning New Research Poster Assessment of Suicidal Chairs: Behavior in Children and Puja Chadha, M.D. NR Poster Session 10 Adolescents Jason E. Cheng, M.D. 2:00 P.M. - 3:30 P.M. Chairs: Presenter(s): Exhibit Hall C-E, Level 2 Magdalena Romanowicz, M.D. Alric D. Hawkins, M.D. Pennsylvania Convention Center Timothy Lineberry, M.D. Ankur Bindal, M.D., M.P.H. Denise Chang, M.D. New Research Other Presenter(s): Ye B. Du, M.D., M.P.H. Magdalena Romanowicz, M.D. Esther E. Oh, M.D. Kathryn M. Schak, M.D. Elena F. Garcia-Aracena, M.D. Stephen O’Connor, Ph.D. Presidential Symposium Sandra Rackley, M.D. Timothy Lineberry, M.D. Workshop 117 Presidential Symposium 4 1:30 P.M. - 3:00 P.M. Workshop 114 Room 111A, Level 1 2:00 P.M. - 5:00 P.M. Pennsylvania Convention Center Room 122A/B, Level 1 1:30 P.M. - 3:00 P.M. Pennsylvania Convention Center Room 102B, Level 1 Malpractice Defense: Strategies Pennsylvania Convention Center for Success Prevention in Geriatric Psychiatry Psychiatrists and the New Chairs: 1 Media: Gaining Control of Our Abe M. Rychik, J.D. Specialty's Public Image Eugene L. Lowenkopf, M.D. Chair: Dilip V. Jeste, M.D. Chair: Steven R. Daviss, M.D. Workshop 118 Discussant(s): Ruth O Hara, Ph.D. Presenter(s): 1:30 P.M. - 3:00 P.M. Dinah Miller, M.D. Room 112A, Level 1 1. Successful Psychosocial Aging Robert C. Hsiung, M.D. Pennsylvania Convention Center Dilip V. Jeste, M.D. 8 MAY TUESDAY, Annette Hanson, M.D. 2. Prevention of Posttraumatic Stress Learning to Practice What Daniel J. Carlat, M.D. Disorder We Preach: Translating Steven Balt, M.D., M.S. Murray A. Raskind, M.D. Neurocognitive and Social Psychological Studies of Racism 3. The “Vascular Depression” Workshop 115 and Sexism Into Our Everyday Hypothesis: Mechanisms, Practice Treatment Development, and 1:30 P.M. - 3:00 P.M. Prevention Room 109A, Level 1 Chair: George S. Alexopoulos, M.D. Pennsylvania Convention Center Annelle B. Primm, M.D., M.P.H. 4. Depression Prevention Strategies From Utilization Analysis to Presenter(s): in Later Life: Overview of a Young Quality Management in Mental Donald H. Williams, M.D. Field Health Care Research Charles Reynolds, M.D. 5. Can We Prevent Alzheimer’s Workshop 119 Chair: Disease? Wolfgang Gaebel, M.D. 1:30 P.M. - 3:00 P.M. Gary W. Small, M.D. Room 126B, Level 1 Presenter(s): Pennsylvania Convention Center Wolfgang Gaebel, M.D. Povl Munk-Jørgensen, M.D. ABPN and APA Perspectives on Harold A. Pincus, M.D. Maintenance of Certification

Chair: Larry R. Faulkner, M.D.

165th Annual Meeting 149 Symposium Symposium 88 Symposium 90 2:00 P.M. - 5:00 P.M. 2:00 P.M. - 5:00 P.M. Symposium 86 Room 104A, Level 1 Room 107B, Level 1 Pennsylvania Convention Center Pennsylvania Convention Center 2:00 P.M. - 5:00 P.M. Room 103B, Level 1 Rapid Urbanization: Impact on Assisted Outpatient Treatment Pennsylvania Convention Center Mental Health for Persons With Severe Mental Illness: The Data and the Psychiatry and Cancer Update Chair: Controversy 3 4 Jitendra Kumar Trivedi, M.D., M.R.C. 5 Chairs: 1. Impact on Mental Health by Rapid Chair: Michelle B. Riba, M.D., M.S. Urbanization in Western and Marvin S. Swartz, M.D. Luigi Grassi, M.D. Central Asia Mohit Ahmad, M.D. Discussant(s): 1. Circadian Cortisol as a Predictor Paul S. Appelbaum, M.D. of Response to Psychotherapy 2. Impact on Mental Health by Rapid for Depression and PTSD Among Urbanization in Southern Asia 1. Is Assisted Outpatient Treatment Breast Cancer Survivors Jitendra Kumar Trivedi, M.D., M.R.C. Effective? David R. Spiegel, M.D. Marvin S. Swartz, M.D. 3. Impact on Mental Health by Rapid 2. Unpacking the Controversy About 2. Spiritual and Religious Coping Urbanization in Eastern Asia Assisted Outpatient Treatment With Cancer Harishchandra Gambheera, M.D. Jeffrey W. Swanson, Ph.D. David W. Kissane, M.D. 4. Impact on Mental Health by Rapid 3. Reviewing New Data on the 3. Update on Pediatric Psycho- Urbanization in Australasia and the Cost and Benefits of Assisted Oncology South Pacific Outpatient Treatment Margaret L. Stuber, M.D. Mohan Isaac, M.D., D.P.M. Richard A. Van Dorn, Ph.D. 4. How to Communicate With Patients and Families Symposium 89 Symposium 91 Walter F. Baile, M.D. 2:00 P.M. - 5:00 P.M. 5. Treatment of Delirium in Cancer Room 106A/B, Level 1 2:00 P.M. - 5:00 P.M. Patients Pennsylvania Convention Center Room 108A/B, Level 1 William Breitbart, M.D. Pennsylvania Convention Center Racial/Ethnic Minority Populations and the Social Choosing the Right Treatment Symposium 87 Determinants of Mental Health for Substance Abuse 2:00 P.M. - 5:00 P.M. 1 3 4 Room 103C, Level 1 Pennsylvania Convention Center Chair: Chair: Ruth S. Shim, M.D., M.P.H. Herbert D. Kleber, M.D. Controversies in Autism 1. Development of the “Barriers to 1. Choosing the Right Treatment for Spectrum Disorder: Separating Health and Mental Health Care Cocaine Dependence Facts From Myths Access Questionnaire” for Use Adam Bisaga, M.D. Among Immigrant Latino Women Chair: 2. Choosing Treatment for Cannabis Shafali S. Jeste, M.D. Kaney K. F. Fedovskiy, M.D., M.P.H. Dependence 2. Securing Civil Commitment Frances R. Levin, M.D. Discussant(s): Between Sovereign Nations 3. Combining Medications and James T. McCracken, M.D.

TUESDAY, MAY 8 Monica Taylor-Desir, M.D., M.P.H. Psychosocial Interventions in the 1. Clinical Considerations in ASD: Treatment of Substance Abuse 3. Racial/Ethnic Minority Populations What Are the Implications of the Edward V. Nunes, M.D. and the Social Determinants of Changes in Diagnostic Criteria? Mental Health 4. Treatment of Chronic Pain and Shafali S. Jeste, M.D. Nhi-Ha T. Trinh, M.D. Opioid Dependence: Role for 2. Epidemiology of ASD: Why the Opioid Agonists and Antagonists 4. Racial/Ethnic Disparities, Social Rise in Prevalence? Maria A. Sullivan, M.D., Ph.D. Support, and Depression: Bennett L. Leventhal, M.D. 5. Detecting and Managing Sedative- Examining a Social Determinant of Hypnotic and Prescription 3. Genetics of ASD: Is It All in the Mental Health Stimulant Abuse Genes? Ruth S. Shim, M.D., M.P.H. John J. Mariani, M.D. Daniel Geschwind, M.D. 4. Early Signs and Biomarkers of ASD: How Early Can We Detect the Disorder? Charles Nelson, Ph.D.

150 www.psychiatry.org Symposium 92 4. Only in New York: Turning It Into 15 Late-Life Mania and Hypomania: Minutes of Fame Randomized Controlled Trial, 2:00 P.M. - 5:00 P.M. Hunter L. McQuistion, M.D. Geriatric Bipolar Disorder Room 117, Level 1 Laszlo Gyulai, M.D. Pennsylvania Convention Center 4. Cognitive Function and Medical Symposium 94 Update on Body Dysmorphic Comorbidity in Elders With Bipolar Disorder 2:00 P.M. - 5:00 P.M. Disorder Participating in Geri-BD Room 120B, Level 1 Ariel Gildengers, M.D. Chairs: Pennsylvania Convention Center Katharine A. Phillips, M.D. Jamie Feusner, M.D. Reclaiming the Role of Symposium 96 Motherhood for Women With Discussant(s): 2:00 P.M. - 5:00 P.M. Serious Mental Illness Helen B. Simpson, M.D., Ph.D. Room 121A, Level 1 Pennsylvania Convention Center 1. Body Dysmorphic Disorder: Chair: Clinical Features, Assessment, and Nikole S. Benders-Hadi, M.D. Controversies in the Under Proposed Changes for DSM-5 Versus Over Diagnosis of Katharine A. Phillips, M.D. Discussant(s): Leah J. Dickstein, M.D., M.A. Bipolar Disorder 2. Abnormalities of Visual and Nada L. Stotland, M.D., M.P.H. 1 Emotional Processing in Body 1. Mothers With Serious Mental Dysmorphic Disorder Illness in a State Psychiatric Chair: Jamie Feusner, M.D. Hospital Setting Joseph F. Goldberg, M.D., M.S. 3. Neuropsychopharmacology of Body Nikole S. Benders-Hadi, M.D. Discussant(s): Dysmorphic Disorder 2. Assessing Parenting Capability in Frederick K. Goodwin, M.D. Eric Hollander, M.D. Mothers With Mental Illness 1. Diagnostic Error in Bipolar 4. Information-Processing Biases and Laura Miller, M.D. Disorder: The Inherent Limits of Cognitive-Behavior Treatment of 3. Exploring How Peer Support Can Criteria-Based Diagnoses and Body Dysmorphic Disorder Expand Parenting Opportunities Its Impact on Overdiagnosis and Sabine Wilhelm, Ph.D. for Women With Serious Mental Underdiagnoses Health Diagnoses in Marginal 5. Body Dysmorphic Disorder and Mark Zimmerman, M.D. Social Circumstances: Part 1 Cosmetic Surgery 2. Why Affective Instability is David Sarwer, Ph.D. Mary Jane Alexander, Ph.D. Different From Bipolarity 4. Exploring How Peer Support Can Joel Paris, M.D. Expand Parenting Opportunities Symposium 93 3. Clinician Versus Patient-Rated for Women With Serious Mental MDQ Screening for Bipolar 2:00 P.M. - 5:00 P.M. Health Diagnoses in Marginal Disorder at Hospitalization: Room 120A, Level 1 Social Circumstances:Part 2 Sources of Discordance Pennsylvania Convention Center Jacki McKinney, M.S.W. Joseph F. Goldberg, M.D., M.S. TUESDAY, MAY 8 MAY TUESDAY, 4. Indices of Bipolar Disorder in 5,635 There Is No Such Thing as a Symposium 95 Patients Seeking Treatment for a “Med Check” Major Depressive Episode American Association of Community 2:00 P.M. - 5:00 P.M. Charles Bowden, M.D. Psychiatrists Room 120C, Level 1 3 Pennsylvania Convention Center Chair: Geriatric Bipolar Disorder: Jeffrey Geller, M.D., M.P.H. Pharmacotherapy of Late-Life Bipolar Mania Discussant(s): Jeffrey Geller, M.D., M.P.H. 1 3 SESSION TRACKS Kenneth S. Thompson, M.D. ! Chair: Anxiety & Mood Disorders 1. An Overview of Shared Decision 1 Robert C. Young, M.D. Making 2 Personality Disorders Lisa A. Mistler, M.D., M.S. 1. Geriatric Bipolar Disorder: Overview of Rationale and Study 3 Psychopharmacology 2. From California: Challenges and Design 4 Psychotherapy Paradoxes John L. Beyer, M.D. Bernadette M. Grosjean, M.D. Schizophrenia and 2. Tolerability of Lithium and 5 Other Psychotic Disorders 3. Group Meetings in Behavioral Valproate in Geri-BD Participants Health That Include Prescribing Robert C. Young, M.D. 6 NIAAA and Discussing Medication as Part 3. Antimanic Effects of Lithium and of the Treatment/Recovery Plan 7 DSM-5 Valproate for the Treatment of Benjamin Crocker, M.D.

165th Annual Meeting 151 Symposium 97 Discussant(s): 4. Group Therapy Treatment of Clarence Watson, M.D., J.D. Functional Somatic Syndromes 2:00 P.M. - 5:00 P.M. and Somatoform Disorders Using 1. Introduction of Speakers and Room 121B, Level 1 CBT, Mindfulness, and ACT in a Overview of Presentations Pennsylvania Convention Center Specialized Setting Clarence Watson, M.D., J.D. Per C. Fink American Psychiatry and Human 2. Autism Spectrum Disorder: Rights in the 21st Century: The Applications of Psychiatric 5. Somatoform Disorders: Patients’ Clinical Process Testimony in Criminal Cases Perspectives American Association for Social Kenneth J. Weiss, M.D. Maria Harmandayan, M.D. Psychiatry 3. Legal Relevance of Brain Function: Chairs: Admissibility of Nuclear Imaging Symposium 101 Following Traumatic Brain Injury Andres J. Pumariega, M.D. 2:00 P.M. - 5:00 P.M. R. Rao Gogineni, M.D. Susan E. Rushing, M.D., J.D. Room 125, Level 1 Discussant(s): 4. Admissibility of Functional Pennsylvania Convention Center William Ulwelling, M.D., M.P.H. Neuroimaging Evidence in US 1. Human Rights and Mental Health Courts Obesity and Bipolar Disorder: Consumers Octavio Choi, M.D., Ph.D. Phenomenological Implications, Charles W. Huffine, M.D. Common Neurobiological 5. Violent Parasomnias and Their Substrates, and the Effect of 2. Human Rights and Managed Care Forensic Issues Bariatric Surgery Steven Moffic, M.D. Elena T. Del Busto, M.D. 1 3. Human Rights and Access to 6. The Role of the Expert in Criminal Preventive Services Juvenile Justice Chair: Carl C. Bell, M.D. Nicole A. Foubister, M.D. Roger S. McIntyre, M.D. 4. Health System Reform and Human 1. Obesity in Bipolar Disorder: The Rights Symposium 100 Causative Effects of Trauma and Steven S. Sharfstein, M.D., M.P.A. Consequences to Cognition 2:00 P.M. - 5:00 P.M. Roger S. McIntyre, M.D. Room 124, Level 1 Symposium 98 Pennsylvania Convention Center 2. Bipolar Disorder and Obesity: The 2:00 P.M. - 5:00 P.M. Contribution of Eating Disorders Room 121C, Level 1 Somatic Symptom Disorders: Susan McElroy, M.D. Pennsylvania Convention Center Treatments That Work 3. Bariatric Surgery and Psychiatric 3 4 Utilization Among Patients With Comprehensive HIV Bipolar Disorder Neuropsychiatry Update Chairs: Ameena T. Ahmed, M.D., M.P.H. 3 Jeffrey P. Staab, M.D., M.S. Arthur J. Barsky, M.D. Chair: Symposium 102 Karl Goodkin, M.D., Ph.D. 1. Treatment of Hypochondriasis: CBT, SSRI, or Both? Results From an 2:00 P.M. - 5:00 P.M. 1. HIV/AIDS Medical Update NIMH-Funded Randomized Study Room 126A, Level 1 Steven Douglas, M.D. Brian A. Fallon, M.D., M.P.H. Pennsylvania Convention Center 2. Neuropsychiatric Overview 2. Short-Term Psychodynamic Marshall Forstein, M.D. Psychiatry in Deradicalizing Psychotherapy for Somatic Violent Extremists 3. Neurocognitive Decline Symptom Disorders: State of World Psychiatric Association Karl Goodkin, M.D., Ph.D. Evidence and Videotape Illustration TUESDAY, MAY 8 4. Psychopharmacology Allan A. Abbass, M.D. Chair: Zebulon Taintor, M.D. Stephen J. Ferrando, M.D. 3. Functional Movement Disorders: Successful Treatment With a Discussant(s): Symposium 99 Rehabilitation Protocol John G. Horgan, Ph.D. Jeff Thompson, M.D. 2:00 P.M. - 5:00 P.M. 1. Psychological Factors in Violent Room 123, Level 1 Extremism Pennsylvania Convention Center ! APA 2012 Annual Zebulon Taintor, M.D. Meeting On Demand Updated Applications of 2. Psychiatry in Deradicalizing Violent • Special onsite pricing Extremists : An Analysis of the Expert Psychiatric Testimony in • Earn CME Credit for top Criminal Justice Saboon Rehabilitation Project lectures and symposia online Feriha N. Peracha, Ph.D., M.Sc. • For more information: Chairs: 3. Integrative Rural Development Clarence Watson, M.D., J.D. Program by Swat Relief Initiative Kenneth J. Weiss, M.D. Zebunisa A. Jilani

152 www.psychiatry.org 4. Building the Capacity of Civil BIOS Society of Pakistan to Work on Counter-Radicalization and John H. Neal Deradicalization Programs ­Krystal, M.D., ­Swerdlow, Farrokh K. Captain, M.B.A. is the Robert M.D., Ph.D., 5. Preventing Radicalization to L. McNeil, Jr., is Professor of Extremist Violence Through Professor of Psychiatry at Raising Integrative Complexity Translational the University Sara Savage, Ph.D. Research and of California Chair of the San Diego School of Medicine; Direc- Department of Psychiatry at the tor of the UCSD Psychiatry Research 3:30 P.M. Sessions Yale University School of Medicine; Residency Track; and Deputy Direc- Chief of Psychiatry at Yale-New tor of the NIMH Consortium on the Advances In Medicine Haven Hospital; and Director of the Genetics of Schizophrenia. His labo- NIAAA Center for the Translational ratories conduct human and animal Advances In Medicine 6 Neuroscience of Alcoholism. He is studies focused on the neural circuit also Codirector of the Alcohol Re- and molecular regulation of informa- 3:30 P.M. - 5:00 P.M. search Center and the Neuroscience tion processing and its deficiencies Room 119A, Level 1 Division of the National Center for in specific brain disorders, including Pennsylvania Convention Center PTSD of the Department of Veterans schizophrenia, Tourette Syndrome, Affairs. Dr. Krystal is a pioneer of and obsessive compulsive disorder. Cardiac Arrhythmias in the the translational neuroscience of He developed a model for preclinical Psychiatric Patient: What to alcoholism. His work combines antipsychotic screening that remains Know and How to Treat? experimental and clinical psycho- the gold standard across industry pharmacology, molecular and cogni- and the FDA. He has chaired the Speaker: Rajat Deo, M.D. tive neuroimaging, and molecular Medical Advisory Boards of the To- genetics in studies of mechanisms urette Syndrome Association and Chair: underlying human alcohol intoxica- NAMI, and is a recipient of the Nyapati R. Rao, M.D., M.S. tion and dependence, the human ACNP Joel Elkes Award, APA Kempf neurobiology of the heritable risk Award, and NAMI Judith Silver for alcoholism, and the treatment Award. Lecture of alcohol dependence. He and his APA/Award for Research in collaborators are known for their Psychiatry groundbreaking studies of the block- Lecture 27 Lecture 28: 3:30 - 5:00 p.m. ade of the NMDA glutamate recep- 3:30 P.M. - 5:00 P.M. tor and the facilitation of GABA-A Room 113A-C, Level 1 receptor function. Dr. Krystal Pennsylvania Convention Center co-led the first multicenter trial that rigorously tested the efficacy of nal- Glutamate, Dopamine, and trexone for alcohol dependence. He Alcoholism: From Vulnerability is a member of the NIAAA National 8 MAY TUESDAY, to Treatment Alcohol Advisory Council and is a APA Frontiers of Science Lecture Series member of the Institute of Medicine of the National Academies. Speaker: John H. Krystal, M.D. APA Frontiers of Science Lecture Series Chair: Lecture 27: 3:30 - 5:00 p.m. Domenic A. Ciraulo, M.D.

Lecture 28 Scientific and Clinical Report Study in Bipolar Disorder 3:30 P.M. - 5:00 P.M. Sagar V. Parikh, M.D. Room 115A-C, Level 1 Pennsylvania Convention Center SCR 27 1 SCR27-2. Quantification of Stigma for Translational Studies of 3:30 P.M. - 5:00 P.M. Clinical Assessment: A Paradigm Preconscious Inhibition: What Room 109B, Level 1 Shift in Anti-Stigma Intervention We’ve Learned in the Blink of Pennsylvania Convention Center Amresh Shrivastava, M.D. an eye APA Award for Research in Psychiatry Stigma 5 SCR27-3. Cyberspace: A Frontier for Speaker: Chair: Confronting Mental Health Stigma Neal R. Swerdlow, M.D., Ph.D. Daniel Chapman, Ph.D. in Ethnic Minority Populations Chair: SCR27-1. Utilizing Theatre to Modify Sarah Vinson, M.D. Darrel A. Regier, M.D., M.P.H. Stigma: A

165th Annual Meeting 153 SCR 28 Workshop 121 Presenter(s): Neisha A. D’Souza, M.D. 3:30 P.M. - 5:00 P.M. 3:30 P.M. - 5:00 P.M. Daniel S. Towns, D.O. Room 111B, Level 1 Room 102A, Level 1 Andrea J. Moore, M.D. Pennsylvania Convention Center Pennsylvania Convention Center Annette M. Matthews, M.D. Jennifer Creedon, M.D. Suicide Cognitive Therapy for Psychosis in Practice by Psychiatrists: Chair: Basic Techniques Workshop 125 Joseph Berger, M.D. 4 5 3:30 P.M. - 5:00 P.M. SCR28-1. Insomnia, Anxiety, and Room 111A, Level 1 Chairs: Suicidal Ideation Pennsylvania Convention Center Stephen B. Woolley, D.Sc., M.P.H. Shanaya Rathod, M.D. David G. Kingdon, M.D. 1 Integrating Psychiatric and General Medical Care: Military SCR28-2. Coping With Challenges of and Civilian Models Risk Assessment: Towards a New Workshop 122 APA Lifers Scale, SIS-MAP 3:30 P.M. - 5:00 P.M. Amresh Shrivastava, M.D. Room 102B, Level 1 Chairs: SCR28-3. Smoking and Suicidal Pennsylvania Convention Center Sheila Hafter Gray, M.D. Behavior in Patients With Stephen C. Scheiber, M.D. Cannabinoid and Opioid Schizophrenia Presenter(s): Jyoti Kanwar, M.D. Systems in Integrated Treatment for Pain and Substance Abuse Marcia K. Goin, M.D., Ph.D. 5 (Part One) Dennis Sarmiento, M.D. Scott Williams, M.D. 3 Charles C. Engel, M.D., M.P.H. Small Interactive Session Chair: Valerie J. Buyse, M.D. Lawrence K. Richards, M.D. Robert W. Johnson, M.D. Presenter(s): Small Interactive Session 17 Amanda Reiman, Ph.D., M.S.W. Workshop 126 3:30 P.M. - 5:00 P.M. Herbert D. Kleber, M.D. 3:30 P.M. - 5:00 P.M. Room 107A, Level 1 Jahan Marcu Room 112A, Level 1 Pennsylvania Convention Center Pennsylvania Convention Center Workshop 123 Psychological Effects of the Learning to Treat Patients With Long War: Strategies for 3:30 P.M. - 5:00 P.M. Self-Harm Behaviors: Two Mitigation Room 109A, Level 1 Models for Teaching DBT to 1 Pennsylvania Convention Center Psychiatry Residents Chair: The American Journal of 4 Elspeth C. Ritchie, M.D., M.P.H. Psychiatry Residents' Journal: Chairs: How to be involved Beth S. Brodsky, M.D., Ph.D. Deborah Cabaniss, M.D. Chair: Workshop Sarah M. Fayad, M.D. Presenter(s): Barbara H. Stanley, Ph.D. Presenter(s): Camille A. LaCroix, M.D. Robert Freedman, M.D. Workshop 120 Aerin M. Hyun, M.D., Ph.D. TUESDAY, MAY 8 Joseph Cerimele, M.D. Emily Gastelum, M.D. 3:30 P.M. - 5:00 P.M. Monifa Seawell, M.D. Room 101, Level 1 Pennsylvania Convention Center Workshop 127 Workshop 124 3:30 P.M. - 5:00 P.M. Developing a Career in Child 3:30 P.M. - 5:00 P.M. and Adolescent Psychiatry Room 112B, Level 1 Room 110B, Level 1 Pennsylvania Convention Center Pennsylvania Convention Center Chair: Ara Anspikian, M.D. Psychotherapeutic Strategies Bath Salts: Not Intended for for Countering Stigma: What Presenter(s): Human Consumption, Seriously! Social Neuroscience Can Teach William Arroyo, M.D. 3 Us Ledro Justice, M.D. Eric R. Williams, M.D. Chairs: 4 Sheryl Kataoka, M.D. Annette M. Matthews, M.D. Chair: Marcy J. Forgey, M.D., M.P.H. Neisha A. D’Souza, M.D. James L. Griffith, M.D.

154 www.psychiatry.org Workshop 128 3:30 P.M. - 5:00 P.M. Room 126B, Level 1 Now Available Pennsylvania Convention Center from the American Psychiatric Association Overcoming ‘Resistance’ in Treatment Resistant Schizophrenia 3 5 APA JobCentral Chair: The Career Hub for Psychiatry Vishal Madaan, M.D. Presenter(s): at Jayakrishna S. Madabushi, M.D. Durga Bestha, M.B.B.S jobs.psychiatry.org Thomas Cyriac, M.D.

Finding or lling a job in psychiatry is about to get a whole lot easier with 6:30 P.M. Sessions APA JobCentral: The Career Hub for Psychiatry! Manage Your Career: Mind Games • Search APA Job Central for psychiatry jobs by specialty, work setting, location to access relevant jobs. • Upload your anonymous resume, excluding name and identity, allows employers to search the resume database. When an employer fi nds a candidate of interest, the employer e-mails the candidate a Contact Request, allowing candidates to decide whether to release his/her contact information to the employer. Mind Games • Set up multiple Job Alerts specifying your skills, interests and location to receive an e-mail when an employer posts a job that matches your criteria. 6:30 P.M. - 8:30 P.M. • Create an account to save jobs, store multiple resumes and cover letter and more through an Grand Ballroom Salon G/H, Level 5 engaging interface. Pennsylvania Convention Center Recruit for Open Positions: Moderator: • Post your job in front of highly qualifi ed psychiatrists. • Increase visibility of your job posting through various enhanced features. Visit APA Job Central at the Glen O. Gabbard, M.D. • Cross promote your job listing in APA print publications, e-newsletters and APA Annual Meeting social networking platforms such as Facebook and Twitter. Teams: • Search the anonymous resume database to fi nd your ideal candidate. Located in the APA Member Center • Manage the activity of job postings and applicants. New York Presbyterian Hospital Philadelphia Convention Center (Cornell Campus) Program Visit APA JobCentral: The Career Hub for Psychiatry today at Exhibit Hall C, next to APP Bookstore jobs.psychiatry.org to nd your ideal job or post your job opening. University of Texas at Houston Program Hours: Saturday, May 5 New York Presbyterian Hospital 9:00 a.m. – 4:00 p.m. (Columbia Campus)/New York State Sunday–Tuesday, May 6 – 8 10:00 a.m. – 4:00 p.m. Psychiatric Institute 8 MAY TUESDAY,

165th Annual Meeting 155 Psychiatryw Online.org Your Destination for Lifelong Learning in Psychiatry

Visit the APP Bookstore for a demo! Your one-stop resource for information on diagnosis, treatment, guidelines, the latest research, and breaking news from the fi eld. From one single location users can access: ® ● DSM-IV-TR Library ● Books ● Practice Guidelines ● CME & Self-Assessments ● Journals: – American Journal of Psychiatry – Psychiatric Services – Journal of Neuropsychiatry and Clinical Neurosciences – Academic Psychiatry – FOCUS: The Lifelong Learning Journal in Psychiatry – Plus Psychiatric News Subscribe to products individually or to the DSM Select package that includes the DSM-IV-TR® library, books and journals.

Features of the new PsychiatryOnline platform include:

● A new mobile interface for smartphones. You can now read APP content on your mobile devices.

● Global search and browse options across books and journals.

● Tools that help you fi lter search results by title, type of content, topic and/or date.

● Customizable interface.

Subscribe at the APA Annual Meeting and Receive a 10% Discount!

Interested in an institutional subscription? Please contact us at [email protected] or call 1-800-368-5777 ext. 8538 or 703-907-8538 for more information and a subscription rate quote.

AH1225 Wednesday’s Program Wednesday’s Program This is for themain TOC. Keep on pasteboard with 2 points This is for theProgGuide TOC. Keep on pasteboard with 2 overlap into live area. points overlap into live area.

2012 ANNUAL MEETING

WEDNESDAY MAY 9

165th Annual Meeting 157 9:00 A.M. Sessions SCR30-3. Comorbidity of Mood and Substance Use Disorders ! Program changes are printed Scientific and Clinical Report in Patients With Binge-Eating each day in the Daily Bulletin Disorder: Associations With which can be picked up in the Personality Disorder and Eating Pennsylvania Convention Center. SCR 29 Pathology A mobile application will also be Daniel F. Becker, M.D. available. 9:00 A.M. - 10:30 A.M. Room 109B, Level 1 1 2 Pennsylvania Convention Center Workshop ! Obtain your Certificate of Treatment Effects and Side Attendance for the 2012 APA Effects Annual Meeting at www.psych. Workshop 129 org/AnnualMeetingCME Chair: Iqbal Ahmed, M.D. 9:00 A.M. - 10:30 A.M. SCR29-1. Assessment of Efficacy Room 101, Level 1 and Safety of Electroconvulsive Pennsylvania Convention Center Therapy for Child and Adolescent Chair: Patients With Severe Psychiatric Blogs and Tweets, Texting and Raymond F. Anton, M.D. Friending: Teaching About Illness Presenter(s): Professionalism and the Soonjo Hwang, M.D. Raymond F. Anton, M.D. Internet SCR29-2. Mortality of Neuroleptic Gregory Skipper, M.D. Malignant Syndrome Induced by Chair: Typical and Atypical Antipsychotics: Sandra M. DeJong, M.D. Workshop 132 Analysis From a Japanese Administrative Claims Database Presenter(s): 9:00 A.M. - 10:30 A.M. Mitsuhiro Nakamura, M.D. Sheldon Benjamin, M.D. Room 106A/B, Level 1 Joan M. Anzia, M.D. Pennsylvania Convention Center 3 Robert J. Boland, M.D. SCR29-3. Antidepressants and the Nadyah J. John, M.D. A Resident's Guide to Risk of Abnormal Bleeding During James Lomax, M.D. Borderline Personality Disorder: Spinal Surgery: A Case-Control Anthony L. Rostain, M.D., M.A. From the Experts (Part I of 2) Study (For Residents Only) Amirali Sayadipour, M.D. Workshop 130 2 3 9:00 A.M. - 10:30 A.M. Chairs: Room 102B, Level 1 Brian A. Palmer, M.D., M.P.H. SCR 30 Pennsylvania Convention Center John G. Gunderson, M.D. 9:00 A.M. - 10:30 A.M. "Don't Label Me!" Working With Presenter(s): Room 111B, Level 1 the Sexual Minority Adolescent John M. Oldham, M.D., M.S. Pennsylvania Convention Center and Their Families Kenneth R. Silk, M.D. Perry D. Hoffman, Ph.D. Treatment Issues in Personality James Hall Disorders Chairs: Cecil R. Webster, M.D. Pedro M. Bustamante, M.D. Chair: Workshop 133 Meera Vaswani, M.D. Presenter(s): 9:00 A.M. - 10:30 A.M. SCR30-1. Six-Month Outcomes Ayesha Mian, M.D. John A. Sargent, M.D. Room 107A, Level 1 of Dynamic Deconstructive Pennsylvania Convention Center Psychotherapy Versus Dialectical Behavior Therapy for Borderline PD Workshop 131 Roles for Psychiatrists in at a University Clinic Integrated Care Robert J. Gregory, M.D. 9:00 A.M. - 10:30 A.M. American Association of Community 2 4 Room 104A, Level 1 Psychiatrists Pennsylvania Convention Center SCR30-2. Personality Traits Plus Chair: Other Variables and the Effect on Biomarkers and Alcohol Use David A. Pollack, M.D. Placebo Response: A Naturalistic Disorders: Applications in Study Clinical Practice Presenter(s): Noshin Chowdhury, M.D. U.S. National Institute on Alcohol Abuse David A. Pollack, M.D. WEDNESDAY, MAY 9 3 and Alcoholism Lori Raney, M.D. Erik R. Vanderlip, M.D. 6

158 www.psychiatry.org Workshop 134 Presenter(s): 3. Attention Retraining as an Trimaine M. Brinkley, M.D. Adjunctive Treatment for 9:00 A.M. - 10:30 A.M. Ye B. Du, M.D., M.P.H. Posttraumatic Stress Disorder Room 109A, Level 1 Ifeanyi Izediuno, M.B.B.S Lauretta Ziajko, M.D. Pennsylvania Convention Center Keith Hermanstyne, M.D., M.P.H. 4. Transcranial Magnetic Stimulation Shana Gage, M.D. Anytime, Anywhere: How Web- for Posttraumatic Stress Disorder Rupinder K. Legha, M.D. Based EHRs Are Changing Donald Hurst, M.D. Psychiatric Practices Workshop 137 Chair: Symposium 104 Vatsal Thakkar, M.D. 9:00 A.M. - 10:30 A.M. 9:00 A.M. - 12:00 P.M. Presenter(s): Room 111A, Level 1 Room 103C, Level 1 Robert Rowley, M.D. Pennsylvania Convention Center Pennsylvania Convention Center

When Is Marijuana Use Genetics of Psychiatric Disease: Workshop 135 Egosyntonic? Current Progress and Future 9:00 A.M. - 10:30 A.M. 5 Goals Room 110A, Level 1 Chair: Chair: Pennsylvania Convention Center Thomas E. Brouette, M.D. Pamela Sklar, M.D., Ph.D. The Future of Psychiatry: The Presenter(s): 1. Overlapping Genetic Vulnerabilities Recovery Model and Severe Ryan Hashem, M.D. in Schizophrenia and Bipolar Mental Illness Disorder APA Council on Advocacy and Pamela Sklar, M.D., Ph.D. Workshop 138 Government Relations 2. Glutamate Signaling Abnormalities Chair: 9:00 A.M. - 10:30 A.M. in Autism and in Intellectual Robert P Cabaj, M.D. Room 112A, Level 1 Disability Pennsylvania Convention Center Joseph Buxbaum, Ph.D. Presenter(s): 3. Progress in ADHD Genetics Gary Tsai, M.D. Dynamic Therapy With Self- Benjamin Neale, Ph.D. Michelle Durham, M.D. Destructive Individuals With Elena F. Garcia-Aracena, M.D. BPD: An Alliance Based 4. Major Depression: An Emerging Intervention for Suicide Story Patrick Sullivan, M.D. Workshop 136 4 9:00 A.M. - 10:30 A.M. Chair: Symposium 105 Room 110B, Level 1 Eric M. Plakun, M.D. Pennsylvania Convention Center 9:00 A.M. - 12:00 P.M. Presenter(s): Donald E. Rosen, M.D. Room 107B, Level 1 The Challenges and Rewards Pennsylvania Convention Center of Building Resiliency in Minority and Underrepresented Symposium Evidence Based Integrative Psychiatry Trainees Therapies for Psychiatric APA/SAMHSA Minority Fellows Disorders Chairs: Symposium 103 1 4 Ashley K. Miller, M.D. 9:00 A.M. - 12:00 P.M. Chair: Kimberly Gordon, M.D. Room 103B, Level 1 Katherine Falk, M.D. Pennsylvania Convention Center Discussant(s):

! SESSION TRACKS 9 MAY WEDNESDAY, New Technology to Treat Scott Shannon, M.D. 1 Anxiety & Mood Disorders Posttraumatic Stress Disorder 1. An Integrative Approach to the 2 Personality Disorders Evaluation and Treatment of Sexual Chair: Dysfunction 3 Psychopharmacology Robert McLay, M.D., Ph.D. Barbara Bartlik, M.D. 4 Psychotherapy 1. Virtual Reality Goes to War: A Brief 2. Stress Management and Mind- 5 Schizophrenia and Review of the Future of Military Body Approaches to Mental Health Other Psychotic Disorders Behavioral Healthcare Problems Albert Rizzo, Ph.D. Sarah Williams, M.D. 6 NIAAA 2. Stellate Ganglion Block for the 3. Mood and Cognition Can Be 7 DSM-5 Treatment of PTSD Derailed by Commonplace Foods Anita H. Hickey, M.D. Richard M. Carlton, M.D.

165th Annual Meeting 159 4. Evidence-Based Integrative Discussant(s): 3. The Use of Telepsychiatry in Approaches in the Treatment of Carla Sharp, Ph.D. Clinical Trials Complex Posttraumatic Stress Janet B. Williams, D.S.W. 1. The Role of Temperament and Disorders 4. Telepsychiatry in a Military Setting Karen Hopenwasser, M.D. Maltreatment in the Emergence of Borderline and Antisocial and the Impact of BRAC 5. Emotional Freedom Technique Personality Pathology During Early Keith Penska, M.D. Anthony J. Tranguch, M.D., Ph.D. Adolescence 5. Recent Advances in Telepsychiatry Andrew M. Chanen, M.B.B.S., Ph.D. Sonya Lazarevic, M.D., M.S.W. Symposium 106 2. Neuroimaging Findings in Adolescent-Onset Borderline 9:00 A.M. - 12:00 P.M. Personality Disorder Symposium 109 Room 108A/B, Level 1 Erin A. Hazlett, Ph.D. Pennsylvania Convention Center 9:00 A.M. - 12:00 P.M. 3. Childhood Adversity Associated Room 120B, Level 1 Neuroendocrine and Gene- With Adolescent-Onset and Adult- Pennsylvania Convention Center Environment Interaction in Onset BPD Psychiatric Disorders: Current Mary C. Zanarini, Ed.D. Evidence-Based Clinical Care of Concepts Challenging Patients: An Update 4. Prospective Predictors of From Emergency Psychiatry 1 5 Adolescent Suicidality: A Six- Month Post-Hospitalization 4 Chairs: Follow-Up Amresh Shrivastava, M.D. Shirley Yen, Ph.D. Chairs: Charles B. Nemeroff, M.D., Ph.D. Scott A. Simpson, M.D., M.P.H. 5. Treatment Histories Reported Jagoda Pasic, M.D., Ph.D. 1. Identification of Genetic by Inpatients With Adolescent- Polymorphisms That Mediate 1. High Utilizer Case Management Onset and Adult-Onset Borderline the Increased Vulnerability to Focuses Resources and Decreases Personality Disorder Costs Mood and Anxiety Disorders After Marianne S. Goodman, M.D. Exposure to Child Abuse and Jagoda Pasic, M.D., Ph.D. Neglect 6. Childhood Adversity Associated 2. Reconsidering Illicit Drug Testing in With Adolescent-Onset and Adult- Charles B. Nemeroff, M.D., Ph.D. Emergency Psychiatry Onset BPD 2. HPA Axis Activity, Genetic David S. Kroll, M.D. Variation, and Psychosis in Major Mary C. Zanarini, Ed.D. Depression 3. Weathering the Storm: Alan F. Schatzberg, M.D. Psychotherapy in the Emergency Symposium 108 Setting 3. Region-Specific Alterations in the Anna McDowell, M.D. Corticotropin Releasing Factor 9:00 A.M. - 12:00 P.M. (CRF) in the Postmortem Brain of Room 120A, Level 1 4. Restraint and Seclusion: Suicide Victims Pennsylvania Convention Center Minimizing Use, Maximizing Ghanshyam N. Pandey, Ph.D. Safety, and Predicting Need Success Stories in Scott A. Simpson, M.D., M.P.H. 4. Neuroendocrines in First Episode Telepsychiatry: Medical Setting Schizophrenia Consultation, Transcultural Amresh Shrivastava, M.D. “Store and Forward”, Clinical Symposium 110 5. The Link Between Stress and Trials Research, and Military Depression at the Neurobiological Applications 9:00 A.M. - 12:00 P.M. and Cognitive Interface Room 120C, Level 1 Pennsylvania Convention Center Gustavo E. Tafet, M.D., Ph.D. Chairs: Sonya Lazarevic, M.D., M.S.W. Trichotillomania: Updates on Steven E. Hyler, M.D. Symposium 107 Phenomenology, Neurobiology, Discussant(s): and Treatments Across the 9:00 A.M. - 12:00 P.M. Steven E. Hyler, M.D. Lifespan Room 117, Level 1 APA Council on Children, Adolescents Pennsylvania Convention Center 1. Telepsychiatry to Medical Settings: Models and Guidelines for Primary and Their Families Adolescent-Onset Borderline Care Clinics and Emergency Rooms 3 4 7 Personality Disorder: Updates Donald M. Hilty, M.D. on Etiology, Phenomenology, Chair: 2. Cross-Cultural Psychiatry Melissa H. Rooney, M.D. and Treatment Utilization Made Simple: Asynchronous 2 Telepsychiatry as a Disruptive 1. An Overview of Trichotillomania: Innovation Phenomenology, Epidemiology,

WEDNESDAY, MAY 9 Chair: Peter Yellowlees, M.D. Comorbidities, and Impairment Marianne S. Goodman, M.D. Douglas W. Woods, Ph.D.

160 www.psychiatry.org 2. Neurobiology, Cognition, and Symposium 112 3. How Treatment for a Variety Psychopharmacologic Treatment of of Clinical Conditions Has Trichotillomania 9:00 A.M. - 12:00 P.M. Been Enhanced by Biomarker Jon E. Grant, M.D., J.D. Room 121B, Level 1 Assessments Pennsylvania Convention Center Dana E. Shaw, M.D. 3. Treatments for Trichotillomania Across the Developmental DSM-5 Personality Disorders 4. Clinical Applications Spectrum: An Empirical Update Over the Ocean: European Elizabeth Stuller, M.D. Martin E. Franklin, Ph.D. Perspectives on Treatment and 4. Pharmacological Treatments for Mental Health Care Symposium 114 Pediatric Trichotillomania 2 3 4 Michael H. Bloch, M.D. 9:00 A.M. - 12:00 P.M. Chairs: 5. Advances in Research and Updates Room 123, Level 1 Simone Kool, M.D., Ph.D. for DSM-5 Pennsylvania Convention Center Theo Ingenhoven, M.D., Ph.D. Eric Hollander, M.D. Discussant(s): New Insights in Treating R. Michael Bagby, Ph.D. Depressed Workers: Focus Symposium 111 on Early Identification and 1. Group Psychotherapy as Preferred Intervention 9:00 A.M. - 12:00 P.M. Treatment for Personality Room 121A, Level 1 Disorders: The Dutch Situation 1 3 4 Pennsylvania Convention Center Konstant Gielen, M.D. Chair: 2. Personality Disorders and Raymond W. Lam, M.D. Adolescent Substance Use Comorbidity: Diagnostic and Disorders: Clinical Updates and 1. Epidemiology of Depression and Clinical Issues and the Need for New Developments in Treatment Work Impairment Integrated Care APA Council on Children, Adolescents Scott Patten, M.D., Ph.D. Simone Kool, M.D., Ph.D. and Their Families 2. The Impact of Depression on 3. European Pharmacotherapy 3 Client Functional Outcomes in an Algorithms in Severe Personality Employee Assistance Program Disorders Chairs: Debra Wolinsky, M.Ed. Christopher J. Hammond, M.D. Theo Ingenhoven, M.D., Ph.D. 3. Work Productivity Gains With Oscar G. Bukstein, M.D., M.P.H. 4. The Management of Persistent Treatment of Depression: Suicidal Behavior in Personality Discussant(s): Benefits of Pharmacotherapy and Disorders Geetha Subramaniam, M.D. Psychotherapy Johannes B. van Luijn, M.S.C. 1. Pharmacotherapy of Comorbid Raymond W. Lam, M.D. 5. Psychiatric Management for Youth 4. Acceptability of Telephone- Personality Disorders the Frame of Jack R. Cornelius, M.D., M.P.H. Delivered Cognitive-Behavioural Treating Personality Disorders 2. N-Acetylcysteine as a Treatment for Therapy for Major Depression in Adrianus J. A. Kaasenbrood, M.D., the Worker Study Cannabis-Dependent Adolescents: Ph.D. Results From a Double-Blind Sagar V. Parikh, M.D. Randomized Controlled Trial Kevin M. Gray, M.D. Symposium 113 Symposium 115 3. Developing a Medication 9:00 A.M. - 12:00 P.M. Integration Protocol for Treatment Room 121C, Level 1 9:00 A.M. - 12:00 P.M. of Co-Occurring ADHD and SUD in Pennsylvania Convention Center Room 124, Level 1 Adolescents Pennsylvania Convention Center Aaron Hogue, Ph.D. Psychoneuroimmunology: Integration and Practical Recent Developments in 4. Clinical and Treatment Implications Cross-Cultural, Ethnic, and of Advances in Adolescent Application of an Emerging 9 MAY WEDNESDAY, Field in Medicine Ethnopsychopharmacological Addiction Research Aspects of Mood Disorders Paula D. Riggs, M.D., M.A. Chair: Sirid Kellermann, Ph.D., M.B.A. A Global Perspective ! APA 2012 Annual 1 3 Meeting On Demand 1. Pnei and Neuro-Immune Connections Chairs: • Special onsite pricing Sirid Kellermann, Ph.D., M.B.A. • Earn CME Credit for top Shamsah B. Sonawalla, M.D. lectures and symposia online 2. Neuro-Endo Connections and Albert Yeung, M.D., Sc.D. Biomarker Validity • For more information: 1. Ethnopsychopharmacology Update Kelly Olson, Ph.D. David C. Henderson, M.D.

165th Annual Meeting 161 2. Culturally Sensitive Collaborative Symposium 117 Workshop Treatment (CSCT) of Depressed Chinese Americans in Primary Care 9:00 A.M. - 12:00 P.M. Room 126B, Level 1 Albert Yeung, M.D., Sc.D. Workshop 139 Pennsylvania Convention Center 3. Depressive Disorders in the 11:00 A.M. - 12:30 P.M. Asian-Indian Population: Effects How to Succeed in Psychiatry: Room 101, Level 1 of Culture, Globalization and An International Early Career Pennsylvania Convention Center Ethnopsychopharmacology Psychiatrist Perspective Rajesh M. Parikh, M.D. 2011 Resident Supervision 4. Major Depressive Disorder With Chairs: Regulations: Are Trainees Atypical Psychotic Symptoms in Julian Beezhold, M.D. Hamstrung or Helped? Latinos Sarah Johnson, M.D. Paolo Cassano, M.D., Ph.D. 1. Towards a New Agenda for Early Chair: Mitchell J. M. Cohen, M.D. 5. Depression in Women: A Cultural Career Psychiatrists Perspective Andrea Fiorillo, Ph.D. Presenter(s): Shamsah B. Sonawalla, M.D. 2. Mental Health and Well-Being of Leah J. Dickstein, M.D., M.A. Early Career Psychiatrists Sheldon Benjamin, M.D. Robert Rohrbaugh, M.D. Nikolina Jovanovic, M.D., Ph.D. Symposium 116 Marika I. Wrzosek, M.D. 3. Setting Priorities for Young Career 9:00 A.M. - 12:00 P.M. Psychiatrists Room 125, Level 1 Joshua Blum, M.D. Workshop 140 Pennsylvania Convention Center 4. Medical Error, Complaints and 11:00 A.M. - 12:30 P.M. Severe Mood Dysregulation, Litigation Room 102B, Level 1 Bipolar, and Attention-Deficit/ Julian Beezhold, M.D. Pennsylvania Convention Center Hyperactivity Symptoms in Childhood: Symptom Overlap Army Psychiatrists in the and Diagnostic Confusion Combat Zone: Personal APA Council on Children, Adolescents 11:00 A.M. Sessions Experiences and Reflections and Their Families Scientific and Clinical Report Chair: 1 Elspeth C. Ritchie, M.D., M.P.H. Chair: SCR 31 Presenter(s): Steven P. Cuffe, M.D. Jerald J. Block, M.D. 11:00 A.M. - 12:30 P.M. Elspeth C. Ritchie, M.D., M.P.H. Discussant(s): Room 109B, Level 1 Robert R. Althoff, M.D., Ph.D. Pennsylvania Convention Center 1. Early Disruptive Disorders: Workshop 141 Trials of Specific Approaches to Comorbidity Guides Diagnostic and Treatment 11:00 A.M. - 12:30 P.M. Treatment Specificity Room 104A, Level 1 Jean M. Thomas, M.D. Chair: Pennsylvania Convention Center 2. Epidemiology and Evolution of Daniel Chapman, Ph.D. ADHD and Bipolar Symptoms: A Barriers to Seeking Treatment SCR31-1. Trials of Technology for Community-Based Study Among Geriatric Minority PTSD in Military Populations: Steven P. Cuffe, M.D. Populations With Mental Illness: Preliminary Results of Four Trials Examining Cultural Views 3. Differentiating Pediatric Robert McLay, M.D., Ph.D. Contributing to Disparities Bipolar Disorder and Severe 1 APA/SAMHSA Minority Fellows Mood Dysregulation Using SCR31-2. Results of a Feasibility Study Neurocognitive Data Chairs: Brendan A. Rich, Ph.D. of Culturally Adapted Cognitive Behaviour Therapy (CACBT) for Deina Nemiary, M.D., M.P.H. Psychosis in Ethnic Minority Kimberly Gordon, M.D. Groups Presenter(s): Shanaya Rathod, M.D. Nicole A. Zuber, M.D. All scientific sessions listed ! Ranjan Avasthi, M.D. in the Annual Meeting Program 4 5 Dorly Nerval, M.D. Book are designated for AMA SCR31-3. Planning Integrated Mental Steven Starks, M.D. PRA Category 1 Credits™, Health Homes: Understanding D. Anton Bland, M.D. except for New Research Poster Needs for Patients at Greatest Risk Mardoche Sidor, M.D. Sessions. WEDNESDAY, MAY 9 for Intensive Services Utilization Nicole V. Christian, M.D. Joyce C. West, Ph.D., M.P.P. Sarah A. Bougary, M.D.

162 www.psychiatry.org Workshop 142 Workshop 145 1:30 P.M. Sessions 11:00 A.M. - 12:30 P.M. 11:00 A.M. - 12:30 P.M. Room 106A/B, Level 1 Room 110A, Level 1 Workshop Pennsylvania Convention Center Pennsylvania Convention Center Workshop 149 A Resident's Guide to How to Be an Ethical Borderline Personality Disorder: Psychiatrist: Lessons Not 1:30 P.M. - 3:00 P.M. From the Experts (Part 2 of 2) Learned From the Movies Room 101, Level 1 Pennsylvania Convention Center 2 Chair: Mark S. Komrad, M.D. Chairs: Polyamory, an Emerging Brian A. Palmer, M.D., M.P.H. Presenter(s): Presenting Issue/Relationship John G. Gunderson, M.D. Mark S. Komrad, M.D. Orientation: What Do I Need to Know From Researchers and a Presenter(s): Clinical Specialist to Improve John M. Oldham, M.D., M.S. Workshop 146 Care? Kenneth R. Silk, M.D. Perry D. Hoffman, Ph.D. 11:00 A.M. - 12:30 P.M. Chair: James Hall Room 110B, Level 1 Bill Slaughter, M.D., M.A. Pennsylvania Convention Center Presenter(s): Workshop 143 Cognitive Behavior Therapy for Bill Slaughter, M.D., M.A. Personality Disorders Richard A. Sprott, Ph.D. 11:00 A.M. - 12:30 P.M. Elisabeth Sheff, Ph.D. Room 107A, Level 1 2 4 Pennsylvania Convention Center Chair: Judith S. Beck, Ph.D. Workshop 150 Integrating Care: Building a Partnership With Public 1:30 P.M. - 3:00 P.M. Room 102B, Level 1 Health, Primary Care, and the Workshop 147 Community to Prevent Suicide Pennsylvania Convention Center 11:00 A.M. - 12:30 P.M. 1 Room 111A, Level 1 Jim Crow Revisited: Mental Pennsylvania Convention Center Illness, Substance Use, and Chair: Disparities From the Cradle to Alex N. Sabo, M.D. Real World Implementation of the Prison Industrial Complex Presenter(s): Integrated Care Programs: Four Brenda A. Bahnson, M.S.W. Perspectives Chairs: Iqbal Rizwan, M.D. Annelle B. Primm, M.D., M.P.H. Chairs: Fred C. Osher, M.D. Anna Ratzliff, M.D., Ph.D. Workshop 144 Jurgen Unutzer, M.D., M.P.H. Presenter(s): John A. Sargent, M.D. 11:00 A.M. - 12:30 P.M. Presenter(s): Arthur L. Burnett Sr., J.D. Room 109A, Level 1 Anna Ratzliff, M.D., Ph.D. Cassandra F. Newkirk, M.D. Pennsylvania Convention Center Michael Lancaster, M.D. Michael A. Trangle, M.D. Multidisciplinary Perspectives Charles C. Engel, M.D., M.P.H. Workshop 151 on Care of the Elderly Patient 1:30 P.M. - 3:00 P.M. in a General Adult Inpatient Room 104A, Level 1 Psychiatry Unit Workshop 148 Pennsylvania Convention Center (For APA Members Only) 11:00 A.M. - 12:30 P.M.

Room 112A, Level 1 The Invisible Spectrum: The 9 MAY WEDNESDAY, Chair: Pennsylvania Convention Center Unspoken Struggles of a David C. Belmonte, M.D., M.S. Woman Psychiatrist as a Presenter(s): Transgender Mental Health "Special" Mom Jolene R. Bostwick, Pharm.D. Care: Teaching Cultural Ilze S. Hallman, M.S. Competency Chairs: Gloria Patterson, M.S.W. Meena Ramani, M.D. Cathy Demars, O.T. Chair: Jack Levine, M.B.A. Christopher Daley, M.D. Presenter(s): Presenter(s): Smita Bhatt, M.D. Willy Wilkinson, M.P.H. Begum Firdous, M.D. Paul M. Elizondo Vikram Dhillon, M.D. Susan Rankin, Ph.D. Raisa Yagudayeva, B.S.

165th Annual Meeting 163 Workshop 152 Workshop 155 Presenter(s): Jacob K. Tebes, Ph.D. 1:30 P.M. - 3:00 P.M. 1:30 P.M. - 3:00 P.M. Arthur C. Evans, Ph.D. Room 106A/B, Level 1 Room 110A, Level 1 Jane Golden, B.A., M.F.A. Pennsylvania Convention Center Pennsylvania Convention Center Samantha Matlin, Ph.D. Integrated Physical and Mental Hands Up: Psychiatrists in the Condition Case Management Crossfire of the Gun Debate in Workshop 159 America 1:30 P.M. - 3:00 P.M. Chair: APA Council on Psychiatry and Law Roger G. Kathol, M.D. Room 112B, Level 1 Pennsylvania Convention Center Chair: Presenter(s): Patricia R. Recupero, M.D., J.D. Roger G. Kathol, M.D. Decision Making Strategies in Cheri Lattimer, B.S.N. Presenter(s): Applied Ethics of Behavioral Lori Raney, M.D. Debra Pinals, M.D. Healthcare Marilyn Price, M.D. Chair: Workshop 153 Marna Barrett, Ph.D. Workshop 156 1:30 P.M. - 3:00 P.M. Room 107A, Level 1 1:30 P.M. - 3:00 P.M. Pennsylvania Convention Center Room 110B, Level 1 2:00 P.M. Sessions Pennsylvania Convention Center Intergenerational Differences Symposium in Self-Identification Among What I Wish I Knew When the Psychiatrists From Minority Disaster Struck and Underrepresented Groups: APA Committee on Psychiatric Symposium 118 Implications for APA Dimensions of Disasters 2:00 P.M. - 5:00 P.M. APA Council on Minority Mental Health Room 120A, Level 1 and Health Disparities Chair: Amelia K. Villagomez, M.D. Pennsylvania Convention Center Chair: Presenter(s): Spiritually Integrated Clinical Tanishia Choice, M.D. Joseph C. Napoli, M.D. Psychiatric Practice and Presenter(s): Catherine S. May, M.D. Psychotherapy Tanishia Choice, M.D. 4 Nicole M. King, M.D. Workshop 157 Kimberly Gordon, M.D. 1:30 P.M. - 3:00 P.M. Chairs: Ashley K. Miller, M.D. Peter J. Verhagen, M.D. Room 111A, Level 1 John Peteet, M.D. Pennsylvania Convention Center Workshop 154 1. Analyzing the Clinical Significance Research Literacy in Psychiatry of Spiritual/Anomalous 1:30 P.M. - 3:00 P.M. Experiences in the Clinical Setting Room 109A, Level 1 Chair: Alexander Moreira-Almeida, M.D., Pennsylvania Convention Center Diana E. Clarke, Ph.D., M.Sc. Ph.D. Psychiatric Comorbidities in Presenter(s): 2. Islamic Religious Experiences and Diana E. Clarke, Ph.D., M.Sc. Patients With Epilepsy Across Concepts in Clinical Psychiatric William E. Narrow, M.D., M.P.H. the Lifespan Practice S. Janet Kuramoto, Ph.D. Walid Y. Sarhan, M.D. Chairs: 3. Using Psychoanalytic Perspectives Tatiana Falcone, M.D. Workshop 158 to Help Patients Benefit From George E. Tesar, M.D. 1:30 P.M. - 3:00 P.M. Spiritual and Religious Resources Presenter(s): Room 112A, Level 1 James Lomax, M.D. George E. Tesar, M.D. Pennsylvania Convention Center 4. Spiritually Integrated Lara Jehi, M.D. Psychotherapy Marcy J. Forgey, M.D., M.P.H. Individual and Community John Peteet, M.D. Tatiana Falcone, M.D. Recovery and Transformation through Public Art: The Porch 5. Using Group Analytic Perspectives Light Initiative, A Mixed to Help Patients Discover Spiritual Methods Comparative Outcome Relationships Trial Peter J. Verhagen, M.D. WEDNESDAY, MAY 9 Chair: Jacob K. Tebes, Ph.D.

164 www.psychiatry.org Symposium 119 Symposium 121 SESSION TRACKS 2:00 P.M. - 5:00 P.M. 2:00 P.M. - 5:00 P.M. ! Room 120B, Level 1 Room 121A, Level 1 1 Anxiety & Mood Disorders Pennsylvania Convention Center Pennsylvania Convention Center 2 Personality Disorders Translational Research on Mood Alzheimer's Disease and Other 3 Psychopharmacology Disorders: A Primer for the Dementias: Hope Through the 4 Psychotherapy Clinician New Research 5 Schizophrenia and 1 1 3 4 Other Psychotic Disorders

Chair: Chairs: 6 NIAAA Jair C. Soares, M.D. Ruby C. Castilla-Puentes, M.D., D.P.H. Allitia DiBernardo, M.D. 7 DSM-5 1. Deconstructing Mood and Anxiety Disorders: Towards a Brain Discussant(s): Circuitry Imaging Classification Alejandra L. Leon, M.D. Yvette I. Sheline, M.D. Miguel E. Habeych, M.D., M.P.H. 2. Genetics of Bipolar and Unipolar 1. Apathy in the Demented Patient: ! Obtain your Certificate of Disorders Identification and Management Attendance for the 2012 APA Wade H Berrettini, M.D., Ph.D. Bernardo Ng, M.D. Annual Meeting at www.psych. org/AnnualMeetingCME 3. The Neurobiology of Children and 2. Novel Composite Endpoints Adolescents With and at Risk for for Improved Sensitivity in Mild Developing Bipolar Disorder Cognitive Impairment (MCI) Trials Melissa DelBello, M.D. Allitia DiBernardo, M.D. 4. Neuroimaging and Neurocognitive 3. Is It Dementia or Depression? Findings in Bipolar Disorder Alzheimer's Disease Versus 3. Variations in Quality of VHA Care Jair C. Soares, M.D. Depressive Pseudodementia for Mentally Ill Veterans 5. Mitochondria and Energy Jose L. Ayuso, M.D., Ph.D. Marcela Horvitz-Lennon, M.D., M.P.H. Metabolism in Mood Disorders and 4. Is Depression Different Among Their Treatment Patients With Alzheimer's Disease L. Trevor Young, M.D., Ph.D. and Vascular Dementia? Symposium 123 Ruby C. Castilla-Puentes, M.D., D.P.H. 2:00 P.M. - 5:00 P.M. Symposium 120 5. Management of Behavioral Room 121C, Level 1 Symptoms in Elderly People With Pennsylvania Convention Center 2:00 P.M. - 5:00 P.M. or Without Dementia Room 120C, Level 1 Carlos A. Leon-Andrade, M.D. Police Encounters With Pennsylvania Convention Center Individuals With Serious Mental Illnesses Psychosomatic Medicine: Topics Symposium 122 Across the Adult Lifespan 5 2:00 P.M. - 5:00 P.M. Chair: Room 121B, Level 1 Chair: Susan Hatters-Friedman, M.D. Pennsylvania Convention Center Michael T. Compton, M.D., M.P.H. 1. Principles of Perinatal Psychiatry The Cost and Quality of Care 1. The Crisis Intervention Team Model and Novel Treatment Options Beth Broussard, M.P.H. Susan Hatters-Friedman, M.D. Provided to Veterans With Mental Health and Substance 2. Use of Force in Police Interactions 2. Integrated Care Within Psycho- Use Disorders With Consumers Oncology Michael T. Compton, M.D., M.P.H. Isabel N. Schuermeyer, M.D. Chair: WEDNESDAY, MAY 9 MAY WEDNESDAY, 3. Getting to the Heart of the Matter Katherine E. Watkins, M.D. 3. Perceived Procedural Justice, Abhishek Jain, M.D. Harold A. Pincus, M.D. Emotional Experience and Cooperation/Resistance in 4. Delirium in the General Medical 1. The Quality of Care Provided to Encounters Between Police and Hospital: Recognition, Evaluation, Veterans With Substance Use Persons With Mental Illnesses and Treatment Disorders Amy C. Watson, Ph.D. Jeanne M. Lackamp, M.D. Katherine E. Watkins, M.D. 4. The Excited Delirium Syndrome 2. The Quality and Costs of Care James Roberts, M.D. Provided to Veterans With Mental Health Disorders Carrie M. Farmer, Ph.D.

165th Annual Meeting 165 Symposium 124 Symposium 125 3. Impact of SSRI Discontinuation Jon E. Grant, M.D., J.D. 2:00 P.M. - 5:00 P.M. 2:00 P.M. - 5:00 P.M. Room 123, Level 1 Room 126B, Level 1 4. Impact and Outcomes of Intensive Pennsylvania Convention Center Pennsylvania Convention Center Residential Treatment for Obsessive-Compulsive Disorder Saving Distressed Marriages: Long-Term Treatment and S. Evelyn Stewart, M.D. Psychiatric and Psychological Outcome of Obsessive- 5. Long-Term Outcome From Approaches to Improving Compulsive Disorder Cognitive Behavioral Therapy for Couples' Relationships 1 3 4 Obsessive-Compulsive Disorder 4 Helen B. Simpson, M.D., Ph.D. Chair: Chair: Jane Eisen, M.D. Scott D. Haltzman, M.D. Discussant(s): 1. Saving Distressed Marriages Wayne Goodman, M.D. Rita DeMaria, Ph.D. 1. Patterns of Remission and Relapse 2. Conjoint Focus, Individual in the Five-Year Course of OCD Approach Christina L. Boisseau, Ph.D. Brendan Greer, M.D., M.B.A. 2. The Impact of Depression on 3. Can Love Be Taught? Cognitive the Treatment of Obsessive and Behavioral Approaches to Compulsive Disorder: Results From Improving Marital Relationships a Five-Year Follow-Up Scott D. Haltzman, M.D. Patricia van Oppen, Ph.D.

American Psychiatric Association CALL FOR ABSTRACTS NEW SUBMISSION SITE FOR 2013! Don’t miss the opportunity to submit your proposed presentation for a symposium, workshop, course, and/or other scienti c session

Reena Young Bev Lloyd-Roberts WEDNESDAY, MAY 9 Visit our website on June 15th for further information regarding submissions. www.psychiatry.org/program

166 www.psychiatry.org Topic Index Topic Index This is for themain TOC. Keep on pasteboard with 2 points This is for theProgGuide TOC. Keep on pasteboard with 2 overlap into live area. points overlap into live area.

2012 ANNUAL MEETING TOPIC INDEX

Page # Page # 39 Neurobehavioral and Pharmacological Addiction Psychiatry/Substance Use Approaches to Target Cognitive Disorders Remediation in Drug-Addiction ...... 77 46 Innovative Substance Abuse Research Advances In Series Findings: What are the Barriers to Implemention? ...... 88 1 Advances in Addiction Psychopharmacology 67 55 Dysconnectivity of the Brain in Addiction and Pain ...... 90 Course 63 Double Trouble: Co-occurrence of Alcoholism and Psychiatric Disorders . . . 98 3 Office-Based Buprenorphine Treatment 83 Assessment of Substance Use of Opioid-Dependent Patients ...... 52 Disorder Patient Outcomes Based on 12 Motivation and Change: The Theory and Longitudinal Registry/EMR Data . . . . . 109 Practice of Motivational Interviewing . . . 69 91 Choosing the Right Treatment for 29 Street Drugs and Mental Disorders: Substance Abuse ...... 116 Overview and Treatment of Dual 111 Adolescent Substance Use Disorders: Diagnosis Patients ...... 84 Clinical Updates and New Developments in Treatment ...... 127 Forum Workshop 7 The Addiction Performance Project Presents Long Day’s Journey Into Night . . 110 3 Reefer Madness? The Role of Psychiatry in the Evolution of Marijuana as a Medical Treatment ...... 53 Lecture 8 Helping Patients Who Drink Too Much: 7 Musings on Decades of Progress in Using the NIAAA Clinician’s Guide . . . . 57 Alcoholism Treatment Research ...... 63 12 Addressing Addiction Among Women: A USA Perspective ...... 58 42 Management of Patients With Alcohol Seminar and Co-Occurring Disorders: Problems and Solutions ...... 74 1 Sexual Compulsivity and Addictions . . . . 52 60 What Psychiatrists Need to Know About Pain Management ...... 80 Symposium 72 Update on Screening and Brief Intervention (SBI): What we Know and 8 Integrating the Full Spectrum of Alcohol Don’t Know About SBI ...... 92 and Other Drug Problems in Psychiatric and Primary Care ...... 55 106 Extended Treatment for Alcohol Use Disorders: An Update ...... 112 10 Social Stress and Drug Addiction in Preclinical and Clinical Studies: Sex/ 124 Bath Salts: Not Intended for Human Gender Matters in Effects on Brain and Consumption, Seriously! ...... 120 Behavior and Treatment Implications . . . 61 131 Biomarkers and Alcohol Use Disorders: 34 A Comprehensive Model for Mental Applications in Clinical Practice . . . . . 124 Health Tobacco Recovery in New Jersey . . 76 137 When Is Marijuana Use Egosyntonic? . . . 125

165th Annual Meeting 167 TOPIC INDEX

Page # Page # Adjustment Disorders Small Interactive Session 14 Posttraumatic Stress Disorder Open Advances In Series Forum: Come Discuss PTSD With the Editors of the Recent Text ‘Clinical 4 Advances in Motivational Interviewing . . 96 Manual for Management of PTSD’ . . . . 112

AIDS & HIV Symposium 2 Scope, Current Evidence, and Innovative Approaches in Managing PTSD in the Scientific and Clinical Reports Military ...... 54 1-3 The Outpatient Clinic for HIV and 7 Spectrum Disorders: The Syndromal Mental Health: Patients’ Characteristics Overlap of Anxiety, Affective Symptoms, and Comparison With Homosexual Non- and Medical Comorbidity ...... 55 HIV Infected Patients ...... 52 54 Addressing the Mental Health Needs of Returning Service Personnel and Veterans . 89 Symposium 103 New Technology to Treat Posttraumatic Stress Disorder ...... 125 51 Impact of Psychiatric Disorder on HIV 125 Long-Term Treatment and Outcome of Management ...... 89 Obsessive-Compulsive Disorder . . . . . 132 65 Trauma, PTSD, and HIV: Psychodynamic and Educational Approaches to Workshop Adherence in a Community Medical Setting . 99 80 Update on HIV and AIDS Psychiatry . . . 109 140 Army Psychiatrists in the Combat Zone: 98 Comprehensive HIV Neuropsychiatry Personal Experiences and Reflections . . . 128 Update ...... 118 Attention Spectrum Disorders Anxiety Disorders Course Scientific and Clinical Reports 21 Essentials of Assessing and Treating 09-2 The Frequency of Comorbid Axis I Attention Deficit Hyperactivity Disorder Diagnosis in Social Anxiety Disorder Patients 74 in Adults and Children ...... 71 17-1 Is Posttraumatic Stress Disorder 26 Advanced Assessment and Treatment of Associated With Increased Risk of Attention Deficit Hyperactivity Disorder . . 84 Metabolic Syndrome Among Inpatients 42 ADHD in Adults - From Clinical With Mood Disorders? ...... 95 Research to Clinical Practice ...... 104 19-1 Relationship Between Plasma 45 Evidence Based Group and Individual Clomipramine Levels and OCD Psychosocial Treatments for Adult Symptoms in Adult Patients ...... 100 ADHD: Theory and Practice ...... 110 19-3 The Long-Term Treatment of Obsessive- Compulsive Disorder With SSRIs and Clomipramine With and Without Scientific and Clinical Reports Benzodiazepines ...... 100 2-1 Prevalence of ADHD and Comorbid 31-1 Trials of Technology for PTSD in Psychiatric Disorders in a Veterans Military Populations: Preliminary Administration Outpatient Clinic . . . . . 57 Results of Four Trials ...... 128

168 www.psychiatry.org Page # Page # 2-2 Adult Attention-Deficit/Hyperactivity 121 Cognitive Therapy for Psychosis in Disorder and Anxiety Disorders: Practice by Psychiatrists: Basic Techniques . 120 Prevalence in a Clinical Sample ...... 57 146 Cognitive Behavior Therapy for 2-3 Duration of Action of Lisdexamfetamine Personality Disorders ...... 129 Dimesylate in Children and Adolescents With Attention Deficit/Hyperactivity Disorder ...... 57 Behavior & Cognitive Therapies

Workshop

73 Integrative Group Therapy for Adult Patients With ADHD: How Can We Make It Effective? ...... 92 Workshop

80 High-Yield Cognitive Behavior Therapy Behavior & Cognitive Therapies for Brief Sessions ...... 96

Course Biological Psychiatry & Neuroscience 44 Cognitive-Behavior Therapy for Severe Mental Illness ...... 104 Course

9 Neuroanatomy of Emotions ...... 58 Lecture 4 Dialectical Behavior Therapy: Where It Lecture Started, Where It Went, Where It May Be Now, and Where Are We Going? . . . . 58 10 Resilience as a Dynamic Concept . . . . . 71

Master Course Scientific and Clinical Reports

3 Practical Cognitive Behavior Therapy . . . 71 03-1 Brain-Derived Neurotrophic Factor Moderates Effects of Job Stress on the Severity of Alcohol Drinking in Korean Scientific and Clinical Reports 20s Office Workers ...... 58 31-2 Results of a Feasibility Study of 03-3 Impaired Semantic Object Recall From Culturally Adapted Cognitive Behaviour Features in Schizophrenia and Bipolar Therapy (CACBT) for Psychosis in Ethnic Disorder ...... 59 Minority Groups ...... 128 11-3 The Effects of Triallelic Serotonin Transporter Gene and Stressful Life Events on Depression in Patients With Small Interactive Session Alcohol Dependence ...... 78 15 Meet the Author Session: Cognitive 18-1 FMRI Guidance Enhances Targeting of Behavior Therapy for Children and Transcranial Magnetic Stimulation (TMS) . 95 Adolescents ...... 112 Seminar

Workshop 4 Mind! Lessons From the Brain ...... 70 98 Cognitive Behavioral Strategies for Weight Loss ...... 106

165th Annual Meeting 169 TOPIC INDEX

Page # Page # Symposium Course

105 Evidence Based Integrative Therapies for 32 Autism Spectrum Disorders: Diagnostic Psychiatric Disorders ...... 125 Classification, Neurobiology, 106 Neuroendocrine and Gene-Environment Biopsychosocial Interventions, and Interaction in Psychiatric Disorders: Pharmacologic Management ...... 90 Current Concepts ...... 126 121 Alzheimer’s Disease and Other Forum Dementias: Hope Through the New Research 131 2 Alcohol Screening and Brief Intervention for Youth: The NIAAA Workshop Practitioner’s Guide ...... 56 30 Do Cognitive Psychology and Neuroscience Have Anything to Teach Lecture Us About Morality? ...... 67 62 Post-Mortem Approaches to Psychiatric 20 Does Psychodynamic Psychotherapy Neuropathology: Logistical, Legal, and Have a Future as a Psychotherapeutic Neuropathological Issues ...... 86 Modality? A Future Perspective on Past Outcomes ...... 104

Brain Imaging Master Course

5 Update on Pediatric Psychopharmacology . 110 Scientific and Clinical Reports 1-1 Contributory Effects of Childhood Scientific and Clinical Reports Trauma to White Matter Tract Injury in Human Immunodeficiency Virus in 01-2 Mental Health Outcomes for Orphans Infected and Uninfected Women . . . . . 52 by AIDS Compared to Orphans by Other 3-2 Significant Association Between IQ and Means ...... 52 Degree of Overall Cortical Gyrification . . . 58 16-1 Mental Health Interventions in Non- Psychiatric Settings: Examples From a Youth Clinic in Geneva, Switzerland . . . . 92 Symposium 17-2 Predictors of Monitoring of Metabolic 15 Pros and Cons of SPECT Brain Imaging: Parameters in Adolescents on Antipsychotics 95 What Is the Status of the Science? . . . . . 61 22-1 Intra-Familial Study of Pregnancy 22 The Contributions of Brain Imaging to Complications in Attention-Deficit/ the Study of Psychosis ...... 67 Hyperactivity Disorder ...... 104 29-1 Assessment of Efficacy and Safety of Electroconvulsive Therapy for Child and Adolescent Patients With Severe Child & Adolescent Psychiatry Psychiatric Illness ...... 124

Advances In Series Symposium

5 Advances in Child Psychopharmacology . . 106 3 Cross Cultural Issues in the Use of Psychotropic Medications in Children . . . 54 85 Psychosocial Treatments for Pediatric Bipolar Disorder: Improving the Prognosis Beyond Medications ...... 110 87 Controversies in Autism Spectrum Disorder: Separating Facts From Myths . . 116

170 www.psychiatry.org Page # Page # Workshop Symposium

14 Psychiatrist’s Response to Young Adult 1 One-Stop Psychiatric Shopping: How to Patients Who Have Had Inappropriate Integrate Medication and Psychotherapy or Abusive Care in Residential in Your Practice ...... 54 Treatment as Adolescents ...... 59 30 Medication Use for Treating Alcohol 29 The ABC’s of Applied Behavioral Analysis Dependence ...... 69 (ABA) for Autism and other Educational Interventions ...... 67 Workshop 40 Child Abuse in Children From Afro- Caribbean, Asian and Hispanic 48 The Art of Narrative Psychiatry: Households: What It Looks Like and Integrating the Values and Strategies How to Approach It ...... 74 of Narrative Psychotherapy With 113 Assessment of Suicidal Behavior in Psychiatric Practice ...... 75 Children and Adolescents ...... 114 120 Developing a Career in Child and Adolescent Psychiatry ...... 120 Computers, Technology, Internet & Related

Cognitive Disorders (Delirium, Dementia, etc.) Course 24 Exploring Technologies in Psychiatry . . . 84 Case Conferences

5 Dementia With Behavioral Disturbance . . 104 Lecture 2 Communicating Psychiatric Knowledge: Scientific and Clinical Reports From Kites to Kindle ...... 57

12-1 Event Related Potentials as a Biomarker for Alzheimer’s Disease: The Cognision Symposium ERP System ...... 79 49 Use of Technology for Research, Treatment, and Evaluation of Alcohol Dependence ...... 89 Combined Pharmacotherapy & Psychotherapy 60 Electronic Health Record Privacy Update . . 98 108 Success Stories in Telepsychiatry: Course Medical Setting Consultation, Transcultural “Store and Forward”, 23 Psychodynamic Psychopharmacology: Clinical Trials Research, and Military Applying Practical Psychodynamics to Applications ...... 126 Improve Pharmacologic Outcomes With Treatment Resistant Patients ...... 71 Workshop

Scientific and Clinical Reports 9 The Ethics of Patient-Targeted Googling . . 57 11 Electronic Health Records (EHRs): What 07-1 Do Psychopharmacologists Speak to to Look for When Selecting an EHR for Psychotherapists About Their Mutual Your Practice ...... 57 Patients? A Survey of Practicing Clinicians . 66 15 Computer-Assisted Cognitive-Behavior Therapy for Depression ...... 59 27 The Internet as a Weapon: Legal, Educational, and Psychiatric Perspectives on Cyberbullying ...... 67

165th Annual Meeting 171 TOPIC INDEX

Page # Page # 114 Psychiatrists and the New Media: Cross-Cultural & Minority Issues Gaining Control of Our Specialty’s Public Image ...... 115 Scientific and Clinical Reports

15-4 An introduction to Psymentology, a new Couple & Family Therapies Persian Ethnopsychiatric Method for the Treatment of Mentally ill Patients . . . 92 Course Symposium 36 Adult Sexual Love and Infidelity ...... 90 29 Promoting Resilience, Recovery, Social Symposium Inclusion, and Behavioral Health Equity: A Historical and Contemporary Profile 14 When Your Patient Is a Parent: of Philadelphia ...... 68 Supporting the Family and Addressing 53 The Black Community and Its LGBT Members 89 the Needs of Children ...... 61 64 Psychiatrists as Activists: On Being Part 43 Attachment Security and Its of the Solution ...... 98 Implications for Psychiatry ...... 78 89 Racial/Ethnic Minority Populations and 81 Improving Quality of Care for Patients the Social Determinants of Mental Health . 116 With Psychiatric Illness: Combining and 115 Recent Developments in Integrating Psychopharmacological, Cross-Cultural, Ethnic, and Individual, and Family Therapy ...... 109 Ethnopsychopharmacological Aspects of 124 Saving Distressed Marriages: Psychiatric Mood Disorders ...... 127 and Psychological Approaches to Improving Couples’ Relationships . . . . 132 Workshop Workshop 4 Prevention of Mental Health Sequelae: Evidence-Based Practices in Protection, 149 Polyamory, an Emerging Presenting Prevention, and Intervention in African- Issue/Relationship Orientation: What American Population ...... 53 Do I Need to Know From Researchers 19 Don’t You Want to Be a Real Doctor? and a Clinical Specialist to Improve Care? . 129 Overcoming Career Development Challenges Faced by Asian Americans in Psychiatry ...... 60 Creativity & the Arts 31 Incarceration of Black Females: Casualties and Collateral Damage From “the War on Drugs” and Other Forum Nonviolent Offences ...... 67 6 The Mind and Music of Beethoven . . . . . 93 34 Better Integration of International Medical Graduates in Psychiatry by Understanding Their Journey Through Workshop Application, Residency and Beyond . . . . 72 97 Incarceration of Black Males: The Effects 74 Virgins, Vixens and Vampires: The Art of of Untreated Bipolar, ADHD, and Edvard Munch ...... 92 Substance Abuse Disorders ...... 106 158 Individual and Community Recovery 118 Learning to Practice What We Preach: and Transformation through Public Translating Neurocognitive and Social Art: The Porch Light Initiative, A Mixed Psychological Studies of Racism and Methods Comparative Outcome Trial . . . 130 Sexism Into Our Everyday Practice . . . . 115

172 www.psychiatry.org Page # Page # 136 The Challenges and Rewards of Seminar Building Resiliency in Minority and Underrepresented Psychiatry Trainees . . 125 6 Seeing the Forest and the Trees: An 150 Jim Crow Revisited: Mental Illness, Approach to Biopsychosocial Formulation . 70 Substance Use, and Disparities From the 20 Performance of the Mental Status Cradle to the Prison Industrial Complex . . 129 Examination: Assessment of Frontal 153 Intergenerational Differences in Self- Cortical Functioning ...... 94 Identification Among Psychiatrists From 21 Understanding the Person Behind the Minority and Underrepresented Groups: Illness: An Approach to Psychodynamic Implications for APA ...... 130 Formulation ...... 104

Small Interactive Session Diagnostic Issues 11 APA Meet the Author Session — Laboratory Medicine: A Case-Based Advances In Medicine Discussion ...... 100 1 Medical Mysteries and Practical Med Psych Updates: Is It “Medical,” Symposium “Psychiatric” or a Little of Both…? . . . . . 75 6 Cardiac Arrhythmias in the Psychiatric 11 Field Trial Testing of Proposed Revisions Patient: What to Know and How to Treat? . 119 to DSM-5: Findings and Implications . . . 61 19 Philosophical and Pragmatic Problems for DSM-5 ...... 62 Course 21 The Future of Psychiatric Diagnosis: 15 Culturally Appropriate Assessment Updates on Proposed Diagnostic Revealed: The DSM-IV-TR Outline for Criteria for DSM-5 (Part I) ...... 67 Cultural Formulation Demonstrated 32 The Future of Psychiatric Diagnosis: With Videotaped Case Vignettes . . . . . 70 Updates on Proposed Diagnostic Criteria for DSM-5 (Part II) ...... 76 44 The Future of Psychiatric Diagnosis: Forum Updates on Proposed Diagnostic Criteria for DSM-5 (Part III) ...... 88 1 DSM-5: Research and Developmen . . . . 52 66 Complicated Grief and DSM-5: A Stress- Response Syndrome ...... 99 Lecture 116 Severe Mood Dysregulation, Bipolar, and Attention-Deficit/Hyperactivity 25 Can We Safely Deliver the DSM‑5 Into Symptoms in Childhood: Symptom the 21st Century? ...... 111 Overlap and Diagnostic Confusion . . . . 128 27 Glutamate, Dopamine, and Alcoholism: From Vulnerability to Treatment . . . . . 119 Dissociative Disorders Scientific and Clinical Reports

04-2 Diagnostic Stability of DSM-IV Clinical Scientific and Clinical Reports Diagnosis of Bipolar Disorder ...... 59 24-1 Frequency of Depression and Anxiety 13-1 The Course of Anxiety Disorders in in Dissociative Conversion Disorder Patients With Borderline Personality Patients Reporting at a Tertiary Care Disorder and Axis II Comparison Psychiatric Facility of Fauji Foundation . . 112 Subjects: A 10-Year Follow-Up Study . . . . 86

165th Annual Meeting 173 TOPIC INDEX

Page # Page # Eating Disorders Seminar 9 Counter-Intuitives in Medical Ethics . . . . 84 Lecture

18 The Persistent Enigma of Anorexia Nervosa 100 Symposium 62 Ethics and Medical Leadership ...... 98 Scientific and Clinical Reports 77 Moral Treatment to Recovery: The Ivy League Hospitals Look at Contemporary 30-3 Comorbidity of Mood and Substance Ethical Issues in Psychiatry ...... 108 Use Disorders in Patients With Binge- : Associations With Personality Disorder and Eating Pathology 124 Workshop

18 Clinical Wisdom in Psychotherapy: A Symposium Philosophical and Qualitative Report . . . 60 61 Ethics and Diagnosis: The 68 Integrated Treatment of Eating Medicalization of Predicaments ...... 80 Disorders: What to Ask and What to Do . . 99 75 Psychiatrists and Pharma: How Should They Interact? ...... 93 Workshop 107 Resolving Ethical Challenges and Promoting Mental Health Recovery . . . . 112 47 Evaluation and Treatment of the Complex Eating Disordered Patient . . . . 75 110 Ethical Dilemmas in Psychiatric Practice . 113 129 Blogs and Tweets, Texting and Friending: Teaching About Epidemiology Professionalism and the Internet . . . . . 124 145 How to Be an Ethical Psychiatrist: Lessons Not Learned From the Movies . . 129 Scientific and Clinical Reports 159 Decision Making Strategies in Applied Ethics of Behavioral Healthcare . . . . . 130 10-2 Characterization of Persons Receiving Primary Care Services in a Mental Health Clinic ...... 74 25-1 Epidemiology of Schizophrenia Patients Factitious Disorders Initiating Long-Acting Injectable Versus Oral Antipsychotics Among U.S. Workshop Medicare and Non-Medicare Populations . 114 29-2 Mortality of Neuroleptic Malignant 108 Great Performances: Malingering in Fiction 112 Syndrome Induced by Typical and Atypical Antipsychotics: Analysis From a Japanese Administrative Claims Database . 124 Forensic Psychiatry

Ethics & Human Rights Course 14 The Detection of Malingered Mental Illness . 70 Lecture 25 The Psychiatrist as Expert Witness . . . . 84 33 Can’t Work or Won’t Work? Psychiatric 8 The Criminalization of Mental Illness . . . 66 Disability Evaluations ...... 90 35 A Practical Approach to Risk Assessment . . 90 49 The Expert Witness in Psychiatric Malpractice Cases ...... 113

174 www.psychiatry.org Page # Page # Symposium Workshop

16 Forensic Psychiatry: Informing Clinical 20 Understanding Genetics: It’s Not Just Practice ...... 62 Mendelian Anymore ...... 64 75 Developments in Forensic Psychiatry in the United States and France: Vive La Difference! ...... 108 Geriatric Psychiatry 90 Assisted Outpatient Treatment for Persons With Severe Mental Illness: The Data and the Controversy ...... 116 Course 99 Updated Applications of Expert 13 Clinician’s Guide to Assessing and Psychiatric Testimony in Criminal Justice . 118 Managing Behavior Disturbances in Patients With Dementia With an Workshop Emphasis on Those With Moderate to Severe Symptoms ...... 69 88 Psychiatry in the Courts: Hot Issues . . . 102 16 Mood Disorders in Later Life ...... 70 117 Malpractice Defense: Strategies for Success 115 Presidential Symposium Gender Issues 4 Prevention in Geriatric Psychiatry . . . . 115

Workshop Scientific and Clinical Reports

103 Role of Gender and Culture in 12-2 The Interplay Between Neuroticism and Professional Psychiatry ...... 112 Atherosclerosis in Late-Life Depression Supports a Hypothesis of Vascular Apathy . 79 12-3 Olanzapine as a Rapidly and Strikingly Genetics Effective Augmenting Strategy for Antidepressant-Resistant Geriatric Outpatients With Major Depressive Disorder 79 Scientific and Clinical Reports

11-1 High Prevalence and Signficant Seminar Pharmacokinetic Implications of the 17 Psychiatric Consultation in Long-Term Cyp2c19 Gain-of-Function Allele *17 in Care: Advanced Seminar ...... 94 Psychotropic-Treated Patients ...... 78 16-3 A Retrospective Analysis of Healthcare Utilization in Psychiatric Outpatients Small Interactive Session in a Staff Model HMO: Applications of a Pharmacogenetic Algorithm ...... 92 8 Top 10 Geriatric Psychiatry Issues for the General Psychiatrists ...... 95 Symposium Workshop 74 Research Advances in Psychiatric Pharmacogenomics ...... 107 92 Prescribing Psychotropic Medication for 76 Genetic and Epigenetic Factors in Geriatric Patients: Pearls and Pitfalls . . . 102 Suicidal Behavior: Effects of Early and 93 Treating Behavioral Disturbances in Late Environmental Stressors ...... 108 Dementia in the Era of Black-Box Warnings 105 78 Personalized Medicine: An Update . . . . 108 104 Genetics of Psychiatric Disease: Current Progress and Future Goals ...... 125

165th Annual Meeting 175 TOPIC INDEX

Page # Page # 141 Barriers to Seeking Treatment Among Symposium Geriatric Minority Populations With Mental Illness: Examining Cultural 31 Current Models of Collaborative Care . . . 69 Views Contributing to Disparities . . . . 128 122 The Cost and Quality of Care Provided 144 Multidisciplinary Perspectives on Care to Veterans With Mental Health and of the Elderly Patient in a General Adult Substance Use Disorders ...... 131 Inpatient Psychiatry Unit ...... 129 Workshop

Global Psychiatry/International Issues 5 Workshop on Integration of Primary Care, Preventive Services, and Assertive Community Treatment Teams ...... 53 Scientific and Clinical Reports 79 The Metrics of Suicide ...... 95 16-2 New Zealand Mental Health: An 91 Using a Checklist to Characterize and American Perspective ...... 92 Impact Antipsychotic Prescribing Patterns: Data From and Implications of the New York State Office of Mental Symposium Health SHAPEMED Project ...... 102 115 From Utilization Analysis to Quality 42 Psychiatrists Working With the United Management in Mental Health Care Nations ...... 78 Research ...... 115 58 Integrating Primary Care, Mental Health, and Public Health: European and American Perspectives ...... 97 Historical Questions 88 Rapid Urbanization: Impact on Mental Health ...... 116 Lecture

Workshop 26 The Goodness of the Physician: From Hippocrates to Hi-Tech ...... 114 77 The Different Faces of Global Mental Health: Current Initiatives, Future Directions 93 Workshop Health Services Research 6 A Historical Overview of the Inception of Moral Treatment in Psychiatry . . . . . 53

Lecture Impulse Control Disorders 24 Value-Based Mental Health Care Delivery . 111

Presidential Symposium Symposium 27 Impulsivity and Behavioral 3 New Approaches to Integration of Dysinhibition Across Psychiatric Mental Health and Medical Health Services . 97 Disorders: Pathological Gambling, Personality Disorders, Suicide, and ADHD . 68 Scientific and Clinical Reports 110 Trichotillomania: Updates on Phenomenology, Neurobiology, and 14-2 The Impact of Hospitalists in Psychiatry . . 86 Treatments Across the Lifespan . . . . . 126 31-3 Planning Integrated Mental Health Homes: Understanding Needs for Patients at Greatest Risk for Intensive Services Utilization ...... 128

176 www.psychiatry.org Page # Page # Individual 138 Dynamic Therapy With Self-Destructive Individuals With BPD: An Alliance Based Intervention for Suicide ...... 125 Case Conference

2 Treating Complicated Grief ...... 73 Integrated Care

Course Forum 22 Davanloo’s Intensive Short-Term Dynamic Psychotherapy in Clinical Practice . 71 3 The Future Is Now: The Evolving Role of Psychiatry in the Integration of 38 Interpersonal Psychotherapy (IPT) . . . . 93 Behavioral Health and Primary Care . . . . 78 47 A Psychodynamic Approach to Treatment-Resistant Mood Disorders: Breaking Through Treatment-Resistance Seminar by Focusing on Comorbidity and Axis II . . 110 22 The Four Pillars of Healthcare Integration: Practice, Workforce, Scientific and Clinical Reports Payment and Policy ...... 113

15-3 The Clinical Relevance and Application of the Real Relationship in Patient Treatment 92 Symposium 23-3 Psychotherapy Practices of Psychiatrists 47 Inventing the Neck: Connecting Body, in the United States: Patterns, Trends, Mind, World From the Top Down and and Reported Barriers to Psychotherapy . . 112 the Bottom Up ...... 88

Seminar Intellectual and Developmental Disabilities 2 Evidence-Based Psychodynamic Therapy: A Clinician’s Guide ...... 52 13 Narrative Hypnosis for Psychiatry: Scientific and Clinical Reports Emphasis on Pain Management ...... 85 17-3 Monitoring Metabolic Side Effects of Atypical Antipsychotics in People With Small Interactive Session Intellectual Disability ...... 95

4 The Vitality of Psychodynamic Psychotherapy 74 Lesbian/Gay/Bisexual/Transgender Issues Symposium

61 The Psychotherapy of Hope: Back to Course the Future in Celebrating the 50th Anniversary of Persuasion and Healing . . . 98 19 A Developmental Approach to Contemporary Issues in Psychotherapy 84 Mentalizing: Current Core Concepts . . . 109 With Gay Men ...... 94

Workshop Media Workshop

53 Psychotherapy Update for the Practicing 1 The Celluloid Closet: A Documentary Psychiatrist ...... 79 About the Development of Gay Movie 65 Factors Affecting Provision of Characters and Its Relation to the Psychotherapy by American and Coming-Out Process ...... 54 Canadian Psychiatrists ...... 86

165th Annual Meeting 177 TOPIC INDEX

Page # Page # 5 Sixty-Five Years After World War II: A Mood Disorders Family Secret ...... 96

Case Conference Workshop 1 A Case of Bipolar Spectrum Depression . . 66 130 “Don’t Label Me!” Working With the Sexual Minority Adolescent and Their Families ...... 124 Course 148 Transgender Mental Health Care: Teaching Cultural Competency ...... 129 8 Melatonin and Light Treatment of SAD, Sleep and Other Body Clock Disorders . . . 58

Managed Care & Health Care Financing Lecture 1 Deep Brain Stimulation: Rethinking Scientific and Clinical Reports Depression and Its Treatment ...... 52 15 A Life in Moods ...... 91 14-3 Inpatient Psychiatric Care: Consequences of Short LOS ...... 86 17 Rethinking Bipolar Disorder: Where We’ve Been, Where We Are, Where We Need to Go ...... 95 Seminar

5 Best Financial Practices for Fiscally Media Workshop Solvent Delivery of Integrated Care . . . . 70 3 “Here One Day:” A Film About Bipolar Disorder and Suicide ...... 76 Symposium

9 Financing Sustainable Interdisciplinary Scientific and Clinical Reports Care in Psychiatric and General Medical Settings ...... 55 04-1 The Clinical Demographics of the Mayo Clinic Bipolar Disorder Biobank ...... 59 04-3 Should the Diagnostic Criteria for Workshop Bipolar Disorder Be Broadened?: Implications From Longitudinal Studies 89 The Mental Health Parity Act: Making it of Subthreshold Conditions ...... 59 Work for You and Your Patients . . . . . 102 04-4 Misuse of the Mood Disorders Questionnaire as a Case-Finding Measure and a Critique of the Concept Men’s Health Issues of Using a Screening Scale for Bipolar Disorder ...... 59 Workshop 05-1 Is Antidepressant Use in Bipolar Disorder Associated With Higher 39 Integrating Psychotherapy and Readmission Rates? ...... 63 Psychopharmacology: The Psychiatrist’s 05-2 Increased Life Events in Bipolar II Role in the Diagnosis and Treatment of Patients Participating in Bipolar Biobank . . 63 Sexual Dysfunction ...... 74 08-1 Why Do Some Depressed Outpatients Who Are in Remission According to the Hamilton Depression Rating Scale Not Consider Themselves to Be in Remission? . . . 72 08-2 Evaluation of Postpartum Depressive Disorders ...... 72

178 www.psychiatry.org Page # Page # 08-3 Light Treatment in African-American Neuropsychiatry Versus Caucasian Patients With Seasonal Affective Disorder ...... 72 09-3 Assessment of Mixed Depression in Course Bipolar Depression Utilizing a Modified Hypomania Checklist ...... 74 27 Advances in Neuropsychiatry: The Neuropsychiatry of Emotion and Its 18-2 Tai Chi Treatment for Depressed Disorders ...... 84 Chinese Americans: A Pilot Study . . . . . 95 37 Repetitive Head Injury in Sports and 20-1 Understanding Fatigue: The Complex Other Life Activities: A Psychiatric Relationship Between Depression and Sleep 100 Perspective: What to Know and How to Treat 93 27-1 Utilizing Theatre to Modify Stigma: A 50 Healthy Brain Aging: Evidence Based Knowledge Translation Study in Bipolar Methods to Preserve and Improve Brain Disorder ...... 119 Health ...... 113

Small Interactive Session Lecture

7 Treatment-Resistant Depression: 13 Why Should Psychiatrists Care About Clinical Guidelines for Treatment and Neuroscience ...... 85 Prevention ...... 92 22 Developmental Risk for Anxiety 16 TMS and ECT in Clinical Practice: Q & A . . 114 and Depression: A Translational Neuroscience Approach ...... 104 Symposium Scientific and Clinical Reports 25 Can Major Depression Be Prevented? New Insights From Basic and Clinical Studies 68 21-1 DCoE for Psychological Health and 26 Bipolar Disorder: State-of-the-Art Traumatic Brain Injury: Resources and Treatments ...... 68 Programs ...... 100 35 Integrative Psychiatry for Treatment of Mood and Anxiety Disorders Across the Life Cycle ...... 76 Seminar 50 Grief or Major Depression? That Is the 14 EEG in Psychiatry Practice ...... 94 Question ...... 89 95 Geriatric Bipolar Disorder: Pharmacotherapy of Late-Life Bipolar Mania 117 Symposium 96 Controversies in the Under Versus Over 59 Clinical Neuromodulation: What Every Diagnosis of Bipolar Disorder ...... 117 Clinician Needs to Know ...... 97 101 Obesity and Bipolar Disorder: Phenomenological Implications, Common Neurobiological Substrates, Workshop and the Effect of Bariatric Surgery . . . . 118 36 Mild Traumatic Brain Injury: 114 New Insights in Treating Depressed Assessment and Initial Management Workers: Focus on Early Identification With Neuropharmacology ...... 73 and Intervention ...... 127 101 Update on Movement Disorders: Clinical 119 Translational Research on Mood Features and Diagnosis ...... 106 Disorders: A Primer for the Clinician . . . 131 154 Psychiatric Comorbidities in Patients With Epilepsy Across the Lifespan . . . . 130 Workshop

111 TMS Beyond the FDA Label: Consensus Guidelines for Best Clinical Practice ...... 113

165th Annual Meeting 179 TOPIC INDEX

Page # Page # Other Somatic Therapies Workshop 26 Pain in the Nursing Home: A Mental Advances In Medicine Health Concern ...... 66

2 Top 10 Medical Articles of 2011: A Comprehensive and Practical Review of Patient Safety & Suicide What We Need to Know ...... 85

Course Scientific and Clinical Reports 28-1 Insomnia, Anxiety, and Suicidal Ideation . 120 1 Brain Stimulation Therapies in Psychiatry . 52 28-2 Coping With Challenges of Risk 5 Kundalini Yoga Meditation for Anxiety Assessment: Towards a New Scale, SIS-MAP 120 Disorders Including OCD, Depression, Attention Deficit Hyperactivity Disorder, and Posttraumatic Stress Disorder 56 Seminar 19 Kundalini Yoga Meditation Techniques for Schizophrenia, the Personality 8 Losing a Patient to Suicide ...... 70 Disorders, and Autism ...... 70 12 Emergency Psychiatry: Theory to Practice . 85 28 ECT Practice Update for the General Psychiatrist ...... 84 Workshop 48 Yoga of the East and West: Experiential Breath Work, Movement, and Meditation . 110 23 Responding to the Impact of Suicide on Clinicians ...... 64 Seminar 46 When Physicians Die by Suicide: What Can We Learn From Their Loved Ones? . . 75 18 Integrative Treatments for Cognitive 143 Integrating Care: Building a Partnership Enhancement, Traumatic Brain Injury, With Public Health, Primary Care, and ADHD, Sexual Enhancement, and Life- the Community to Prevent Suicide . . . . 129 Stage Issues for Men and Women . . . . . 94

Personality Disorders Pain Management Advances In Series Advances In Medicine 3 Advances in Mentalization Based Therapy . 87 3 Pain Medicine: An Evolving Field for Psychiatry ...... 91 Course Scientific and Clinical Reports 11 Mentalization Based Treatment for Borderline Personality Disorder: 20-2 A Correlation of the Psychosocial Introduction to Clinical Practice ...... 69 Distress Status and the Physical 40 Transference-Focused Psychotherapy for Performance of Individuals With Poly- Borderline Personality Disorder ...... 93 Trauma History: Two Years and Chronic Pain ...... 100 46 Systems Training for Emotional Predictability and Problem Solving 20-3 The Use of a Novel Multi-Coil (STEPPS) Treatment Program for RTMS Device for the Treatment Borderline Personality Disorder . . . . . 110 of Fibromyalgia Pain: Results of a Feasibility Study ...... 100 51 Good Psychiatric Management (GPM) for Borderline Personality Disorder: What Every Psychiatrist Should Know . . 113

180 www.psychiatry.org Page # Page # Lecture 17 STEPPS (Systems Training for Emotional Predictability and Problem 3 Understanding Patients With Borderline Solving): Treating Borderline Personality Personality Disorder ...... 58 Disorder in Diverse Settings Around the Globe ...... 62 Scientific and Clinical Reports 18 Narcissistic Personality Disorder in DSM-5: Impact on Research, Diagnosis, 06-1 Is Dimensional Scoring of Borderline and Treatment ...... 62 Personality Disorder Only Important for 20 New Paradigms for Investigating Subthreshold Levels of Severity? . . . . . 63 Relational Disturbances in Borderline 06-2 Distinguising Bipolar II and Borderline Personality Disorder ...... 62 Personality Disorder: A Review of 33 Clinical and Administrative Aspects of Current Literature ...... 64 the DSM-5 Personality Disorders . . . . . 76 06-3 Borderline Personality Disorder and 37 Neurobiological Mechanisms in Atypical Depression: Controversies and Borderline Personality Disorder ...... 77 Convergence ...... 64 38 Borderline Personality Disorder and 09-1 Patients With Intellectual Disability the Mood Disorders Spectrum: Co- and Personality Disorders: Closer to Morbidity, Confusion, and Controversy . . 77 Personality Disorders or Intellectual 69 Integrated Approaches to the Care of Disability? ...... 74 Patients With Borderline Personality Disorder 99 13-2 The Relationship Between Childhood 107 Adolescent-Onset Borderline Personality Adversity and Dysphoric Inner States Disorder: Updates on Etiology, Among Borderline Patients Followed Phenomenology, and Treatment Utilization 126 Prospectively for 10 Years ...... 86 112 DSM-5 Personality Disorders Over 13-3 Personality Trait Changes in Patients the Ocean: European Perspectives on With Borderline Personality Disorder Treatment and Mental Health Care . . . . 127 and Other Personality Disorders Over 16 Years ...... 86 30-1 Six-Month Outcomes of Dynamic Workshop Deconstructive Psychotherapy Versus Dialectical Behavior Therapy for 2 Management Strategies for Antisocial Borderline PD at a University Clinic . . . 124 Personality Disorders ...... 53 30-2 Personality Traits Plus Other Variables 45 Group Schema Therapy for Borderline and the Effect on Placebo Response: A Personality Disorder ...... 75 Naturalistic Study ...... 124 90 Collaborating for Change: Training Families to Become Clinical Allies so as to Improve BPD Treatment Outcomes . . 102 Small Interactive Session 132 A Resident’s Guide to Borderline Personality Disorder: From the Experts 5 Mentalizing in Mental Health Practice . . . 79 (Part I of 2) ...... 124 13 The Interplay of Love and Aggression . . . 105 142 A Resident’s Guide to Borderline Personality Disorder: From the Experts Symposium (Part 2 of 2) ...... 129

5 Personality Disorders: DSM-5 and Beyond . 54 6 The Long-Term Course of Borderline Personality Disorder: 16-Year Findings From the McLean Study of Adult Development ...... 55

165th Annual Meeting 181 TOPIC INDEX

Page # Page # Political Questions Professional & Personal Issues

Symposium Media Workshop

48 Psychiatry and the Role of Psychiatrists 2 Lucy Ozarin, M.D.: An Inspiring Life as Leaders in the Field of Medicine in of one who Continues on Her Path of Terms of Health Policy and the Changes Learning and Giving ...... 60 in Health Care Delivery ...... 88 Scientific and Clinical Reports Workshop 23-1 Burnout Among Psychiatrists and 52 Public Law 111-148 (The Patient Pediatricians at LAC and USC Medical Protection and Affordable Care Act) Is Center ...... 111 Deeply Flawed and Should Be Repealed: Views From the Left and the Right . . . . 79 Seminar 155 Hands Up: Psychiatrists in the Crossfire of the Gun Debate in America ...... 130 7 Writing, Blogging, and Podcasting About Psychiatry for the Public: A Guide for the Perplexed ...... 70 Practice Management 10 Treating Medical Students and Physicians . 84

Course Small Interactive Session

17 Current Procedural Terminology Coding 6 APA Meet the Author Session— Women and Documentation ...... 70 in Psychiatry: Personal Perspectives . . . . 86 41 Intermediate CPT Coding: Evaluation and Management (E/M) Codes in Depth . . . . 93 Symposium

Scientific and Clinical Reports 117 How to Succeed in Psychiatry: An International Early Career Psychiatrist 10-1 Improving Access and Efficient Care for Perspective ...... 128 Patients With Psychiatric Illnesses in an Academic Teaching Medical Center . . . . 74 Workshop

Workshop 21 Children of Psychiatrists ...... 64 25 Joining the Ranks of Military Psychiatry 33 Quality Improvement: What It Means as a Civilian Contractor: Lessons Learned . 64 for Psychiatrists ...... 72 44 How Does She Do It All? Balancing 49 CPT Coding and Documentation Update . . 75 Family, Life, and Career ...... 74 58 Legal, Risk, and Ethical Considerations 69 American Board of Psychiatry and in the Age of Technology and Online Neurology Update: Certification in Social Networking ...... 80 Psychiatry and Its Subspecialties . . . . . 87 134 Anytime, Anywhere: How Web-Based 83 “Maybe You Should See Someone…”: EHRs Are Changing Psychiatric Practices . 125 The Challenges of Referring Resident Colleagues to Mental Health and Substance Abuse Treatment ...... 96 87 Successful Career Planning for Women . . 102 96 Medi-Medi: A Ghost Story ...... 106

182 www.psychiatry.org Page # Page # 105 The Cobbler’s Children: Dealing With Master Course Mental Illness in Our Own Families . . . 112 119 ABPN and APA Perspectives on 1 2012 Psychiatry Review ...... 56 Maintenance of Certification ...... 115 151 The Invisible Spectrum: The Unspoken Presidential Symposium Struggles of a Woman Psychiatrist as a “Special” Mom ...... 129 1 Teaching Psychodynamic Psychiatry in the 21st Century ...... 60

Psychiatric Administration & Services: Seminar Public, Private & University 3 The International Medical Graduate Insitute 56 16 How to Give a More Effective Lecture: Course Punch, Passion, and Polish ...... 94 7 Basic Concepts in Administrative Psychiatry I ...... 56 Symposium 20 Basic Concepts in Administrative Psychiatry II ...... 71 41 The Widening Scope of Psychodynamic Psychiatry ...... 77 82 Integrated Care and the Future of Scientific and Clinical Reports Psychiatry: Teaching Psychiatry Residents and Fellows to Work at the 07-2 Assessing the Practices and Perceptions Interface of Mental Health and Primary of Dually-Trained Physicians: A Pilot Study . 66 Care ...... 109

Workshop Workshop

32 Psychiatrist Workforce Shortage: 43 Writing for the Lay Public: Pointers Challenges and Solutions ...... 72 From a Psychiatrist Writer, Investigative 63 Waste in Psychiatry: An Overview of the Journalist, and the Trainee Perspective . . 74 Problem and Some Suggested Solutions . . 86 64 True Integrated Care: The Role of 67 Transformational Leadership to Improve Combined Training in Family-Medicine Mental Health Care Delivery in Minority Psychiatry and Internal Medicine and Underserved Populations ...... 87 Psychiatry in the Era of Integration . . . . 86 112 Small, Medium, or Large? A Panel 66 Addressing Mental Health Care Discussion With Psychiatrists From Disparities Through Interdisciplinary Three College Campuses ...... 114 Training in Integrated Health Care, 125 Integrating Psychiatric and General Cultural Competence, and Family Systems . 87 Medical Care: Military and Civilian Models 120 116 Lost in Translation: Taking Cultural 133 Roles for Psychiatrists in Integrated Care . 124 Sensitivity From Theory to the Bedside . . . . 115

Psychiatric Education Psychiatric Rehabilitation

Lecture Seminar

11 My Interest and Experience in Working 11 Recovery: How to Transform Your with International Medical Graduates [IMGs] 73 Clinical Practice Effectively and Efficiently . 84 23 Basic Sciences and Interviewing Skills: Educational Conundrums? ...... 110

165th Annual Meeting 183 TOPIC INDEX

Page # Page # Symposium Small Interactive Session

13 Time-Limited Psychotherapy for Cancer: 2 Meet the Author of the Evidence-Based From Diagnosis to Remission or End of Life 61 Guide to Antidepressant Medications . . . 66

Workshop Workshop

70 DSM-5 and the Prisons ...... 92 16 2012 Revision of the Schizophrenia Psychopharmacology Algorithm From the Harvard South Shore Psychiatry Program 60 55 The Sigma Enigma: The Role of Sigma Receptors in the Current Practice of Psychopharmacology ...... 79 81 Antipsychotics in the Medically Ill . . . . . 96 99 Brief Psychotherapeutic Strategies to Enhance Psychopharmacological Treatments 106 122 Cannabinoid and Opioid Systems in Integrated Treatment for Pain and Substance Abuse (Part One) ...... 120 Psychoanalysis 128 Overcoming ‘Resistance’ in Treatment Resistant Schizophrenia ...... 121 Scientific and Clinical Reports 15-2 Adolescence and the Reorganization Psychosomatic Medicine of Infant Development: a Neuro- Psychoanalytic Model ...... 92 Advances In Medicine Psychoimmunology 4 Advances in Medicine: Palliative Medicine . 94

Symposium Case Conferences 3 “Doctor, Would You Please Kill Me?”: 113 Psychoneuroimmunology: Integration What Are the Boundaries of Self- and Practical Application of an Emerging Determination and Suicide? ...... 85 Field in Medicine ...... 127

Course Psychopharmacology 4 Integrating Behavioral Health and Primary Care: Practical Skills for the Course Consultant Team Psychiatrist ...... 56 6 Neuropsychiatric Masquerades: Medical 4 Essential Psychopharmacology ...... 90 and Neurological Disorders That Present 18 Treatment of Schizophrenia ...... 70 With Psychiatric Symptoms ...... 56

Scientific and Clinical Reports Scientific and Clinical Reports

22-2 Antipsychotics During Pregnancy: 07-3 Characteristics of Patients Enrolled in Relation to Fetal and Maternal a Collaborative Care Pilot for Patients Metabolic Effects ...... 105 With Chronic Medical Illness and Depression and/ or Harmful Drinking . . . 66

184 www.psychiatry.org Page # Page # 24-2 The Relationship of Health Anxiety Scientific and Clinical Reports to State Anxiety, Depression, Somatic Symptom Burden, and Disability in a 18-3 Healing the Mind: The Role of Tertiary Psychosomatic Medicine Population 112 Spirituality in Depression ...... 95 24-3 Developing an Emergency Psychiatry Consultation Sevice Within a C-L Symposium Program: Impact and Change ...... 112 118 Spiritually Integrated Clinical Psychiatric Practice and Psychotherapy . . 130 Symposium

56 Mythbusters: Untangling Psychiatric Myths From Truths ...... 97 Research Issues 86 Psychiatry and Cancer Update ...... 115 109 Evidence-Based Clinical Care of Advances In Research Challenging Patients: An Update From Emergency Psychiatry ...... 126 1 Advances in Research ...... 87 120 Psychosomatic Medicine: Topics Across the Adult Lifespan ...... 131 Lecture

Workshop 28 Translational Studies of Preconscious Inhibition: What We’ve Learned in the 10 Health Care Reform and Psychiatry Blink of an eye ...... 119 Training for Primary Care Physicians: What to Teach, How to Teach, Where to Teach 57 Scientific and Clinical Reports 51 Psychiatric Factors in Bariatric Surgery: Assessment and Beyond ...... 79 29-3 Antidepressants and the Risk of 76 Medical Conditions Mimicking Abnormal Bleeding During Spinal Psychiatric Disorders Versus Psychiatric Surgery: A Case-Control Study ...... 124 Disorders Mimicking Medical Conditions - Diagnostic and Treatment Challenges ...... 93 Workshop 95 Primary Care Behavioral Health 157 Research Literacy in Psychiatry . . . . . 130 Integration: Roles of the Key Team Members 106 102 A Tale of Two Specialities: The Integration of Oncology and Psychiatry . . 106 Resident & Medical Student Concerns 104 A Primer on Psychotherapy in the Medically Ill ...... 112 147 Real World Implementation of Symposium Integrated Care Programs: Four Perspectives 129 24 Patient Suicide in Residency Training . . . 68 28 First Annual Member in Training/ Early Religion, Spirituality, & Psychiatry Career Psychiatrist Leadership Forum . . . 68

Workshop Lecture 17 Promoting Emotional and Physical 14 The Chariot and the Couch: Western Safety During Residency: Being Psychotherapeutic Models and Eastern Prepared for Life Threatening Emergencies . 60 Insights ...... 86 24 Making the Most of Your Chief Year: Chief Residents’ Forum I ...... 64

165th Annual Meeting 185 TOPIC INDEX

Page # Page # 38 A Resident Leader’s Tool Kit ...... 73 26-2 Clinical Deficits Underlying the Denial 56 Making the Most of Your Chief Year: of Aggression and Symptoms in Patients Chief Residents’ Forum II ...... 80 With Schizophrenia Randomized to Clozapine, Olanzapine, and Haloperidol . . 114 68 Transition to Practice and Transitions in Practice: A Workshop for Members- 26-3 Primary Polydipsia in a Chronic In-Training (MITs) and Early Career Psychiatric Outpatient Population . . . . 114 Psychiatrists (ECPs) ...... 87 28-3 Smoking and Suicidal Behavior in 123 The American Journal of Psychiatry Patients With Schizophrenia ...... 120 Residents’ Journal: How to be involved . . 120 126 Learning to Treat Patients With Self- Symposium Harm Behaviors: Two Models for Teaching DBT to Psychiatry Residents . . 120 23 Advances in the Assessment and 139 2011 Resident Supervision Regulations: Treatment of Negative Symptoms of Are Trainees Hamstrung or Helped? . . . 128 Schizophrenia 68 36 Characterization and Treatment of Early Schizophrenia & Other Psychotic Disorders Stages of Schizophrenia ...... 77 45 Schizophrenia and Bipolar Disorder Spectrum: New Findings and Clinical Case Conferences Implications ...... 88 4 Early Intervention and Continuity of 57 Beyond DSM-5: Shifting Paradigms in Care for the Early-Stage Schizophrenic Person 94 Schizophrenia ...... 97

Lecture Workshop

6 Schizophrenia as a Learning and 54 Bedlam Revisited: Society, Psychiatry, Memory Disorder ...... 63 and Severely Mentally Ill Individuals . . . . 79 16 Mice, Men, and Mental Illness: Animal Models of Cognitive and Negative Symptoms of Schizophrena ...... 91 Sleep Disorders

Scientific and Clinical Reports Advances In Medicine

11-2 Toxoplasma Gondii Antibody Titers and 5 Update on Sleep Disorders: What’s New History of Suicide Attempts in Patients Under the Moon ...... 113 With Schizophrenia ...... 78 15-1 Challenges in the Treatment of a Scientific and Clinical Reports Physician Patient With Psychosis . . . . . 92 25-2 Glycine Reuptake Inhibitor (GRI) 21-2 Sleep Dysfunction: the TBI and Enhances NMDA Receptor Activity: A Psychological Health Co-occurring Novel Approach to the Treatment of Disorders Dilema ...... 100 Schizophrenia ...... 114 25-3 Metformin for Treatment of Antipsychotic-Induced Amenorrhea Workshop and Weight Gain in Female Patients 1 Update on Parasomnias: a Review for With First-Episode Schizophrenia: A Psychiatric Practice ...... 53 Randomized, Double Blind Study . . . . . 114 57 Evaluation and Management of Patients With Excessive Daytime Sleepiness in Psychiatric Practice ...... 80

186 www.psychiatry.org Page # Page # Social & Community Psychiatry 22 Promoting Improved Integration: The Role of Collaborative Health Care in Today’s Society ...... 64 Forum 28 CBASP, an Evidence-Based Psychotherapy for the Treatment of the 5 Witness to an Extreme Century ...... 91 Chronically Depressed Patient ...... 67 50 A Terrible Melancholy: Depression in Lecture the Legal Profession ...... 75 86 Discharged to Shelter: The Theory and 5 Teaching Illness Self-Management to Practice of Homeless Psychiatry . . . . . 100 Improve the Integration of Care among 94 Building Resilience: Responding to Hispanics ...... 58 College Student Mental Health Needs . . . 105 109 Strengthening Resilience and Media Workshop Developing Posttraumatic Growth in Children, Adults, and Communities 4 Beginners: Conundrums of Human Following Disasters ...... 113 Bonding, Young and Old, LGBT, and 135 The Future of Psychiatry: The Recovery Otherwise ...... 88 Model and Severe Mental Illness . . . . . 125

Scientific and Clinical Reports Somatoform Disorders 23-2 Learning From a Case-Based Workshop for Interprofessional Audience ...... 111 Symposium

Seminar 92 Update on Body Dysmorphic Disorder . . 117 15 Integrating Mental Health Services 100 Somatic Symptom Disorders: Within Primary Care Setting: Effective Treatments That Work ...... 118 Strategies and Practical Tips ...... 94 Stigma/Advocacy Symposium

4 A Primer on Prevention in Psychiatry . . . 54 Scientific and Clinical Reports 40 Integrated Psychiatry: Primary Care Services in Houston, Texas ...... 77 27-2 Quantification of Stigma for Clinical 79 American Psychiatry and Human Rights Assessment: A Paradigm Shift in Anti- in the 21st Century: Services to Special Stigma Intervention ...... 119 Populations ...... 108 27-3 Cyberspace: A Frontier for Confronting 93 There Is No Such Thing as a “Med Check” . 117 Mental Health Stigma in Ethnic Minority Populations ...... 119 97 American Psychiatry and Human Rights in the 21st Century: The Clinical Process . 117 123 Police Encounters With Individuals With Workshop Serious Mental Illnesses ...... 131 78 Advocating for Your Patients in an Era of Health Care Reform ...... 95 Workshop 127 Psychotherapeutic Strategies for Countering Stigma: What Social 7 Training for the Future: Addressing Neuroscience Can Teach Us ...... 120 Community Psychiatry Workforce Shortages and Health Care Reform Through Resident Training in Public Psychiatry ...... 53

165th Annual Meeting 187 TOPIC INDEX

Page # Page # Stress 100 Bootcamp for Burnout: Strategies to Promote Resilience and Wellness for Psychiatrists ...... 106 Advances In Series

2 Advances in Posttraumatic Stress Disorder . 75 Treatment Techniques & Outcome Studies

Course Scientific and Clinical Reports 10 Mindfulness: Practical Applications for Psychiatry ...... 69 10-3 National Telemental Health Outcomes in 98,609 Patients ...... 74 26-1 Drug Compliance and Associated Forum Outcomes in Schizophrenia Patients Before and After the Initiation of Depot 4 Combat-Related PTSD: Injury or Disorder? . 85 Antipsychotic Agents ...... 114

Media Workshop Small Interactive Session

7 “Unmourned Loss in Saraband”: Ingmar 3 Implementing Interpersonal and Social Bergman’s Last Film ...... 102 Rhythm Therapy Across a Range of Clinical Settings ...... 72 Presidential Symposium 9 Maximizing the Treatment Response for Depression ...... 95 2 Mindfulness-Based Practices in the Treatment of Stress and Psychiatric Illness . 60 Workshop

Small Interactive Session 82 Applying Recovery and Trauma- Informed Care Principles to an Inpatient 12 Sports Psychiatry: Strategies for Life Psychiatric Setting ...... 96 Balance & Peak Performance (MTA) . . . 105 84 Treatment of PTSD and Depression in DOD: Taking Lessons Learned from Symposium the Trenches into Your Practice and the Community ...... 96 12 Rebound and Recovery in the Athlete . . . 61 152 Integrated Physical and Mental 67 Updates on Screening and Treatment of Condition Case Management ...... 130 the Psychological Effects of the Wars in Iraq and Afghanistan ...... 99 Violence, Trauma & Victimization Workshop Case Conferences 13 Evidence-Based Integrative Treatments for Anxiety, Depression, and Trauma in 6 PTSD and the US Soldier Today . . . . . 113 Mass Disasters ...... 58 37 Mindfulness for the Next Generation: The Koru Program for Teaching Course Mindfulness and Meditation to 2 How to Detect, Prevent, and Treat University Students and Other Bullying Related Morbidity Along the Emerging Adults ...... 73 Lifespan ...... 52 31 Disaster Psychiatry ...... 84

188 www.psychiatry.org Page # Page # 34 Trauma-Informed Care: Principles and Workshop Implementation ...... 90 43 Risk Assessment for Violence ...... 104 35 Psychiatry on the Forefront: Increasing Access to Care in the Disaster Setting . . . 73 41 Prevention of Harm From Stalking . . . . 74 Lecture 85 Bullying: Prevention and Intervention: An Overview ...... 96 12 Workplace Violence in Mental and General Healthcare Settings: 156 What I Wish I Knew When the Disaster Development and Concepts ...... 78 Struck ...... 130

Media Workshop Women’s Health Issues 6 Sixty-Five Years After World War II: A Family Secret ...... 96 Course 8 The Cycle of Inner-City Violence in Bunuel’s Los Olvidados ...... 107 39 Management of Psychiatric Disorders in Pregnant and Postpartum Women . . . . . 93 Scientific and Clinical Reports Lecture 14-1 Clinical and Demographic Profile of Repeatedly Violent Patients in an 9 Perinatal Psychiatry: Reflections Over Acute : a One-Year Three Decades of Research ...... 71 Retrospective Study ...... 86 19-2 Prevalence of Stalking in General Medical Practice ...... 100 Scientific and Clinical Reports 22-3 Does New Jersey’s Screening Law Small Interactive Session Increase the Detection of Postpartum Depression? ...... 105 1 Sports Psychiatry: Helping Teams Manage Suicide and Sudden Death in Athletes ...... 66 Symposium 10 What Is Bullying and Why Is It Such a 52 Fundamentals of the Perinatal Problem in Schools, Workplaces, and Psychiatric Consultation ...... 89 Home Posing as Domestic Violence . . . . 100 71 Updates on Reproductive Issues in 17 Small Interactive Session 17 ...... 120 Women’s Mental Health ...... 107 94 Reclaiming the Role of Motherhood for Symposium Women With Serious Mental Illness . . . 117

70 The Role of Psychiatrists in the Prevention of Violence at the Level of Workshop Nations, Communities, and Individuals . . 107 59 How Girls, Mothers, and Mother- 72 The Changing Face of Terrorism . . . . . 107 Daughter Relationships Can Thrive 73 Complementary and Alternative Through Adolescence: Updates From the Medicine Relevant to Psychiatry . . . . . 107 Mother-Daughter Project ...... 80 102 Psychiatry in Deradicalizing Violent 71 Women in Psychiatry: Pregnancy and Extremists ...... 118 Parenthood ...... 92

165th Annual Meeting 189 New Research Program Book This is for themain TOC. Keep on pasteboard with 2 points overlap into live area.

2012 ANNUAL MEETING 165TH ANNUAL MEETING • PHILADELPHIA, PA • MAY 5-9, 2012

New Research

CONTENTS

Poster Session 1, Saturday 10:00 AM . . 192

Poster Session 2, Saturday 2:00 PM ...... 195

Poster Session 3, Sunday 10:00 AM . . . 197

Poster Session 4, Sunday 1:00 PM . . . .200

Poster Session 5, Monday 9:00 AM . . . 203

Poster Session 6, Monday 11:00 AM . . .206

Poster Session 7, Monday 2:00 PM . . . .208

Poster Session 8, Tuesday 9:00 AM . . . 211

Poster Session 9, Tuesday 11:00 AM . . .213

Poster Session 10, Tuesday 2:00 PM . . .215

New Research Topic Index ...... 219 © Richard Cummins/CORBIS© Richard Saturday’s Poster Sessions Poster Session 1, Saturday 10:00 AM This is for the main TOC. Keep on pasteboard This is for theNR TOC. Keep on pasteboard with 2 points with 2 points overlap into live area. overlap into live area.

NR1‑06 NR1‑14

Associations of Mental, and Patterns of Utilization of Medical Illnesses With Against Pediatric Medical Advice Discharges: The for Psychiatric Emergencies National Hospital Discharge Polina Shats, D.O. 1 Survey, 1988‑2006 Poster Session 1 NR1‑15 Saturday, May 5 Rima Tawk, Ph.D. Frequency of Delirium and NR1‑07 Factors Contributing to Patterns of Positive Symptom Misdiagnosis Among Elderly NEW RESEARCH SATURDAY, MAY 5 Emergence in First‑Episode Patients Admitted to an Inpatient Resident Poster Psychosis Geriatric Psychiatry Unit Competition Dawn Flosnik, M.D. Meera Balasubramaniam, M.B.B.S

10:00 A.M. – 11:30 A.M. NR1‑08 NR1‑16 Exhibit Hall C-E, Level 2 Patient Factors Associated With Temporal Changes in Initiation Pennsylvania Convention Center Extended Length of Stay in the Of Injection Drug Use, and Inpatient Psychiatric Units of a Associated Risk Factors, in Large County Hospital Heroin Users in Malaysia, Jason E. Cheng, M.D. 1968‑1999 Patient-Oriented and Emily Tejani, M.D. Epidemiology NR1‑09 NR1‑17 Mental Health Service Contacts Among Sexual Minority and Increased Body Mass Index in NR1‑01 Heterosexual Girls in Boston Toxoplasma Gondii Positive Public Schools Patients With Schizophrenia Depression and Anxiety Contributing to Super Obesity. Jeremy Kidd, M.P.H. Sara Mazaheri, M.D. The Case Report of a 1018‑lb Male NR1‑10 NR1‑18 Steven Powell, M.D. Geographic Variability in Depression and Amyloidosis: Internet Searches for Suicide Current Findings and Future NR1‑02 and Suicide Rates in the United Directions States in 2007 Delusional Parasitosis and Janet Shu, M.D. Polysubstance Dependance: Matthew Burkey, M.D. A Case Report NR1‑19 NR1‑11 Vishwani Sahai, M.D. The Potential Metabolic Weight Change and Mediation of Reduced NR1‑03 Cardiometabolic Risk With Remission Rates in African Antipsychotic Polypharmacy: Americans With Seasonal Quality of Care Provided by Meta‑Analysis Showing Affective Disorder Treated With the Child and Adolescent Improved Outcomes Bright Light Psychiatrist: A Parent Survey With Certain Aripiprazole — To provide Pharmacotherapy Olaoluwa Okusaga, M.D. Combinations and Psychotherapy in the Managed Care Era Vishesh Agarwal, M.D. NR1‑20 Nirupama Natarajan, M.D. Measuring Empathy, Emotional NR1‑12 Intelligence, and Anger in NR1‑04 Psychiatric Comorbidities Resident Physicians of in Treatment and Treatment and USA: Finding Predictors of 12 Year Old Autistic Spectrum Planning in Refractory Child and Variations in Scores Male With Compulsive Adolescent Patients in a Tertiary Overdoses: A Diagnostic Deshmukh Parikshit, M.D. State Hospital: A Case Series Quandary Meredith Weiss, M.D. NR1‑21 Aghaegbulam Uga, M.D. Huntington’s Disease and NR1‑13 NR1‑05 the Effect of Dopamine Bath Salt Intoxication: A Dysregulation on Gambling, Integration of Mental Health Literature Review of the Clinical Decision Making and Risk and Primary Care in Screening Signs, Symptoms, Physiology, Taking Behavior and Treatment of Postraumatic and Current Treatment Stress Disorder in the VA Salman Majeed, M.D. Recommendations Clinical Setting Scott Yoho, D.O. Elliot Lee, M.D.

192 www.psychiatry.org NR1‑22 NR1‑31 NR1‑39 NEW RESEARCH NEW

Transcultural Psychiatry and Impact of Depression on Prophylaxis With Antipsychotic 5 MAY SATURDAY, Indigenous People: A Case Survival, Rejection, and Medication Reduces the Report Hospitalization Rates After Risk of Post‑Operative Sorin Nica, M.D. Heart Transplantation Delirium in Elderly Patients: A Dara Pumphrey, M.D. Meta‑Analysis NR1‑23 Veronika Stock, M.D. NR1‑32 Committing to Treatment: The NR1‑40 Use of “Involuntary” Inpatient 6 Month Follow‑up of rTMS Addiction Services for Patients Efficacy in Treatment Resistant A Life‑Threatening Case of

With Grave Substance Use Major Depression: A Case Aripiprazole‑Induced Dysphagia Disorders Report Muhammad Majeed, M.D. Arthur Williams, M.D. Onur Durmaz, M.D. NR1‑41 NR1‑24 NR1‑33 Catatonia – How Much Impulsivity and Suicidality in a Symptom Mirroring of Lorazepam is Too Much? War Veteran Necrotizing Fasciitis in Identical John Gillean, M.D. Andrea Brownridge, M.D. Twin Brothers While Deployed to Combat Zone NR1‑42 NR1‑25 David Hanrahan, M.D. Two Cases Highlighting the Anxiety Disorder and Importance of Differentiating NR1‑34 Schizencephaly: A Connection? Between Primary and Neha Kansara, M.D. Long Term Follow Up of a Secondary Causes of Delusional Patient With Schizophrenia Perasitosis NR1‑26 Superimposed With Myasthenia Mohammad Khan, M.B.B.S Gravis Assessing the Quality of NR1‑43 Medical Decision Making Haebin Kim, M.D. Capacity Consults at an Risk Factor Analysis of NR1‑35 Academic Center Syndrome of Inappropriate Gaurav Jain, M.D. Continuity of Care After Secretion of Anti Diuretic Inpatient Discharge of Patients Hormone (SIADH) in Psychiatric NR1‑27 With Schizophrenia in Korea Emergency Room (ER) Population Anorexia Nervosa and Folie a Seungyup Lee, M.D. Deux: A Case Report Eswar Kumar Dayanandam, M.D. NR1‑36 Raman Baweja, M.D. NR1‑44 Post‑Traumatic Left Temporal NR1‑28 Seizure Manifesting as Bizarre Lamotrigine’s Apparent Efficacy Behavior and Suicidality in a in Treating Irritable Bowel Falls Amongst Psychiatric Young Soldier Syndrome in Addition to the Inpatients: A Case Control Symptoms of Bipolar Affective Retrospective Study in a Center Adam Hunzeker, M.D. Disorder Type II ‑ A Case Report City Psychiatric‑Medical Care Unit NR1‑37 Jonathan Barton, M.D. Deana Sabol, D.O. Effects of Transcranial Magnetic NR1‑45 NR1‑29 Stimulation in the Treatment of Cocaine Dependence Managing Clozapine Side Unique Aspects in Treating Effects: Three Case Studies Somatoform Spectrum Philip Ribeiro, M.D. Disorders by Combined Internal Pedro Bauza, M.D. NR1‑38 Medicine/Psychiatry Physicians NR1‑46 Sherrell Lam, M.D. Baclofen Dependence and Withdrawal Delirium: A EKG Changes in Asymptomatic NR1‑30 Review of Neuropsychiatric Cocaine Users?: A Cross Presentations and Management Sectional Study of 269 In‑Patients Improvement of Severe Strategies With a Case Report Psychosis Immediately After Nivedita Mathur, M.D. Delivery in a Patient With Rohul Amin, M.D. Schizophrenia: A Case Report ! All scientific sessions listed Natasha Dalseth, M.D. in the Annual Meeting Program Book are designated for AMA PRA Category 1 Credits™, except for New Research Poster Sessions.

165th Annual Meeting 193 NR1‑47 NR1‑56 NR1‑65

Synthetic Cannabis “Spice”, Antipsychotic Dose Escalation Collaborative Models of More Potent Than Natural Prior to the Development Care for Medical Inpatients Cannabis and May Have of Neuroleptic Malignant With Psychiatric Disorders: A Increased Risk for Psychosis? Syndrome (NMS) Systematic Review Carlos Alverio‑Pares, M.D. Julie Langan Maria Hussain, M.B.B.S

NR1‑48 NR1‑57 NR1‑66 Trauma and Dissociation in Emerging Strategies in the An Analysis of Somatic Social Phobia: A Comparative Treatment of Poststroke Symptoms Occurring During NEW RESEARCH SATURDAY, MAY 5 and Controlled Study Depression and Psychiatric Therapy for Posttraumatic Sermin Kesebir, M.D. Distress in Patients Stress Disorder Vincent Capaldi, M.D. Robert Lloyd, M.D. NR1‑49 NR1‑58 NR1-67 Sleep Stages and Behavioral Abnormalities in Children and Tinnitus and Insomnia: A A Diagnosis Dilemma Adolescents Significant Relationship With Florentina Luiza Popescu, M.D. Manana Lapidus, M.D. Psychological Consequence Kiran Majeed, M.D. NR1‑68 NR1‑50 Changes in the ICNDS Between NR1‑59 Cotard Syndrome in a 65 yo Two Visits in 762 Youth With Hispanic Male With Major Psychoactive Bath Salts: A Case Epilepsy Depression Series Diana Lorenzo, M.D. Nubia Lluberes, M.D. Benjamin Boche, D.O. NR1‑69 NR1‑51 NR1‑60 Fitness to Stand Trial: An Early Response to Bright Light Risk of Withdrawal Dyskinesia Attempt at Educating an and Outcome at Six Weeks in Children Inpatient Forensic Patient Monika Acharya Garima Singh, M.D. Population Through Audio/ Visual Aids and Measuring Time NR1‑52 NR1‑61 to Achieve Fitness An Unusual Case of Association Between Short Peter Szymczak, M.D. CPAP‑Induced Mania Serotonin Transporter Gene NR1‑70 Richa Aggarwal, M.D. Promoter Polymorphisms (5HTTLPR) and History of Abuse Building a Team Involved in NR1‑53 on Blood Pressure Prevention and Treatment of Primary Polydipsia in a Psycho‑Education in Bipolar Yingying Kumar, B.S. Psychiatric Outpatient/Inpatient Disorder: How Much do our NR1‑62 Population: A Pilot Study Patients Know? Peter Szymczak, M.D. Mario Cristancho, M.D. Toxoplasma Gondii and Suicide Behavior NR1‑71 NR1‑54 Yuanfen Zhang, M.D. A Practical Approach to Suicide on Facebook: Suicide NR1‑63 Psychiatrist’s Roles and Assessment Using Online Social Responsibilities When Media Kava Intoxication: Acute Assessing Patient’s Capacity to Movement Disorders in Patient Amir Ahuja, M.D. Drive With Kava Addiction Dimitri D. Markov, M.D. NR1‑55 Liudmila Lobach, M.D. “My Child Won’t Speak”: NR1‑64 Treating Selective Mutism in Children and Adolescents With The Effect of Treatment on Escitalopram, a Case Study Social Functioning Among Gaurav Kulkarni, M.D. Cocaine Dependent Individuals Elia Valladares Juarez, M.D. ! Obtain your Certificate of Attendance for the 2012 APA Annual Meeting at www.psych. org/AnnualMeetingCME

194 www.psychiatry.org Poster Session 2, Saturday 2:00 PM This is for theNR TOC. Keep on pasteboard with 2 points overlap into live area.

NR2‑06 NR2‑15 NEW RESEARCH NEW

Outcomes of 17 Years of Integration of Mental Health 5 MAY SATURDAY, Structured Rehabilitation and Primary Care Services in a Program in a Half-Way House Student‑Faculty Collaborative Pablo Gabay, M.D. Primary Care Clinic: An 2 Approach for Psychiatry Poster Session 2 NR2‑07 Education Saturday, May 5 Professionalism in Social Chuan-Mei Lee, M.A. Networking NR2‑16 Almari Ginory, D.O.

Resident Poster Designing a Religion and Competition NR2‑08 Spirituality Curriculum in a Psychiatry Residency Utilization of the Program. Part 1: Identifying the 2:00 pm‑ 3:30 pm Psychodynamic Diagnostic Knowledge Gap Exhibit Hall C‑E, Level 2 Manual (PDM) in Psychiatry Pennsylvania Convention Center Residency Training Programs: A Harshad Patel, M.D. Clinical Review and Proposal NR2‑17 Lauren Schwartz, M.D. Use of “The Bridge” to Augment Community Service, NR2‑09 the Suicide Curriculum in Undergraduate Medical Curriculum Development International Medical Graduates Education in Psychiatry: Understanding and Educational, Leorah Walsh, M.D. Psychosocial and/or Their Journey Through the Interview Trail NR2‑18 Biomedical Research Lama Bazzi, M.D. Resident Led Morning Report: NR2‑10 A Model for Integrating Case NR2‑01 Based Learning and Resident ‘Bridging the Gap’: Using Led Curriculum Psychiatric Disorders in Free Internet‑Based Tools for Homeless Youth: A Review of Multi‑Site Resident Education Michael Francis, M.D. the Current Literature and Areas Ujjwal Ramtekkar, M.D. for Future Research NR2‑19 Nicole Kozloff, M.D. NR2‑11 Improving Child and Adolescent Forensic Psychiatry Training: Message on the Bottle ‑ NR2-02 Development of a CAP Forensic Importance of Transfer of Care Track General Practitioner’s From Front Line Teams to Satisfaction With the Treatment Teams in the Hospital Peter S. Martin, M.D. Implementation of a C-L Madhavi Nagalla, M.D. Psychiatry Service in ULSM, NR2‑20 Portugal NR2‑12 Shorter Psychiatry Clerkship Filipa R. Silva, M.D. Length is Associated With Fellowship in Leadership and Lower NBME Psychiatry Shelf Management During Psychiatry NR2‑03 Exam Performance Residency in London Through a Time to Hand Over the Keys: Live Project: Payment by Results Cara Alexander, M.D. The Psychiatrist’s Role in Mental Health and Responsibilities When NR2‑21 Pratima Singh, M.D. Assessing a Patient’s Capacity I Phoned it in: A Novel Way of to Drive NR2-13 Assessing Change of Mental Christine Marchionni, M.D. Status in a Non‑Responsive Medical Student Stress and Patient Through Family Group Cohesion in a Revised, NR2‑04 Smartphone Videos Systems-Based Pre-Clinical Suicidal Mass Murder Curriculum Muhammad Majeed, M.D. John Liebert, M.D. Ugur Sener, B.S. NR2‑23 NR2‑05 NR2‑14 Understanding Patterns of Inter‑Partner Abuse in Psychotherapeutic Approach of International Medical Graduates Male‑Male, Male‑Female, and Primary Polydipsia in Psychiatric in Psychiatry: Setting Out Female‑Female Couples Outpatient Population: A Pilot and Deciding to Apply to US Study Programs Alexandru Gaman, M.D. Varinderjit Parmar, M.D. Renata Sanders, M.D.

165th Annual Meeting 195 NR2‑24 NR2‑32 NR2‑40

Dissociated Aß Antibody Level The Beauty Queue: How do the Development and Validation of and Oxidative Stress Parameters Physical Traits of Body Size and a Social Cognitive Theory‑Based in Alzheimer’s Disease‑ Skin Complexion Intersect in Measure for Intention to Adhere Population Based Study the Educated African American to HIV Treatment Kasia Rothenberg, M.D. Community? Andrea Nelsen, M.D. Aminata Cisse, B.A. NR2‑25 NR2‑41 NR2‑33 Health Policy and Intervention Longitudinal Study of Symptom Strategy Issues With Current Sleep and Bipolar Disorder: Remission in Older Adults NEW RESEARCH SATURDAY, MAY 5 Epidemiology in Alcoholic Association Between Clinical With Schizophrenia: A 4.5 Year Population Improvement and Sleep in Acute Follow‑Up Study Vatsalya Vatsalya, M.D. Mania Mudassar Iqbal, M.D. Barney Vaughan, M.D. NR2‑26 NR2‑42 NR2‑34 Substance P and Affect Serotonin Transporter Intensity; a Novel Correlation Healthcare Decision‑Making Gene‑Linked Polymorphic Rakesh John, M.D. as a Potential Source of Region (5HTTLPR) and Body Psychological Distress Among Mass Index in a Psychiatric NR2‑27 Religious Nonbelievers Population Neurobiological Relevance Samuel Weber, M.D. Brooke Rosen, B.A. of Schizophrenia‑Associated NR2‑35 NR2‑43 Genetic Polymorphisms: The Effect of SMARCA2 and NIPA1 Should We Routinely Ask Identification of Personality Over‑Expression on Neural Cell About Problematic Computer Disorder Traits and Tendencies Signaling and Internet Use as Part of the for Better Clinical Direction to Frank Fetterolf, B.S. Psychiatric History? Treatment Himanshu Tyagi, M.D. Yakir Vaks, M.D. NR2‑28 NR2‑36 NR2‑44 The Utility of Stellate Ganglion Blocks in Dual Diagnosis: PTSD Gene Expression Patterns from Is it Ethical Not to Prescribe and Neuropathic Pain Brain Samples in Alcoholics Placebo? The Patient’s Robert Nastasi, M.D. Kamal Bhatia, M.D. Perspective on the Usage of Placebo for the Treatment of NR2‑29 NR2‑37 Depression–A Comparative Study Biomarkers of Gluten Sensitivity Evaluation of the Kfir Feffer, M.D. in Patients With Schizophrenia: Prevalence and Severity of NR2‑45 A Meta‑Analysis Depression in Patients With Laura Lachance, M.D. Obsessive‑Compulsive Disorder The Relationship Between (OCD) Cognitive Decline Elderly People NR2‑30 Rupal Patel, M.D. and Blood Metal Levels: A Systematic Review Executive Function and NR2‑38 Prefrontal Dopamine Uptake in Lee Sangkyung, M.D. a Rodent Model Of Adolescent A Retrospective Study of Oral NR2‑46 Bullying Versus Long‑Acting Injectable Andrew Novick, B.S. Naltrexone for Treatment of EEG and Power Spectral Alcohol Dependence in Patients Density in First Episode Mania: NR2‑31 at the Ralph H. Johnson VA Comparing With remission Do Neighborhood Todd Magro, M.D. Sermin Kesebir, M.D. Characteristics Prompt Earlier NR2‑39 NR2‑47 Cannabis Use in Patients Diagnosed With First-Episode A Novel Approach to Adverse Psychiatric Events Psychosis? Individualized Treatment in Associated With Levetiracetam: Christopher Horne, J.D. Psychiatry: Use of Neuroimaging An Analysis to Predict Efficacy and Olufemi Ogundeji, M.D. Tolerability of ECT Treatment for Depression Manjola Ujkaj, M.D.

196 www.psychiatry.org Sunday’s Poster Sessions Poster Session 3, Sunday 10:00 AM This is for the main TOC. Keep on pasteboard This is for theNR TOC. Keep on pasteboard with 2 points with 2 points overlap into live area. overlap into live area.

NR2‑48 NR3‑06 Long Range Frontal/Posterior Tobacco Abuse and Phase Synchronization During Dependence, the Invisible Remembered Pursuit Task is Diagnoses Impaired in Schizophrenia Yakir Vaks, M.D. Nithin Krishna, M.D. 3 Poster Session 3 NR3‑07 NR2‑49 Sunday, May 6 Case Report of Facial Tics The Change of Metabolic Following Self Reported Parameters and PANSS Score Young Investigators Psychoactive Bath Salt (PABS) of Patients With Schizophrenia Intoxication in a Healthy 19 Year 8 Weeks After Switching to 10:00 am‑11:30 am Old Male Paliperidone Exhibit Hall C‑E, Level 2 Chai Wu, M.D. Jeong Tae-Yeong, M.D.

Pennsylvania Convention Center RESEARCH NEW NR3‑08 NR2‑50 6 MAY SUNDAY, Curriculum to Teach Opioid’s Induced Evidence‑Based Medicine to Leucoencephalopathy NR3‑01 Psychiatry Residents Kasia Rothenberg, M.D. Developing the North Division Shah Jalees, M.D. Department of Psychiatry at NR2‑51 Montefiore Medical Center, NR3‑09 Outcomes of 17 Years of a Bronx, NY: From Acquisition to Medical Student Tobacco Integration Structured Rehabilitation Cessation Consult Program Program in a Half-Way House Yener Balan, M.D. (MSTCCP): A Quality Pablo Gabay, M.D. Improvement Project NR3‑02 Danielle Alexander, M.S. NR2‑52 Cannabis‑Induced Atrial NR3‑10 Meta‑Analysis of Efficacy of Fibrillation in a Patient With Mirtazapine as an Adjunctive Traumatic Brain Injury Psychoactive Bath Salts: A Case Treatment for Schizophrenia Lauren Mikesell, M.S. Series Carolina Vidal, M.D. Benjamin Boche, D.O. NR3‑03 NR2‑53 Do Premorbid Alcohol NR3‑11 A Comparison of Inflammatory Challenge Responses Predict Clonidine Treatment of Markers in Depressed and Alcohol Dependence by Age 40? Nightmares Among Patients Non‑Depressed Smokers Syed Karim, M.D. With Co‑Morbid PTSD and Sandra Nunes, M.D. Traumatic Brain Injury NR3‑04 Adekola Alao, M.D. NR2‑54 Clozapine and Lithium NR3‑12 Topography of Mood Symptoms Combination Leading to Lithium and Personality Traits in Toxicity: A Case Report and Types Of Social Fears Can Mood Disorders and Cluster Literature Review Inform Assessment of Social B Personality Disorders Phobia Severity Naveen Yarasi, M.D. (Preliminary Results) Erica Crome Sergio Apfebaum, M.D. NR3‑05 NR3‑13 NR2‑55 Drug Addiction in Sickle Cell Disease Brain‑Derived Neurotrophic Adjunctive Lisdexamfetamine Factor, Posttraumatic Stress Adekola Alao, M.D. Dimesylate With Antipsychotics: Disorder and Memory Effects on Negative Symptoms of Sharain Suliman, M.A. Schizophrenia and Self‑Reported Executive Function NR3‑14 APA 2012 Annual Henry A. Nasrallah, M.D. ! Meeting On Demand Factor Structure of the Beck Depression Inventory in Anxiety NR2‑56 • Special onsite pricing Disorder • Earn CME Credit for top Changes in Symptoms and lectures and symposia online Chung Yeub Chung, M.D. Function of Adult ADHD • For more information: Patients With or Without Co‑Morbid Generalized Anxiety Sylvia Mousa, M.D.

165th Annual Meeting 197 NR3‑15 NR3‑25 NR3‑34 Salivary Cortisol as a Predicting Self‑Circumcision in a Teenager: Perioperative Supportive Factor of Burn PTSD a Case Report Psychotherapy Can Reduce Jin‑Nah Kim, M.D. Lauren Mikesell, M.S. Postoperative Delirium in Patients After Cardiac Surgery: NR3‑16 NR3‑26 A Retrospective Study Clonidine and PTSD ; Quality of Life in Youth With Jeewon Lee, M.D. Hypothesis for the Etiology and Epilepsy: The Role of Inattention NR3‑35 Treatment of Stuttering a 1500 Patient Study Jennifer Selvarajah, M.D. Sarah Matthys, B.S. Symptom Magnification in Patients With a Traumatic Brain NR3‑17 NR3‑27 Injury Covered by Workers’ Compensation Xeplekomania – a Rare Variant A 15‑Year‑Old Patient With of Trichotillomania an Atypical Neuropsychiatric Kyoung-Sae Na, M.D.

Juliana Kalaf, M.D. Presentation of Lyme Disease NR3‑36 (OCD) NR3‑18 Carolina Mercader, D.O. Cognitive Deterioration and Evaluation of the Voiding Difficulty in Patient With Prevalence and Severity of NR3‑28 Neurosyphilis – Case Report Depression in Patients With Personality Disorders in Female Jongha Lee, M.D. Obsessive‑Compulsive Disorder Adolescents in a Residential NR3‑37 (OCD) Program SUNDAY, MAY 6 Rupal Patel, M.D. NEW RESEARCH Samuel Neuhut, M.D. Telepsychiatry: An Emerging Modality in Behavioral Health NR3‑19 NR3‑29 Asim Rizvi, M.D. The Need for a Perinatal Specific Is There an Association NR3‑38 Generalized Anxiety Scale Between Cohen Syndrome and Jasmin Abizadeh, B.A. Attention Deficit Hyperactivity Should We Routinely Ask Disorder? About Problematic Computer NR3‑20 Ayme Frometa, M.D. and Internet Use as Part of the Memory and Executive Psychiatric History? Functions After Vagus Nerve NR3‑30 Himanshu Tyagi, M.D. Stimulation for Refractory Post‑Traumatic Stress Disorder Depression NR3‑39 Among Hospitalized Children Veronique Desbeaumes Jodoin, M.A. and Adolescents: Prevalence, The Virtual Object and Its Role Co‑Morbidities and Associated in Traumatic Attachment (Case NR3‑21 Variables Report) Effects of Antipsychotics on Pavan Madan, M.D. Kerrigan Sean, M.D. Sodium Channels: A Case Report on Cystic Fibrosis NR3‑31 NR3‑40 Ferhana Nadeem, M.D. Correlation Between Psychiatry on YouTube: NR3‑22 Self‑Reports of Child’s Information or Misinformation? Depression and Parent’s Rajnish Mago, M.D. Use of Paliperidone in a Assessment of Child’s Behaviour Patient With Cytochrome p450 Kwon Yunyoung, M.D. NR3‑41 Deficiency 32 Year Old Iraq Veteran Man Shilpa Sachdeva, M.D. NR3‑32 Presenting With Psychosis NR3‑23 Psychological Reactions of Jamsheed Khan, M.D. Children and Adolescents to the A Case of Delayed Hyponatremia 2005 Earthquake in Pakistan: NR3‑42 With Setraline Therapy Effects of Relocation Shilpa Sachdeva, M.D. Emotion Dysregulation and Nisha Warikoo, M.B.B.S Treatment Response in Binge Eating Disorder Subtypes NR3‑24 NR3‑33 Iris Lin, M.A. Emotion Processing in Young Anorexia Nervosa and Folie a Women With Borderline Deux: A Case Report Personality Disorder: A Raman Baweja, M.D. Functional Magnetic Resonance Imaging Study Lori LaRiviere, M.D.

198 www.psychiatry.org NR3‑43 NR3‑52 NR3‑61 Prevalence of Main Psychiatric Relationship Between Working/ Comparing Video Game Play in Disorders in Relation to Volunteer Status and Successful Impulse Control Disorder and Urbanization in Gyeonggi Aging in the Successful AGing Control Children Province by Using the K‑Mini Evaluation (SAGE) Study Cristian Penciu, M.D. Seongjin Cho, M.D. Steve Koh, M.D. NR3‑62 NR3‑44 NR3‑53 Acne Excoriee: A Review Variation by Month and Day of Hallucinations in Older Adults Jillian Wong, B.A. the Week in Internet Searches With Schizophrenia on 4.5 Year for Suicide in the United States Follow‑Up NR3‑63 Audra Yadack, M.D. Jacob Taylor, M.P.H. Association of Attachment Style to Measures of Impulsivity in NR3‑45 NR3‑54

Psychiatric Inpatients RESEARCH NEW

Understanding Risk for Suicide Quality of Life in Older Melanie Kopp, M.D. 6 MAY SUNDAY, Attempts: A Latent Class Adults With Schizophrenia: A Analysis of Multiple Risk Factors Longitudinal Population Based NR3‑64 in a Nationally Representative Study Integration of Mental Health Sample Of U.S. Adults Elena F. Garcia-Aracena, M.D. and Primary Care in Screening Daniel Rasic, B.S. and Treatment of Postraumatic NR3‑55 Stress Disorder in the VA NR3‑46 Gender Differences in the Impact Clinical Setting

Undergraduate Medical of Optimism on Successful Elliot Lee, M.D. Students’ Attitude Towards Aging and Mental Health Psychiatry: A Comparative Study Ipsit Vahia, M.D. NR3‑65 From India and Japan Depression in Sarcoidosis Jatinder Chawla, M.D. NR3‑56 Patients of a Tertiary Care General Hospital in South India NR3‑47 Service Use and Barriers to Mental Health Care in Major Arjun Lakshmana Balaji, M.B.B.S The Effectiveness of Modern Depression and Comorbid Treatment Modalities on Substance Use Disorders NR3‑66 Reducing Recidivism in Sexual Lian Yu Chen, M.D. True Integrated Care: The Offenders: A Systematic Review Role of Combined Training in and Meta‑Analysis NR3‑57 Family Medicine‑Psychiatry and Monica Chawla, M.D. Prevalence of Medical Illnesses Internal Medicine‑Psychiatry in the Era of Integration NR3‑48 in Patients With Psychotic Disorders: A Retrospective Monika Jindal, M.D. Restoring Gun Rights: What is Chart Review Study the Role of the Psychiatrist? Amy Shah, M.D. NR3‑67 George Annas, M.D. NR3‑58 An Experiment in Integrated NR3‑49 Care Education An Overview of Specialized Testing a Diathesis‑Stress Follow Up of Children With Sosunmolu O. Shoyinka, M.D. Model: Potential Genetic Risk Concurrent Axis I and Axis III Factors for Development of Diagnoses NR3‑68 Distress in Context of Cancer Cristian Penciu, M.D. Examining Quality of Life in a Diagnosis and Transplant Sample of Narcoleptic Patients Magdalena Romanowicz, M.D. NR3‑59 Harnek Kahlon, M.D. Effective Treatment of NR3‑50 Trichotillomania With NR3‑69 Association of Serotonin Aripiprazole, as an Adjunct, in a Comparison of Clinician Rated Transporter Linked Polymorphic Patient With Major Depressive MHCT(HONOS‑PbR) Scores Region (5HTTLPR) and Disorder ‑ A Case Report in Cluster With Standard: Escitalopram Antidepressant Yakir Vaks, M.D. Implications for a New Financing Treatment Response Mental Health Model in England Eunsoo Won, M.D. NR3‑60 Pratima Singh, M.D. A Case of Kleptomania Treated NR3‑51 With Naltrexone as an Adjunct Withdrawn to Fluoxetine Aderezza Ferrer, M.D.

165th Annual Meeting 199 Poster Session 4, Sunday 1:00 PM This is for theNR TOC. Keep on pasteboard with 2 points overlap into live area.

NR3‑70 NR4‑07 Psychotropic Medication Cost Prevalence of Smoking in Awareness: A Comparison Moderate to Severe OCD Survey Evaluating Knowledge Himanshu Tyagi, M.D. and Attitudes of Resident and Attending Primary Care 4 NR4‑08 Providers Poster Session 4 Prevalence and Related Satinder Mahal, D.O. Sunday, May 6 Variables to Risk of Anxiety Disorders in Colombian Medical NR3‑71 Students Disrupted Resting‑State New Research Adalberto Campo-Arias, M.D. Functional Connectivity of the Hippocampus in 1:00 pm‑ 3:00 pm NR4‑09 Medication‑Naïve Patients With Exhibit Hall C‑E, Level 2 Interpersonal Psychotherapy Major Depressive Disorder Pennsylvania Convention Center (IPT) for Posttraumatic Stress Xiaohua Cao, Ph.D. Disorder John C. Markowitz, M.D. Mood Disorders ! Program changes are printed NR4‑10 each day in the Daily Bulletin Could REM Sleep Be a which can be picked up in the NR4‑01 Biological Biomarker for Anxiety Pennsylvania Convention Center. The Temperament and Character Disorders?

SUNDAY, MAY 6 A mobile application will also be

NEW RESEARCH of Korean Soldiers With Military Abid Malik, M.D. available. Maladjustment: A Preliminary Study NR4‑11 Kyoungho Han, M.D. Methylphenidate Transdermal System in Treatment of NR4‑02 Attention Deficit Hyperactivity Epidemiology of Anxiety Disorder: Analysis of Disorder Amongst High School Responses in Younger vs. Older Students (Grade 5 to 10) of an Adolescents Urban‑Metro Community in Raun Melmed, M.D. Mumbai Amresh Shrivastava, M.D. NR4‑12 A Comparison of Rates and NR4‑03 Reasons for Urgent Care Internet Screening for Utilization Among Children Anxiety Disorders: Effects With ADHD Treated With on Treatment‑Seeking in a Atypical Antipsychotics vs. Three‑Month Follow‑Up Study Non‑Antipsychotics Michael Van Ameringen, M.D. Keith Betts, Ph.D.

NR4‑04 NR4‑13 Pharmacotherapy of Panic Methylphenidate Transdermal Disorder: Tapering Out System for Treatment of Clonazepam and Paroxetine Attention Deficit Hyperactivity After Three Years of Treatment Disorder (ADHD) in Antonio Nardi, M.D. Adolescents: Gender Subgroup Analyses NR4‑05 Robert L. Findling, M.D. Lu AA21004 in the Prevention of NR4‑14 Relapse in Adult Patients With Generalised Anxiety Disorder Methylphenidate Transdermal David Baldwin, M.B.B.S System for Treatment of Attention Deficit Hyperactivity NR4‑06 Disorder in Adolescents: Impact of Prior Stimulant Use Psychosis in Social Anxiety Robert L. Findling, M.D. Patients: Frontiers of Psychopathology Andre Veras, M.D. 200 www.psychiatry.org NR4‑15 NR4-22 NR4‑30 Efficacy of Guanfacine Extended Profile of Sexual and Lu AA21004, a Multimodal Release Administered in the Genitourinary Treatment- Antidepressant, is Active in a Morning or Evening as Assessed Emergent Adverse Events Fluoxetine‑Insensitive Rat Model by the Conners’ Parent Rating Associated With Atomoxetine of Depression and Enhances Scale‑Revised: Short Form Treatment: A Pooled Analysis Cognitive Function in Rats Thomas Rugino, M.D. Douglas K. Kelsey, M.D. Connie Sanchez, Ph.D.

NR4‑16 NR4‑23 NR4‑31 Effect of Lisdexamfetamine Completed in the Lu AA21004 Effects on Attention Dimesylate on Symptoms of United States Between 1979 and and Vigilance Measured as EEG Hyperactivity/Impulsivity and 2007: Relationship to Age, Sex Activity in the Rat Inattention in Children and and Antidepressant Prescription Steven Leiser, Ph.D. Adolescents With ADHD Patterns David R. Coghill, M.D. Arif Khan, M.D. NR4‑32 RESEARCH NEW SUNDAY, MAY 6 MAY SUNDAY, Early Improvement as a NR4‑17 NR4‑24 Predictor of Later Treatment Lisdexamfetamine Dimesylate Early Detection and Treatment Response in Acute Manic or Impact on 2 Subjective of Mental Illness Within the Mixed Episodes Using CGI Quality of Life Scales in Adult Workplace Assessments: A Pooled, Attention‑Deficit/Hyperactivity Helle Sorensen, B.S.N. Post‑Hoc Analysis Disorder and Executive Armin Szegedi, M.D. Dysfunction NR4‑25 NR4‑33 Lenard Adler, M.D. Factors Predicting Premature Dropout of Treatment Amongst Maintenance Treatment With NR4‑18 Female Substance Abusers Risperidone Long‑Acting Urgent Care Utilization for Aparna Iyer, M.D. Injection vs. Placebo in Subjects Adolescents Treated With Recently Diagnosed With Atypical Antipsychotics NR4‑26 Bipolar Disorder: A Subgroup or Non‑Antipsychotics: A Analysis Impact of the Multimodal Comparison of Rates and Larry Alphs, M.D. Antidepressant Lu AA21004 on Reasons Serotonin Transmission in the NR4‑34 Steven Pliszka, M.D. Rat Hippocampus The Multimodal Antidepressant Maurice Lecours, B.S.C. NR4‑19 Lu AA21004 But Not The Hidden Costs of Attention NR4‑27 Escitalopram Reverses Deficit/Hyperactivity Disorder Cognitive Dysfunction Produced Four Hygienic‑Dietary (ADHD): A Focus on School and by Serotonin Depletion in Rats Recommendations as Add‑On Work in the United States Alan Pehrson, D.Phil. Treatment in Depression Doshi Jalpa, Ph.D. Mauro Garcia-Toro, M.D. NR4‑35 NR4‑20 Effect of Monitoring Depression NR4‑28 Severity on Patient Behavior ADHD Symptoms During The Impact of Comorbid Anxiety in the Clinical Outcomes in Morning, Afternoon, and Disorders in Subsyndromally Measurement-Based Treatment Evening With Guanfacine Depressed Participants (Comet) Trial Extended Release Treatment Presenting for a Depression Administered in the AM or PM Trina Chang, M.D. Prevention Research Joel Young, M.D. Intervention NR4‑36 NR4‑21 John Kasckow, M.D. Differential Regulation of 5‑HT1B Receptors by Escitalopram and Efficacy of Lisdexamfetamine NR4-29 the Multimodal Antidepressant Dimesylate on Self‑ and Lurasidone Adjunctive to Lu AA21004 Informant‑Reported Executive Lithium or Valproate for Dysfunction in Adults With Todd Hillhouse, M.S. the Treatment of Bipolar I Attention‑Deficit/Hyperactivity Depression: Results of a NR4‑37 Disorder 6-Week, Double-Blind, Placebo- Richard Weisler, M.D. Maternal, But Not Paternal, Controlled Study Mood and Anxiety Disorders Antony Loebel, M.D. are Associated With Psychiatric Disorders in Young Adults Nancy Low, M.D.

165th Annual Meeting 201 NR4‑38 NR4‑46 NR4‑52 Mixed Depression: A Study of its Efficacy of Lisdexamfetamine Adjunctive Use of Aripiprazole Phenomenology and Relation to Dimesylate Augmentation for or Bupropion? Treatment Response Executive Dysfunction in Adults Suhayl Nasr, M.D. Chi-Un Pae, M.D. With Fully or Partially Remitted Major Depressive Disorder NR4‑53 NR4‑39 Robert Roth, Ph.D. Ketamine Safety: A Description Association of the 5‑HTTLPR of Physiological and NR4‑47 With Treatment Response to Psychological Event Monitoring Escitalopram in Patients With Long‑Term Safety and During Administration of Major Depressive Disorder Tolerability of Once‑Monthly Low‑Dose Intravenous Ketamine Min-Soo Lee, M.D. Aripiprazole Intramuscular in Treatment Depot (ARI‑IM‑Depot) for Nora Finnegan, B.S.N. NR4‑40 Maintenance Treatment in Schizophrenia NR4‑54 Apparent Rates of Bipolar Disorder in Patients With Wolfgang Fleischhacker, M.D. Improving Metabolic Health and Combat‑Related Post Traumatic Quality of Life in Mental Health NR4‑48 Stress Disorder: A Situation of Consumers With the CHUQ Possible False Positives Efficacy and Safety of IUSMQ Mieux Être Wellness Robert McLay, M.D., Ph.D. Desvenlafaxine 50 mg/d for Program Prevention of Relapse in Adult Christian Shriqui, M.D. NR4‑41 Outpatients Treated for Major

SUNDAY, MAY 6 Depressive Disorder NR4‑55

NEW RESEARCH Hyponatremia Induced Psychosis in a 38 Year Old Male Joshua Rosenthal, M.D. The Mini Mental Status on Citalopram Examination and Global NR4‑49 Jamsheed Khan, M.D. Assessment of Functioning Efficacy and Safety as Determinants of Medical NR4‑42 of Desvenlafaxine 50 Decision Making Capacity mg/d in a Randomized, The Association of Gaurav Jain, M.D. Placebo‑Controlled Study of Proopiomelanocortin Peri/Postmenopausal Women NR4‑56 Polymorphism With the Risk With Major Depressive Disorder of Major Depressive Disorder Anhedonia in Stroke Patients: and With Responses to Anita Clayton, M.D. Neuroanatomical and Antidepressants Endocrinological Correlates NR4‑50 Min-Soo Lee, M.D. Luisa Terroni, Ph.D. Abrupt Discontinuation NR4‑43 Compared With a 1‑Week NR4‑57 Taper Regimen in Depressed Assessment of Executive A Novel Treatment of Outpatients Treated for 24 Dysfunction in Adults With Hallucinogen Persisting Weeks With Desvenlafaxine 50 Major Depressive Disorder Perception Disorder mg/d Receiving Lisdexamfetamine Henry Abraham, M.D. Dimesylate Augmentation of Arif Khan, M.D. Escitalopram NR4‑51 Philip Harvey, Ph.D. Levomilnacipran in the NR4‑44 Treatment of Major Depressive Disorder: Functional Health Adjunctive Aripiprazole Doubles and Well‑Being Efficacy Results the Rate of Early and Sustained From a Phase III Clinical Trial Response in MDD Patients With an Inadequate Response to Steve Blum, M.B.A. Antidepressant Monotherapy Daniel Casey, M.D.

NR4‑45 ! Obtain your Certificate of Long‑Term Safety and Tolerability Attendance for the 2012 APA of Lu AA21004 in Subjects With Annual Meeting at www.psych. Major Depressive Disorder org/AnnualMeetingCME Mohammed Alam, M.D.

202 www.psychiatry.org Monday’s Poster Sessions Poster Session 5, Monday 9:00 AM This is for the main TOC. Keep on This is for theNR TOC. Keep on pasteboard with 2 points pasteboard with 2 points overlap into live overlap into live area. area.

NR5‑07 NR5‑15 The International Mood Network Combined Use of Suicide (IMN): Preliminary Feasibility Intent Scale and Karolinska and Findings Interpersonal Violence Scale in Paul Vohringer, M.D. the Prediction of Suicide 5 Jon Stefansson, M.D. Poster Session 5 NR5‑08 NR5‑16 Monday, May 7 Underdiagnosis of Bipolar Disorders: An International Parental Bonding and Suicide in Reality Adolescents and Adults Young Investigators Niki Holtzman, B.A. Simona Goschin, M.D.

9:00 am‑10:30 am NR5‑09 NR5‑17 Exhibit Hall C‑E, Level 2 Clinical Predictive Features Correlation Between Sleep Pennsylvania Convention Center of Mixed Depression: An Disturbance, Quality of Life International Study Impairment and Increased Matthew Sullivan, B.A. Suicide Risk Among Hemodialysis Patients NR5‑01 NR5‑10 Valfrido De-Melo-Neto, M.D. Severity of Depressive Clinical Predictive Features Symptoms in Late Pregnancy NR5‑18 Depends on the Interaction of Substance Abuse in Mood Between Circadian Rhythm and Disorders: An International Study Suicide Risk in a Cardiology Outpatient Service Sleep Disturbances Derick Vergne, M.D. William Simpson, B.S.C. Valfrido De-Melo-Neto, M.D. NR5‑11 NR5‑19 RESEARCH NEW

NR5‑02 7 MAY MONDAY, Association of Subjective Relationship of SIPP‑118 A Clinical Comparison Between Depression and Cognitive Personality Dimensions to DSM Younger and Older Psychiatric Functions in Traumatic Brain IV Axis II Diagnoses Outpatients With Depression Injury Thachell Tanis, B.A. Reshmi Saranga, M.D. Heesung Hwang, M.D. NR5‑20 NR5‑03 NR5‑12 Asenapine in Developmentally Plasma Aß Levels, Dementia, A Comparison Study Between Disabled Adults and Depression in Elderly Visual Interpretation and Persons: The Rotterdam Study Statistical Parametric Mapping Sridhar Reddy, B.S. Nese Direk, M.D. (SPM) Analysis of SPECT NR5‑21 Images in Traumatic Brain Injury NR5‑04 Patients The Impact of the 2003 Duty Emotional Processing Deficits in Hyun Jin Jung, M.D. Hours Regulations on National Patients With a First Episode of Psychiatry Board Pass Rates Major Depressive Disorder: An NR5‑13 Gaurav Jain, M.D. fMRI Study A Systematic Review of the NR5‑22 Jianying Li, M.Med. Management of Impulse Control Disorders in Parkinson’s Efficacy of Haloperidol vs. NR5‑05 Disease Patients Levosulpiride Injection in The Effect of Antidepressant Rohini Ravindran, M.D. Patients With Acute Psychosis: Administration on Awakening A Randomized Double-Blind Cortisol Level NR5‑14 Study Wonwoo Kim, M.D. Case Report of a Young Female Sagar Lavania, M.D. With Catatonia and Pneumonia NR5‑23 NR5‑06 Responding Rapidly to Right An Unusual Case of Unilateral Ultra‑Brief Pulse Polysomnographic Predictors CPAP‑Induced Mania Electroconvulsive Therapy of Response to Milnacipran in Depression Richa Aggarwal, M.D. Kevin Holleman, D.O. Sagar Lavania, M.D.

165th Annual Meeting 203 NR5‑24 NR5‑33 NR5‑42 Antipsychotic Use and Inpatient Psychiatric Manifestations of Delusional Parasitosis Induced Admissions at the VA; What is H.Pylori: A Case Report by Methylenedioxypyrovalerone the Relationship? Sadia Ghaffar, M.D. (MDPV) Stephanie Peglow, D.O. Arlenne Shapov, M.D. NR5‑34 NR5‑25 NR5‑43 Dose‑Related Effect of Multiple Episodes of Acculturation on Suicidal BDNF and S100B in Rhabdomyolysis in a Patient Ideation and Attempts Among Schizophrenia Spectrum With Schizoaffective Disorder, Hispanics Living in the US Disorders: Associations With Induced by Paliperidone, M. Mercedes Perez-Rodriguez, M.D., Symptomatology and Treatment Ziprasidone, Quetiapine and Ph.D. Responsiveness Haloperidone Noortje Van De Kerkhof, M.D. Kapila Marambage, M.D. NR5‑35 NR5‑44 Is There an Association NR5‑26 Between First Episode of A Study of Health Hair Loss Associated With SSRIs Psychosis and Polycythemia Communications: How Well Do Sadia Ghaffar, M.D. Vera?: A Case Report Psychiatrists Communicate at Syed Hussaini, M.D. the Time of Initial Diagnosis of NR5‑27 Schizophrenia? NR5‑36 Efficacy of Adjunctive Treatment Gretchen Barnas, M.D. of Schizophrenia With A Case Report of a 47 Year‑Old NR5‑45 Celecoxib: A Systematic Review Woman With Myxedema Pamela Ramos, M.D. Madness Status Post Vaptans: A Potential New Radioiodide Ablation for Grave’s Approach for Treating Chronic NR5‑28 Disease Hyponatremia in Psychotic Patients Valproate Serum Concentrations David Edgcomb, M.D. Following a Single 500 mg Test Dawn Filmyer, M.S. NR5‑37 Dose NR5‑46 Aarti Gupta, M.B.B.S What Predicts Neuropathic Pain in Severely Alcohol Dependent Reductions in Falls and NR5‑29 Subjects? Medical Costs Associated With Vaptan‑Corrected Chronic Rapid Treatment of Depression Tulasi Kanukuntla, M.D. Hyponatremia in Psychotic in Patients Receiving Hospice MONDAY, MAY 7 Inpatients

NEW RESEARCH NR5‑38 Care With Methylphenidate and Ketamine Religion, Spiritual Beliefs and Alexander Geboy, M.S. Expectations of Treatment Steve Koh, M.D. NR5‑47 Matej Markota NR5‑30 Suicide in Schizophrenia: NR5‑39 Relation to Drug Treatment and Hyponatremia Directly Caused Side Effects by Atypical Antipsychotics: Standardization of the Korean a Retrospective Study and version of the Post‑Traumatic Johan Reutfors, M.D. Literature Review for Quality Emitterment Disorder NR5‑48 Improvement Self‑Rating Scale Mehnaz Waseem, M.D. Cheolmin Shin, M.D. Functional Status Rating Scales as Predictors of Everyday NR5‑31 NR5‑40 Functioning in People With Schizophrenia: Global vs. The Impact of the Psychiatric Future Challenges in Psychiatry Subscale Ratings Consultation/Liaison Service on Alexander Nawka, M.D. Healthcare Outcomes Samir Sabbag, M.D. Lance Feldman, M.D. NR5‑41 NR5‑49 Influencing Controlled NR5‑32 Predictors of Community Substance Prescribing: Integration in Older Adults With Delirium in Centenarians: A Two Attending and Resident Schizophrenia Case Series Physician Use of a State Carolina Jimenez, M.D. Antonio Nascimento, M.D. Prescription Monitoring System Lance Feldman, M.D.

204 www.psychiatry.org NR5‑50 NR5‑58 NR5‑67 From Community Integration Food Insecurity, Nutritional Risk The Benefits of a Cambodian To Successful Aging In and Utilization of Psychiatric Health Promotion Program Schizophrenia Emergency Services Sarah Berkson, B.A. Carolina Jimenez, M.D. Lauren McGuire, B.S. NR5‑68 NR5‑51 NR5‑59 Long‑Term Improvement in Security of Attachment Across Ethnic Disparities in Child Self‑Injurious Behavior and Axis I Diagnoses in Psychiatric and Adolescent Patients Continual Stabilization of Mood Inpatients Who Present to Psychiatric Symptoms Over Three Years of Eeva Mikkola, M.D. Emergency Services Maintenance ECT in an Autistic David Seigler, M.D. Child NR5‑52 Katherine Lubarsky, B.A. NR5‑60 BDNF Plasma Levels and NR5‑69 Cognitive Function of Muscle Dysmorphia in Brazilian Schizophrenic Patients in Weightlifters: Prevalence and Exploring the Impact of Treatment With Second Clinical Characteristics Maternal Stress Exposure on Generation Antipsychotics Milena França, M.D. Fetal Adrenal Volumes Rodrigo Nieto, M.D. Samantha Powell NR5‑61 NR5‑53 NR5‑70 Violence, Mental Illness, and the Course of Depression Media: Just How Bad is it? A Case of Clozapine Induced Among Older Adults With George Annas, M.D. Acute Renal Failure Schizophrenia: A 4‑Year Na‑Young An, M.D. Follow‑Up NR5‑62

Helen Ryu, M.D. NR5‑71 RESEARCH NEW

Investigations for Relationship 7 MAY MONDAY, Between Stress and Depression More Severe Longitudinal NR5‑54 in Health Promotion Center Bipolar Illness Course Venous Thromboembolism Inbo Shim, M.D. Associated With Early Life in a Patient With Catatonic Stress in BDNF Met Allele Schizophrenia Treated With NR5‑63 Carriers But Not Non‑Met Allele Clozapine. A Case Study and Carriers The Safe Haven Program: A Review of Recommendations on Model for Improving Outcomes Shefali Srivastava, M.D. Risk Assessment for Undomiciled Patients With

Kapila Marambage, M.D. Serious Mental Illnesses NR5‑55 Victoria Brown‑Nyseth, M.D. Comparison of Heart Rate NR5‑64 Variability Indices Between The Effectiveness of Residential Obstructive Sleep Apnea Care for Combat Related PTSD Syndrome and Primary Insomnia in an Active Duty Military Jiwon Nam, M.D. Population NR5‑56 Adeniyi Alatise, M.D. Bone Health and Nutritional NR5‑65 Status in Children With Comparison of Four Intellectual Disability in Pakistan Commonly‑Used Sleep Mohsin Cheema, M.B.B.S Medications NR5‑57 Adeniyi Alatise, M.D. Changes in Brain Activity Among NR5‑66 Sleep Deprived Physicians The Use of Mentalization in Vincent Capaldi, M.D. Outpatient Psychiatric Clinic. Residents’ Capacity to Think Psychologically Improve Their Obtain your Certificate of ! Patient‑Doctor Interaction Attendance for the 2012 APA Annual Meeting at www.psych. Magdalena Romanowicz, M.D. org/AnnualMeetingCME

165th Annual Meeting 205 Poster Session 6, Monday 11:00 AM This is for theNR TOC. Keep on pasteboard with 2 points overlap into live area.

Yong-Ku Kim, M.D. NR6‑15 Comparison of Outcomes NR6‑07 in Patients With Early Active Medical and Psychiatric Phase Versus Later Phase Comorbidities in Adult Schizophrenia 6 Schizophrenic Inpatients: Holland Detke, Ph.D. Poster Session 6 Impact on Length of Stay Monday, May 7 Javad Moamai, M.D. NR6‑16 Effect of Adding NR6‑08 11:00 am‑12:30 pm Lisdexamfetamine Dimesylate Assessment of Change in Body to Antipsychotics on Exhibit Hall C‑E, Level 2 Weight After Antipsychotic Predominant Negative Pennsylvania Convention Center Treatments is Confounded By Symptoms of Schizophrenia: Regression to the Mean Analysis of PANSS Factors Jane Xu, Ph.D. Bryan Dirks, M.D.

Schizophrenia and Other NR6‑09 NR6‑17 Psychotic Disorders Real‑World Use Patterns The Effectiveness of of Olanzapine Long‑Acting Paliperidone Extended‑Release Injection (ER) in Improving Subjective NR6‑01 Michael Case, M.S. Symptoms in Patients With Lurasidone for the Acute Schizophrenia Treatment of Adults With NR6‑10 Chul-Eung Kim, M.D. Schizophrenia: What is the NNT, Novel System for Monitoring NNH and LHH? Quality and Consistency of NR6‑18 Leslie Citrome, M.D. Interview Technique and Ratings Efficacy and Safety of in Global Schizophrenia Clinical Paliperidone Extended NR6‑02 Trials Release (ER) in Schizophrenia Clinical Functional Dimensions David Daniel, M.D. Patients Requiring a Switch in and Cognitive Functions in Antipsychotic Medication Female Schizophrenic Patients NR6‑11 Young Moon, M.D. Ioana Valentina Miclutia, Ph.D. Effect of Body Mass Index on Metabolic Events in Patients NR6‑19 NR6‑03 With Schizophrenia During Suicide History as a Moderator

MONDAY, MAY 7 Adherence to Medication in Long-Term Treatment With of Effect of Paliperidone ER on NEW RESEARCH Patients With Schizophrenia Paliperidone Palmitate Depressive Symptoms in Adults or Schizoaffective Disorder With Schizoaffective Disorder: Jennifer Sliwa, Pharm.D. Included in the PRECOG Study. Results of a Path Analysis A Three Year Survey NR6‑12 Ibrahim Turkoz, M.S. Mario Pena, M.D. Building a Team Involved in NR6‑20 NR6‑04 Prevention and Treatment First Controlled Study of of Primary Polydipsia in a Efficacy and Effectiveness of a Long‑Acting Injectable Psychiatric Outpatient/Inpatient Depot vs. Oral Antipsychotics Antipsychotic for the Population: A Pilot Study in Schizophrenia: Synthesizing Maintenance Treatment of Results Across Different Peter Szymczak, M.D. Schizoaffective Disorder: Research Designs Baseline Data NR6‑13 Noam Kirson, Ph.D. Dong-Jing Fu, M.D. TRIES: An Open, Randomized, NR6‑05 Prospective, Multicenter Study, NR6‑21 Searching the Best Switch Patient Satisfaction and Timing of Risperidone Policy of Sertindole in Patients Caregiver Burden Related to Long‑Acting Injection With Schizophrenia Olanzapine Long‑Acting Injection Initiation in Newly Diagnosed Koksal Alptekin, M.D. David McDonnell, M.B. Schizophrenia Patients in the Veterans Health Administration NR6‑14 NR6‑06 Pesa Jacqueline, Ph.D. Psychotherapeutic Approach of Adjunctive Treatment of Bimodal Primary Polydipsia in Psychiatric TMS in Pharmacologically Outpatient Population: A Pilot Non‑Responsive Patients With Study Schizophrenia Varinderjit Parmar, M.D.

206 www.psychiatry.org NR6‑22 NR6‑31 NR6‑38 Remission With Continued How Related are Obsessive Adding Lisdexamfetamine Paliperidone Palmitate Compulsive Disorder and Dimesylate to Antipsychotics: Treatment in Stable Subjects Schizophrenia? A Familial Does Functional Capacity With Schizophrenia Aggregation Study From Danish Improve in Tandem With Joseph Hulihan, M.D. Health Registry System Negative Symptoms of Hale Yapici Eser, M.D. Schizophrenia? NR6‑23 Jean-Pierre Lindenmayer, M.D. NR6‑32 Achievement of Remission Is NR6‑39 Similar With Iloperidone and Cognitive Performance in Haloperidol: A Meta‑analysis Patients With Schizophrenia Safety and Tolerability of of 3 Year‑Long, Double‑Blind Treated With Lurasidone: Results Switching to Asenapine From Studies From a 6‑Week Core Study and 6 Other Antipsychotic Agents in Marla Hochfeld, M.D. Month Double‑Blind Extension Stable Patients With Persistent Cynthia Siu, Ph.D. Negative Symptoms NR6‑24 Armin Szegedi, M.D. NR6‑33 Characteristics of Medicaid NR6‑40 Patients Initiating Paliperidone The Effect of Modified Palmitate Compared With Oral Electroconvulsive Therapy Dose-Response Model of Atypical Antipsychotics on EEG Gamma Activities in Lurasidone Treatment in Elaine Morrato, D.P.H. Patients With Schizophrenia Schizophrenia Masatomo Suetsugi, M.D. Sunny Chapel, Ph.D. NR6‑25 NR6‑34 NR6‑41 Characteristics Associated With Antipsychotic Drug Adherence Adjunctive Lisdexamfetamine Efficacy of Aripiprazole

Among Schizophrenic Patients Dimesylate With Antipsychotics: Intramuscular Depot RESEARCH NEW in a US Managed Care Effects on Negative Symptoms of (ARI‑IM‑Depot) for the 7 MAY MONDAY, Environment Schizophrenia and Self‑Reported Long‑Term Maintenance Bruce Wong, M.D. Executive Function Treatment of Schizophrenia Henry A. Nasrallah, M.D. John Kane, M.D. NR6‑26 NR6‑35 NR6‑42 The Severity and Demographics of Schizophrenia Patients Switching to Aripiprazole Patient‑Reported Outcomes Switching to Depot Decreases Non‑HDL‑C Levels With Aripiprazole Intramuscular

Antipsychotic Agents in Patients With Schizophrenia Depot (ARI‑IM‑Depot) for Dario Mirski, M.D. or Bipolar I Disorder Who Long‑Term Maintenance Have Pre‑Existing Metabolic Treatment in Schizophrenia NR6‑27 Syndrome Raymond Sanchez, M.D. Barriers to the Utilization Zia Rahman, Ph.D. NR6‑43 of Long‑Acting Injectable NR6‑36 Antipsychotics in Schizophrenia Effect of 12 Months of Dale D’Mello, M.D. Effectiveness of Lurasidone Lurasidone on Weight in vs. Quetiapine XR for Relapse Subjects With Schizophrenia NR6‑28 Prevention in Schizophrenia: A Jonathan Meyer, M.D. 12-Month, Double-Blind Study Time Course of Dropout Rates in NR6‑44 Schizophrenia Trials Conducted Antony Loebel, M.D. from 1966 to 2010: A Systematic Effects of a Long‑Acting NR6‑37 Review and Meta‑Analysis Injectable Formulation of Ofer Agid, M.D. Long-Term Safety and Aripiprazole on Secondary Effectiveness of Lurasidone Efficacy Outcomes in NR6‑29 in Schizophrenia: Results Maintenance Treatment of of a 22-Month, Open-Label Schizophrenia Are Patients With Schizophrenia Extension Study Happy? William Carson, M.D. Robert Silva, Ph.D. Ofer Agid, M.D.

NR6‑30 Clinical Decision‑Making in Outpatient Mental Health Care Malene Krogsgaard Bording

165th Annual Meeting 207 Poster Session 7, Monday 2:00 PM This is for theNR TOC. Keep on pasteboard with 2 points overlap into live area.

NR6‑45 NR6‑52 Economic Impact of Safety and Tolerability of Relapse‑Related Hospitalization Lurasidone in Seven Short- in Adults With Schizophrenia Term Schizophrenia Trials: Using Data From 12‑Month A Comprehensive Database Double‑Blind Lurasidone vs. Analysis 7 QuetiapineXR Study Andrei Pikalov, M.D. Poster Session 7 Krithika Rajagopalan, Ph.D. Monday, May 7 NR6‑53 NR6‑46 The Utility of MMPI‑2 for Switching to Lurasidone in Assessment in Patients With New Research Patients With Schizophrenia: Schizophrenia and Depression Tolerability and Effectiveness of 2:00 pm‑ 3:30 pm Min-Cheol Park, M.D. Three Switch Strategies Exhibit Hall C‑E, Level 2 Joseph McEvoy, M.D. NR6‑54 Pennsylvania Convention Center NR6‑47 Switching from Olanzapine to Lurasidone: Results From a Assessing Medication 6-Month Open Label Extension Treatment and Services Adherence and Healthcare Study Utilization and Costs Patterns Stephen Stahl, M.D. Among Hospital Discharged NR7‑01 Patients With Schizoaffective NR6‑55 Disorder Attachment Security Michael C. Markowitz, M.D. Personality Disorders in Independently Predicts Psychiatric Inpatients in Sweden Problematic Drug Use in Low NR6‑48 Emma Bjorkenstam, B.S.C. Income, Suicidal, Abused, African American Women i‑FANS Study Design NR6‑56 to Evaluate Iloperidone Suena Massey, M.D. 12‑24mg/d After Gradual Personality Disorders and or Immediate Antipsychotic Suicide in Young Individuals in NR7‑02 Sweden Switch in Suboptimally Treated Factors Determining Successful Schizophrenia Patients Charlotte Bjorkenstam, M.S.C. Smoking Cessation in Bipolar Peter Weiden, M.D. Disorder: Interim Look NR6-57 Annette M. Matthews, M.D.

MONDAY, MAY 7 NR6‑49 Decreased Plasma Methionine- NEW RESEARCH The schizophrenia With Criminal Enkephalin Levels In Cluster NR7‑03 Headache Patients History Subgroup: Associated Exposure to Drug-Related Aron Mosnaim, Ph.D. Clinical and Neurocognitive “People, Places and Things” Characteristics NR6‑58 Via Online Social Networking Giovanna Musso, Ph.D. Sites Among Adolescents in Non‑Epileptic Seizures vs. Substance Abuse Treatment NR6‑50 Panic Disorder in Patient With David Tran, B.A. Pervasive Developmental Safety and Tolerability of Disorder Cariprazine in the Long‑Term NR7‑04 Lidija Petrovic-Dovat, M.D. Treatment of Schizophrenia: Study of Interface Between Results From a 48‑Week NR6‑59 Alcohol Dependence and Extension Study Depression: Diagnosis and Andrew Cutler, M.D. The Impact of Shift Duration Phenomenology on the Efficacy and Tolerability Amresh Shrivastava, M.D. NR6‑51 of Armodafinil in Patients With Excessive Sleepiness Associated Efficacy of Lurasidone in NR7‑05 With Shift Work Disorder Schizophrenia: Factor Analysis John Harsh, Ph.D. Recommendation‑Concordant of Short-Term Trials Management of Metabolic Josephine Cucchiaro, Ph.D. NR6‑60 Side Effects Associated With Antipsychotic Use in Veterans Behavioral Activation Therapy in Dinesh Mittal, M.D. Medication‑Responsive Chronic Depression With Persistent Psychosocial Dysfunction: A Pilot Study David J. Hellerstein, M.D.

208 www.psychiatry.org Poster Session 7, Monday 2:00 PM This is for theNR TOC. Keep on pasteboard with 2 points overlap into live area.

NR7‑06 NR7‑14 NR7‑23 Low Dose Naltrexone‑Clonidine Buproprion SR and Improvements in Citalopram Treatment and Tobacco Harm Reduction vs. Sexual Dysfunction by Switching Smoking During Opioid Abstinence‑Focused Treatment to Escitalopram Detoxification for Problem Gambling Andres Avellaneda Ojeda, M.D. Paolo Mannelli, M.D. Nitigna Desai, M.D.

NR7‑07 NR7‑15 NR7‑24 Curtailing Antipsychotic Organization of Stop Smoking Effectiveness of Addiction Polypharmacy in a State Units in Turkey; Preparations and Pharmacotherapy in a Institution: Revisiting an Recent Decisions by Ministry of Community Treatment Program Intervention After Ten Years Health From 2008‑2012 David Lott, M.D. Jeffry Nurenberg, M.D. Derya Iren Akbiyik, M.D. NR7‑16 NR7‑25 NR7‑08 Cognitive Task Performance and Drug Utilization Patterns for Hot and Spicy: A Look into Alcohol Usage in Young Adults Paliperidone Palmitate in the Profound Disinhibition, Arit Harvanko, B.A. Medicaid Patients Aggression, and Paranoia of a Previously High Functioning NR7‑17 Erik Muser, Pharm.D. Sailor Following “Spice” Use Antipsychotic Dose Escalation NR7‑26 Robert Lovern, M.D. Prior to the Development of Neuroleptic Malignant N‑Acetyl Cysteine Reduces NR7‑09 Syndrome (NMS) Aggressive Behavior in Chronically Hospitalized The Cost Effectiveness of Julie Langan Mentally Ill Patients Treatment With Extended- NR7-18 Swapnil Gupta, M.B.B.S Release Naltrexone: A Structured RESEARCH NEW Review Across Four Studies 7 MAY MONDAY, Effectiveness vs. Efficacy NR7‑27 Dennis McCarty, Ph.D. Rankings by a Modified PRECIS Tool for Schizophrenia Trials of Effect of Modafinil Compared NR7‑10 Long-Acting Injectable vs. Daily With Caffeine on Preattentive Auditory Processing as Safety and Effectiveness of Oral Antipsychotic Treatments Reflected by Mismatch Treatment With a Once-Monthly, Cynthia A. Bossie, PhD Negativity (MMN) Injectable Formulation of Naltrexone in a Real-World NR7‑19 In Won Chung, M.D.

Clinical Practice Setting Can a Computer Administer NR7‑28 Bernard Silverman, Ph.D. the MADRS? Comparison With Site‑Based Raters in Three Treatment Patterns, Healthcare NR7‑11 Global Clinical Trials Utilization and Cost Among Patients With Major Depressive Open-Label Study of Extended- Gary Sachs, M.D. Disorder (MDD) Treated With Release Injectable Naltrexone NR7‑20 Antidepressants (XR-NTX) in Healthcare Professionals With Opioid Extrapyramidal Symptoms Keith Isenberg, M.D. Dependence in Recovered First Episode NR7‑29 Paul Earley, M.D. Schizophrenia Patients at Ten Years A Survey of Patient’s Medication NR7‑12 Amresh Shrivastava, M.D. Knowledge at Time of Discharge: A Benchmark and an Injectable Extended-Release NR7‑21 Update Naltrexone (XR-NTX) for Opioid Dependence: Long-Term Safety Atypical Antipsychotics Usage in Ronald Rosenberg, M.D. and Effectiveness Long‑Term, Ten Year’s Follow Up David R. Gastfriend, M.D. of First Episode Schizophrenia Amresh Shrivastava, M.D. NR7‑13 ! APA 2012 Annual Varenicline In Outpatient NR7‑22 Meeting On Demand Psychiatric Heavy Smokers Use of Lisdexamfetamine • Special onsite pricing Faruk Abuzzahab, M.D. Dimesylate in Treatment of • Earn CME Credit for top Cognitive Impairment and lectures and symposia online Fatigue: A Double Blind, • For more information: Placebo Controlled Study Joel Young, M.D.

165th Annual Meeting 209 NR7‑30 NR7‑38 NR7‑45 Evaluating the Safety and Concordances in Normal Cultural Mistrust and Metabolic Profile of Vyvanse Clinical Practice With the Psychopathology in African for the Treatment of ADHD in Spanish Clinical Consensus Americans Euthymic Adults With Bipolar I/ Recommendations for William B. Lawson, M.D., Ph.D. II Disorder Improving Treatment Adherence Roger S. McIntyre, M.D. in Schizophrenia NR7‑46 Mario Pena, M.D. Treatment of Depression in NR7‑31 Latino Women: Relevance of NR7‑39 Effect of Lurasidone on Activation and Self Management Depressive Symptoms in Antipsychotic Drug Adherence Training Patients With Schizophrenia Correlates With Hospitalization Laura Safar, M.D. Henry A. Nasrallah, M.D. Rates and Length of Stay among Medicare and Non‑Medicare NR7‑47 NR7‑32 Schizophrenia Populations Pilot Survey of Cognitive Ventricular Fibrillation Arrest Ross Baker, Ph.D. Behavioral Psychotherapy With Therapeutic Venlafixine (CBT) Supervisors to Determine NR7‑40 Dosing: A Case Report Their Supervisory Practice and Mayuri Hassano, M.Psy. Drug Compliance and Learning Needs Associated Outcomes in Diana Kljenak, M.D. NR7‑33 Schizophrenia Patients Before and After the Initiation of Depot NR7‑48 Using an EMR to Improve Antipsychotic Agents Metabolic Monitoring for Tattoos in the United States Patients on Antipsychotic Steve J. Offord, Ph.D. Armed Forces Medicines: An Interdepartmental NR7‑41 Bhagwan Bahroo, M.D. Interdiciplinary Quality Project

Ronit Dedesma, M.D. Patient Characteristics of NR7‑49 Paliperidone Palmitate Users A Case of Grave’s Disease NR7‑34 and Oral Second Generation Treated by a Psychiatric ACT Antipsychotic Users in the South Treatment of Clozapine Induced Team Carolina Medicaid Program Sialorrhea With Bupropion ‑ A Mary Woesner, M.D. Case Series Meera Narasimhan, M.D. Robert Stern, M.D. NR7‑42 NR7‑50 Medical Clearance for MONDAY, MAY 7 Improvement in the Language

NEW RESEARCH NR7‑35 Psychiatric Patients in Function of a Patient With Rates of Monitoring for the Emergency Room: A Autism Spectrum Disorder After Metabolic Side Effects of Literature Review and Future Treatment With Transcranial Antipsychotics at 32 VA Medical Recommendations Magnetic Stimulation: A Case Centers Report Deepa Hasija, M.D. Richard Owen, M.D. Matisyahu Shulman, B.A. NR7‑51 NR7‑36 NR7‑43 Understanding Barriers to Evaluation of Metabolic Metabolic Screening for People Depression and History of Laboratory Monitoring and With Severe Mental Illness: Suicide Attempts are Risk Co‑morbid Metabolic Conditions A Survey of Psychiatrists and Factors for Pregnancy Among in Members of a Managed Primary Care Providers Adolescent Girls in Bolivia: A Medicaid Plan Using Atypical Case‑Control Study Aishat Giwa, B.A. Antipsychotics Rosario Martinez‑Saravia, M.D. Lisa Werner, D.O. NR7‑52 NR7‑44 Meeting the Needs of Veterans NR7‑37 With Gambling Problems The Status and Perceptions Ginsana‑115 Effect on of Mental Health in Marriage Nitigna Desai, M.D. Framingham Risk Score Immigrants and Their Children in Schizophrenia Patients in Korea NR7‑53 Maintained on Atypical Homelessness and Recovery Anti‑Psychotics: A Posthoc Yong-Chon Park, M.D. from the Perspectives of People Analysis of RCT With Dual Diagnosis Simon Chiu, M.D. Maria Mananita Hipolito, M.D.

210 www.psychiatry.org Tuesday’s Poster Sessions Poster Session 8, Tuesday 9:00 AM This is for the main TOC. Keep on This is for theNR TOC. Keep on pasteboard with 2 points pasteboard with 2 points overlap into overlap into live area. live area.

NR7‑54 NR8‑07 Social Adjustment of Effect of Symptom Severity on First‑Episode Schizophrenia Amygdala and Hippocampus Patients: Stability During a Year Volumes in Youth With and at of Treatment High Risk for Bipolar Disorder Swapnil Gupta, M.B.B.S 8 Erica Sanders, B.A. Poster Session 8 NR7‑55 Tuesday, May 8 NR8‑08 Two‑Year Prospective Study of Mortality in Eating Disorders Patients of Schizophrenia in Jaana Suokas, M.D. a Community Mental Health New Research Center in Korea NR8‑09 9:00 am‑10:30 am Sohn Jee Hoon, M.D. Effectiveness of Exhibit Hall C‑E, Level 2 Telepsychiatry‑Based Culturally NR7‑56 Pennsylvania Convention Center Sensitive Collaborative An Initial Evaluation of the Treatment for Depressed Chinese Intensive Case Management Americans in Primary Care Services in a Recovery‑Based Albert Yeung, M.D., ScD. Program: Opening Doors to Psychiatric Recovery in Southeast Georgia Subspecialities NR8‑10 Thomas Reed, B.S. A Validation Study of a Proposed DSM‑V Diagnostic NR7‑57 NR8‑01 Entry: Disruptive Mood Reading is Associated With Brief Rating of Aggression Dysregulation Disorder Better Outcome Through by Children and Adolescents David Pogge, Ph.D. Increased Ocular Illuminance (BRACHA): A Reliability Study During Light Treatment Drew Barzman, M.D. NR8-11 Aamar Sleemi, M.D. Prevalence and Precursors NR8‑02 of the Use of Restraint NR7‑58 Asthma and Suicidality Among and Seclusion in a Private Measuring Global Mental Adolescents in the Youth Risk Psychiatric Hospital: Health, Multi‑Morbidity Burden, Behavioral Survey Comparison of Child and Pain‑Impairment, and Functional Ivan Aldea, M.D. Adolescent Patients Performance in Subjects With Stephen Pappalardo, B.A. TBI and Chronic Pain NR8‑03 Armando S. Miciano, M.D. Geographic Moves and Mental NR8‑12 Health Service Use Among US Lower Rates of Publication NEW RESEARCH NEW

NR7‑59 8 MAY TUESDAY, Military Children About Delirium in Pediatrics Response to PGY‑1 Resident Jeffrey Millegan, M.D. Versus Child and Adolescent Physician Suicide at an Psychiatry Journals From Academic Institution NR8‑04 2001‑2011 Christina Girgis, M.D. Overlapping Symptoms and Patrick Kelly, M.D. Diagnostic Dialemma in Autism Spectrum Disorder vs. Bipolar NR8‑13 Disorder in Children and Adolescents’ Beliefs About

Adolescents Medication, Family Beliefs, Garima Singh, M.D. and Therapeutic Alliance With Their Doctors: Predictors NR8‑05 of Adherence to Prescribed Psychiatric Gender‑Specific Association of Norepinephrine Transporter Fayez El Gabalawi, M.D. Polymorphisms in Attention Deficit‑Hyperactivity Disorder NR8‑14 Yong-Ku Kim, M.D. Help Seeking Behaviors Among ! Program changes are printed Adolescents With Self Harm: each day in the Daily Bulletin NR8‑06 Representative Self‑Report which can be picked up in the Survey of 18104 Students Pennsylvania Convention Center. Changes in the ICNDS Between Norio Watanabe, M.D. A mobile application will also be Two Visits in 762 Youth With available. Epilepsy Diana Lorenzo, M.D.

165th Annual Meeting 211 NR8‑15 NR8‑24 NR8‑32 Determining an Optimal Cut Off A 3 Years Survey of Quetiapine The Evaluation of Primary Score for the WFIRS-P Using in the Treatment of Dementia Idiopathic Focal Hyperhidrosis ROC Curve Analysis Patients With Psychotic Patients in Terms of Alexithymia Trevor Thompson, Ph.D. Symptoms in Taiwan and Temperament and Character Hsinte Huang, M.D. Properties NR8-16 Mehmet Ak, M.D. NR8‑25 Moderators of Efficacy NR8‑33 and Adverse Events During Correlation Between Gray Aripiprazole Treatment of Matter Volume of Temporal Benefit/Risk Analysis of Pediatric Bipolar I Disorder Lobe and Depressive Symptoms Olanzapine Long-Acting Kiki Chang, M.D. in Patients With Alzheimer’s Injection at 1 and 2 Years of Disease Treatment in Clinical Trials of NR8‑17 Ji Hyun Son, M.D. Schizophrenia Time of Onset and Resolution John Lauriello, M.D. NR8‑26 of Common Adverse Events in NR8‑34 the Aripiprazole Treatment of Joining Extremes‑Uniendo Pediatric (10–17 Years) Bipolar I Extremos Educational Workshop Collaborative Models of Disorder in Alzheimer Disease for Pre Carefor Medical Inpatients Benjamin Goldstein, M.D. Adolescent Children in the US With Psychiatric Disorders: A Mexico Border Systematic Review NR8‑18 Bernardo Ng, M.D. Maria Hussain, M.B.B.S Use of the Test of Emotion NR8‑27 NR8‑35 Comprehension in Children With Attention‑Deficit Hyperactivity Correlation Between Attitude Original Research: Treating Disorder Toward Gays and Lesbians in Sleep Disorders Has Positive Alfredo Minervino, M.D. Colombian Medical Students Outcomes in Psychiatric Edwin Herazo, M.D. Illnesses NR8‑19 Umesh Vyas, M.D. NR8‑28 A Novel Method for Improving NR8‑36 Diagnostic and Efficacy Reliability and Validity of the Assessments in Child Homophobia Scale Among An Analysis of the Efficacy Psychiatric Multinational Colombian Medical Students and Tolerability of Armodafinil Clinical Trials Heidi Oviedo, M.D. in Healthcare Workers Joan Busner,Ph.D. With Excessive Sleepiness NR8‑29 Associated With Shift Work NR8‑20 Disorder Critical Success Factors

Anxiety and Depression Among in Implementing Case Richard Bogan, M.D. Parents of Children With Mental Management in Tertiary NR8‑37 Retardation Psychiatric Care Muhammad Waqar Azeem, M.D. Rathi Mahendran, M.B.B.S Zolpidem Tartrate Sublingual Tablet C‑IV: PK/PD Profile Supports Middle- NR8‑21 NR8‑30 of-the-Night Dosing of 1.75 Mg in Women and 3.5 Mg in Men Children’s Psychiatric Hospital ADHD is a Notable Initiatives in Reducing Characteristic of Patients David Greenblatt, M.D. TUESDAY, MAY 8

NEW RESEARCH Restraints and Providing Trauma Suffering From Chronic Lyme Informed Care Disease: A Survey of Adults NR8‑38 Muhammad Waqar Azeem, M.D. at the Michigan Lyme Disease Association Conference Serious or Undiagnosed NR8-22 Joel Young, M.D. Medical Conditions With Bipolar Disorder Preventing Clinical Trial Greater Hippocampal Volume is NR8‑31 Randomization: A Case Series Related to Increased Empathy in Anorexia Nervosa Outcome of Admission Trisha Suppes, M.D.. Ph.D. Hyponatremia Among Janelle Beadle, Ph.D. NR8‑39 Psychiatric Inpatients NR8‑23 Kevin Ray, M.D. Evaluation of Affective Temperaments in Patients With Selective Discharge of Male Vocal Nodules Suicide Attempters from Psychiatric Emergency Room Selcuk Aslan, M.D. Evan Gilmer, B.A.

212 www.psychiatry.org Poster Session 9, Tuesday 11:00 AM This is for theNR TOC. Keep on pasteboard with 2 points overlap into live area.

NR8‑40 NR9‑06 Cigarette Smoking, Chronic Pain Indicators of and Disability in Hospitalized Neurodevelopmental, Depressed Patients Neurocognitive, Neuromotor Joseph Rieman, D.O. Abnormalities and Stress 9 Sensitivity Response in NR8‑41 Poster Session 9 Schizophrenic Offspring Deep Brain Stimulation and Tuesday, May 8 Adel Elsheshai, M.D. Mood in Parkinson’s Disease: A NR9‑07 Prospective Follow‑Up Study New Research Electroconvulsive Amit Chopra Therapy‑Induced Late‑Appearing 11:00 am‑12:30 pm Seizure in a Psychotic Patient NR8‑42 Exhibit Hall C‑E, Level 2 With Epilepsy Efficacy and Aafety Pennsylvania Convention Center Hsinte Huang, M.D. of Lu AA21004 in a Randomised, Double‑Blind, NR9‑08 Placebo‑Controlled, Effect of Aripirazole Compared Active‑Referenced, Fixed‑Dose Biological Psychiatry, With Caffeine on Preattentive Study in Elderly Depressed Neuroscience, Genetics, Processing as Reflected by Patients Mismatch Negativity (MMN) Christina Olsen, Ph.D. and Other Youn Tak, M.D. NR8‑43 NR9‑01 NR9‑09 The Association Between One Year High Remission Childhood Adversity and Genetic Variations and Rate With Vagus Nerve Subcomponents of Metabolic Synergistic Effects of COMT and Stimulation for Treatment Syndrome in Adults With Mood TPH2 on Social Cognition in Resistant‑Depression Disorders Healthy Individuals Elise LaGarde, R.N. Danielle Cha Chieh-Hsin Lin, M.D. NR9‑10 NR8‑44 NR9‑02 Residual Cognitive Impairment Escitalopram for Chronic Genetic Variability at IMPA‑2, in Euthymic Patients With Tension‑Type Headache in INPP‑1 AND GSK‑3b Increases Bipolar Disorder: A Study With Patients With Major Depressive the Risk of Suicidal Behaviour Functional Magnetic Resonance Disorder in Bipolar Patients Imaging (fMRI) Hyun Kim, M.D. Ester Jimenez M.Carlotta Palazzo, M.D. NEW RESEARCH NEW

NR9‑03 8 MAY TUESDAY, NR8‑45 NR9‑11 Gender Differences in Bipolar Operant Conditioning of Magnetic Resonance Disorder: Data on Illness Frontal‑Limbic Pathways in Spectroscopy in Adults With Severity and Treatment Rodents: First Steps Towards a Borderline Personality Disorder Strategies of Patients Diagnosed Closed‑Loop Psychiatric Neural With a Manic/Mixed Episode Prosthesis Alaa Houri, B.S. Alik Widge, M.D. Francisco Linares, M.D. NR9‑12 NR9‑04 NR8‑46 Obsessive‑Compulsive Disorder (OCD): Increase of White Matter Incorrect Diagnosis and D‑Cycloserine Improves Tissue Within the Left External Ineffective Treatment of Sociability and Spontaneous Capsule – A Voxel‑Based Attention Deficit Hyperactivity Stereotypic Behaviors in 4‑Week Morphometric MRI study (ADHD) May Decrease Old Mice Children’s IQ, The Efficacy of Stephen I. Deutsch, M.D., Ph.D. Thomas Sobanski, M.D. QEEG and Neurofeed NR9‑13 Tanju Surmelli, M.D. NR9‑05 Lithium-Response in Bipolar Enlarged Thalamic Volume Disorder is Associated With Found in Children But Not Genetic Variability at IMPA2 and Adults With Autism Spectrum INPP1 Genes Disorder Ester Jimenez Ish Bhalla, B.S.

165th Annual Meeting 213 NR9‑14 NR9‑22 NR9‑31 Comparison of Risperidone Neuropsychiatric Manifestations Quality of Life and Functional and Quetiapine in Alzheimer’s of Autoimmune Limbic Status Outcomes With TMS in Disease Patients With Encephalitis Routine Practice: A Pragmatic Behavioral and Psychological Rohini Ravindran, M.D. Clinical Trial in the Treatment of Symptoms Major Depression Kang Joon Lee, M.D. NR9‑23 Mark Demitrack, M.D. Musical Hallucinations and NR9‑15 NR9‑32 Cochlear Nucleus Infarcts IGF‑1, CRP and TNF‑a Role In Michael Serby, M.D. A Pooled Analysis of Vilazodone Post‑Operative Delirium in the Treatment of Major Mehmet Alper Cinar, M.D. NR9‑24 Depressive Disorder: Efficacy Across Symptoms Association Between Domains NR9‑16 of Depressive Symptoms Arif Khan, M.D. DTNBP1, HSPs and TAAR6 and Executive Dysfunction NR9‑33 Variations Influence Three Months Post Stroke: Schizophrenic Phenotype and the Influence of the Major Levomilnacipran in the Treatment Response Depressive Episode Treatment of Major Depressive Tae-Youn Jun, M.D. Matldes Sobreiro, Psy.D. Disorder: An Analysis of Efficacy Data From 2 Phase III Studies NR9‑17 NR9‑25 Anjana Bose, Ph.D. Differences of Selective DNA Effects of Antidepressants on NR9‑34 Methylation of BDNF Gene Neuropsychological Function Between Bipolar Patients and Related to Combat Performance Vilazodone in the Treatment Controls and Potential Influence Ralph Tuttle, D.O. of Major Depressive Disorder: of Pharmacological Treatments Effects on Weight and Bernardo Dell’Osso, M.D. NR9‑26 Laboratory Values Effects of Low‑Dose Michael E. Thase, M.D. NR9‑18 Quinidine on the Steady‑State NR9‑35 Investigating Telomere Length Pharmacokinetics Of and Psychological Stress in Dextromethorphan Predictors of Relapse in a South African Rape Victims Laura Pope, Ph.D. Fixed‑Dose, Randomized, Sian Hemmings, Ph.D. Double‑Blind, 52‑Week Relapse NR9‑27 Prevention Trial of Selegiline NR9‑19 Transdermal System (STS) Cognitive Functions of the Characteristics of Patients Depressive Patients Compared Saeheon Jang, M.D. Selected to Receive Genetic With Healthy Controls Through NR9‑36 Testing to Inform Psychiatric Meta‑Analysis Treatment Cheolmin Shin, M.D. Levomilnacipran in the Treatment Rachel Dicker, Pharm.D. of Major Depressive Disorder: An NR9‑28 Analysis of Safety and Tolerability NR9‑20 Data From 2 Randomized Memantine for Cognitive Placebo‑Controlled Trials Apolipoprotein E e4-e2 Alleles Deficits In Bipolar Disorder William Greenberg, M.D. Reduce the Age of Onset and Dan Iosifescu, M.D. Increase the Risk of Developing NR9‑37 TUESDAY, MAY 8

NEW RESEARCH Schizophrenia in Medellin, NR9‑29 Colombia: A Case-Cohort Study External Trigeminal Nerve Effect of the Multimodal Stimulation: Noninvasive Juan Arango, M.D. Antidepressant LU AA21004 Neuromodulation in Major on Recognition Memory and NR9‑21 Depression Hippocampal Plasticity in Rats Ian Cook, M.D. The Differences in Nasser Haddjeri, Ph.D. Characteristics of Bipolar NR9-38 and Schizophrenic Patients NR9‑30 Prematurely Dying from Assessment of Anxiety in Adults Lisdexamfetamine Dimesylate Circulatory Diseases With Fully or Partially Remitted in the Treatment of Cognitive Major Depressive Disorder Shang-Ying Tsai, M.D. Dysfunction in Patients With Receiving Lisdexamfetamine Partially or Fully Remitted Major Dimesylate Augmentation Depressive Disorder Therapy Richard Keefe, Ph.D. Robert Lasser, M.D.

214 www.psychiatry.org Poster Session 10, Tuesday 2:00 PM This is for theNR TOC. Keep on pasteboard with 2 points overlap into live area.

NR9-39 NR9‑47 Disease Patterns in Bipolar Results of Transcranial Disorder Patients Reveal Magnetic Stimulation (TMS) in Unmet Treatment Need in Latin a Naturalistic Clinical Setting: American Countries: Results a Biopsychosocial Integrated of a Large Ambispective Study Clinical Care Approach 10 (WAVE-bd) James Halper, M.D. Poster Session 10 Eduard Vieta, M.D. Tuesday, May 8 NR9‑48 NR9‑40 The Efficacy of Levomilnacipran Efficacy and Tolerability of in the Treatment of Major New Research Vilazodone in Patients With Depressive Disorder: Results Moderate, Moderately Severe, From a Phase III Clinical Trial 2:00 pm‑ 3:30 pm and Severe Depression – Pooled Carl Gommoll, M.S. Exhibit Hall C‑E, Level 2 Analyses From 2 Phase III Trials Pennsylvania Convention Center Donald Robinson, M.D. NR9‑49 NR9‑41 The Clinical Relevance of Results Achieved With Mania and Antisocial Personality Vilazodone in the Treatment of New Research Other Disorder Trends in Upper Middle Major Depressive Disorder Class Caucasian Adults John Edwards, M.D. Sally Blanco-Lutzen, B.A. NR9‑50 NR10‑01 NR9‑42 12‑Month, Open‑Label, Internet Addiction: A Review of Cariprazine in the Treatment Relapse‑Prevention Study Available Measures of Acute Mania in Bipolar of L‑methylfolate 15 mg as Jayce Fryman Disorder: A Double‑Blind, Adjunctive Therapy With SSRIs Placebo‑Controlled, Phase III Following Acute Remission of NR10‑02 Trial MDD Anju Starace, B.S.C. Selegiline Transdermal System John Zajecka, M.D. (STS) for Major Depressive NR9‑43 Disorder (MDD): Use Pattern, NR9‑51 Adherence, and Effect on Health A Randomized Controlled Predictors of Response Service Expenditures Trial of Escitalopram and and Remission During an David Sclar, Ph.D. Telephone‑Administered Open‑Label 10‑Week Trial With Psychotherapy in Major Selegiline Transdermal System NR10‑03 Depressive Disorder: Focus on (STS) A Comparison of Diagnostic Work Productivity RESEARCH NEW

Sungwon Jung, M.D. 8 MAY TUESDAY, Raymond W. Lam, M.D. Clarity Using the MINI and SCID in a Community Mental Health NR9‑44 Setting Obtain your Certificate of ! Raymond Kotwicki, M.D. The Relationship Between Attendance at: www.psych.org/ Personality Traits and Coping AnnualMeetingCME NR10‑04 Styles in Bipolar Patients and Their Caregivers Presenting for Adolescents at Risk of Family‑Inclusive Treatment Depressive Disorders:

Allison M. Lee, M.D. Prevalence and Associated Factor in Colombian Students NR9‑45 Zuleima Cogollo, R.N. A Pilot Study of Functional Outcome in Postpartum NR10‑05 Depression in Women Treated Mood Disorder Questionnaire With Desvenlafaxine for Screening Bipolar Disorders Shaila Misri, M.D. in Emergency Department Patients in Latin‑American NR9‑46 Countries Use of Adjunctive L‑methylfolate Ruby C. Castilla-Puentes, M.D., D.P.H. as Personalized Therapy in SSRI‑Resistant Major Depressive Disorder George Papakostas, M.D.

165th Annual Meeting 215 NR10‑06 NR10‑15 NR10‑23 The Ohio Army National Guard Rates and Time Course of Home Treatment for the Acutely Mental Health Initiative: Extrapyramidal Symptoms: Mentally Ill in Rural Southern Prevalence of DSM‑IV Disorders A Comparison of Oral and Germany as an Alternative Marijo Tamburrino, M.D. Long‑Acting Intramuscular to Inpatient Treatment – An (LAI) Paliperidone Randomized Economic Analysis NR10‑07 Controlled Studies Karel Frasch, M.D. Shoplifting Behavior in a Srihari Gopal, M.D. NR10‑24 Group of Elderly Patients in a NR10‑16 Psychiatric Outpatient Service A Statewide Telepsychiatry Matt Robillard, M.D. NO Axis I Diagnosis in Patients Program to Improve Access, Hospitalized Due to a Suicide Affordability and Quality Care NR10‑08 Attempt or Crisis Meera Narasimhan, M.D. General Practitioner’s Amresh Shrivastava, M.D. NR10‑25 Satisfaction With the NR10‑17 Implementation of a C‑L Giving Bad News: Comparing Psychiatry Service in ULSM, Risk of Development of First and Third Year Medical Portugal Osteoporosis Due to Depression Student Skills Using Filipa R. Silva, M.D in the Elderly Individuals: A Standardized Patients Literature Review Kristi Williams, M.D. NR10‑09 Umesh Vyas, M.D. NR10‑26 Profile and Impact of Physician NR10‑18 Assistants in Psychiatry Can Perceptions About Sheila Mauldin Variables Associated With Falls Psychiatrists Change? A Study Among Psychiatric Inpatients: Amongst Medical Students in A NR10‑10 The Institute of Living Falls Psychiatry Rotation Intervention Initiative Factors Associated With Rathi Mahendran, M.B.B.S Re‑Admission to a Psychiatric Ellen Blair, B.S.N. NR10‑27 Unit NR10‑19 Cheryl Ann Kennedy, M.D. An Approach to Improve Suicide Rates and Its Monitoring for Metabolic NR10‑11 Relationship With Quality of Life Syndrome in Patients Treated Indicators With Antipsychotics, a Quality Stigma Experiences of Combat Improvement Project Follow‑Up Veterans With PTSD From Iraq Jaime Santander, M.D. and Afghanistan Wars Deepa Hasija, M.D. NR10‑20 Dinesh Mittal, M.D. NR10‑28 The Confirmatory Factor

NR10‑12 Analysis of the Suicide Trigger The Power of Expectation Bias Scale (STS‑3): A Measure of a The Impact of Hospitalists on Janet Williams, D.S.W. Hypothesized Suicide Trigger Adverse Incidents in Acute State NR10‑29 Psychiatry: A Study of 5019 Admissions in Norfolk, UK From Zimri Yaseen, M.D. A Quality Improvement Project 2002‑2010 Assessing the Repetition NR10‑21 Julian Beezhold, M.D. of Laboratory Testing in Improving the Care of Patients Patients Admitted Through the TUESDAY, MAY 8

NEW RESEARCH NR10‑13 With Psychiatric Disabilities Psychiatric Emergency Room in the Community With Impact of Coverage Policies on Deepa Hasija, M.D. Proactive Strategies to Promote Patient Access to Paliperidone Treatment Adherence NR10‑30 Palmitate Margaret Hendriks, B.S.N. Cynthia Mueller, M.S. PRO Depression Scale Development: A New NR10‑22 NR10‑14 Depression Scale, the Impact of a Coordinated, Rosenberg Mood Scale Managed Care Cost Savings Community-Based, Behavioral Associated With the Use of Long Leon Rosenberg, M.D. Health, Crisis System of Care on Acting Injectable Formulations the Acute Psychiatric Admission NR10‑31 of Antipsychotic Agents in Rate From a Specialized Schizophrenia Predictors of Suicidal Ideation Behavior Jay Lin, Ph.D. in a Prospective Study of Body Kathleen Crapanzano, M.D. Dysmorphic Disorder Katharine A. Phillips, M.D.

216 www.psychiatry.org NR10‑32 NR10‑37 NR10‑42 Gender Differences in Body Efficacy Expectations are Childhood Trauma, Attachment Dysmorphic Disorder Associated With Risk of New Style, and Depression in Young Himanshu Tyagi, M.D. Onset PTSD in New Jersey Adult Women National Guard Troops Jena Bobish, B.A. NR10‑33 Donald Ciccone, Ph.D. NR10‑43 Traumatic Loss in Hurricane NR10‑38 Survivors: Heart Rate Variability A Virtual Study Design (HRV) Changes in Depression, Trauma and Mental Illness to Reduce “Real World” Not PTSD Among African American Male Challenges of a Treatment Phebe Tucker, M.D. in Juvenile Detention Resistant Depression Study in a Kenneth Rogers, M.D. Managed Care Setting NR10‑34 Bryce Kasuba, M.A. NR10‑39 Stress Indicators in the Skeletal NR10‑44 Remains of a Late Post‑Classic Factors Deteriorating Mexica Population Depression in Mothers Relationship of Impulsivity and Jacqueline Cortes, M.D. With Children in Social Support to Number and Separation‑Individuation Period Severity of Suicide Attempts in NR10‑35 Hyungin Choi, M.D. Bipolar Disorder Quantification of the Permanent Deimante McClure, B.A. NR10‑40 Impairment Due to Mental NR10‑45 and Behavioral Disorder in Incidence and Risk Factors for Individuals With Poly‑Trauma, Pregnancy Among Adolescent Factors Impacting Medication According to AMA Guides 6th Females in Colombia: A Refusal and Adherence in Edition Population‑Based Cohort Study Pregnant Depressed Women: Armando S. Miciano, M.D. Wilma Castilla-Puentes, M.D., D.P.H. Maternal and Newborn Outcomes NR10‑36 NR10‑41 Deirdre Ryan, M.D. Predictive Value of 4 Different Continuous Expression of NR10‑46 Definitions of Subthreshold GSK‑3ß in the Hippocampal Post‑Traumatic Stress Disorder: Dentate Gyrus Induces Systematic Literature Review Relationship to Severity of Prodepressant‑Like Effects and of Economic Costs in the US Symptoms and Functioning Increases Sensitivity to Chronic of Major Depressive Disorder John Kasckow, M.D. Mild Stress in Adults Who Are Inadequate Kerang Zhang, M.D. Responders to Initial Treatment Eduard Vieta, M.D. NEW RESEARCH NEW TUESDAY, MAY 8 MAY TUESDAY, American Psychiatric Association CALL FOR ABSTRACTS NEW SUBMISSION SITE FOR 2013! Don’t miss the opportunity to submit your proposed presentation for a symposium, workshop, course, and/or other scienti c session

Reena Young Bev Lloyd-Roberts

Visit our website on June 15th for further information regarding submissions. www.psychiatry.org/program

165th Annual Meeting 217 APP Advances In Sessions at the 165th APA Annual Meeting Advances In Sessions provide meeting attendees with an opportunity to gain in-depth information on clinical and research advances in specific areas of psychiatry. These 3-hour didactic lecture series feature well-known experts presenting clinical and research findings and allowing time for questions and answers. No registration is necessary for these sessions.

Advances in Addiction Advances in Motivational Psychopharmacology Interviewing Sunday, May 6 • 8:00am-11:00am Monday, May 7 • 2:00pm-5:00pm Henry Kranzler, M.D., and Petros Levounis, M.D., M.A., and Domenic A. Ciraulo, M.D. Bachaar Arnout, M.D.

Advances in PTSD Advances in Child Sunday, May 6 • 12:30pm-4:00pm Psychopharmacology David M. Benedek, M.D., and Tuesday, May 8 • 9:00am-12:00pm Gary M. Wynn, M.D. Robert Findling, M.D., and Molly McVoy, M.D.

Advances in Mentalization- Based Therapy Monday, May 7 • 9:00am-12:00pm APP Bookstore Anthony Bateman, M.D., and Be sure to stop by the APP bookstore to check Peter Fonagy, Ph.D. out APP’s latest selections, from the newest textbooks, clinical manuals, and journals, to electronic products for your mobile devices.

BOOKSTORE HOURS www.appi.org Saturday, May 5 9:00am - 4:00pm Email: [email protected] Sunday, May 6 10:00am - 4:00pm Monday, May 7 10:00am - 4:00pm Phone: 1-800-368-5777 Tuesday, May 8 10:00am - 4:00pm The First and Last Word in Psychiatry

Find us on Facebook and Twitter. Priority Code AH1220 New Research Topic Index New Research Topic Index This is for themain TOC. Keep on pasteboard with 2 This is for theNR TOC. Keep on pasteboard with 2 points points overlap into live area. overlap into live area.

2012 ANNUAL MEETING NEW RESEARCH: TOPIC INDEX

Addiction Psychiatry/Substance Use Geriatric Psychiatry Disorders NR3-52 to NR3-55, NR8-24 to NR8-26 NR3-02, NR3-03, NR3-06, NR3-07, NR3-09, NR4-25, NR4-57, NR5-37, NR7-02 to NR7-04, NR7-06 to NR7-16 Health Services Research NR3-56 to NR3-58, NR7-05, NR10-08 to NR10-12 Adjustment Disorders NR3-10, NR4-01 Impulse Control Disorders NR3-59 to NR3-63 Anxiety Disorders NR3-11 to NR3-19, NR4-02 to NR4-10 Individual Psychotherapies NR7-47 Attention Spectrum Disorders NR4-11 to NR4-22 Integrated Care NR3-64 to NR3-67, NR7-49 to NR7-52, NR8-29 Biological Psychiatry and Neuroscience NR3-21 to NR3-23, NR6-57, NR7-01, NR9-01 to NR9-09 Intellectual and Developmental Disabilities NR5-56 Brain Imaging NR3-24, NR9-10 to NR9-13 Lesbian/Gay/Bisexual/Transgender Issues NR8-27, NR8-28 Child and Adolescent Psychiatry NR3-25 to NR3-33, NR5-68, NR6-58, NR8-01 to NR8- Managed Care and Health Care Financing 07, NR8-10 to NR8-21, NR8-46 NR3-69, NR3-70, NR10-13, NR10-14 Cognitive Disorders (Delirium, Dementia, etc.) Mood Disorders NR3-34 to NR3-36, NR9-14, NR9-15 NR3-71, NR4-23, NR4-24, NR4-26 to NR4-54, NR5-01 to NR5-10, NR5-71, NR6-60, NR8-09, NR8-38 to NR8- Community Service 45, NR9-21, NR9-27 to NR9-51, NR10-02, NR10-41 to NR2-01 to NR2-06 NR10-46 Computers, Technology, Internet, and Related Neuropsychiatry NR3-37 to NR3-40, NR7-19, NR10-01 NR4-56, NR5-11 to NR5-13, NR9-22 to NR9-26 Creativity and the Arts Other Somatic Therapies NR7-48 NR5-14, NR7-57 Cross-Cultural and Minority Issues Pain Management NR5-34, NR7-43 to NR7-46 NR7-58 Curriculum Development and Educational Patient-Oriented and Epidemiology NR2-08 to NR2-25 NR1-01 to NR1-71 Diagnostic Issues Patient Safety and Suicide NR3-41, NR10-03 NR5-15 to NR5-18, NR10-15 to NR10-20 Eating Disorders Personality Disorders NR3-42, NR8-08, NR8-22 NR5-19, NR6-55, NR6-56 Epidemiology Practice Management NR3-43 to NR3-46, NR10-04 to NR10-06 NR10-21 Forensic Psychiatry Psychiatric Administration and Services: NR3-47, NR3-48, NR10-07 Public, Private, and University NR3-01, NR10-22 to NR10-24 Gender Issues NR8-23 Psychiatric Education NR3-08, NR5-21, NR10-25 to NR10-27 Genetics NR3-49 to NR3-50, NR9-16 to NR9-20

165th Annual Meeting 219 NEW RESEARCH: TOPIC INDEX

Psychopharmacology Sleep Disorders NR3-04, NR5-20, NR5-22 to NR5-28, NR5-70, NR7-17, NR3-68, NR5-55, NR5-57, NR6-59, NR8-35 to NR8-37 NR7-18, NR7-20 to NR7-37, NR8-33 Social and Community Psychiatry Psychosocial and/or Biomedical Research NR5-58, NR5-59, NR7-53 to NR7-56 NR2-26 to NR2-56 Somatoform Disorders Psychosomatic Medicine NR5-60, NR10-31, NR10-32 NR3-05, NR4-55, NR5-29 to NR5-33, NR5-35, NR5-36, Stigma/Advocacy NR8-30 to NR8-32, NR8-34 NR5-61, NR7-59 Religion, Spirituality, and Psychiatry Stress NR5-38 NR5-62, NR10-33, NR10-34 Research Issues Treatment Techniques and Outcome Studies NR5-39, NR10-28 to NR10-30 NR5-63 to NR5-66, NR7-38 to NR7-42 Resident and Medical Student Concerns Violence, Trauma and Victimization NR5-40, NR5-41 NR5-67, NR10-35 to NR10-38 Schizophrenia and Other Psychotic Disorders Women’s Health Issues NR5-42 to NR5-54, NR6-01 to NR6-54 NR5-69, NR10-39, NR10-40

INTRODUCING THE APA ANNUAL MEETING APP! COMING SOON!

Get 24-hour access to unique, • Interactive scientific program on-the-go meeting information, & event schedules maps, and networking. Stay • Customizable calendar tuned for download instructions & itinerary builder and get ready for a completely • Exhibitor listing with interactive meeting experience! interactive booth map • Social media interaction • Meeting alerts

Supported by Sunovion Pharmaceuticals Inc., the APA Annual Meeting App is compatible with iPhone, BlackBerry, and Android smartphones.

220 www.psychiatry.org